1	Lung	NN	O	lung	nn	2	SENT_1	[p1l881t82r942b108],
2	Cancer	NN	O	cancer	_	0	SENT_1	[p1l950t82r1036b103],
3	64	CD	NUMBER	64	number	4	SENT_1	[p1l1044t82r1074b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1083t81r1166b108],
5	2009	CD	DATE	2009	dep	4	SENT_1	[p1l1083t81r1166b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1083t81r1166b108],
7	314-318	CD	NUMBER	314-318	dep	2	SENT_1	[p1l1175t82r1278b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l778t189r914b214],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l927t189r985b214],
3	available	JJ	O	available	amod	2	SENT_2	[p1l997t189r1133b214],
4	at	IN	O	at	_	0	SENT_2	[p1l1145t192r1172b214],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1184t189r1393b214],

1	Lung	NN	O	lung	nn	2	SENT_3	[p1l925t290r1056b345],
2	Cancer	NN	O	cancer	_	0	SENT_3	[p1l1074t289r1260b333],

1	P	NN	O	p	_	0	SENT_4	[p1l37t375r126b397],
2	g	NN	O	g	dep	1	SENT_4	[p1l37t375r126b397],
3	+	CC	O	+	_	0	SENT_4	[p1l37t375r126b397],
4	~	NN	O	~	dep	1	SENT_4	[p1l141t377r212b397],
5	.	.	O	.	_	0	SENT_4	[p1l141t377r212b397],

1	_	SYM	O	_	dep	3	SENT_5	[p1l141t377r212b397],
2	-	:	O	-	_	0	SENT_5	[p1l141t377r212b397],
3	mi	FW	O	mi	_	0	SENT_5	[p1l141t377r212b397],
4	.	.	O	.	_	0	SENT_5	[p1l141t377r212b397],

1	.	.	O	.	_	0	SENT_6	[p1l224t373r253b396],

1	ELSEVIER	NNP	O	ELSEVIER	nn	3	SENT_7	[p1l15t418r249b454],
2	journal	NN	O	journal	nn	3	SENT_7	[p1l575t419r707b450],
3	homepage	NN	O	homepage	_	0	SENT_7	[p1l729t419r933b450],
4	:	:	O	:	_	0	SENT_7	[p1l729t419r933b450],
5	www	NN	O	www	dep	3	SENT_7	[p1l949t419r1594b450],
6	.	.	O	.	_	0	SENT_7	[p1l949t419r1594b450],

1	e	LS	O	e	dep	3	SENT_8	[p1l949t419r1594b450],
2	|	SYM	O	|	dep	3	SENT_8	[p1l949t419r1594b450],
3	sevier.com/locate/Iungcan	NN	O	sevier.com/locate/iungcan	_	0	SENT_8	[p1l949t419r1594b450],

1	Prospective	JJ	O	prospective	dep	118	SENT_9	[p1l6t569r309b624],
2	phase	NN	O	phase	dep	118	SENT_9	[p1l329t568r481b624],
3	II	CD	NUMBER	ii	dep	118	SENT_9	[p1l500t571r531b613],
4	study	NN	O	study	dep	118	SENT_9	[p1l551t568r697b624],
5	of	IN	O	of	dep	118	SENT_9	[p1l714t568r769b613],
6	geﬁtinib	NN	O	geﬁtinib	dep	118	SENT_9	[p1l780t568r1001b624],
7	in	IN	O	in	dep	118	SENT_9	[p1l1020t569r1069b613],
8	non	JJ	O	non	dep	118	SENT_9	[p1l1087t568r1355b613],
9	—	JJ	O	—	dep	118	SENT_9	[p1l1087t568r1355b613],
10	small	JJ	O	small	dep	118	SENT_9	[p1l1087t568r1355b613],
11	cell	NN	O	cell	dep	118	SENT_9	[p1l1374t568r1463b613],
12	lung	NN	O	lung	dep	118	SENT_9	[p1l1482t568r1599b624],
13	cancer	NN	O	cancer	dep	118	SENT_9	[p1l1616t581r1790b613],
14	with	IN	O	with	dep	118	SENT_9	[p1l1805t568r1927b613],
15	epidermal	JJ	O	epidermal	dep	118	SENT_9	[p1l6t639r275b695],
16	growth	NN	O	growth	dep	118	SENT_9	[p1l293t639r484b695],
17	factor	NN	O	factor	dep	118	SENT_9	[p1l503t639r655b684],
18	receptor	NN	O	receptor	dep	118	SENT_9	[p1l672t646r894b695],
19	gene	NN	O	gene	dep	118	SENT_9	[p1l910t652r1034b695],
20	mutations	NNS	O	mutation	dep	118	SENT_9	[p1l1053t640r1322b684],
21	l	NN	O	l	dep	118	SENT_9	[p1l8t742r112b786],
22	(	CD	NUMBER	(	dep	118	SENT_9	[p1l8t742r112b786],
23	enji	NN	O	enjus	dep	118	SENT_9	[p1l8t742r112b786],
24	Sugio	NN	ORGANIZATION	sugio	dep	118	SENT_9	[p1l127t742r240b786],
25	3	CD	NUMBER	3	dep	118	SENT_9	[p1l248t744r303b783],
26	*	NN	O	*	dep	118	SENT_9	[p1l248t744r303b783],
27	,	,	O	,	_	0	SENT_9	[p1l248t744r303b783],
28	Hidetaka	NNP	PERSON	Hidetaka	dep	118	SENT_9	[p1l319t742r504b777],
29	Uramoto	NNP	PERSON	Uramoto	dep	118	SENT_9	[p1l518t744r698b777],
30	*	NN	O	*	dep	118	SENT_9	[p1l706t744r733b783],
31	1	CD	NUMBER	1	dep	118	SENT_9	[p1l706t744r733b783],
32	,	,	O	,	_	0	SENT_9	[p1l706t744r733b783],
33	Takamitsu	NNP	PERSON	Takamitsu	dep	118	SENT_9	[p1l747t742r962b777],
34	Onitsuka	NNP	PERSON	Onitsuka	dep	118	SENT_9	[p1l977t742r1162b777],
35	*	NN	O	*	dep	118	SENT_9	[p1l1170t744r1197b783],
36	1	CD	NUMBER	1	dep	118	SENT_9	[p1l1170t744r1197b783],
37	,	,	O	,	_	0	SENT_9	[p1l1170t744r1197b783],
38	Makiko	NNP	PERSON	Makiko	dep	118	SENT_9	[p1l1212t742r1365b777],
39	Mizukami	NNP	PERSON	Mizukami	dep	118	SENT_9	[p1l1380t742r1588b777],
40	3	CD	NUMBER	3	dep	118	SENT_9	[p1l1596t744r1623b783],
41	,	,	O	,	_	0	SENT_9	[p1l1596t744r1623b783],
42	Yoshinobu	NNP	PERSON	Yoshinobu	dep	118	SENT_9	[p1l1637t742r1856b777],
43	Ichiki	NNP	PERSON	Ichiki	dep	118	SENT_9	[p1l1871t742r1983b777],
44	*	NN	O	*	dep	118	SENT_9	[p1l1991t744r2018b783],
45	1	CD	NUMBER	1	dep	118	SENT_9	[p1l1991t744r2018b783],
46	,	,	O	,	_	0	SENT_9	[p1l1991t744r2018b783],
47	Masakazu	NNP	PERSON	Masakazu	dep	118	SENT_9	[p1l8t795r215b831],
48	Sugaya	NNP	PERSON	Sugaya	dep	118	SENT_9	[p1l230t797r373b840],
49	a	DT	O	a	dep	118	SENT_9	[p1l381t797r408b837],
50	,	,	O	,	_	0	SENT_9	[p1l381t797r408b837],
51	Manabu	NNP	PERSON	Manabu	dep	118	SENT_9	[p1l423t795r592b831],
52	Yasuda	NNP	PERSON	Yasuda	dep	118	SENT_9	[p1l604t795r751b831],
53	3	CD	NUMBER	3	dep	118	SENT_9	[p1l758t797r785b837],
54	,	,	O	,	_	0	SENT_9	[p1l758t797r785b837],
55	Mitsuhiro	NNP	PERSON	Mitsuhiro	dep	118	SENT_9	[p1l801t795r1004b831],
56	Takenoyama	NNP	PERSON	Takenoyama	dep	118	SENT_9	[p1l1017t795r1278b840],
57	3	CD	NUMBER	3	dep	118	SENT_9	[p1l1286t797r1313b837],
58	,	,	O	,	_	0	SENT_9	[p1l1286t797r1313b837],
59	Tsunehiro	NNP	PERSON	Tsunehiro	dep	118	SENT_9	[p1l1326t795r1533b831],
60	Oyama	NNP	PERSON	Oyama	dep	118	SENT_9	[p1l1548t797r1692b840],
61	'	POS	O	'	_	0	SENT_9	[p1l1699t790r1728b837],
62	3	CD	NUMBER	3	dep	118	SENT_9	[p1l1699t790r1728b837],
63	,	,	O	,	_	0	SENT_9	[p1l1699t790r1728b837],
64	Takeshi	NNP	PERSON	Takeshi	dep	118	SENT_9	[p1l6t852r162b887],
65	Hanagiria	NNP	PERSON	Hanagiria	dep	118	SENT_9	[p1l177t852r389b896],
66	,	,	O	,	_	0	SENT_9	[p1l177t852r389b896],
67	Kosei	NNP	ORGANIZATION	Kosei	dep	118	SENT_9	[p1l404t852r513b887],
68	Yasumotoa	NNP	ORGANIZATION	Yasumotoa	dep	118	SENT_9	[p1l526t854r754b887],
69	3	CD	DURATION	3	dep	118	SENT_9	[p1l7t929r15b940],
70	Second	NNP	ORGANIZATION	Second	dep	118	SENT_9	[p1l22t928r107b950],
71	Department	NNP	ORGANIZATION	Department	dep	118	SENT_9	[p1l115t930r262b955],
72	of	IN	ORGANIZATION	of	dep	118	SENT_9	[p1l269t928r295b955],
73	Surgery	NNP	ORGANIZATION	Surgery	dep	118	SENT_9	[p1l298t929r394b955],
74	,	,	O	,	_	0	SENT_9	[p1l298t929r394b955],
75	School	NNP	ORGANIZATION	School	dep	118	SENT_9	[p1l403t928r481b950],
76	of	IN	ORGANIZATION	of	dep	118	SENT_9	[p1l489t928r515b955],
77	Medicine	NNP	ORGANIZATION	Medicine	dep	118	SENT_9	[p1l518t928r633b953],
78	,	,	O	,	_	0	SENT_9	[p1l518t928r633b953],
79	University	NNP	ORGANIZATION	University	dep	118	SENT_9	[p1l644t929r765b955],
80	of	IN	ORGANIZATION	of	dep	118	SENT_9	[p1l774t928r800b955],
81	Occupational	NNP	ORGANIZATION	Occupational	dep	118	SENT_9	[p1l804t928r963b955],
82	and	CC	ORGANIZATION	and	dep	118	SENT_9	[p1l971t928r1015b950],
83	Environmental	NNP	ORGANIZATION	Environmental	dep	118	SENT_9	[p1l1023t928r1201b950],
84	Health	NNP	ORGANIZATION	Health	dep	118	SENT_9	[p1l1209t928r1293b953],
85	,	,	O	,	_	0	SENT_9	[p1l1209t928r1293b953],
86	1-1	CD	NUMBER	1-1	dep	118	SENT_9	[p1l1306t929r1340b950],
87	Iseigaoka	NNP	O	Iseigaoka	dep	118	SENT_9	[p1l1351t928r1469b955],
88	,	,	O	,	_	0	SENT_9	[p1l1351t928r1469b955],
89	Yahatanishi	NNP	O	Yahatanishi	dep	118	SENT_9	[p1l1479t928r1666b953],
90	—	CD	NUMBER	—	dep	118	SENT_9	[p1l1479t928r1666b953],
91	l	NN	O	l	dep	118	SENT_9	[p1l1479t928r1666b953],
92	<	JJR	O	<	dep	118	SENT_9	[p1l1479t928r1666b953],
93	u	CD	NUMBER	u	dep	118	SENT_9	[p1l1479t928r1666b953],
94	,	,	O	,	_	0	SENT_9	[p1l1479t928r1666b953],
95	Kitakyushu	NNP	LOCATION	Kitakyushu	dep	118	SENT_9	[p1l1675t928r1810b955],
96	807-8555	CD	NUMBER	807-8555	dep	118	SENT_9	[p1l1819t929r1940b953],
97	,	,	O	,	_	0	SENT_9	[p1l1819t929r1940b953],
98	japan	JJ	LOCATION	japan	dep	118	SENT_9	[p1l1945t930r2017b955],
99	"	``	O	"	dep	118	SENT_9	[p1l7t957r17b972],
100	Department	NNP	ORGANIZATION	Department	dep	118	SENT_9	[p1l24t962r171b987],
101	of	IN	ORGANIZATION	of	dep	118	SENT_9	[p1l178t960r204b987],
102	Environmental	NNP	ORGANIZATION	Environmental	dep	118	SENT_9	[p1l207t960r385b982],
103	Health	NNP	ORGANIZATION	Health	dep	118	SENT_9	[p1l393t960r477b985],
104	,	,	O	,	_	0	SENT_9	[p1l393t960r477b985],
105	School	NNP	ORGANIZATION	School	dep	118	SENT_9	[p1l486t960r564b982],
106	of	IN	ORGANIZATION	of	dep	118	SENT_9	[p1l572t960r598b987],
107	Medicine	NNP	ORGANIZATION	Medicine	dep	118	SENT_9	[p1l601t960r716b985],
108	,	,	O	,	_	0	SENT_9	[p1l601t960r716b985],
109	University	NNP	ORGANIZATION	University	dep	118	SENT_9	[p1l727t961r848b987],
110	of	IN	ORGANIZATION	of	dep	118	SENT_9	[p1l857t960r883b987],
111	Occupational	NNP	ORGANIZATION	Occupational	dep	118	SENT_9	[p1l887t960r1046b987],
112	and	CC	ORGANIZATION	and	dep	118	SENT_9	[p1l1054t960r1099b982],
113	Environmental	NNP	ORGANIZATION	Environmental	dep	118	SENT_9	[p1l1106t960r1285b982],
114	Health	NNP	ORGANIZATION	Health	dep	118	SENT_9	[p1l1292t960r1377b985],
115	,	,	O	,	_	0	SENT_9	[p1l1292t960r1377b985],
116	Kitakyushu	NNP	LOCATION	Kitakyushu	dep	118	SENT_9	[p1l1386t960r1527b987],
117	,	,	O	,	_	0	SENT_9	[p1l1386t960r1527b987],
118	japan	NN	LOCATION	japan	_	0	SENT_9	[p1l1532t962r1604b987],

1	ARTICLE	NN	O	article	_	0	SENT_10	[p1l6t1096r232b1118],
2	INFO	NN	O	info	nn	3	SENT_10	[p1l277t1096r400b1118],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_10	[p1l690t1096r962b1118],

1	Article	NNP	O	Article	nn	2	SENT_11	[p1l6t1176r86b1198],
2	history	NN	O	history	_	0	SENT_11	[p1l94t1176r184b1203],
3	:	:	O	:	_	0	SENT_11	[p1l94t1176r184b1203],
4	Background	NN	O	background	dep	2	SENT_11	[p1l6t1224r176b1254],
5	:	:	O	:	_	0	SENT_11	[p1l6t1224r176b1254],
6	This	DT	O	this	det	7	SENT_11	[p1l187t1224r245b1248],
7	study	NN	O	study	nsubj	9	SENT_11	[p1l258t1224r335b1254],
8	prospectively	RB	O	prospectively	advmod	9	SENT_11	[p1l346t1224r536b1254],
9	assessed	VBD	O	assess	dep	4	SENT_11	[p1l547t1224r668b1248],
10	the	DT	O	the	det	11	SENT_11	[p1l679t1224r724b1248],
11	efﬁcacy	NN	O	efﬁcacy	dobj	9	SENT_11	[p1l736t1224r844b1254],
12	of	IN	O	of	_	0	SENT_11	[p1l855t1224r884b1248],
13	geﬁtinib	NN	O	geﬁtinib	prep_of	11	SENT_11	[p1l891t1224r1009b1254],
14	and	CC	O	and	_	0	SENT_11	[p1l1021t1224r1072b1248],
15	the	DT	O	the	det	17	SENT_11	[p1l1083t1224r1128b1248],
16	survival	NN	O	survival	nn	17	SENT_11	[p1l1140t1224r1250b1248],
17	beneﬁt	NN	O	beneﬁt	dobj	9	SENT_11	[p1l1261t1224r1361b1248],
18	for	IN	O	for	_	0	SENT_11	[p1l1372t1224r1412b1248],
19	nonReceived	JJ	O	nonreceived	amod	20	SENT_11	[p1l1422t1231r1488b1248, p1l7t1258r118b1279],
20	29	CD	DATE	29	prep_for	17	SENT_11	[p1l126t1259r156b1279],
21	July	NNP	DATE	July	tmod	9	SENT_11	[p1l162t1258r213b1285],
22	2008	CD	DATE	2008	num	21	SENT_11	[p1l221t1259r283b1279],
23	Received	VBN	O	receive	dep	9	SENT_11	[p1l7t1293r118b1315],
24	in	IN	O	in	_	0	SENT_11	[p1l127t1294r150b1315],
25	revised	JJ	O	revised	amod	26	SENT_11	[p1l159t1293r249b1315],
26	form	NN	O	form	prep_in	23	SENT_11	[p1l258t1293r318b1315],
27	17	CD	DATE	17	num	28	SENT_11	[p1l9t1330r34b1350],
28	September	NNP	DATE	September	dep	26	SENT_11	[p1l44t1329r180b1356],
29	2008	CD	DATE	2008	num	28	SENT_11	[p1l188t1330r250b1351],
30	Accepted	JJ	O	accepted	amod	31	SENT_11	[p1l6t1365r121b1392],
31	20	CD	DATE	20	dep	28	SENT_11	[p1l130t1366r160b1386],
32	September	NNP	DATE	September	tmod	23	SENT_11	[p1l169t1365r306b1392],
33	2008	CD	DATE	2008	num	32	SENT_11	[p1l314t1366r376b1386],

1	small	JJ	O	small	amod	4	SENT_12	[p1l7t1482r82b1506],
2	cell	NN	O	cell	nn	4	SENT_12	[p1l92t1482r139b1506],
3	lung	NN	O	lung	nn	4	SENT_12	[p1l150t1482r212b1512],
4	cancer	NN	O	cancer	_	0	SENT_12	[p1l221t1489r314b1506],
5	(	CD	NUMBER	(	num	8	SENT_12	[p1l323t1482r436b1512],
6	NSCLC	NN	O	nsclc	nn	8	SENT_12	[p1l323t1482r436b1512],
7	)	CD	NUMBER	)	num	8	SENT_12	[p1l323t1482r436b1512],
8	patients	NNS	O	patient	dep	4	SENT_12	[p1l446t1482r559b1512],
9	with	IN	O	with	_	0	SENT_12	[p1l569t1482r634b1506],
10	epidermal	JJ	O	epidermal	amod	13	SENT_12	[p1l644t1482r787b1512],
11	growth	NN	O	growth	nn	13	SENT_12	[p1l797t1482r899b1512],
12	factor	NN	O	factor	nn	13	SENT_12	[p1l909t1482r990b1506],
13	receptor	NN	O	receptor	prep_with	8	SENT_12	[p1l999t1485r1118b1512],
14	(	CD	NUMBER	(	num	17	SENT_12	[p1l1127t1482r1222b1512],
15	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_12	[p1l1127t1482r1222b1512],
16	)	NN	O	)	nn	17	SENT_12	[p1l1127t1482r1222b1512],
17	mutations	NNS	O	mutation	dep	8	SENT_12	[p1l1232t1482r1383b1506],
18	.	.	O	.	_	0	SENT_12	[p1l1232t1482r1383b1506],

1	Method	NN	O	method	_	0	SENT_13	[p1l6t1522r119b1546],
2	:	:	O	:	_	0	SENT_13	[p1l6t1522r119b1546],
3	Patients	NNS	O	patient	dep	1	SENT_13	[p1l127t1522r239b1546],
4	with	IN	O	with	prep	3	SENT_13	[p1l246t1522r311b1546],
5	either	CC	O	either	dep	4	SENT_13	[p1l318t1522r402b1546],
6	recurrent	JJ	O	recurrent	amod	7	SENT_13	[p1l409t1525r541b1546],
7	disease	NN	O	disease	conj	4	SENT_13	[p1l548t1522r650b1546],
8	after	IN	O	after	_	0	SENT_13	[p1l657t1522r723b1546],
9	undergoing	VBG	O	undergo	prepc_after	4	SENT_13	[p1l729t1522r892b1552],
10	surgery	NN	O	surgery	nn	14	SENT_13	[p1l899t1529r1005b1552],
11	or	CC	O	or	_	0	SENT_13	[p1l1011t1529r1040b1546],
12	advanced	JJ	O	advanced	conj_or	10	SENT_13	[p1l1047t1522r1180b1546],
13	NSCLC	NN	O	nsclc	nn	14	SENT_13	[p1l1188t1523r1278b1546],
14	disease	NN	O	disease	dobj	9	SENT_13	[p1l1285t1522r1387b1546],
15	(	CD	NUMBER	(	num	16	SENT_13	[p1l1395t1522r1451b1552],
16	lllB	NN	O	lllb	dep	14	SENT_13	[p1l1395t1522r1451b1552],
17	or	CC	O	or	_	0	SENT_13	[p1l1459t1529r1488b1546],
18	IV	CD	NUMBER	iv	num	19	SENT_13	[p1l7t1562r46b1592],
19	)	NN	O	)	conj_or	14	SENT_13	[p1l7t1562r46b1592],
20	which	WDT	O	which	nsubj	21	SENT_13	[p1l54t1562r141b1586],
21	demonstrated	VBD	O	demonstrate	rcmod	19	SENT_13	[p1l148t1562r346b1586],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_13	[p1l355t1563r428b1586],
23	mutations	NNS	O	mutation	nsubj	25	SENT_13	[p1l435t1562r578b1586],
24	were	VBD	O	be	cop	25	SENT_13	[p1l586t1569r656b1586],
25	eligible	JJ	O	eligible	ccomp	21	SENT_13	[p1l664t1562r766b1592],
26	for	IN	O	for	_	0	SENT_13	[p1l774t1562r814b1586],
27	this	DT	O	this	det	28	SENT_13	[p1l820t1562r872b1586],
28	study	NN	O	study	prep_for	25	SENT_13	[p1l880t1562r963b1592],
29	.	.	O	.	_	0	SENT_13	[p1l880t1562r963b1592],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_14	[p1l971t1563r1045b1586],
2	mutations	NNS	O	mutation	nsubjpass	7	SENT_14	[p1l1052t1562r1195b1586],
3	in	IN	O	in	_	0	SENT_14	[p1l1204t1562r1230b1586],
4	exons	NNS	O	exon	prep_in	2	SENT_14	[p1l1238t1569r1317b1586],
5	19-21	CD	DATE	19-21	dep	4	SENT_14	[p1l1327t1563r1406b1586],
6	were	VBD	O	be	auxpass	7	SENT_14	[p1l1417t1569r1487b1586],
7	examined	VBN	O	examine	_	0	SENT_14	[p1l7t1602r153b1626],
8	.	.	O	.	_	0	SENT_14	[p1l7t1602r153b1626],

1	The	DT	O	the	det	2	SENT_15	[p1l163t1602r214b1626],
2	patients	NNS	O	patient	nsubjpass	7	SENT_15	[p1l225t1602r339b1632],
3	with	IN	O	with	_	0	SENT_15	[p1l349t1602r415b1626],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_15	[p1l425t1603r499b1626],
5	mutations	NNS	O	mutation	prep_with	2	SENT_15	[p1l508t1602r652b1626],
6	were	VBD	O	be	auxpass	7	SENT_15	[p1l663t1609r732b1626],
7	enrolled	VBN	O	enrol	_	0	SENT_15	[p1l743t1602r860b1626],
8	in	IN	O	in	_	0	SENT_15	[p1l871t1602r897b1626],
9	this	DT	O	this	det	10	SENT_15	[p1l907t1602r959b1626],
10	study	NN	O	study	prep_in	7	SENT_15	[p1l970t1602r1048b1632],
11	after	IN	O	after	_	0	SENT_15	[p1l1058t1602r1124b1626],
12	obtaining	VBG	O	obtain	prepc_after	7	SENT_15	[p1l1134t1602r1269b1632],
13	their	PRP$	O	they	poss	15	SENT_15	[p1l1279t1602r1347b1626],
14	informed	VBN	O	inform	amod	15	SENT_15	[p1l1357t1602r1487b1626],
15	consent	NN	O	consent	dobj	12	SENT_15	[p1l686t1709r796b1730],
16	a	DT	DURATION	a	det	18	SENT_15	[p1l805t1713r819b1730],
17	second	JJ	DURATION	second	amod	18	SENT_15	[p1l829t1706r925b1730],
18	time	NN	O	time	tmod	12	SENT_15	[p1l935t1706r1006b1733],
19	,	,	O	,	_	0	SENT_15	[p1l935t1706r1006b1733],
20	and	CC	O	and	_	0	SENT_15	[p1l1016t1706r1067b1730],
21	they	PRP	O	they	nsubjpass	24	SENT_15	[p1l1076t1706r1138b1736],
22	were	VBD	O	be	auxpass	24	SENT_15	[p1l1147t1713r1216b1730],
23	thereafter	RB	O	thereafter	advmod	24	SENT_15	[p1l1225t1706r1366b1730],
24	treated	VBN	O	treat	conj_and	7	SENT_15	[p1l1374t1706r1474b1730],
25	with	IN	O	with	_	0	SENT_15	[p1l1483t1706r1548b1730],
26	geﬁtinib	NN	O	geﬁtinib	prep_with	24	SENT_15	[p1l1557t1706r1681b1736],
27	.	.	O	.	_	0	SENT_15	[p1l1557t1706r1681b1736],

1	gggordsi	NNS	O	gggordsus	nn	2	SENT_16	[p1l6t1730r130b1786],
2	Results	NNS	O	result	_	0	SENT_16	[p1l685t1745r788b1769],
3	:	:	O	:	_	0	SENT_16	[p1l685t1745r788b1769],
4	EGFR	NN	O	egfr	nn	5	SENT_16	[p1l800t1747r873b1769],
5	mutations	NNS	O	mutation	nsubjpass	7	SENT_16	[p1l884t1746r1027b1769],
6	were	VBD	O	be	auxpass	7	SENT_16	[p1l1038t1752r1107b1769],
7	detected	VBN	O	detect	dep	2	SENT_16	[p1l1119t1745r1239b1769],
8	in	IN	O	in	_	0	SENT_16	[p1l1251t1746r1277b1769],
9	20	CD	NUMBER	20	prep_in	7	SENT_16	[p1l1289t1747r1322b1769],
10	of	IN	O	of	_	0	SENT_16	[p1l1334t1745r1363b1769],
11	48	CD	NUMBER	48	num	12	SENT_16	[p1l1371t1746r1405b1769],
12	patients	NNS	O	patient	prep_of	9	SENT_16	[p1l1418t1746r1530b1775],
13	with	IN	O	with	_	0	SENT_16	[p1l1542t1745r1607b1769],
14	NSCLC	NN	LOCATION	nsclc	prep_with	12	SENT_16	[p1l1619t1747r1715b1773],
15	,	,	O	,	_	0	SENT_16	[p1l1619t1747r1715b1773],
16	and	CC	O	and	_	0	SENT_16	[p1l1727t1745r1778b1769],
17	19	CD	NUMBER	19	num	18	SENT_16	[p1l1791t1747r1821b1769],
18	patients	NNS	O	patient	nsubjpass	26	SENT_16	[p1l1833t1746r1946b1775],
19	were	VBD	O	be	auxpass	20	SENT_16	[p1l1957t1752r2026b1769],
20	enrolled	VBN	O	enrol	conj_and	7	SENT_16	[p1l2038t1745r2154b1769],
21	NSCLC	NNP	O	NSCLC	dobj	20	SENT_16	[p1l7t1802r87b1822],
22	onto	IN	O	onto	_	0	SENT_16	[p1l686t1788r749b1809],
23	this	DT	O	this	det	24	SENT_16	[p1l760t1785r810b1809],
24	study	NN	O	study	prep_onto	20	SENT_16	[p1l822t1785r900b1815],
25	and	CC	O	and	_	0	SENT_16	[p1l910t1785r961b1809],
26	treated	VBN	O	treat	conj_and	7	SENT_16	[p1l972t1785r1072b1809],
27	with	IN	O	with	_	0	SENT_16	[p1l1082t1785r1147b1809],
28	geﬁtinib	NN	O	geﬁtinib	prep_with	26	SENT_16	[p1l1157t1785r1281b1815],
29	.	.	O	.	_	0	SENT_16	[p1l1157t1785r1281b1815],

1	Seven	CD	NUMBER	seven	num	2	SENT_17	[p1l1292t1786r1374b1809],
2	patients	NNS	O	patient	nsubj	3	SENT_17	[p1l1385t1785r1498b1815],
3	had	VBD	O	have	_	0	SENT_17	[p1l1509t1785r1560b1809],
4	an	DT	O	a	det	7	SENT_17	[p1l1571t1792r1604b1809],
5	exon	NN	O	exon	nn	7	SENT_17	[p1l1615t1792r1681b1809],
6	19	CD	NUMBER	19	num	7	SENT_17	[p1l1693t1786r1723b1809],
7	deletion	NN	O	deletion	dobj	3	SENT_17	[p1l1734t1785r1856b1812],
8	,	,	O	,	_	0	SENT_17	[p1l1734t1785r1856b1812],
9	10	CD	NUMBER	10	nsubj	11	SENT_17	[p1l1869t1786r1899b1809],
10	had	VBD	O	have	aux	11	SENT_17	[p1l1910t1785r1961b1809],
11	l.	VBN	O	l.	ccomp	3	SENT_17	[p1l1972t1786r2065b1812],
12	858R	NN	O	858r	dobj	11	SENT_17	[p1l1972t1786r2065b1812],
13	,	,	O	,	_	0	SENT_17	[p1l1972t1786r2065b1812],
14	1	CD	NUMBER	1	nsubj	15	SENT_17	[p1l2078t1786r2088b1808],
15	had	VBD	O	have	ccomp	3	SENT_17	[p1l2103t1785r2154b1809],
16	Adenocardnoma	NNP	O	Adenocardnoma	dobj	15	SENT_17	[p1l6t1836r217b1857],
17	both	CC	O	both	advmod	15	SENT_17	[p1l686t1824r756b1852],
18	,	,	O	,	_	0	SENT_17	[p1l686t1824r756b1852],
19	and	CC	O	and	_	0	SENT_17	[p1l769t1824r820b1848],
20	1	CD	NUMBER	1	nsubj	21	SENT_17	[p1l834t1826r845b1848],
21	had	VBD	O	have	conj_and	3	SENT_17	[p1l861t1824r911b1848],
22	an	DT	O	a	det	25	SENT_17	[p1l924t1831r957b1848],
23	exon	NN	O	exon	nn	25	SENT_17	[p1l969t1831r1035b1848],
24	19	CD	NUMBER	19	num	25	SENT_17	[p1l1049t1826r1079b1848],
25	deletion	NN	O	deletion	dobj	21	SENT_17	[p1l1092t1824r1207b1848],
26	and	CC	O	and	_	0	SENT_17	[p1l1219t1824r1270b1848],
27	G796A	NN	O	g796a	conj_and	25	SENT_17	[p1l1283t1825r1383b1848],
28	.	.	O	.	_	0	SENT_17	[p1l1283t1825r1383b1848],

1	The	DT	O	the	det	4	SENT_18	[p1l1395t1824r1446b1848],
2	overall	JJ	O	overall	amod	4	SENT_18	[p1l1459t1824r1553b1848],
3	response	NN	O	response	nn	4	SENT_18	[p1l1566t1831r1690b1854],
4	rate	NN	O	rate	nsubj	7	SENT_18	[p1l1703t1828r1756b1848],
5	was	VBD	O	be	cop	7	SENT_18	[p1l1768t1831r1822b1848],
6	63.2	CD	PERCENT	63.2	num	7	SENT_18	[p1l1835t1825r1919b1852],
7	%	NN	PERCENT	%	_	0	SENT_18	[p1l1835t1825r1919b1852],
8	,	,	O	,	_	0	SENT_18	[p1l1835t1825r1919b1852],
9	and	CC	O	and	_	0	SENT_18	[p1l1932t1824r1983b1848],
10	the	DT	O	the	det	15	SENT_18	[p1l1995t1824r2040b1848],
11	disease	NN	O	disease	nn	15	SENT_18	[p1l2053t1824r2154b1848],
12	prospective	JJ	O	prospective	amod	15	SENT_18	[p1l6t1872r150b1898],
13	study	NN	O	study	nn	15	SENT_18	[p1l161t1871r230b1898],
14	control	NN	O	control	nn	15	SENT_18	[p1l695t1864r795b1888],
15	rate	NN	O	rate	nsubj	18	SENT_18	[p1l811t1867r864b1888],
16	was	VBD	O	be	cop	18	SENT_18	[p1l879t1871r933b1888],
17	89.5	CD	PERCENT	89.5	num	18	SENT_18	[p1l949t1865r1034b1888],
18	%	NN	PERCENT	%	conj_and	7	SENT_18	[p1l949t1865r1034b1888],
19	.	.	O	.	_	0	SENT_18	[p1l949t1865r1034b1888],

1	In	IN	O	in	_	0	SENT_19	[p1l1050t1865r1076b1888],
2	patients	NNS	O	patient	prep_in	16	SENT_19	[p1l1092t1864r1205b1894],
3	with	IN	O	with	_	0	SENT_19	[p1l1220t1864r1285b1888],
4	an	DT	O	a	det	5	SENT_19	[p1l1301t1871r1333b1888],
5	exon	NN	O	exon	prep_with	2	SENT_19	[p1l1349t1871r1415b1888],
6	19	CD	NUMBER	19	num	5	SENT_19	[p1l1432t1865r1462b1888],
7	del	DT	O	del	dep	5	SENT_19	[p1l1478t1864r1519b1888],
8	and	CC	O	and	_	0	SENT_19	[p1l1535t1864r1586b1888],
9	L858R	NN	O	l858r	dep	5	SENT_19	[p1l1602t1865r1695b1892],
10	,	,	O	,	_	0	SENT_19	[p1l1602t1865r1695b1892],
11	the	DT	O	the	det	13	SENT_19	[p1l1711t1864r1755b1888],
12	response	NN	O	response	nn	13	SENT_19	[p1l1771t1871r1896b1894],
13	rates	NNS	O	rate	nsubj	18	SENT_19	[p1l1912t1867r1979b1888],
14	were	VBD	O	be	cop	16	SENT_19	[p1l1994t1871r2064b1888],
15	71.4	CD	PERCENT	71.4	num	16	SENT_19	[p1l2080t1865r2154b1888],
16	%	NN	PERCENT	%	_	0	SENT_19	[p1l2080t1865r2154b1888],
17	and	CC	O	and	_	0	SENT_19	[p1l6t1903r57b1928],
18	Acquired	VBN	O	acquire	conj_and	16	SENT_19	[p1l73t1907r185b1934],
19	resistance	NN	O	resistance	dobj	18	SENT_19	[p1l197t1907r323b1929],
20	60.0	CD	PERCENT	60.0	num	21	SENT_19	[p1l764t1904r849b1931],
21	%	NN	PERCENT	%	dep	19	SENT_19	[p1l764t1904r849b1931],
22	,	,	O	,	_	0	SENT_19	[p1l764t1904r849b1931],
23	respectively	RB	O	respectively	advmod	19	SENT_19	[p1l863t1903r1038b1934],
24	.	.	O	.	_	0	SENT_19	[p1l863t1903r1038b1934],

1	The	DT	O	the	det	7	SENT_20	[p1l1050t1903r1101b1928],
2	median	JJ	O	median	amod	7	SENT_20	[p1l1115t1903r1221b1928],
3	progression	NN	O	progression	nn	7	SENT_20	[p1l1234t1903r1467b1934],
4	—	CD	NUMBER	—	num	7	SENT_20	[p1l1234t1903r1467b1934],
5	free	JJ	O	free	amod	7	SENT_20	[p1l1234t1903r1467b1934],
6	survival	NN	O	survival	nn	7	SENT_20	[p1l1481t1903r1591b1928],
7	time	NN	O	time	nsubj	10	SENT_20	[p1l1604t1903r1668b1928],
8	was	VBD	O	be	cop	10	SENT_20	[p1l1680t1910r1735b1928],
9	7.1	CD	DURATION	7.1	num	10	SENT_20	[p1l1749t1904r1781b1928],
10	months	NNS	NUMBER	month	_	0	SENT_20	[p1l1798t1903r1912b1931],
11	.	.	O	.	_	0	SENT_20	[p1l1798t1903r1912b1931],

1	and	CC	O	and	cc	9	SENT_21	[p1l1925t1903r1976b1928],
2	the	DT	O	the	det	6	SENT_21	[p1l1989t1903r2034b1928],
3	median	JJ	O	median	amod	6	SENT_21	[p1l2048t1903r2154b1928],
4	survival	NN	O	survival	nn	6	SENT_21	[p1l6t1943r116b1968],
5	T790M	NN	O	t790m	nn	6	SENT_21	[p1l135t1944r223b1965],
6	time	NN	O	time	nsubj	9	SENT_21	[p1l828t1944r892b1968],
7	was	VBD	O	be	cop	9	SENT_21	[p1l910t1950r964b1968],
8	20.0	CD	DURATION	20.0	num	9	SENT_21	[p1l983t1945r1042b1968],
9	months	NNS	NUMBER	month	_	0	SENT_21	[p1l1060t1943r1174b1968],
10	.	.	O	.	_	0	SENT_21	[p1l1060t1943r1174b1968],

1	No	DT	O	no	det	3	SENT_22	[p1l1193t1945r1231b1968],
2	life-threatening	JJ	O	life-threatening	amod	3	SENT_22	[p1l1250t1943r1472b1974],
3	toxicity	NN	O	toxicity	nsubjpass	5	SENT_22	[p1l1490t1944r1596b1974],
4	was	VBD	O	be	auxpass	5	SENT_22	[p1l1613t1951r1667b1968],
5	observed	VBN	O	observe	_	0	SENT_22	[p1l1686t1943r1820b1968],
6	.	.	O	.	_	0	SENT_22	[p1l1686t1943r1820b1968],

1	Four	CD	NUMBER	four	nsubj	4	SENT_23	[p1l1839t1945r1903b1968],
2	of	IN	O	of	_	0	SENT_23	[p1l1920t1943r1949b1968],
3	ﬁve	NN	O	ﬁve	prep_of	1	SENT_23	[p1l1964t1943r2014b1968],
4	acquired	VBD	O	acquire	_	0	SENT_23	[p1l2032t1943r2154b1974],
5	resistant	JJ	O	resistant	amod	6	SENT_23	[p1l6t1984r128b2008],
6	tumors	NNS	O	tumor	nsubj	7	SENT_23	[p1l138t1987r239b2008],
7	showed	VBD	O	show	ccomp	4	SENT_23	[p1l811t2023r919b2047],
8	an	DT	O	a	det	11	SENT_23	[p1l929t2030r962b2047],
9	acquired	VBN	O	acquire	amod	11	SENT_23	[p1l972t2023r1094b2053],
10	T790M	NN	O	t790m	nn	11	SENT_23	[p1l1102t2024r1201b2047],
11	mutation	NN	O	mutation	dobj	7	SENT_23	[p1l1212t2023r1349b2047],
12	.	.	O	.	_	0	SENT_23	[p1l1212t2023r1349b2047],

1	Conclusions	NNS	O	conclusion	_	0	SENT_24	[p1l6t2063r250b2098],
2	:	:	O	:	_	0	SENT_24	[p1l6t2063r250b2098],
3	EGFR	NN	O	egfr	nn	4	SENT_24	[p1l269t2065r376b2098],
4	mutations	NNS	O	mutation	nsubjpass	11	SENT_24	[p1l392t2064r600b2098],
5	in	IN	O	in	_	0	SENT_24	[p1l619t2064r657b2097],
6	exons	NNS	O	exon	prep_in	4	SENT_24	[p1l674t2073r790b2098],
7	19	CD	NUMBER	19	num	6	SENT_24	[p1l811t2065r854b2098],
8	or	CC	O	or	_	0	SENT_24	[p1l872t2073r915b2098],
9	21	CD	NUMBER	21	prep_in	4	SENT_24	[p1l931t2065r973b2097],
10	are	VBP	O	be	auxpass	11	SENT_24	[p1l996t2073r1058b2098],
11	considered	VBN	O	consider	dep	1	SENT_24	[p1l1076t2063r1300b2098],
12	to	TO	O	to	aux	16	SENT_24	[p1l1318t2068r1356b2098],
13	be	VB	O	be	cop	16	SENT_24	[p1l1374t2063r1422b2098],
14	a	DT	O	a	det	16	SENT_24	[p1l1440t2073r1460b2098],
15	good	JJ	O	good	amod	16	SENT_24	[p1l1477t2063r1576b2106],
16	predictor	NN	O	predictor	xcomp	11	SENT_24	[p1l1595t2063r1784b2106],
17	of	IN	O	of	_	0	SENT_24	[p1l1800t2063r1843b2098],
18	the	DT	O	the	det	19	SENT_24	[p1l1855t2063r1920b2098],
19	efﬁcacy	NN	O	efﬁcacy	prep_of	16	SENT_24	[p1l1939t2063r2095b2106],
20	of	IN	O	of	_	0	SENT_24	[p1l2112t2063r2154b2098],
21	geﬁtinib	NN	O	geﬁtinib	prep_of	19	SENT_24	[p1l1345t2125r1588b2184],
22	.	.	O	.	_	0	SENT_24	[p1l1345t2125r1588b2184],

1	1	LS	NUMBER	1	_	0	SENT_25	[p1l10t2463r57b2512],
2	.	.	O	.	_	0	SENT_25	[p1l10t2463r57b2512],

1	Introduction	NN	O	introduction	_	0	SENT_26	[p1l101t2460r516b2512],

1	Lung	NN	O	lung	nn	2	SENT_27	[p1l106t2634r254b2695],
2	cancer	NN	O	cancer	nsubj	7	SENT_27	[p1l279t2645r480b2682],
3	remains	VBZ	O	remain	cop	7	SENT_27	[p1l505t2631r750b2682],
4	the	DT	O	the	det	7	SENT_27	[p1l776t2630r874b2682],
5	most	RBS	O	most	advmod	6	SENT_27	[p1l901t2638r1052b2682],
6	common	JJ	O	common	amod	7	SENT_27	[p1l1077t2645r1348b2682],
7	cause	NN	O	cause	_	0	SENT_27	[p1l1374t2645r1542b2682],
8	of	IN	O	of	_	0	SENT_27	[p1l1568t2630r1632b2682],
9	cancer	NN	O	cancer	nn	10	SENT_27	[p1l1651t2645r1851b2682],
10	death	NN	O	death	prep_of	7	SENT_27	[p1l1876t2630r2048b2682],
11	worldwide	RB	O	worldwide	advmod	7	SENT_27	[p1l7t2713r355b2773],
12	,	,	O	,	_	0	SENT_27	[p1l7t2713r355b2773],
13	and	CC	O	and	_	0	SENT_27	[p1l383t2713r494b2765],
14	the	DT	O	the	det	15	SENT_27	[p1l522t2713r619b2765],
15	incidence	NN	O	incidence	nsubj	21	SENT_27	[p1l647t2713r940b2765],
16	of	IN	O	of	_	0	SENT_27	[p1l968t2713r1031b2765],
17	lung	NN	O	lung	nn	18	SENT_27	[p1l1052t2713r1186b2778],
18	cancer	NN	O	cancer	prep_of	15	SENT_27	[p1l1212t2728r1413b2765],
19	is	VBZ	O	be	aux	21	SENT_27	[p1l1439t2714r1483b2765],
20	still	RB	O	still	advmod	21	SENT_27	[p1l1513t2713r1622b2765],
21	increasing	VBG	O	increase	conj_and	7	SENT_27	[p1l1651t2714r1965b2778],
22	in	IN	O	in	_	0	SENT_27	[p1l1992t2714r2048b2765],
23	both	DT	O	both	preconj	24	SENT_27	[p1l8t2797r147b2848],
24	men	NNS	O	man	prep_in	21	SENT_27	[p1l176t2811r310b2848],
25	and	CC	O	and	_	0	SENT_27	[p1l339t2797r450b2848],
26	women	NNS	O	woman	prep_in	21	SENT_27	[p1l478t2811r709b2848],
27	in	IN	O	in	_	0	SENT_27	[p1l738t2797r794b2848],
28	Japan	NNP	LOCATION	Japan	prep_in	24	SENT_27	[p1l815t2800r1005b2861],
29	.	.	O	.	_	0	SENT_27	[p1l815t2800r1005b2861],

1	Despite	IN	O	despite	_	0	SENT_28	[p1l1036t2797r1265b2861],
2	recent	JJ	O	recent	amod	3	SENT_28	[p1l1295t2804r1487b2848],
3	improvements	NNS	O	improvement	prep_despite	14	SENT_28	[p1l1515t2797r1961b2861],
4	in	IN	O	in	_	0	SENT_28	[p1l1992t2797r2048b2848],
5	diagnostic	JJ	O	diagnostic	amod	6	SENT_28	[p1l9t2880r323b2944],
6	technologies	NNS	O	technology	prep_in	3	SENT_28	[p1l345t2880r748b2944],
7	,	,	O	,	_	0	SENT_28	[p1l345t2880r748b2944],
8	more	JJR	O	more	mwe	9	SENT_28	[p1l772t2895r929b2932],
9	than	IN	O	than	quantmod	10	SENT_28	[p1l951t2880r1089b2932],
10	50	CD	PERCENT	50	num	11	SENT_28	[p1l1113t2883r1227b2932],
11	%	NN	PERCENT	%	nsubj	14	SENT_28	[p1l1113t2883r1227b2932],
12	of	IN	O	of	_	0	SENT_28	[p1l1249t2880r1313b2932],
13	patients	NNS	O	patient	prep_of	11	SENT_28	[p1l1328t2881r1575b2944],
14	present	JJ	DATE	present	_	0	SENT_28	[p1l1598t2888r1829b2944],
15	locally	RB	O	locally	advmod	16	SENT_28	[p1l1851t2880r2050b2944],
16	advanced	JJ	O	advanced	dobj	14	SENT_28	[p1l9t2963r298b3015],
17	or	CC	O	or	_	0	SENT_28	[p1l317t2978r381b3015],
18	distant	JJ	O	distant	amod	20	SENT_28	[p1l398t2963r611b3015],
19	metastatic	JJ	O	metastatic	amod	20	SENT_28	[p1l628t2964r949b3015],
20	disease	NN	O	disease	dobj	14	SENT_28	[p1l967t2963r1203b3022],
21	,	,	O	,	_	0	SENT_28	[p1l967t2963r1203b3022],
22	whose	WP$	O	whose	poss	23	SENT_28	[p1l1221t2963r1421b3015],
23	prognosis	NN	O	prognosis	nsubj	27	SENT_28	[p1l1440t2964r1735b3027],
24	is	VBZ	O	be	cop	27	SENT_28	[p1l1756t2964r1800b3015],
25	still	RB	O	still	advmod	27	SENT_28	[p1l1821t2963r1930b3015],
26	not	RB	O	not	neg	27	SENT_28	[p1l1950t2971r2049b3015],
27	satisfactory	JJ	O	satisfactory	rcmod	16	SENT_28	[p1l10t3045r373b3110],
28	.	.	O	.	_	0	SENT_28	[p1l10t3045r373b3110],

1	The	DT	O	the	det	2	SENT_29	[p1l400t3045r512b3097],
2	use	NN	O	use	nsubj	9	SENT_29	[p1l541t3060r643b3097],
3	of	IN	O	of	_	0	SENT_29	[p1l672t3045r736b3097],
4	platinum	NN	O	platinum	nn	5	SENT_29	[p1l757t3045r1245b3110],
5	—	NN	O	—	prep_of	2	SENT_29	[p1l757t3045r1245b3110],
6	based	VBN	O	base	partmod	5	SENT_29	[p1l757t3045r1245b3110],
7	combination	NN	O	combination	nn	8	SENT_29	[p1l1275t3045r1663b3097],
8	chemotherapeutics	NNS	O	chemotherapeutic	dobj	6	SENT_29	[p1l1692t3045r2047b3097, p1l9t3129r262b3193],
9	offer	VBP	O	offer	dep	43	SENT_29	[p1l292t3128r436b3180],
10	modest	JJ	O	modest	amod	11	SENT_29	[p1l464t3128r691b3180],
11	efﬁcacy	NN	O	efﬁcacy	dobj	9	SENT_29	[p1l719t3128r963b3193],
12	,	,	O	,	_	0	SENT_29	[p1l719t3128r963b3193],
13	but	CC	O	but	_	0	SENT_29	[p1l992t3128r1095b3180],
14	the	DT	O	the	det	17	SENT_29	[p1l1122t3128r1219b3180],
15	objective	JJ	O	objective	amod	17	SENT_29	[p1l1249t3128r1525b3193],
16	response	NN	O	response	nn	17	SENT_29	[p1l1555t3143r1827b3193],
17	rate	NN	O	rate	nsubj	18	SENT_29	[p1l1857t3136r1973b3180],
18	is	VBZ	O	be	conj_but	9	SENT_29	[p1l2002t3129r2047b3180],
19	around	IN	O	around	_	0	SENT_29	[p1l9t3211r225b3263],
20	30	CD	PERCENT	30	num	21	SENT_29	[p1l249t3214r366b3263],
21	%	NN	PERCENT	%	prep_around	18	SENT_29	[p1l249t3214r366b3263],
22	and	CC	O	and	_	0	SENT_29	[p1l391t3211r501b3263],
23	the	DT	O	the	det	29	SENT_29	[p1l526t3211r624b3263],
24	median	JJ	O	median	amod	29	SENT_29	[p1l649t3211r879b3263],
25	survival	NN	O	survival	nn	29	SENT_29	[p1l905t3211r1143b3263],
26	time	NN	O	time	nn	29	SENT_29	[p1l1167t3212r1306b3263],
27	(	CD	NUMBER	(	num	29	SENT_29	[p1l1332t3211r1512b3276],
28	MST	NN	O	mst	nn	29	SENT_29	[p1l1332t3211r1512b3276],
29	)	NN	O	)	prep_around	18	SENT_29	[p1l1332t3211r1512b3276],
30	is	VBZ	O	be	cop	43	SENT_29	[p1l1538t3212r1582b3263],
31	13-14	CD	NUMBER	13-14	num	32	SENT_29	[p1l1611t3214r1790b3263],
32	months	NNS	NUMBER	month	npadvmod	43	SENT_29	[p1l1815t3211r2047b3263],
33	in	IN	O	in	_	0	SENT_29	[p1l9t3295r66b3346],
34	non-resectable	JJ	O	non-resectable	amod	36	SENT_29	[p1l92t3295r548b3346],
35	non	JJ	O	non	amod	36	SENT_29	[p1l575t3295r885b3346],
36	—	NN	O	—	prep_in	43	SENT_29	[p1l575t3295r885b3346],
37	small	JJ	O	small	amod	43	SENT_29	[p1l575t3295r885b3346],
38	cell	NN	O	cell	nn	43	SENT_29	[p1l912t3295r1015b3346],
39	lung	NN	O	lung	nn	43	SENT_29	[p1l1042t3295r1176b3359],
40	cancer	NN	O	cancer	nn	43	SENT_29	[p1l1200t3310r1401b3346],
41	(	CD	NUMBER	(	num	43	SENT_29	[p1l1425t3295r1671b3359],
42	NSCLC	NN	O	nsclc	nn	43	SENT_29	[p1l1425t3295r1671b3359],
43	)	NN	O	)	_	0	SENT_29	[p1l1425t3295r1671b3359],
44	in	IN	O	in	_	0	SENT_29	[p1l1697t3295r1754b3346],
45	Japanese	JJ	MISC	japanese	amod	47	SENT_29	[p1l1771t3298r2047b3359],
46	randomized	JJ	O	randomized	amod	47	SENT_29	[p1l9t3378r377b3430],
47	phase	NN	O	phase	prep_in	43	SENT_29	[p1l400t3378r576b3442],
48	III	CD	NUMBER	iii	num	50	SENT_29	[p1l599t3381r656b3429],
49	study	NN	O	study	nn	50	SENT_29	[p1l679t3378r848b3442],
50	[	NN	O	[	dep	47	SENT_29	[p1l871t3378r966b3442],
51	1	CD	NUMBER	1	num	52	SENT_29	[p1l871t3378r966b3442],
52	]	NN	O	]	nsubj	43	SENT_29	[p1l871t3378r966b3442],
53	.	.	O	.	_	0	SENT_29	[p1l871t3378r966b3442],

1	Therefore	RB	O	therefore	advmod	5	SENT_30	[p1l986t3378r1298b3437],
2	,	,	O	,	_	0	SENT_30	[p1l986t3378r1298b3437],
3	it	PRP	O	it	nsubj	5	SENT_30	[p1l1322t3379r1363b3430],
4	is	VBZ	O	be	cop	5	SENT_30	[p1l1384t3379r1428b3430],
5	important	JJ	O	important	_	0	SENT_30	[p1l1451t3379r1762b3442],
6	and	CC	O	and	_	0	SENT_30	[p1l1783t3378r1894b3430],
7	necessary	JJ	O	necessary	conj_and	5	SENT_30	[p1l1917t3393r2047b3430, p1l9t3475r202b3525],
8	to	TO	O	to	aux	9	SENT_30	[p1l226t3468r284b3512],
9	identify	VB	O	identify	xcomp	5	SENT_30	[p1l312t3460r550b3525],
10	patients	NNS	O	patient	dobj	9	SENT_30	[p1l575t3461r821b3525],
11	who	WP	O	who	nsubj	14	SENT_30	[p1l847t3460r981b3512],
12	are	VBP	O	be	cop	14	SENT_30	[p1l1008t3475r1100b3512],
13	highly	RB	O	highly	advmod	14	SENT_30	[p1l1127t3460r1319b3525],
14	sensitive	JJ	O	sensitive	dep	9	SENT_30	[p1l1345t3461r1611b3512],
15	for	IN	O	for	_	0	SENT_30	[p1l1639t3460r1724b3512],
16	particular	JJ	O	particular	amod	18	SENT_30	[p1l1749t3460r2050b3525],
17	anticancer	JJ	O	anticancer	amod	18	SENT_30	[p1l9t3544r331b3595],
18	agents	NNS	O	agent	prep_for	14	SENT_30	[p1l350t3551r547b3608],
19	and	CC	O	and	_	0	SENT_30	[p1l569t3543r680b3595],
20	who	WP	O	who	nsubj	22	SENT_30	[p1l701t3543r834b3595],
21	thus	RB	O	thus	advmod	22	SENT_30	[p1l856t3543r987b3595],
22	demonstrate	VBP	O	demonstrate	conj_and	14	SENT_30	[p1l1010t3543r1398b3595],
23	a	DT	O	a	det	25	SENT_30	[p1l1420t3558r1451b3595],
24	good	JJ	O	good	amod	25	SENT_30	[p1l1471t3543r1619b3608],
25	prognosis	NN	O	prognosis	dobj	22	SENT_30	[p1l1642t3544r1953b3608],
26	.	.	O	.	_	0	SENT_30	[p1l1642t3544r1953b3608],

1	Somatically	RB	O	somatically	advmod	2	SENT_31	[p1l106t3626r463b3691],
2	acquired	VBN	O	acquire	amod	3	SENT_31	[p1l483t3626r747b3691],
3	mutations	NNS	O	mutation	nsubjpass	18	SENT_31	[p1l769t3627r1081b3678],
4	in	IN	O	in	_	0	SENT_31	[p1l1104t3627r1160b3678],
5	the	DT	O	the	det	13	SENT_31	[p1l1180t3626r1277b3678],
6	epidermal	JJ	O	epidermal	amod	13	SENT_31	[p1l1299t3626r1610b3691],
7	growth	NN	O	growth	nn	13	SENT_31	[p1l1631t3626r1852b3691],
8	factor	NN	O	factor	nn	13	SENT_31	[p1l1873t3626r2050b3678],
9	receptor	NN	O	receptor	nn	13	SENT_31	[p1l9t3717r266b3774],
10	(	CD	NUMBER	(	num	13	SENT_31	[p1l293t3710r499b3774],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_31	[p1l293t3710r499b3774],
12	)	NN	O	)	nn	13	SENT_31	[p1l293t3710r499b3774],
13	gene	NN	O	gene	prep_in	3	SENT_31	[p1l528t3724r671b3774],
14	in	IN	O	in	_	0	SENT_31	[p1l701t3710r758b3761],
15	NSCLC	NNP	O	NSCLC	prep_in	13	SENT_31	[p1l787t3712r983b3761],
16	have	VBP	O	have	aux	18	SENT_31	[p1l1012t3709r1152b3761],
17	been	VBN	O	be	auxpass	18	SENT_31	[p1l1181t3709r1329b3761],
18	reported	VBN	O	report	_	0	SENT_31	[p1l1359t3709r1622b3774],
19	to	TO	O	to	aux	22	SENT_31	[p1l1651t3717r1709b3761],
20	be	VB	O	be	cop	22	SENT_31	[p1l1738t3709r1809b3761],
21	associ	JJ	O	associ	amod	22	SENT_31	[p1l1838t3710r2047b3761, p2l55t177r76b201],
22	*	NN	O	*	xcomp	18	SENT_31	[p1l1838t3710r2047b3761, p2l55t177r76b201],

1	Corresponding	VBG	O	correspond	_	0	SENT_32	[p2l119t176r482b229],
2	author	NN	O	author	dobj	1	SENT_32	[p2l497t177r668b219],
3	.	.	O	.	_	0	SENT_32	[p2l497t177r668b219],

1	Tel.	NNP	O	Tel.	_	0	SENT_33	[p2l684t176r782b219],
2	:	:	O	:	_	0	SENT_33	[p2l684t176r782b219],
3	+81 93 691 7442	CD	NUMBER	+81 93 691 7442	dep	1	SENT_33	[p2l1091t179r1223b225],[p2l803t179r885b218],
4	;	:	O	;	_	0	SENT_33	[p2l1091t179r1223b225],
5	fax	NN	O	fax	dep	1	SENT_33	[p2l1245t176r1332b219],
6	:	:	O	:	_	0	SENT_33	[p2l1245t176r1332b219],
7	+81 93 692 4004	CD	NUMBER	+81 93 692 4004	dep	5	SENT_33	[p2l1640t179r1777b219],[p2l1353t179r1435b218],
8	.	.	O	.	_	0	SENT_33	[p2l1640t179r1777b219],

1	E-mail	NN	O	e-mail	nn	2	SENT_34	[p2l106t254r262b295],
2	address	NN	O	address	_	0	SENT_34	[p2l278t254r469b296],
3	:	:	O	:	_	0	SENT_34	[p2l278t254r469b296],
4	kensugio@med.uoeh-u.ac.jp	JJ	O	kensugio@med.uoeh-u.ac.jp	amod	8	SENT_34	[p2l488t254r1180b306],
5	(	NN	O	(	nn	8	SENT_34	[p2l1198t254r1260b306],
6	K.	NNP	PERSON	K.	nn	8	SENT_34	[p2l1198t254r1260b306],
7	Sugio	NNP	PERSON	Sugio	nn	8	SENT_34	[p2l1279t254r1444b306],
8	)	NN	O	)	dep	2	SENT_34	[p2l1279t254r1444b306],
9	.	.	O	.	_	0	SENT_34	[p2l1279t254r1444b306],

1	0169-5002	CD	DURATION	0169-5002	_	0	SENT_35	[p2l8t399r320b452],
2	/	:	O	/	punct	1	SENT_35	[p2l8t399r320b452],
3	$	$	MONEY	$	nsubj	5	SENT_35	[p2l8t399r320b452],
4	—	CD	MONEY	—	num	3	SENT_35	[p2l338t425r364b429],
5	see	VBP	O	see	dep	1	SENT_35	[p2l383t412r459b442],
6	front	JJ	O	front	amod	7	SENT_35	[p2l477t400r596b442],
7	matter	NN	O	matter	dobj	5	SENT_35	[p2l613t406r779b442],
8	©	CD	NUMBER	©	num	12	SENT_35	[p2l794t403r833b441],
9	2008	CD	DATE	2008	num	12	SENT_35	[p2l850t402r972b442],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_35	[p2l991t400r1183b442],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_35	[p2l1199t400r1370b442],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_35	[p2l1388t400r1475b442],
13	.	.	O	.	_	0	SENT_35	[p2l1388t400r1475b442],

1	All	DT	O	all	det	2	SENT_36	[p2l1491t400r1556b441],
2	rights	NNS	O	rights	nsubj	3	SENT_36	[p2l1575t400r1714b452],
3	reserved	VBN	O	reserve	_	0	SENT_36	[p2l1733t400r1954b442],
4	.	.	O	.	_	0	SENT_36	[p2l1733t400r1954b442],

1	doi	FW	O	doi	_	0	SENT_37	[p2l8t469r846b522],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_37	[p2l8t469r846b522],
3	/	:	O	/	punct	5	SENT_37	[p2l8t469r846b522],
4	j.	NN	O	j.	nn	5	SENT_37	[p2l8t469r846b522],
5	lungcan	NN	O	lungcan	dep	2	SENT_37	[p2l8t469r846b522],
6	.2008.09.010	CD	NUMBER	.2008.09.010	dep	2	SENT_37	[p2l8t469r846b522],

1	©	RB	O	©	advmod	2	SENT_38	[p2l807t552r852b597],
2	2008	CD	DATE	2008	_	0	SENT_38	[p2l872t552r1013b597],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_38	[p2l1035t549r1258b597],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_38	[p2l1276t549r1474b597],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_38	[p2l1494t549r1595b597],
6	.	.	O	.	_	0	SENT_38	[p2l1494t549r1595b597],

1	All	DT	O	all	det	2	SENT_39	[p2l1613t549r1690b596],
2	rights	NNS	O	rights	nsubj	3	SENT_39	[p2l1710t549r1872b609],
3	reserved	VBN	O	reserve	_	0	SENT_39	[p2l1893t549r2150b597],
4	.	.	O	.	_	0	SENT_39	[p2l1893t549r2150b597],

1	ated	VBN	O	ate	partmod	16	SENT_40	[p2l52t813r187b866],
2	with	IN	O	with	_	0	SENT_40	[p2l211t813r357b866],
3	a	DT	O	a	det	6	SENT_40	[p2l383t828r414b866],
4	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_40	[p2l440t813r769b879],
5	clinical	JJ	O	clinical	amod	6	SENT_40	[p2l793t813r1015b866],
6	response	NN	O	response	prep_with	1	SENT_40	[p2l1042t828r1322b879],
7	to	TO	O	to	_	0	SENT_40	[p2l1348t821r1407b866],
8	geﬁtinib	NN	O	geﬁtinib	prep_to	1	SENT_40	[p2l1432t813r1695b879],
9	or	CC	O	or	_	0	SENT_40	[p2l1721t828r1786b866],
10	erlotinib	NN	O	erlotinib	prep_to	1	SENT_40	[p2l1809t813r2093b874],
11	,	,	O	,	_	0	SENT_40	[p2l1809t813r2093b874],
12	a	DT	O	a	det	15	SENT_40	[p2l2120t828r2151b866],
13	tyrosine	NN	O	tyrosine	nn	15	SENT_40	[p2l52t899r309b965],
14	kinase	NN	O	kinase	nn	15	SENT_40	[p2l338t898r537b951],
15	inhibitors	NNS	O	inhibitor	nsubj	16	SENT_40	[p2l566t898r871b951],
16	(	VBP	O	(	_	0	SENT_40	[p2l900t898r1082b964],
17	TKIs	NNS	O	tki	nsubj	18	SENT_40	[p2l900t898r1082b964],
18	)	VBP	O	)	ccomp	16	SENT_40	[p2l900t898r1082b964],
19	that	IN	O	that	complm	20	SENT_40	[p2l1110t898r1238b951],
20	targets	VBZ	O	target	dep	18	SENT_40	[p2l1264t906r1478b965],
21	the	DT	O	the	det	22	SENT_40	[p2l1506t898r1606b951],
22	EGFR	NN	ORGANIZATION	egfr	dobj	20	SENT_40	[p2l1636t901r1812b960],
23	,	,	O	,	_	0	SENT_40	[p2l1636t901r1812b960],
24	especially	RB	O	especially	amod	33	SENT_40	[p2l1841t898r2153b965],
25	in	IN	O	in	_	0	SENT_40	[p2l53t985r111b1037],
26	patients	NNS	O	patient	prep_in	24	SENT_40	[p2l147t985r400b1051],
27	with	IN	O	with	_	0	SENT_40	[p2l436t984r582b1037],
28	adenocarcinoma	NN	O	adenocarcinoma	prep_with	26	SENT_40	[p2l617t984r1156b1046],
29	,	,	O	,	_	0	SENT_40	[p2l617t984r1156b1046],
30	females	NNS	O	female	appos	28	SENT_40	[p2l1193t984r1451b1046],
31	,	,	O	,	_	0	SENT_40	[p2l1193t984r1451b1046],
32	never/light	JJ	O	never/light	amod	33	SENT_40	[p2l1488t984r1836b1051],
33	smokers	NNS	O	smoker	appos	22	SENT_40	[p2l1872t984r2150b1046],
34	,	,	O	,	_	0	SENT_40	[p2l1872t984r2150b1046],
35	and/or	IN	O	and/or	_	0	SENT_40	[p2l52t1070r262b1137],
36	East	NNP	MISC	East	nn	38	SENT_40	[p2l293t1074r420b1124],
37	Asians	NNPS	MISC	Asians	nn	38	SENT_40	[p2l449t1071r652b1124],
38	[	NN	O	[	prep_and/or	20	SENT_40	[p2l689t1070r868b1137],
39	2	CD	NUMBER	2	num	40	SENT_40	[p2l689t1070r868b1137],
40	—	CD	NUMBER	—	dep	38	SENT_40	[p2l689t1070r868b1137],
41	4	CD	NUMBER	4	num	42	SENT_40	[p2l689t1070r868b1137],
42	]	NN	O	]	nsubj	20	SENT_40	[p2l689t1070r868b1137],
43	.	.	O	.	_	0	SENT_40	[p2l689t1070r868b1137],

1	Subsequently	RB	O	subsequently	advmod	7	SENT_41	[p2l901t1070r1338b1137],
2	,	,	O	,	_	0	SENT_41	[p2l901t1070r1338b1137],
3	several	JJ	O	several	amod	4	SENT_41	[p2l1373t1070r1590b1124],
4	groups	NNS	O	group	nsubj	7	SENT_41	[p2l1623t1086r1837b1137],
5	of	IN	O	of	_	0	SENT_41	[p2l1871t1070r1936b1124],
6	investigators	NNS	O	investigator	prep_of	4	SENT_41	[p2l1962t1071r2150b1124, p2l52t1157r290b1223],
7	identiﬁed	VBD	O	identiﬁed	_	0	SENT_41	[p2l317t1156r621b1210],
8	a	DT	O	a	det	10	SENT_41	[p2l646t1172r679b1210],
9	striking	JJ	O	striking	amod	10	SENT_41	[p2l704t1157r945b1223],
10	association	NN	O	association	dobj	7	SENT_41	[p2l969t1157r1320b1210],
11	between	IN	O	between	_	0	SENT_41	[p2l1344t1157r1617b1210],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_41	[p2l1642t1159r1806b1210],
13	mutations	NNS	O	mutation	prep_between	10	SENT_41	[p2l1829t1157r2150b1210],
14	and	CC	O	and	_	0	SENT_41	[p2l52t1243r167b1296],
15	TKI	NN	O	tkus	nn	16	SENT_41	[p2l181t1246r284b1295],
16	sensitivity	NN	O	sensitivity	conj_and	10	SENT_41	[p2l302t1244r627b1309],
17	[	CD	NUMBER	[	num	19	SENT_41	[p2l645t1243r823b1309],
18	S-7	NN	O	s-7	nn	19	SENT_41	[p2l645t1243r823b1309],
19	]	NN	O	]	dep	16	SENT_41	[p2l645t1243r823b1309],
20	,	,	O	,	_	0	SENT_41	[p2l645t1243r823b1309],
21	In	IN	O	in	_	0	SENT_41	[p2l841t1246r900b1295],
22	our	PRP$	O	we	poss	24	SENT_41	[p2l916t1258r1023b1296],
23	retrospective	JJ	O	retrospective	amod	24	SENT_41	[p2l1038t1244r1449b1309],
24	study	NN	O	study	prep_in	37	SENT_41	[p2l1467t1243r1651b1309],
25	,	,	O	,	_	0	SENT_41	[p2l1467t1243r1651b1309],
26	cases	NNS	O	case	nsubj	37	SENT_41	[p2l1668t1258r1830b1296],
27	with	IN	O	with	_	0	SENT_41	[p2l1846t1243r1992b1296],
28	such	JJ	O	such	amod	30	SENT_41	[p2l2009t1243r2151b1296],
29	EGFR	NN	ORGANIZATION	egfr	nn	30	SENT_41	[p2l53t1332r217b1382],
30	mutations	NNS	O	mutation	prep_with	26	SENT_41	[p2l237t1330r558b1382],
31	as	IN	O	as	_	0	SENT_41	[p2l581t1344r642b1382],
32	exon	NN	O	exon	prep_as	30	SENT_41	[p2l666t1344r814b1382],
33	19	CD	NUMBER	19	num	32	SENT_41	[p2l840t1332r906b1382],
34	del	DT	O	del	dep	32	SENT_41	[p2l930t1329r1023b1382],
35	or	CC	O	or	_	0	SENT_41	[p2l1046t1344r1111b1382],
36	L858R	NN	O	l858r	dep	32	SENT_41	[p2l1132t1332r1328b1382],
37	showed	VBD	O	show	ccomp	7	SENT_41	[p2l1348t1329r1590b1382],
38	a	DT	O	a	det	40	SENT_41	[p2l1613t1344r1645b1382],
39	high	JJ	O	high	amod	40	SENT_41	[p2l1667t1329r1804b1395],
40	sensitivity	NN	O	sensitivity	dobj	37	SENT_41	[p2l1827t1330r2153b1395],
41	to	TO	O	to	_	0	SENT_41	[p2l52t1422r112b1467],
42	geﬁtinib	NN	O	geﬁtinib	prep_to	37	SENT_41	[p2l141t1414r418b1481],
43	,	,	O	,	_	0	SENT_41	[p2l141t1414r418b1481],
44	and	CC	O	and	_	0	SENT_41	[p2l449t1414r563b1467],
45	the	DT	O	the	det	46	SENT_41	[p2l593t1414r693b1467],
46	patients	NNS	O	patient	nsubj	52	SENT_41	[p2l723t1415r977b1481],
47	with	IN	O	with	_	0	SENT_41	[p2l1006t1414r1151b1467],
48	sensitive	JJ	O	sensitive	amod	50	SENT_41	[p2l1182t1415r1456b1467],
49	EGFR	NN	ORGANIZATION	egfr	nn	50	SENT_41	[p2l1486t1417r1650b1467],
50	mutations	NNS	O	mutation	prep_with	46	SENT_41	[p2l1677t1415r1998b1467],
51	also	RB	O	also	advmod	52	SENT_41	[p2l2028t1414r2150b1467],
52	tended	VBD	O	tend	conj_and	7	SENT_41	[p2l52t1500r271b1553],
53	to	TO	O	to	aux	54	SENT_41	[p2l304t1508r363b1553],
54	have	VB	O	have	xcomp	52	SENT_41	[p2l398t1500r542b1553],
55	a	DT	O	a	det	58	SENT_41	[p2l575t1516r607b1553],
56	more	RBR	O	more	advmod	57	SENT_41	[p2l640t1516r802b1553],
57	favorable	JJ	O	favorable	amod	58	SENT_41	[p2l836t1500r1125b1553],
58	prognosis	NN	O	prognosis	dobj	54	SENT_41	[p2l1159t1501r1463b1567],
59	than	IN	O	than	_	0	SENT_41	[p2l1496t1500r1638b1553],
60	those	DT	O	those	prep_than	54	SENT_41	[p2l1670t1500r1841b1553],
61	with	IN	O	with	_	0	SENT_41	[p2l1872t1500r2019b1553],
62	the	DT	O	the	det	64	SENT_41	[p2l2050t1500r2150b1553],
63	wild-type	JJ	O	wild-type	amod	64	SENT_41	[p2l51t1586r361b1653],
64	gene	NN	O	gene	prep_with	60	SENT_41	[p2l390t1602r538b1653],
65	after	IN	O	after	_	0	SENT_41	[p2l568t1586r715b1640],
66	geﬁtinib	NN	O	geﬁtinib	nn	67	SENT_41	[p2l742t1586r1005b1653],
67	treatment	NN	O	treatment	prep_after	54	SENT_41	[p2l1034t1594r1352b1640],
68	[	CD	NUMBER	[	number	69	SENT_41	[p2l1384t1586r1538b1653],
69	8,9	CD	NUMBER	8,9	num	70	SENT_41	[p2l1384t1586r1538b1653],
70	]	NN	O	]	dep	54	SENT_41	[p2l1384t1586r1538b1653],
71	.	.	O	.	_	0	SENT_41	[p2l1384t1586r1538b1653],

1	The	DT	O	the	det	3	SENT_42	[p2l1567t1586r1681b1640],
2	present	JJ	DATE	present	amod	3	SENT_42	[p2l1712t1594r1949b1653],
3	study	NN	O	study	nsubj	5	SENT_42	[p2l1979t1586r2152b1653],
4	prospectively	RB	O	prospectively	advmod	5	SENT_42	[p2l53t1673r477b1739],
5	assessed	VBD	O	assess	_	0	SENT_42	[p2l511t1673r781b1726],
6	the	DT	O	the	det	7	SENT_42	[p2l816t1673r916b1726],
7	efﬁcacy	NN	O	efﬁcacy	dobj	5	SENT_42	[p2l953t1672r1193b1739],
8	of	IN	O	of	_	0	SENT_42	[p2l1228t1672r1293b1726],
9	geﬁtinib	NN	O	geﬁtinib	prep_of	7	SENT_42	[p2l1320t1672r1582b1739],
10	and	CC	O	and	_	0	SENT_42	[p2l1618t1673r1732b1726],
11	the	DT	O	the	det	13	SENT_42	[p2l1768t1673r1868b1726],
12	survival	NN	O	survival	nn	13	SENT_42	[p2l1905t1673r2150b1726],
13	beneﬁt	NN	O	beneﬁt	conj_and	7	SENT_42	[p2l52t1759r275b1812],
14	for	IN	O	for	_	0	SENT_42	[p2l293t1759r381b1812],
15	patients	NNS	O	patient	prep_for	13	SENT_42	[p2l398t1760r652b1825],
16	with	IN	O	with	_	0	SENT_42	[p2l670t1759r816b1812],
17	NSCLC	NN	ORGANIZATION	nsclc	prep_with	5	SENT_42	[p2l836t1762r1038b1812],
18	who	WP	O	who	nsubj	19	SENT_42	[p2l1054t1759r1192b1812],
19	demonstrate	VBP	O	demonstrate	rcmod	17	SENT_42	[p2l1212t1759r1611b1812],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_42	[p2l1632t1762r1796b1812],
21	mutations	NNS	O	mutation	dobj	19	SENT_42	[p2l1813t1760r2150b1813],
22	.	.	O	.	_	0	SENT_42	[p2l1813t1760r2150b1813],

1	2	LS	NUMBER	2	_	0	SENT_43	[p2l52t1979r106b2030],
2	.	.	O	.	_	0	SENT_43	[p2l52t1979r106b2030],

1	Patients	NNS	O	patient	_	0	SENT_44	[p2l152t1976r421b2029],
2	and	CC	O	and	_	0	SENT_44	[p2l442t1976r566b2029],
3	methods	NNS	O	method	conj_and	1	SENT_44	[p2l586t1976r877b2029],

1	2.1	CD	NUMBER	2.1	_	0	SENT_45	[p2l48t2153r143b2204],
2	.	.	O	.	_	0	SENT_45	[p2l48t2153r143b2204],

1	Study	NNP	O	Study	_	0	SENT_46	[p2l190t2150r361b2217],
2	design	NN	O	design	dep	1	SENT_46	[p2l383t2150r573b2217],

1	This	DT	O	this	det	5	SENT_47	[p2l150t2325r280b2378],
2	phase	NN	O	phase	nn	5	SENT_47	[p2l307t2325r488b2391],
3	II	CD	NUMBER	ii	num	5	SENT_47	[p2l515t2328r552b2377],
4	clinical	JJ	O	clinical	amod	5	SENT_47	[p2l580t2325r801b2378],
5	study	NN	O	study	nsubj	6	SENT_47	[p2l829t2325r1003b2391],
6	consisted	VBD	O	consist	_	0	SENT_47	[p2l1027t2325r1322b2378],
7	of	IN	O	of	_	0	SENT_47	[p2l1349t2325r1414b2378],
8	two	CD	NUMBER	two	num	9	SENT_47	[p2l1432t2333r1551b2378],
9	stages	NNS	O	stage	prep_of	6	SENT_47	[p2l1579t2333r1784b2391],
10	.	.	O	.	_	0	SENT_47	[p2l1579t2333r1784b2391],

1	First	RB	ORDINAL	first	advmod	9	SENT_48	[p2l1812t2326r1962b2386],
2	,	,	O	,	_	0	SENT_48	[p2l1812t2326r1962b2386],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_48	[p2l1990t2328r2154b2378],
4	mutations	NNS	O	mutation	nsubjpass	9	SENT_48	[p2l53t2412r374b2464],
5	in	IN	O	in	_	0	SENT_48	[p2l399t2412r457b2464],
6	exons	NNS	O	exon	prep_in	4	SENT_48	[p2l480t2427r659b2464],
7	19-21	CD	DATE	19-21	dep	6	SENT_48	[p2l686t2414r864b2464],
8	were	VBD	O	be	auxpass	9	SENT_48	[p2l894t2427r1049b2464],
9	analyzed	VBN	O	analyze	_	0	SENT_48	[p2l1073t2411r1353b2478],
10	as	IN	O	as	mark	11	SENT_48	[p2l1377t2427r1439b2464],
11	described	VBN	O	describe	advcl	9	SENT_48	[p2l1463t2411r1768b2464],
12	below	IN	O	below	prep	11	SENT_48	[p2l1792t2411r1996b2465],
13	.	.	O	.	_	0	SENT_48	[p2l1792t2411r1996b2465],

1	Second	RB	ORDINAL	second	advmod	10	SENT_49	[p2l2021t2414r2150b2464, p2l53t2497r186b2559],
2	,	,	O	,	_	0	SENT_49	[p2l2021t2414r2150b2464, p2l53t2497r186b2559],
3	only	RB	O	only	advmod	4	SENT_49	[p2l216t2497r352b2564],
4	patients	NNS	O	patient	nsubjpass	10	SENT_49	[p2l380t2498r633b2564],
5	with	IN	O	with	_	0	SENT_49	[p2l662t2497r807b2550],
6	the	DT	O	the	det	8	SENT_49	[p2l836t2497r936b2550],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_49	[p2l966t2500r1129b2550],
8	mutation	NN	O	mutation	prep_with	4	SENT_49	[p2l1156t2498r1447b2550],
9	were	VBD	O	be	auxpass	10	SENT_49	[p2l1474t2513r1630b2550],
10	enrolled	VBN	O	enrol	_	0	SENT_49	[p2l1659t2497r1919b2550],
11	in	IN	O	in	_	0	SENT_49	[p2l1949t2498r2007b2550],
12	this	DT	O	this	prep_in	10	SENT_49	[p2l2035t2497r2150b2550],

1	K.	NNP	PERSON	K.	nn	2	SENT_50	[p2l396t2640r417b2661],
2	Sugio	NNP	PERSON	Sugio	_	0	SENT_50	[p2l426t2639r491b2666],
3	et	FW	O	et	nn	4	SENT_50	[p2l500t2642r523b2661],
4	al.	FW	O	al.	dep	2	SENT_50	[p2l530t2639r556b2661],
5	/	:	O	/	punct	2	SENT_50	[p2l562t2639r640b2666],
6	Lung	NN	O	lung	nn	7	SENT_50	[p2l562t2639r640b2666],
7	Cancer	NN	O	cancer	dep	2	SENT_50	[p2l647t2640r730b2661],
8	64	CD	NUMBER	64	number	9	SENT_50	[p2l737t2640r766b2661],
9	(	CD	NUMBER	(	num	10	SENT_50	[p2l775t2639r856b2666],
10	2009	CD	DATE	2009	dep	7	SENT_50	[p2l775t2639r856b2666],
11	)	CD	NUMBER	)	number	12	SENT_50	[p2l775t2639r856b2666],
12	314-318 315	CD	NUMBER	314-318 315	num	10	SENT_50	[p2l1722t2640r1764b2661],[p2l863t2640r964b2661],

1	(	NN	O	(	_	0	SENT_51	[p2l16t2849r155b2939],
2	A	NN	O	a	nn	3	SENT_51	[p2l16t2849r155b2939],
3	)	NN	O	)	dep	1	SENT_51	[p2l16t2849r155b2939],

1	PFS	NNP	O	PFS	dep	6	SENT_52	[p3l1181t216r1362b287],
2	:	:	O	:	_	0	SENT_52	[p3l1181t216r1362b287],
3	Till	IN	O	till	dep	1	SENT_52	[p3l1395t220r1500b287],
4	lTlIn	NN	O	ltlin	pobj	3	SENT_52	[p3l1538t220r1814b287],
5	‘	CD	NUMBER	‘	num	4	SENT_52	[p3l1538t220r1814b287],
6	Jl	NN	O	jl	_	0	SENT_52	[p3l1538t220r1814b287],
7	'	''	O	'	_	0	SENT_52	[p3l1538t220r1814b287],
8	lIthE	JJ	O	lithe	dep	6	SENT_52	[p3l1538t220r1814b287],

1	Prngressiun	NNP	O	Prngressiun	_	0	SENT_53	[p3l7t667r107b1221],
2	free	JJ	O	free	amod	3	SENT_53	[p3l7t453r88b634],
3	survival	NN	O	survival	dep	1	SENT_53	[p3l7t68r88b420],

1	o	NN	O	o	_	0	SENT_54	[p3l354t1335r402b1406],
2	5	CD	NUMBER	5	num	5	SENT_54	[p3l853t1279r901b1406],
3	112	CD	NUMBER	112	num	5	SENT_54	[p3l1357t1335r1448b1406],
4	-13	CD	NUMBER	-13	num	5	SENT_54	[p3l1857t1335r1947b1406],
5	Mﬂnths	NNS	O	mﬂnths	dep	1	SENT_54	[p3l458t1482r797b1568],
6	after	IN	O	after	_	0	SENT_54	[p3l830t1482r1044b1567],
7	ge-fitilrlib	JJ	O	ge-fitilrlib	amod	8	SENT_54	[p3l1072t1482r1433b1582],
8	treatment	NN	O	treatment	prep_after	5	SENT_54	[p3l1466t1487r1914b1567],
9	.	.	O	.	_	0	SENT_54	[p3l1466t1487r1914b1567],

1	(	NN	O	(	nn	2	SENT_55	[p3l6t1603r134b1690],
2	B	NN	O	b	_	0	SENT_55	[p3l6t1603r134b1690],
3	)	CD	NUMBER	)	dep	2	SENT_55	[p3l6t1603r134b1690],

1	MST	NNP	O	MST	_	0	SENT_56	[p3l1419t1904r1607b1973],
2	:	:	O	:	_	0	SENT_56	[p3l1419t1904r1607b1973],
3	20.0	CD	NUMBER	20.0	num	4	SENT_56	[p3l1638t1908r1794b1973],
4	mtnnltihs	NNS	O	mtnnltih	dep	1	SENT_56	[p3l1821t1908r2086b1973],
5	1	CD	NUMBER	1	num	6	SENT_56	[p3l1420t2009r1447b2073],
6	yeart	NN	O	yeart	dep	4	SENT_56	[p3l1484t2009r1963b2091],
7	.	.	O	.	_	0	SENT_56	[p3l1484t2009r1963b2091],

1	s	NNS	O	s	_	0	SENT_57	[p3l1484t2009r1963b2091],
2	:	:	O	:	_	0	SENT_57	[p3l1484t2009r1963b2091],
3	uWi	NN	O	uwus	dep	1	SENT_57	[p3l1484t2009r1963b2091],
4	‘	CD	NUMBER	‘	num	3	SENT_57	[p3l1484t2009r1963b2091],
5	vaI	NNP	O	vaI	nn	6	SENT_57	[p3l1484t2009r1963b2091],
6	|	NNP	O	|	dep	3	SENT_57	[p3l1484t2009r1963b2091],
7	:	:	O	:	_	0	SENT_57	[p3l1484t2009r1963b2091],
8	?	.	O	?	_	0	SENT_57	[p3l1994t2009r2154b2073],

1	‘	NN	O	‘	_	0	SENT_58	[p3l1994t2009r2154b2073],
2	T	NN	O	t	nn	4	SENT_58	[p3l1994t2009r2154b2073],
3	'	''	PERCENT	'	_	0	SENT_58	[p3l1994t2009r2154b2073],
4	%	NN	PERCENT	%	dep	1	SENT_58	[p3l1994t2009r2154b2073],

1	Overalll	NNP	O	Overalll	nn	3	SENT_59	[p3l20t2337r102b2653],
2	BU	NNP	O	BU	nn	3	SENT_59	[p3l42t2205r102b2301],
3	Wival	NNP	O	Wival	_	0	SENT_59	[p3l24t1968r102b2192],

1	5	CD	NUMBER	5	num	2	SENT_60	[p3l681t2978r726b3046],
2	12	CD	NUMBER	12	_	0	SENT_60	[p3l941t2978r1028b3046],
3	118	CD	NUMBER	118	number	4	SENT_60	[p3l1233t2978r1320b3046],
4	24	CD	NUMBER	24	num	6	SENT_60	[p3l1506t2978r1602b3046],
5	so	IN	O	so	amod	6	SENT_60	[p3l1816t2929r1908b3046],
6	Mtmnths	NNS	O	mtmnth	dep	2	SENT_60	[p3l484t3119r809b3201],
7	after	IN	O	after	_	0	SENT_60	[p3l840t3119r1042b3201],
8	geﬁtinib	NN	O	geﬁtinib	nn	9	SENT_60	[p3l1073t3119r1415b3215],
9	treatmelnt	NN	O	treatmelnt	prep_after	6	SENT_60	[p3l1447t3124r1876b3201],

1	Fig	NN	O	fig	_	0	SENT_61	[p3l28t3258r74b3285],
2	.	.	O	.	_	0	SENT_61	[p3l28t3258r74b3285],

1	1	LS	NUMBER	1	_	0	SENT_62	[p3l82t3259r102b3280],
2	.	.	O	.	_	0	SENT_62	[p3l82t3259r102b3280],

1	(	NN	O	(	nn	2	SENT_63	[p3l118t3258r155b3285],
2	A	NN	O	a	_	0	SENT_63	[p3l118t3258r155b3285],
3	)	CD	NUMBER	)	num	4	SENT_63	[p3l118t3258r155b3285],
4	Progression	NN	O	progression	dep	2	SENT_63	[p3l163t3258r370b3285],
5	—	CD	NUMBER	—	num	7	SENT_63	[p3l163t3258r370b3285],
6	free	JJ	O	free	amod	7	SENT_63	[p3l163t3258r370b3285],
7	survival	NN	O	survival	dep	4	SENT_63	[p3l379t3258r476b3280],
8	(	CD	NUMBER	(	num	10	SENT_63	[p3l485t3258r548b3285],
9	PFS	NN	O	pf	nn	10	SENT_63	[p3l485t3258r548b3285],
10	)	NN	O	)	dep	2	SENT_63	[p3l485t3258r548b3285],
11	and	CC	O	and	_	0	SENT_63	[p3l557t3258r602b3280],
12	(	NN	O	(	nn	13	SENT_63	[p3l611t3258r646b3285],
13	B	NN	O	b	conj_and	10	SENT_63	[p3l611t3258r646b3285],
14	)	CD	NUMBER	)	num	16	SENT_63	[p3l611t3258r646b3285],
15	overall	JJ	O	overall	amod	16	SENT_63	[p3l655t3258r739b3280],
16	survival	NN	O	survival	dep	2	SENT_63	[p3l748t3258r846b3280],
17	(	CD	NUMBER	(	number	18	SENT_63	[p3l855t3258r908b3285],
18	05	CD	NUMBER	05	dep	16	SENT_63	[p3l855t3258r908b3285],
19	)	NN	O	)	dep	2	SENT_63	[p3l855t3258r908b3285],
20	of	IN	O	of	_	0	SENT_63	[p3l916t3258r943b3280],
21	eligible	JJ	O	eligible	amod	22	SENT_63	[p3l948t3258r1039b3285],
22	g.	NN	O	g.	prep_of	19	SENT_63	[p3l1048t3258r1149b3306],
23	a	DT	O	a	det	24	SENT_63	[p3l1048t3258r1149b3306],
24	(	NN	O	(	dep	2	SENT_63	[p3l1048t3258r1149b3306],
25	1	CD	NUMBER	1	number	26	SENT_63	[p3l1048t3258r1149b3306],
26	)	CD	NUMBER	)	num	27	SENT_63	[p3l1048t3258r1149b3306],
27	ti0ents	NNS	O	ti0ent	dep	24	SENT_63	[p3l1048t3258r1149b3306],
28	(	CD	NUMBER	(	num	29	SENT_63	[p3l1158t3258r1182b3285],
29	n	NN	O	n	dep	2	SENT_63	[p3l1158t3258r1182b3285],
30	=	JJ	O	=	amod	32	SENT_63	[p3l1189t3267r1202b3274],
31	19	CD	NUMBER	19	tmod	30	SENT_63	[p3l1210t3258r1253b3285],
32	)	NN	O	)	dep	29	SENT_63	[p3l1210t3258r1253b3285],
33	.	.	O	.	_	0	SENT_63	[p3l1210t3258r1253b3285],

1	The	DT	O	the	det	3	SENT_64	[p3l1261t3258r1307b3280],
2	median	JJ	O	median	amod	3	SENT_64	[p3l1316t3258r1410b3280],
3	PFS	NN	O	pf	nsubj	6	SENT_64	[p3l1419t3259r1461b3280],
4	was	VBD	O	be	cop	6	SENT_64	[p3l1469t3264r1517b3280],
5	7.1	CD	DURATION	7.1	num	6	SENT_64	[p3l1527t3259r1555b3280],
6	months	NNS	NUMBER	month	_	0	SENT_64	[p3l1567t3258r1669b3283],
7	,	,	O	,	_	0	SENT_64	[p3l1567t3258r1669b3283],
8	the	DT	O	the	det	14	SENT_64	[p3l1678t3258r1718b3280],
9	median	JJ	O	median	amod	14	SENT_64	[p3l1727t3258r1821b3280],
10	survival	NN	O	survival	nn	14	SENT_64	[p3l1830t3258r1927b3280],
11	time	NN	O	time	nn	14	SENT_64	[p3l1936t3258r1993b3280],
12	(	CD	NUMBER	(	num	14	SENT_64	[p3l2002t3258r2076b3285],
13	MST	NN	O	mst	nn	14	SENT_64	[p3l2002t3258r2076b3285],
14	)	NN	O	)	nsubj	16	SENT_64	[p3l2002t3258r2076b3285],
15	was	VBD	O	be	cop	16	SENT_64	[p3l2084t3264r2132b3280],
16	months	NNS	DURATION	month	dep	6	SENT_64	[p3l10t3324r218b3375],
17	,	,	O	,	_	0	SENT_64	[p3l10t3324r218b3375],
18	and	CC	O	and	_	0	SENT_64	[p3l237t3324r330b3368],
19	1-year	JJ	DURATION	1-year	amod	21	SENT_64	[p3l351t3327r515b3379],
20	survival	NN	O	survival	nn	21	SENT_64	[p3l532t3324r732b3368],
21	rate	NN	O	rate	nsubj	24	SENT_64	[p3l750t3331r848b3368],
22	was	VBD	O	be	cop	24	SENT_64	[p3l865t3337r963b3368],
23	77	CD	PERCENT	77	num	24	SENT_64	[p3l983t3302r1091b3368],
24	%	NN	PERCENT	%	conj_and	6	SENT_64	[p3l983t3302r1091b3368],
25	;	:	O	;	_	0	SENT_64	[p3l983t3302r1091b3368],

1	study	NN	O	study	_	0	SENT_65	[p4l12t70r189b139],
2	and	CC	O	and	_	0	SENT_65	[p4l218t70r334b125],
3	treated	VBN	O	treat	conj_and	1	SENT_65	[p4l365t70r594b125],
4	with	IN	O	with	_	0	SENT_65	[p4l624t70r773b125],
5	oral	JJ	O	oral	amod	6	SENT_65	[p4l803t70r924b125],
6	administration	NN	O	administration	prep_with	3	SENT_65	[p4l955t70r1434b125],
7	of	IN	O	of	_	0	SENT_65	[p4l1464t70r1531b125],
8	geﬁtinib	NN	O	geﬁtinib	prep_of	6	SENT_65	[p4l1553t70r1820b139],
9	at	IN	O	at	_	0	SENT_65	[p4l1852t78r1911b125],
10	a	DT	O	a	det	11	SENT_65	[p4l1941t86r1973b125],
11	dose	NN	O	dose	prep_at	3	SENT_65	[p4l2004t70r2149b125],
12	of	IN	O	of	_	0	SENT_65	[p4l11t159r77b214],
13	250	CD	NUMBER	250	num	14	SENT_65	[p4l112t162r229b214],
14	mg/day	NN	O	mg/day	prep_of	11	SENT_65	[p4l246t159r488b228],
15	until	IN	O	until	mark	21	SENT_65	[p4l529t159r677b214],
16	disease	NN	O	disease	nn	17	SENT_65	[p4l720t159r953b214],
17	progression	NN	O	progression	nsubj	21	SENT_65	[p4l996t160r1372b228],
18	or	CC	O	or	_	0	SENT_65	[p4l1414t175r1481b214],
19	intolerable	JJ	O	intolerable	amod	20	SENT_65	[p4l1522t159r1868b214],
20	toxicity	NN	O	toxicity	conj_or	17	SENT_65	[p4l1910t160r2152b228],
21	occurred	VBD	O	occur	dep	3	SENT_65	[p4l11t248r309b312],
22	,	,	O	,	_	0	SENT_65	[p4l11t248r309b312],
23	or	CC	O	or	_	0	SENT_65	[p4l339t264r406b303],
24	until	IN	O	until	mark	27	SENT_65	[p4l432t248r581b303],
25	the	DT	O	the	det	26	SENT_65	[p4l610t248r712b303],
26	patient	NN	O	patient	nsubj	27	SENT_65	[p4l742t249r972b317],
27	refused	VBD	O	refuse	conj_or	21	SENT_65	[p4l999t248r1236b303],
28	to	TO	O	to	aux	29	SENT_65	[p4l1265t256r1326b303],
29	continue	VB	O	continue	xcomp	27	SENT_65	[p4l1356t249r1638b303],
30	treatment	NN	O	treatment	dobj	29	SENT_65	[p4l1667t256r2005b304],
31	.	.	O	.	_	0	SENT_65	[p4l1667t256r2005b304],

1	The	DT	O	the	det	3	SENT_66	[p4l2032t248r2149b303],
2	primary	JJ	O	primary	amod	3	SENT_66	[p4l11t338r271b406],
3	endpoint	NN	O	endpoint	nsubj	8	SENT_66	[p4l291t337r582b406],
4	was	VBD	O	be	cop	8	SENT_66	[p4l600t353r724b392],
5	the	DT	O	the	det	8	SENT_66	[p4l745t337r847b392],
6	objective	JJ	O	objective	amod	8	SENT_66	[p4l869t337r1158b406],
7	response	NN	O	response	nn	8	SENT_66	[p4l1181t353r1466b406],
8	rate	NN	O	rate	_	0	SENT_66	[p4l1489t346r1626b393],
9	.	.	O	.	_	0	SENT_66	[p4l1489t346r1626b393],

1	Secondary	JJ	O	secondary	amod	2	SENT_67	[p4l1649t337r1984b406],
2	endpoints	NNS	O	endpoint	nsubj	5	SENT_67	[p4l2003t337r2149b392, p4l11t427r209b495],
3	were	VBD	O	be	cop	5	SENT_67	[p4l242t442r401b482],
4	adverse	JJ	O	adverse	amod	5	SENT_67	[p4l434t427r680b482],
5	effects	NNS	O	effect	_	0	SENT_67	[p4l714t426r939b490],
6	,	,	O	,	_	0	SENT_67	[p4l714t426r939b490],
7	progression	NN	O	progression	npadvmod	9	SENT_67	[p4l973t426r1504b495],
8	—	CD	NUMBER	—	num	7	SENT_67	[p4l973t426r1504b495],
9	free	JJ	O	free	amod	10	SENT_67	[p4l973t426r1504b495],
10	survival	NN	O	survival	conj_and	5	SENT_67	[p4l1539t427r1789b482],
11	(	CD	NUMBER	(	num	13	SENT_67	[p4l1823t427r1999b495],
12	PFS	NN	O	pf	nn	13	SENT_67	[p4l1823t427r1999b495],
13	)	NN	O	)	dep	10	SENT_67	[p4l1823t427r1999b495],
14	,	,	O	,	_	0	SENT_67	[p4l1823t427r1999b495],
15	and	CC	O	and	_	0	SENT_67	[p4l2033t427r2149b482],
16	overall	JJ	O	overall	amod	17	SENT_67	[p4l11t516r226b571],
17	survival	NN	O	survival	conj_and	5	SENT_67	[p4l252t516r501b571],
18	(	CD	NUMBER	(	num	20	SENT_67	[p4l526t516r677b584],
19	OS	NN	O	os	nn	20	SENT_67	[p4l526t516r677b584],
20	)	NN	O	)	dep	17	SENT_67	[p4l526t516r677b584],
21	.	.	O	.	_	0	SENT_67	[p4l526t516r677b584],

1	This	DT	O	this	det	2	SENT_68	[p4l700t516r832b571],
2	study	NN	O	study	nsubjpass	4	SENT_68	[p4l858t516r1035b584],
3	was	VBD	O	be	auxpass	4	SENT_68	[p4l1056t532r1179b571],
4	approved	VBN	O	approve	_	0	SENT_68	[p4l1204t516r1505b584],
5	by	IN	O	by	_	0	SENT_68	[p4l1529t516r1605b584],
6	the	DT	O	the	det	9	SENT_68	[p4l1627t516r1729b571],
7	Institutional	JJ	ORGANIZATION	institutional	amod	9	SENT_68	[p4l1754t516r2149b571],
8	Review	NNP	ORGANIZATION	Review	nn	9	SENT_68	[p4l11t605r243b659],
9	Board	NNP	ORGANIZATION	Board	agent	4	SENT_68	[p4l279t604r463b659],
10	of	IN	ORGANIZATION	of	_	0	SENT_68	[p4l501t604r567b659],
11	University	NNP	ORGANIZATION	University	prep_of	9	SENT_68	[p4l596t605r927b673],
12	of	IN	ORGANIZATION	of	_	0	SENT_68	[p4l962t604r1029b659],
13	Occupational	NNP	ORGANIZATION	Occupational	nn	16	SENT_68	[p4l1058t604r1481b673],
14	and	CC	ORGANIZATION	and	_	0	SENT_68	[p4l1519t604r1635b659],
15	Environmental	NNP	ORGANIZATION	Environmental	nn	16	SENT_68	[p4l1673t604r2149b659],
16	Health	NNP	ORGANIZATION	Health	prep_of	11	SENT_68	[p4l11t693r239b748],
17	.	.	O	.	_	0	SENT_68	[p4l11t693r239b748],

1	2.2	CD	NUMBER	2.2	_	0	SENT_69	[p4l7t900r113b952],
2	.	.	O	.	_	0	SENT_69	[p4l7t900r113b952],

1	Patients	NNS	O	patient	_	0	SENT_70	[p4l162t898r409b952],
2	eligibility	NN	O	eligibility	dep	1	SENT_70	[p4l431t897r717b965],
3	and	CC	O	and	_	0	SENT_70	[p4l739t897r853b952],
4	treatment	NN	O	treatment	nn	5	SENT_70	[p4l877t905r1184b952],
5	plan	NN	O	plan	dep	1	SENT_70	[p4l1198t897r1334b965],

1	The	DT	O	the	det	4	SENT_71	[p4l110t1075r227b1130],
2	primary	JJ	O	primary	amod	4	SENT_71	[p4l260t1076r520b1144],
3	entry	NN	O	entry	nn	4	SENT_71	[p4l550t1083r722b1144],
4	criteria	NNS	O	criterion	nsubj	9	SENT_71	[p4l752t1076r982b1130],
5	for	IN	O	for	_	0	SENT_71	[p4l1014t1075r1104b1130],
6	this	DT	O	this	det	7	SENT_71	[p4l1133t1075r1249b1130],
7	study	NN	O	study	prep_for	4	SENT_71	[p4l1284t1075r1460b1144],
8	were	VBD	O	be	cop	9	SENT_71	[p4l1489t1091r1648b1130],
9	adults	NNS	O	adult	_	0	SENT_71	[p4l1680t1075r1875b1130],
10	(	CD	NUMBER	(	num	11	SENT_71	[p4l1908t1075r2040b1144],
11	age	NN	O	age	dep	9	SENT_71	[p4l1908t1075r2040b1144],
12	20	CD	DURATION	20	num	13	SENT_71	[p4l2073t1078r2150b1130],
13	years	NNS	NUMBER	year	tmod	9	SENT_71	[p4l9t1180r176b1233],
14	or	CC	O	or	_	0	SENT_71	[p4l200t1180r266b1219],
15	older	JJR	O	older	amod	16	SENT_71	[p4l287t1164r477b1233],
16	)	NN	O	)	conj_or	9	SENT_71	[p4l287t1164r477b1233],
17	with	IN	O	with	_	0	SENT_71	[p4l498t1164r647b1219],
18	histologically	RB	O	histologically	dep	23	SENT_71	[p4l669t1164r1098b1233],
19	or	CC	O	or	_	0	SENT_71	[p4l1119t1180r1185b1219],
20	cytologically	RB	O	cytologically	advmod	21	SENT_71	[p4l1206t1164r1612b1233],
21	conﬁrmed	JJ	O	conﬁrmed	conj_or	18	SENT_71	[p4l1633t1164r1963b1219],
22	stage	NN	O	stage	nn	23	SENT_71	[p4l1987t1172r2149b1233],
23	IIIB	NN	O	iiib	prep_with	16	SENT_71	[p4l11t1257r114b1308],
24	or	CC	O	or	_	0	SENT_71	[p4l153t1269r220b1309],
25	IV	CD	NUMBER	iv	conj_or	9	SENT_71	[p4l257t1257r336b1317],
26	,	,	O	,	_	0	SENT_71	[p4l257t1257r336b1317],
27	or	CC	O	or	_	0	SENT_71	[p4l376t1269r443b1309],
28	recurrent	JJ	O	recurrent	amod	29	SENT_71	[p4l480t1262r781b1309],
29	NSCLC	NN	O	nsclc	conj_or	9	SENT_71	[p4l819t1256r1025b1309],
30	after	IN	O	after	_	0	SENT_71	[p4l1063t1253r1213b1309],
31	surgery	NN	O	surgery	prep_after	29	SENT_71	[p4l1251t1269r1503b1322],
32	.	.	O	.	_	0	SENT_71	[p4l1251t1269r1503b1322],

1	Secondary	JJ	O	secondary	amod	3	SENT_72	[p4l1544t1254r1879b1322],
2	eligible	JJ	O	eligible	amod	3	SENT_72	[p4l1916t1254r2149b1322],
3	patients	NNS	O	patient	nsubj	7	SENT_72	[p4l11t1344r269b1411],
4	for	IN	O	for	_	0	SENT_72	[p4l298t1343r387b1398],
5	geﬁtinib	NN	O	geﬁtinib	nn	6	SENT_72	[p4l411t1343r679b1411],
6	treatment	NN	O	treatment	prep_for	3	SENT_72	[p4l706t1351r1030b1398],
7	included	VBD	O	include	_	0	SENT_72	[p4l1056t1343r1354b1398],
8	:	:	O	:	_	0	SENT_72	[p4l1056t1343r1354b1398],
9	(	VB	O	(	parataxis	7	SENT_72	[p4l1386t1343r1470b1411],
10	a	DT	O	a	det	24	SENT_72	[p4l1386t1343r1470b1411],
11	)	JJ	O	)	amod	13	SENT_72	[p4l1386t1343r1470b1411],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_72	[p4l1498t1346r1665b1398],
13	mutations	NNS	O	mutation	nn	24	SENT_72	[p4l1690t1344r2033b1406],
14	,	,	O	,	_	0	SENT_72	[p4l1690t1344r2033b1406],
15	(	NN	O	(	nn	16	SENT_72	[p4l2062t1343r2150b1411],
16	b	NN	O	b	appos	13	SENT_72	[p4l2062t1343r2150b1411],
17	)	CD	NUMBER	)	num	21	SENT_72	[p4l2062t1343r2150b1411],
18	measurable	JJ	O	measurable	amod	21	SENT_72	[p4l11t1431r383b1486],
19	or	CC	O	or	_	0	SENT_72	[p4l415t1447r481b1486],
20	assessable	JJ	O	assessable	conj_or	18	SENT_72	[p4l510t1431r841b1486],
21	lesions	NNS	O	lesion	dep	16	SENT_72	[p4l873t1431r1109b1494],
22	,	,	O	,	_	0	SENT_72	[p4l873t1431r1109b1494],
23	(	NN	O	(	nn	24	SENT_72	[p4l1141t1431r1222b1499],
24	c	NN	O	c	dobj	9	SENT_72	[p4l1141t1431r1222b1499],
25	)	CD	NUMBER	)	dep	37	SENT_72	[p4l1141t1431r1222b1499],
26	Eastern	NNP	ORGANIZATION	Eastern	nn	28	SENT_72	[p4l1254t1434r1492b1486],
27	Cooperative	NNP	ORGANIZATION	Cooperative	nn	28	SENT_72	[p4l1523t1432r1905b1500],
28	Oncology	NNP	ORGANIZATION	Oncology	dep	25	SENT_72	[p4l1937t1431r2149b1486, p4l11t1536r125b1589],
29	group	NN	O	group	dep	37	SENT_72	[p4l156t1536r343b1589],
30	(	CD	NUMBER	(	num	29	SENT_72	[p4l378t1520r607b1588],
31	ECOG	NN	O	ecog	nn	37	SENT_72	[p4l378t1520r607b1588],
32	)	NN	O	)	nn	37	SENT_72	[p4l378t1520r607b1588],
33	performance	NN	O	performance	nn	37	SENT_72	[p4l642t1520r1054b1589],
34	status	NN	O	status	nn	37	SENT_72	[p4l1090t1528r1277b1575],
35	(	CD	NUMBER	(	num	37	SENT_72	[p4l1312t1520r1437b1588],
36	PS	NNP	O	PS	nn	37	SENT_72	[p4l1312t1520r1437b1588],
37	)	NN	O	)	dep	24	SENT_72	[p4l1312t1520r1437b1588],
38	of	IN	O	of	_	0	SENT_72	[p4l1471t1520r1538b1575],
39	0-2	CD	NUMBER	0-2	prep_of	37	SENT_72	[p4l1565t1523r1698b1584],
40	,	,	O	,	_	0	SENT_72	[p4l1565t1523r1698b1584],
41	(	CD	NUMBER	(	num	42	SENT_72	[p4l1733t1520r1822b1588],
42	d	NN	O	d	appos	39	SENT_72	[p4l1733t1520r1822b1588],
43	)	CD	NUMBER	)	num	46	SENT_72	[p4l1733t1520r1822b1588],
44	adequate	JJ	O	adequate	amod	46	SENT_72	[p4l1857t1520r2150b1589],
45	organ	NN	O	organ	nn	46	SENT_72	[p4l11t1625r192b1678],
46	function	NN	O	function	nsubj	9	SENT_72	[p4l224t1609r508b1665],
47	.	.	O	.	_	0	SENT_72	[p4l224t1609r508b1665],

1	The	DT	O	the	det	3	SENT_73	[p4l538t1609r656b1664],
2	exclusion	NN	O	exclusion	nn	3	SENT_73	[p4l688t1609r990b1664],
3	criteria	NNS	O	criterion	nsubj	4	SENT_73	[p4l1022t1610r1251b1664],
4	included	VBD	O	include	_	0	SENT_73	[p4l1283t1609r1561b1664],
5	interstitial	JJ	O	interstitial	amod	6	SENT_73	[p4l1594t1609r1928b1664],
6	pneumonia	NN	O	pneumonia	dobj	4	SENT_73	[p4l1961t1625r2149b1678, p4l11t1699r213b1753],
7	or	CC	O	or	_	0	SENT_73	[p4l248t1714r314b1753],
8	pulmonary	JJ	O	pulmonary	amod	9	SENT_73	[p4l347t1698r704b1767],
9	ﬁbrosis	NN	O	ﬁbrosis	dobj	4	SENT_73	[p4l738t1698r969b1753],
10	as	IN	O	as	mark	14	SENT_73	[p4l1005t1714r1068b1753],
11	determined	VBN	O	determine	csubj	14	SENT_73	[p4l1104t1698r1479b1753],
12	by	IN	O	by	_	0	SENT_73	[p4l1514t1698r1590b1767],
13	chest	NN	O	chest	prep_by	11	SENT_73	[p4l1624t1698r1791b1753],
14	computed	VBD	O	compute	advcl	4	SENT_73	[p4l1825t1698r2149b1767],
15	tomography	NN	O	tomography	nn	18	SENT_73	[p4l10t1787r404b1856],
16	(	CD	NUMBER	(	num	18	SENT_73	[p4l420t1788r565b1856],
17	CT	NN	O	ct	nn	18	SENT_73	[p4l420t1788r565b1856],
18	)	NN	O	)	dobj	14	SENT_73	[p4l420t1788r565b1856],
19	,	,	O	,	_	0	SENT_73	[p4l420t1788r565b1856],
20	or	CC	O	or	_	0	SENT_73	[p4l584t1803r651b1843],
21	prior	JJ	O	prior	amod	22	SENT_73	[p4l667t1788r826b1856],
22	treatment	NN	O	treatment	dobj	14	SENT_73	[p4l841t1796r1165b1843],
23	with	IN	O	with	_	0	SENT_73	[p4l1180t1788r1328b1843],
24	an	DT	O	a	det	25	SENT_73	[p4l1346t1803r1421b1843],
25	EGFR	NN	ORGANIZATION	egfr	prep_with	22	SENT_73	[p4l1440t1790r1751b1843],
26	.	.	O	.	_	0	SENT_73	[p4l1440t1790r1751b1843],

1	—	NN	O	—	_	0	SENT_74	[p4l1440t1790r1751b1843],
2	.	.	O	.	_	0	SENT_74	[p4l1440t1790r1751b1843],

1	TI	NNP	O	TI	_	0	SENT_75	[p4l1440t1790r1751b1843],
2	(	CD	NUMBER	(	num	1	SENT_75	[p4l1440t1790r1751b1843],
3	I	PRP	O	I	dep	1	SENT_75	[p4l1440t1790r1751b1843],
4	or	CC	O	or	_	0	SENT_75	[p4l1770t1803r1836b1843],
5	antibody	NN	O	antibody	dep	1	SENT_75	[p4l1852t1788r2149b1856],
6	.	.	O	.	_	0	SENT_75	[p4l1852t1788r2149b1856],

1	No	DT	O	no	det	2	SENT_76	[p4l11t1880r97b1932],
2	radiotherapy	NN	O	radiotherapy	nsubjpass	4	SENT_76	[p4l125t1877r539b1945],
3	was	VBD	O	be	auxpass	4	SENT_76	[p4l562t1893r685b1932],
4	performed	VBN	O	perform	_	0	SENT_76	[p4l713t1877r1054b1945],
5	in	IN	O	in	_	0	SENT_76	[p4l1082t1878r1141b1931],
6	patients	NNS	O	patient	prep_in	4	SENT_76	[p4l1167t1878r1426b1945],
7	with	IN	O	with	_	0	SENT_76	[p4l1452t1877r1600b1932],
8	stage	NN	O	stage	nn	9	SENT_76	[p4l1627t1885r1790b1945],
9	IIIB	NN	O	iiib	prep_with	6	SENT_76	[p4l1818t1880r1920b1931],
10	before	IN	O	before	_	0	SENT_76	[p4l1946t1877r2150b1932],
11	geﬁtinib	NN	O	geﬁtinib	nn	12	SENT_76	[p4l10t1965r277b2034],
12	treatment	NN	O	treatment	prep_before	4	SENT_76	[p4l302t1973r640b2021],
13	.	.	O	.	_	0	SENT_76	[p4l302t1973r640b2021],

1	Written	VBN	O	write	csubjpass	5	SENT_77	[p4l664t1966r917b2020],
2	informed	JJ	O	informed	amod	3	SENT_77	[p4l943t1965r1239b2020],
3	consent	NN	O	consent	dobj	1	SENT_77	[p4l1265t1973r1517b2020],
4	was	VBD	O	be	auxpass	5	SENT_77	[p4l1539t1981r1662b2020],
5	obtained	VBN	O	obtain	_	0	SENT_77	[p4l1689t1965r1972b2020],
6	from	IN	O	from	_	0	SENT_77	[p4l1998t1965r2150b2020],
7	all	DT	O	all	det	8	SENT_77	[p4l11t2054r84b2109],
8	patients	NNS	O	patient	prep_from	5	SENT_77	[p4l115t2055r390b2123],
9	.	.	O	.	_	0	SENT_77	[p4l115t2055r390b2123],

1	Five	CD	NUMBER	five	nsubjpass	39	SENT_78	[p4l421t2055r545b2109],
2	acquired	VBN	O	acquire	partmod	1	SENT_78	[p4l575t2054r852b2123],
3	resistant	JJ	O	resistant	amod	4	SENT_78	[p4l883t2055r1161b2109],
4	tumors	NNS	O	tumor	dobj	2	SENT_78	[p4l1188t2062r1418b2109],
5	to	TO	O	to	aux	6	SENT_78	[p4l1449t2062r1509b2109],
6	geﬁtinib	VB	O	geﬁtinib	xcomp	2	SENT_78	[p4l1538t2054r1806b2123],
7	(	NN	O	(	nn	9	SENT_78	[p4l1836t2054r1890b2122],
8	1	CD	NUMBER	1	num	9	SENT_78	[p4l1836t2054r1890b2122],
9	lung	NN	O	lung	dobj	6	SENT_78	[p4l1928t2054r2083b2123],
10	,	,	O	,	_	0	SENT_78	[p4l1928t2054r2083b2123],
11	2	CD	NUMBER	2	num	13	SENT_78	[p4l2114t2057r2148b2109],
12	lymph	NN	O	lymph	nn	13	SENT_78	[p4l11t2143r216b2212],
13	nodes	NNS	O	node	conj_and	9	SENT_78	[p4l244t2143r448b2207],
14	,	,	O	,	_	0	SENT_78	[p4l244t2143r448b2207],
15	and	CC	O	and	_	0	SENT_78	[p4l477t2143r593b2198],
16	2	CD	NUMBER	2	num	19	SENT_78	[p4l622t2146r656b2198],
17	pleural	JJ	O	pleural	amod	19	SENT_78	[p4l686t2143r910b2212],
18	effusion	NN	O	effusion	nn	19	SENT_78	[p4l938t2143r1238b2212],
19	)	NN	O	)	conj_and	9	SENT_78	[p4l938t2143r1238b2212],
20	,	,	O	,	_	0	SENT_78	[p4l938t2143r1238b2212],
21	which	WDT	O	which	nsubjpass	23	SENT_78	[p4l1266t2143r1464b2198],
22	were	VBD	O	be	auxpass	23	SENT_78	[p4l1490t2159r1648b2198],
23	deﬁned	VBN	O	deﬁned	rcmod	1	SENT_78	[p4l1677t2143r1918b2198],
24	by	IN	O	by	_	0	SENT_78	[p4l1946t2143r2022b2212],
25	the	DT	O	the	det	26	SENT_78	[p4l2048t2143r2149b2198],
26	criteria	NNS	O	criterion	agent	23	SENT_78	[p4l11t2233r240b2287],
27	of	IN	O	of	_	0	SENT_78	[p4l268t2232r335b2287],
28	Response	NN	O	response	nn	30	SENT_78	[p4l355t2236r655b2301],
29	Evaluation	NN	O	evaluation	nn	30	SENT_78	[p4l684t2232r1024b2287],
30	Criteria	NNS	O	criterion	prep_of	26	SENT_78	[p4l1052t2233r1290b2287],
31	in	IN	O	in	_	0	SENT_78	[p4l1319t2233r1378b2287],
32	Solid	JJ	O	solid	amod	33	SENT_78	[p4l1406t2232r1562b2287],
33	Tumors	NNS	O	tumor	prep_in	23	SENT_78	[p4l1588t2236r1832b2287],
34	(	VBP	O	(	dep	33	SENT_78	[p4l1862t2233r2149b2301],
35	RECIST	NN	O	recist	dobj	34	SENT_78	[p4l1862t2233r2149b2301],
36	)	CD	NUMBER	)	num	35	SENT_78	[p4l1862t2233r2149b2301],
37	,	,	O	,	_	0	SENT_78	[p4l1862t2233r2149b2301],
38	were	VBD	O	be	auxpass	39	SENT_78	[p4l9t2337r167b2377],
39	obtained	VBN	O	obtain	_	0	SENT_78	[p4l189t2322r488b2385],
40	,	,	O	,	_	0	SENT_78	[p4l189t2322r488b2385],
41	and	CC	O	and	_	0	SENT_78	[p4l510t2322r627b2377],
42	analysis	NN	O	analysis	nsubjpass	49	SENT_78	[p4l649t2322r902b2390],
43	of	IN	O	of	_	0	SENT_78	[p4l924t2321r991b2377],
44	the	DT	O	the	det	46	SENT_78	[p4l1003t2322r1105b2377],
45	EGFR	NN	ORGANIZATION	egfr	nn	46	SENT_78	[p4l1127t2324r1294b2377],
46	exon	NN	O	exon	prep_of	42	SENT_78	[p4l1313t2337r1464b2377],
47	20	CD	NUMBER	20	dep	46	SENT_78	[p4l1486t2324r1562b2377],
48	was	VBD	O	be	auxpass	49	SENT_78	[p4l1582t2337r1705b2377],
49	performed	VBN	O	perform	conj_and	39	SENT_78	[p4l1728t2321r2069b2390],
50	in	IN	O	in	_	0	SENT_78	[p4l2091t2322r2150b2376],
51	these	DT	O	these	det	52	SENT_78	[p4l10t2411r181b2465],
52	tumors	NNS	O	tumor	prep_in	49	SENT_78	[p4l203t2419r450b2466],
53	.	.	O	.	_	0	SENT_78	[p4l203t2419r450b2466],

1	2.3	CD	NUMBER	2.3	_	0	SENT_79	[p4l7t2617r113b2670],
2	.	.	O	.	_	0	SENT_79	[p4l7t2617r113b2670],

1	Evaluation	NN	O	evaluation	_	0	SENT_80	[p4l162t2615r491b2670],
2	of	IN	O	of	_	0	SENT_80	[p4l514t2614r581b2683],
3	efﬁcacy	NN	O	efﬁcacy	prep_of	1	SENT_80	[p4l591t2614r823b2683],
4	and	CC	O	and	_	0	SENT_80	[p4l844t2614r958b2670],
5	toxicity	NN	O	toxicity	prep_of	1	SENT_80	[p4l982t2616r1206b2683],

1	The	DT	O	the	det	3	SENT_81	[p4l110t2793r227b2848],
2	objective	JJ	O	objective	amod	3	SENT_81	[p4l263t2793r553b2861],
3	response	NN	O	response	nsubjpass	8	SENT_81	[p4l589t2809r874b2861],
4	of	IN	O	of	_	0	SENT_81	[p4l911t2793r978b2848],
5	the	DT	O	the	det	6	SENT_81	[p4l1005t2793r1107b2848],
6	patients	NNS	O	patient	prep_of	3	SENT_81	[p4l1143t2794r1401b2861],
7	were	VBD	O	be	auxpass	8	SENT_81	[p4l1437t2809r1595b2848],
8	evaluated	VBN	O	evaluate	_	0	SENT_81	[p4l1631t2793r1942b2848],
9	using	VBG	O	use	xcomp	8	SENT_81	[p4l1979t2794r2151b2861],
10	the	DT	O	the	det	11	SENT_81	[p4l10t2881r112b2936],
11	RECIST	NNP	O	RECIST	dobj	9	SENT_81	[p4l145t2884r376b2945],
12	,	,	O	,	_	0	SENT_81	[p4l145t2884r376b2945],
13	and	CC	O	and	_	0	SENT_81	[p4l410t2881r526b2936],
14	routine	JJ	O	routine	amod	15	SENT_81	[p4l560t2882r792b2936],
15	clinical	JJ	O	clinical	nsubjpass	31	SENT_81	[p4l826t2881r1052b2936],
16	and	CC	O	and	_	0	SENT_81	[p4l1086t2881r1202b2936],
17	laboratory	JJ	O	laboratory	amod	18	SENT_81	[p4l1236t2881r1570b2950],
18	assessments	NNS	O	assessment	nsubjpass	31	SENT_81	[p4l1601t2889r1999b2936],
19	and	CC	O	and	_	0	SENT_81	[p4l2033t2881r2149b2936],
20	chest	NN	O	chest	nn	21	SENT_81	[p4l11t2970r178b3025],
21	X	NN	O	x	nsubjpass	31	SENT_81	[p4l198t2974r373b3039],
22	—	CD	NUMBER	—	num	23	SENT_81	[p4l198t2974r373b3039],
23	ray	NN	O	ray	nsubjpass	25	SENT_81	[p4l198t2974r373b3039],
24	were	VBD	O	be	auxpass	25	SENT_81	[p4l393t2986r552b3025],
25	performed	VBN	O	perform	rcmod	21	SENT_81	[p4l577t2970r918b3039],
26	biweekly	RB	SET	biweekly	advmod	25	SENT_81	[p4l941t2970r1234b3039],
27	and	CC	O	and	_	0	SENT_81	[p4l1256t2970r1372b3025],
28	CT	NN	O	ct	nsubj	29	SENT_81	[p4l1397t2973r1476b3025],
29	scan	VBP	O	scan	rcmod	21	SENT_81	[p4l1499t2986r1638b3025],
30	was	VBD	O	be	auxpass	31	SENT_81	[p4l1660t2986r1783b3025],
31	performed	VBN	O	perform	conj_and	8	SENT_81	[p4l1808t2970r2149b3039],
32	1	CD	DURATION	1	num	33	SENT_81	[p4l14t3062r38b3114],
33	month	NN	NUMBER	month	dobj	31	SENT_81	[p4l71t3059r284b3114],
34	after	IN	O	after	dep	33	SENT_81	[p4l307t3059r458b3114],
35	the	DT	O	the	det	36	SENT_81	[p4l479t3059r580b3114],
36	start	NN	O	start	pobj	34	SENT_81	[p4l605t3067r750b3114],
37	of	IN	O	of	_	0	SENT_81	[p4l773t3059r839b3114],
38	geﬁtinib	NN	O	geﬁtinib	prep_of	36	SENT_81	[p4l854t3059r1122b3128],
39	and	CC	O	and	_	0	SENT_81	[p4l1146t3059r1262b3114],
40	thereafter	RB	O	thereafter	conj_and	34	SENT_81	[p4l1286t3059r1608b3114],
41	every	DT	SET	every	quantmod	42	SENT_81	[p4l1630t3075r1807b3128],
42	3	CD	SET	3	num	43	SENT_81	[p4l1828t3062r1862b3114],
43	months	NNS	NUMBER	month	tmod	31	SENT_81	[p4l1889t3059r2149b3123],
44	,	,	O	,	_	0	SENT_81	[p4l1889t3059r2149b3123],
45	and	CC	O	and	_	0	SENT_81	[p4l11t3149r127b3204],
46	imaging	NN	O	imaging	nn	47	SENT_81	[p4l144t3149r404b3217],
47	studies	NNS	O	study	nsubj	48	SENT_81	[p4l419t3149r645b3204],
48	(	VBP	O	(	conj_and	8	SENT_81	[p4l661t3149r843b3217],
49	bone	NN	O	bone	nsubj	50	SENT_81	[p4l661t3149r843b3217],
50	scan	VB	O	scan	ccomp	48	SENT_81	[p4l860t3164r1000b3204],
51	and	CC	O	and	_	0	SENT_81	[p4l1015t3149r1131b3204],
52	brain	NN	O	brain	nn	54	SENT_81	[p4l1147t3148r1313b3204],
53	imaging	NN	O	imaging	nn	54	SENT_81	[p4l1328t3149r1613b3217],
54	)	NN	O	)	nsubjpass	56	SENT_81	[p4l1328t3149r1613b3217],
55	were	VBD	O	be	auxpass	56	SENT_81	[p4l1627t3164r1786b3204],
56	done	VBN	O	do	conj_and	8	SENT_81	[p4l1802t3149r1959b3204],
57	every	DT	SET	every	det	59	SENT_81	[p4l1975t3164r2152b3217],
58	3	CD	SET	3	num	59	SENT_81	[p4l9t3241r44b3293],
59	months	NNS	NUMBER	month	tmod	56	SENT_81	[p4l83t3238r326b3293],
60	after	IN	O	after	_	0	SENT_81	[p4l362t3238r512b3293],
61	the	DT	O	the	det	62	SENT_81	[p4l545t3238r647b3293],
62	initiation	NN	O	initiation	prep_after	56	SENT_81	[p4l683t3239r978b3293],
63	of	IN	O	of	_	0	SENT_81	[p4l1014t3238r1080b3293],
64	geﬁtinib	NN	O	geﬁtinib	nn	65	SENT_81	[p4l1106t3238r1374b3306],
65	treatment	NN	O	treatment	prep_of	62	SENT_81	[p4l1409t3246r1747b3293],
66	.	.	O	.	_	0	SENT_81	[p4l1409t3246r1747b3293],

1	All	DT	O	all	det	3	SENT_82	[p4l1781t3238r1867b3292],
2	adverse	JJ	O	adverse	amod	3	SENT_82	[p4l1904t3238r2149b3293],
3	effects	NNS	O	effect	nsubjpass	5	SENT_82	[p4l11t3327r218b3382],
4	were	VBD	O	be	auxpass	5	SENT_82	[p4l246t3343r405b3382],
5	graded	VBN	O	grade	_	0	SENT_82	[p4l432t3327r654b3395],
6	using	VBG	O	use	xcomp	5	SENT_82	[p4l683t3328r856b3395],
7	the	DT	O	the	det	13	SENT_82	[p4l882t3327r984b3382],
8	National	NNP	ORGANIZATION	National	nn	13	SENT_82	[p4l1014t3327r1284b3382],
9	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_82	[p4l1313t3330r1532b3382],
10	Institute	NNP	ORGANIZATION	Institute	nn	13	SENT_82	[p4l1559t3328r1829b3382],
11	Common	NNP	O	Common	nn	13	SENT_82	[p4l1858t3330r2150b3382],
12	Terminology	NNP	O	Terminology	nn	13	SENT_82	[p4l8t3415r417b3484],
13	Criteria	NNP	O	Criteria	dobj	6	SENT_82	[p4l438t3416r676b3470],
14	for	IN	O	for	_	0	SENT_82	[p4l699t3415r788b3470],
15	Adverse	JJ	O	adverse	amod	16	SENT_82	[p4l806t3415r1064b3470],
16	Events	NNS	O	event	prep_for	13	SENT_82	[p4l1087t3418r1313b3478],
17	,	,	O	,	_	0	SENT_82	[p4l1087t3418r1313b3478],
18	version	NN	O	version	appos	16	SENT_82	[p4l1334t3416r1571b3470],
19	3.0	CD	NUMBER	3.0	num	18	SENT_82	[p4l1592t3418r1702b3471],
20	.	.	O	.	_	0	SENT_82	[p4l1592t3418r1702b3471],

1	2.4	CD	NUMBER	2.4	_	0	SENT_83	[p4l7t3623r113b3675],
2	.	.	O	.	_	0	SENT_83	[p4l7t3623r113b3675],

1	Mutation	NN	O	mutation	nn	2	SENT_84	[p4l162t3621r449b3675],
2	analysis	NN	O	analysis	_	0	SENT_84	[p4l472t3620r718b3688],
3	of	IN	O	of	_	0	SENT_84	[p4l740t3620r806b3688],
4	the	DT	O	the	det	5	SENT_84	[p4l818t3620r911b3675],
5	EGFR	NN	ORGANIZATION	egfr	prep_of	2	SENT_84	[p4l931t3623r1089b3675],

1	Genomic	JJ	O	genomic	amod	2	SENT_85	[p5l113t63r400b117],
2	DNA	NN	O	dna	nsubjpass	4	SENT_85	[p5l437t65r581b117],
3	was	VBD	O	be	auxpass	4	SENT_85	[p5l615t78r738b117],
4	extracted	VBN	O	extract	_	0	SENT_85	[p5l777t62r1077b117],
5	and	CC	O	and	_	0	SENT_85	[p5l1115t62r1231b117],
6	puriﬁed	VBN	O	puriﬁed	conj_and	4	SENT_85	[p5l1270t62r1523b131],
7	from	IN	O	from	_	0	SENT_85	[p5l1562t62r1714b117],
8	fresh	JJ	O	fresh	amod	10	SENT_85	[p5l1752t62r1910b117],
9	frozen	JJ	O	frozen	amod	10	SENT_85	[p5l1948t62r2150b117],
10	tumors	NNS	O	tumor	prep_from	4	SENT_85	[p5l10t159r256b215],
11	,	,	O	,	_	0	SENT_85	[p5l10t159r256b215],
12	tumors	NNS	O	tumor	appos	10	SENT_85	[p5l286t159r516b206],
13	embedded	VBN	O	embed	partmod	12	SENT_85	[p5l546t151r887b206],
14	in	IN	O	in	_	0	SENT_85	[p5l917t152r976b206],
15	parafﬁn	NN	O	parafﬁn	nn	16	SENT_85	[p5l1005t151r1255b220],
16	blocks	NNS	O	block	prep_in	13	SENT_85	[p5l1283t151r1501b215],
17	,	,	O	,	_	0	SENT_85	[p5l1283t151r1501b215],
18	or	CC	O	or	_	0	SENT_85	[p5l1532t167r1598b206],
19	aspirated	JJ	O	aspirated	amod	21	SENT_85	[p5l1625t151r1922b220],
20	tumor	NN	O	tumor	nn	21	SENT_85	[p5l1951t159r2152b206],
21	cells	NNS	O	cell	appos	10	SENT_85	[p5l11t240r150b295],
22	obtained	VBN	O	obtain	partmod	21	SENT_85	[p5l170t240r453b295],
23	from	IN	O	from	_	0	SENT_85	[p5l473t240r625b295],
24	pleural	JJ	O	pleural	amod	25	SENT_85	[p5l644t240r868b309],
25	effusions	NNS	O	effusion	prep_from	22	SENT_85	[p5l887t240r1193b296],
26	.	.	O	.	_	0	SENT_85	[p5l887t240r1193b296],

1	A	DT	O	a	det	3	SENT_86	[p5l1210t243r1257b295],
2	mutational	JJ	O	mutational	amod	3	SENT_86	[p5l1275t240r1628b295],
3	analysis	NN	O	analysis	nsubjpass	19	SENT_86	[p5l1648t240r1901b309],
4	of	IN	O	of	_	0	SENT_86	[p5l1921t240r1988b295],
5	exon	NN	O	exon	nn	7	SENT_86	[p5l1999t256r2150b295],
6	19	CD	NUMBER	19	num	7	SENT_86	[p5l14t332r82b385],
7	deletion	NN	O	deletion	prep_of	3	SENT_86	[p5l113t330r376b385],
8	and	CC	O	and	_	0	SENT_86	[p5l405t330r521b385],
9	exon	NN	O	exon	nn	12	SENT_86	[p5l551t345r703b385],
10	21	CD	NUMBER	21	num	12	SENT_86	[p5l732t332r798b384],
11	L858R	NN	O	l858r	nn	12	SENT_86	[p5l836t332r1035b385],
12	point	NN	O	point	nn	13	SENT_86	[p5l1062t330r1232b398],
13	mutation	NN	O	mutation	conj_and	3	SENT_86	[p5l1260t330r1557b385],
14	of	IN	O	of	_	0	SENT_86	[p5l1586t329r1653b385],
15	the	DT	O	the	det	17	SENT_86	[p5l1674t330r1776b385],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_86	[p5l1807t332r1974b385],
17	gene	NN	O	gene	prep_of	13	SENT_86	[p5l1999t345r2150b398],
18	was	VBD	O	be	auxpass	19	SENT_86	[p5l9t435r132b474],
19	performed	VBN	O	perform	_	0	SENT_86	[p5l156t419r497b487],
20	as	IN	O	as	mark	22	SENT_86	[p5l520t435r582b474],
21	previously	RB	DATE	previously	advmod	22	SENT_86	[p5l606t419r943b487],
22	described	VBN	O	describe	advcl	19	SENT_86	[p5l964t419r1275b474],
23	[	CD	NUMBER	[	number	24	SENT_86	[p5l1301t419r1401b487],
24	9	CD	NUMBER	9	num	25	SENT_86	[p5l1301t419r1401b487],
25	]	NN	O	]	dobj	22	SENT_86	[p5l1301t419r1401b487],
26	.	.	O	.	_	0	SENT_86	[p5l1301t419r1401b487],

1	For	IN	O	for	_	0	SENT_87	[p5l113t510r214b562],
2	the	DT	O	the	det	3	SENT_87	[p5l271t507r373b562],
3	detection	NN	O	detection	prep_for	16	SENT_87	[p5l432t507r734b562],
4	of	IN	O	of	_	0	SENT_87	[p5l793t507r860b562],
5	the	DT	O	the	prep_of	3	SENT_87	[p5l910t507r1012b562],
6	in	IN	O	in	_	0	SENT_87	[p5l1072t507r1351b562],
7	—	NN	O	—	nn	9	SENT_87	[p5l1072t507r1351b562],
8	frame	NN	O	frame	nn	9	SENT_87	[p5l1072t507r1351b562],
9	deletion	NN	O	deletion	prep_in	5	SENT_87	[p5l1410t507r1674b562],
10	in	IN	O	in	_	0	SENT_87	[p5l1733t508r1792b562],
11	exon	NN	O	exon	prep_in	9	SENT_87	[p5l1851t523r2002b562],
12	19	CD	NUMBER	19	num	11	SENT_87	[p5l2065t510r2149b571],
13	,	,	O	,	_	0	SENT_87	[p5l2065t510r2149b571],
14	primers	NNS	O	primer	nsubjpass	16	SENT_87	[p5l11t597r261b665],
15	were	VBD	O	be	auxpass	16	SENT_87	[p5l312t612r471b651],
16	constructed	VBN	O	construct	_	0	SENT_87	[p5l524t596r904b651],
17	in	IN	O	in	_	0	SENT_87	[p5l957t597r1017b651],
18	order	NN	O	order	prep_in	16	SENT_87	[p5l1069t596r1243b651],
19	to	TO	O	to	aux	20	SENT_87	[p5l1292t604r1353b651],
20	make	VB	O	make	xcomp	16	SENT_87	[p5l1407t596r1579b651],
21	a	DT	O	a	det	24	SENT_87	[p5l1631t612r1664b651],
22	147	CD	NUMBER	147	num	24	SENT_87	[p5l1719t599r1824b651],
23	bp	NN	O	bp	nn	24	SENT_87	[p5l1841t596r1920b665],
24	product	NN	O	product	dobj	20	SENT_87	[p5l1973t596r2149b665, p5l10t693r124b748],
25	,	,	O	,	_	0	SENT_87	[p5l1973t596r2149b665, p5l10t693r124b748],
26	when	WRB	O	when	advmod	32	SENT_87	[p5l180t685r361b740],
27	the	DT	O	the	det	28	SENT_87	[p5l417t685r519b740],
28	allele	NN	O	allele	nsubj	32	SENT_87	[p5l576t685r745b740],
29	was	VBD	O	be	cop	32	SENT_87	[p5l801t701r924b740],
30	wild	JJ	O	wild	amod	32	SENT_87	[p5l980t685r1311b754],
31	—	NN	O	—	nn	32	SENT_87	[p5l980t685r1311b754],
32	type	NN	O	type	dep	24	SENT_87	[p5l980t685r1311b754],
33	.	.	O	.	_	0	SENT_87	[p5l980t685r1311b754],

1	The	DT	O	the	det	3	SENT_88	[p5l1367t685r1484b740],
2	primer	NN	O	primer	nn	3	SENT_88	[p5l1542t686r1763b754],
3	sequences	NNS	O	sequence	nsubj	5	SENT_88	[p5l1818t701r2145b754],
4	were	VBD	O	be	cop	5	SENT_88	[p5l9t790r167b828],
5	5	CD	NUMBER	5	_	0	SENT_88	[p5l224t776r1393b828],
6	’	SYM	O	’	dep	8	SENT_88	[p5l224t776r1393b828],
7	-	:	O	-	_	0	SENT_88	[p5l224t776r1393b828],
8	GTCTTCCTTCTCTCTCTGTCATAG-3	NN	O	gtcttccttctctctctgtcatag-3	dep	5	SENT_88	[p5l224t776r1393b828],
9	’	RB	O	’	advmod	8	SENT_88	[p5l224t776r1393b828],
10	as	IN	O	as	_	0	SENT_88	[p5l1452t790r1514b828],
11	a	DT	O	a	det	12	SENT_88	[p5l1571t790r1603b828],
12	sense	NN	O	sense	prep_as	8	SENT_88	[p5l1660t790r1834b828],
13	and	CC	O	and	_	0	SENT_88	[p5l1891t774r2007b828],
14	5	CD	NUMBER	5	number	15	SENT_88	[p5l2064t776r2146b828, p5l11t865r1156b917],
15	’	CD	NUMBER	’	num	17	SENT_88	[p5l2064t776r2146b828, p5l11t865r1156b917],
16	CCACACAGCAAAGCAGAAACTCAG3	NN	O	ccacacagcaaagcagaaactcag3	nn	17	SENT_88	[p5l2064t776r2146b828, p5l11t865r1156b917],
17	’	NN	O	’	prep_as	8	SENT_88	[p5l2064t776r2146b828, p5l11t865r1156b917],
18	as	IN	O	as	_	0	SENT_88	[p5l1200t878r1263b917],
19	an	DT	O	a	det	22	SENT_88	[p5l1306t878r1381b917],
20	anti	JJ	O	anti	amod	22	SENT_88	[p5l1423t863r1770b918],
21	—	NN	O	—	nn	22	SENT_88	[p5l1423t863r1770b918],
22	sense	NN	O	sense	prep_as	17	SENT_88	[p5l1423t863r1770b918],
23	.	.	O	.	_	0	SENT_88	[p5l1423t863r1770b918],

1	PCR	NN	O	pcr	nn	2	SENT_89	[p5l1814t865r1938b917],
2	assay	NN	O	assay	nsubjpass	4	SENT_89	[p5l1977t878r2148b931],
3	was	VBD	O	be	auxpass	4	SENT_89	[p5l9t967r131b1006],
4	carried	VBN	O	carry	_	0	SENT_89	[p5l155t951r378b1006],
5	out	RP	O	out	prt	4	SENT_89	[p5l401t959r507b1006],
6	for	IN	O	for	_	0	SENT_89	[p5l528t951r617b1006],
7	35	CD	NUMBER	35	num	8	SENT_89	[p5l635t954r710b1006],
8	cycles	NNS	O	cycle	prep_for	4	SENT_89	[p5l735t951r923b1020],
9	and	CC	O	and	_	0	SENT_89	[p5l946t951r1062b1006],
10	the	DT	O	the	det	12	SENT_89	[p5l1084t951r1186b1006],
11	PCR	NN	MISC	pcr	nn	12	SENT_89	[p5l1208t954r1332b1006],
12	products	NNS	O	product	nsubjpass	14	SENT_89	[p5l1351t951r1632b1020],
13	were	VBD	O	be	auxpass	14	SENT_89	[p5l1653t967r1811b1006],
14	separated	VBN	O	separate	conj_and	4	SENT_89	[p5l1835t951r2146b1020],
15	by	IN	O	by	_	0	SENT_89	[p5l10t1041r86b1109],
16	electrophoresis	NN	O	electrophoresis	agent	14	SENT_89	[p5l108t1041r600b1109],
17	in	IN	O	in	_	0	SENT_89	[p5l625t1041r684b1095],
18	a	DT	O	a	det	22	SENT_89	[p5l707t1056r739b1096],
19	4	CD	PERCENT	4	number	20	SENT_89	[p5l760t1043r842b1096],
20	%	NN	PERCENT	%	amod	22	SENT_89	[p5l760t1043r842b1096],
21	agarose	NN	O	agarose	nn	22	SENT_89	[p5l865t1056r1107b1109],
22	gel	NN	O	gel	prep_in	16	SENT_89	[p5l1130t1041r1222b1109],
23	containing	VBG	O	contain	xcomp	14	SENT_89	[p5l1245t1041r1588b1109],
24	0.5	CD	NUMBER	0.5	num	26	SENT_89	[p5l1610t1043r1701b1096],
25	mg/ml	NN	O	mg/ml	nn	26	SENT_89	[p5l1720t1040r1929b1109],
26	ethid	NN	O	ethid	nsubj	29	SENT_89	[p5l1953t1041r2146b1096],
27	—	CD	NUMBER	—	num	29	SENT_89	[p5l1953t1041r2146b1096],
28	ium	NN	O	ium	nn	29	SENT_89	[p5l11t1131r135b1185],
29	bromide	NN	O	bromide	xcomp	23	SENT_89	[p5l161t1130r432b1185],
30	and	CC	O	and	_	0	SENT_89	[p5l459t1130r576b1185],
31	visualized	VBN	O	visualize	conj_and	14	SENT_89	[p5l602t1130r926b1185],
32	under	IN	O	under	_	0	SENT_89	[p5l954t1130r1145b1185],
33	UV	NN	O	uv	nn	34	SENT_89	[p5l1169t1133r1266b1185],
34	light	NN	O	light	prep_under	31	SENT_89	[p5l1291t1130r1451b1198],
35	.	.	O	.	_	0	SENT_89	[p5l1291t1130r1451b1198],

1	Direct	JJ	O	direct	amod	2	SENT_90	[p5l1480t1131r1673b1185],
2	sequence	NN	O	sequence	nsubjpass	4	SENT_90	[p5l1700t1146r1996b1198],
3	was	VBD	O	be	auxpass	4	SENT_90	[p5l2022t1146r2145b1185],
4	used	VBN	O	use	_	0	SENT_90	[p5l10t1218r159b1273],
5	to	TO	O	to	aux	6	SENT_90	[p5l186t1226r247b1273],
6	conﬁrm	VB	O	conﬁrm	xcomp	4	SENT_90	[p5l275t1218r525b1273],
7	any	DT	O	any	det	8	SENT_90	[p5l552t1234r665b1287],
8	tumors	NNS	O	tumor	nsubj	9	SENT_90	[p5l690t1226r920b1273],
9	expressing	VBG	O	express	dep	6	SENT_90	[p5l948t1219r1293b1287],
10	the	DT	O	the	det	13	SENT_90	[p5l1318t1218r1420b1273],
11	exon	NN	O	exon	nn	13	SENT_90	[p5l1448t1234r1599b1273],
12	19	CD	NUMBER	19	num	13	SENT_90	[p5l1629t1221r1697b1273],
13	deletion	NN	O	deletion	dobj	9	SENT_90	[p5l1725t1218r2004b1274],
14	.	.	O	.	_	0	SENT_90	[p5l1725t1218r2004b1274],

1	The	DT	O	the	det	3	SENT_91	[p5l2029t1218r2146b1273],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_91	[p5l11t1310r178b1362],
3	mutation	NN	O	mutation	nsubjpass	22	SENT_91	[p5l201t1308r498b1362],
4	in	IN	O	in	_	0	SENT_91	[p5l524t1308r582b1362],
5	exon	NN	O	exon	prep_in	3	SENT_91	[p5l608t1323r759b1362],
6	20	CD	NUMBER	20	num	5	SENT_91	[p5l785t1310r862b1362],
7	was	VBD	O	be	auxpass	9	SENT_91	[p5l886t1323r1009b1362],
8	also	RB	O	also	advmod	9	SENT_91	[p5l1036t1307r1160b1362],
9	examined	VBN	O	examine	_	0	SENT_91	[p5l1187t1307r1502b1362],
10	using	VBG	O	use	xcomp	9	SENT_91	[p5l1528t1308r1701b1376],
11	PCR	NN	O	pcr	dobj	10	SENT_91	[p5l1726t1310r1850b1362],
12	with	IN	O	with	_	0	SENT_91	[p5l1871t1307r2019b1362],
13	the	DT	O	the	det	16	SENT_91	[p5l2044t1307r2146b1362],
14	previously	RB	DATE	previously	advmod	15	SENT_91	[p5l11t1396r347b1465],
15	reported	VBN	O	report	amod	16	SENT_91	[p5l368t1396r644b1465],
16	primers	NNS	O	primer	prep_with	10	SENT_91	[p5l668t1397r917b1465],
17	[	VBP	O	[	dep	16	SENT_91	[p5l944t1396r1043b1465],
18	4	CD	NUMBER	4	num	19	SENT_91	[p5l944t1396r1043b1465],
19	]	CD	NUMBER	]	dobj	17	SENT_91	[p5l944t1396r1043b1465],
20	,	,	O	,	_	0	SENT_91	[p5l944t1396r1043b1465],
21	and	CC	O	and	_	0	SENT_91	[p5l1067t1396r1183b1451],
22	sequenced	VBN	O	sequence	conj_and	9	SENT_91	[p5l1207t1396r1545b1465],
23	directly	RB	O	directly	advmod	22	SENT_91	[p5l1569t1396r1824b1465],
24	.	.	O	.	_	0	SENT_91	[p5l1569t1396r1824b1465],

1	The	DT	O	the	det	2	SENT_92	[p5l109t1486r226b1541],
2	3	CD	NUMBER	3	_	0	SENT_92	[p5l276t1486r513b1541],
3	’	NN	O	’	dep	2	SENT_92	[p5l276t1486r513b1541],
4	.	.	O	.	_	0	SENT_92	[p5l276t1486r513b1541],

1	—	NN	O	—	_	0	SENT_93	[p5l276t1486r513b1541],
2	.	.	O	.	_	0	SENT_93	[p5l276t1486r513b1541],

1	ends	NNS	O	end	nsubj	9	SENT_94	[p5l276t1486r513b1541],
2	of	IN	O	of	_	0	SENT_94	[p5l565t1485r631b1541],
3	the	DT	O	the	det	8	SENT_94	[p5l673t1486r775b1541],
4	22	CD	NUMBER	22	number	5	SENT_94	[p5l826t1486r1078b1541],
5	—	CD	NUMBER	—	dep	6	SENT_94	[p5l826t1486r1078b1541],
6	base	NN	O	base	dep	8	SENT_94	[p5l826t1486r1078b1541],
7	pair	NN	O	pair	nn	8	SENT_94	[p5l1128t1486r1255b1554],
8	oligonucleotides	NNS	O	oligonucleotide	prep_of	1	SENT_94	[p5l1303t1486r1832b1554],
9	used	VBD	O	use	_	0	SENT_94	[p5l1884t1486r2032b1541],
10	as	IN	O	as	mark	13	SENT_94	[p5l2083t1501r2145b1541],
11	PCR	NN	O	pcr	nn	12	SENT_94	[p5l11t1578r134b1630],
12	primers	NNS	O	primer	nsubj	13	SENT_94	[p5l186t1576r435b1643],
13	corresponded	VBD	O	correspond	advcl	9	SENT_94	[p5l491t1575r932b1643],
14	to	TO	O	to	_	0	SENT_94	[p5l986t1583r1047b1630],
15	a	DT	O	a	det	16	SENT_94	[p5l1101t1591r1134b1630],
16	G	NN	O	g	prep_to	13	SENT_94	[p5l1188t1578r1232b1630],
17	for	IN	O	for	_	0	SENT_94	[p5l1287t1575r1376b1630],
18	T	NN	O	t	nn	19	SENT_94	[p5l1425t1578r1465b1629],
19	exchange	NN	O	exchange	prep_for	13	SENT_94	[p5l1517t1575r1814b1643],
20	of	IN	O	of	_	0	SENT_94	[p5l1869t1575r1936b1630],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_94	[p5l1982t1578r2149b1630],
22	codon	NN	O	codon	prep_of	19	SENT_94	[p5l10t1664r205b1719],
23	858	CD	NUMBER	858	num	22	SENT_94	[p5l254t1667r387b1719],
24	.	.	O	.	_	0	SENT_94	[p5l254t1667r387b1719],

1	That	DT	O	that	dep	15	SENT_95	[p5l435t1664r580b1719],
2	is	VBZ	O	be	dep	1	SENT_95	[p5l628t1665r691b1727],
3	,	,	O	,	_	0	SENT_95	[p5l628t1665r691b1727],
4	the	DT	O	the	det	8	SENT_95	[p5l742t1664r843b1719],
5	sense	NN	O	sense	nn	8	SENT_95	[p5l894t1665r1324b1732],
6	—	NN	O	—	nn	8	SENT_95	[p5l894t1665r1324b1732],
7	primer	NN	O	primer	nn	8	SENT_95	[p5l894t1665r1324b1732],
8	sequence	NN	O	sequence	nsubj	15	SENT_95	[p5l1372t1680r1668b1732],
9	for	IN	O	for	_	0	SENT_95	[p5l1718t1664r1808b1719],
10	the	DT	O	the	det	12	SENT_95	[p5l1855t1664r1956b1719],
11	wild	JJ	O	wild	amod	12	SENT_95	[p5l2004t1664r2146b1719],
12	type	NN	O	type	prep_for	8	SENT_95	[p5l10t1760r150b1821],
13	was	VBD	O	be	cop	15	SENT_95	[p5l198t1768r321b1807],
14	5	CD	NUMBER	5	num	15	SENT_95	[p5l372t1754r1419b1816],
15	’	NN	O	’	_	0	SENT_95	[p5l372t1754r1419b1816],
16	.	.	O	.	_	0	SENT_95	[p5l372t1754r1419b1816],

1	—	NN	O	—	_	0	SENT_96	[p5l372t1754r1419b1816],
2	.	.	O	.	_	0	SENT_96	[p5l372t1754r1419b1816],

1	TCAAGATCACAGATTTTGGGCT	NNP	LOCATION	TCAAGATCACAGATTTTGGGCT	_	0	SENT_97	[p5l372t1754r1419b1816],
2	,	,	O	,	_	0	SENT_97	[p5l372t1754r1419b1816],
3	and	CC	O	and	_	0	SENT_97	[p5l1469t1752r1585b1807],
4	that	IN	O	that	dep	8	SENT_97	[p5l1635t1752r1764b1807],
5	for	IN	O	for	_	0	SENT_97	[p5l1813t1752r1902b1807],
6	L858R	NN	O	l858r	nn	7	SENT_97	[p5l1950t1755r2149b1807],
7	mutation	NN	O	mutation	prep_for	8	SENT_97	[p5l11t1842r307b1895],
8	was	VBD	O	be	conj_and	1	SENT_97	[p5l357t1857r480b1895],
9	5	CD	NUMBER	5	advmod	8	SENT_97	[p5l534t1844r1595b1896],
10	’	SYM	O	’	dep	12	SENT_97	[p5l534t1844r1595b1896],
11	-	:	O	-	_	0	SENT_97	[p5l534t1844r1595b1896],
12	TCAAGATCACAGATTITGGGCG	NN	PERSON	tcaagatcacagattitgggcg	dep	8	SENT_97	[p5l534t1844r1595b1896],
13	.	.	O	.	_	0	SENT_97	[p5l534t1844r1595b1896],

1	The	DT	O	the	det	3	SENT_98	[p5l1645t1841r1762b1895],
2	anti-sense	JJ	O	anti-sense	amod	3	SENT_98	[p5l1815t1842r2146b1895],
3	primer	NN	O	primer	nsubj	17	SENT_98	[p5l11t1930r231b1998],
4	for	IN	O	for	_	0	SENT_98	[p5l297t1929r387b1984],
5	both	CC	O	both	preconj	9	SENT_98	[p5l451t1929r597b1984],
6	the	DT	O	the	det	9	SENT_98	[p5l663t1929r765b1984],
7	wild	JJ	O	wild	amod	9	SENT_98	[p5l831t1929r1146b1998],
8	—	NN	O	—	nn	9	SENT_98	[p5l831t1929r1146b1998],
9	type	NN	O	type	prep_for	3	SENT_98	[p5l831t1929r1146b1998],
10	and	CC	O	and	_	0	SENT_98	[p5l1213t1929r1329b1984],
11	mutant	JJ	O	mutant	amod	13	SENT_98	[p5l1398t1937r1806b1998],
12	—	NN	O	—	nn	13	SENT_98	[p5l1398t1937r1806b1998],
13	type	NN	O	type	prep_for	3	SENT_98	[p5l1398t1937r1806b1998],
14	was	VBD	O	be	cop	17	SENT_98	[p5l1872t1945r1995b1984],
15	5	CD	NUMBER	5	number	16	SENT_98	[p5l2064t1932r2146b1984, p5l11t2021r1046b2074],
16	’	CD	NUMBER	’	num	17	SENT_98	[p5l2064t1932r2146b1984, p5l11t2021r1046b2074],
17	CATCCTCCCCTGCATGTGTTAAAC	NN	O	catcctcccctgcatgtgttaaac	_	0	SENT_98	[p5l2064t1932r2146b1984, p5l11t2021r1046b2074],
18	.	.	O	.	_	0	SENT_98	[p5l2064t1932r2146b1984, p5l11t2021r1046b2074],

1	PCR	NN	O	pcr	nn	2	SENT_99	[p5l1081t2021r1205b2074],
2	assays	NNS	O	assay	nsubjpass	4	SENT_99	[p5l1236t2034r1435b2087],
3	were	VBD	O	be	auxpass	4	SENT_99	[p5l1468t2034r1627b2074],
4	carried	VBN	O	carry	_	0	SENT_99	[p5l1662t2019r1885b2074],
5	out	RP	O	out	prt	4	SENT_99	[p5l1921t2027r2026b2074],
6	for	IN	O	for	_	0	SENT_99	[p5l2059t2018r2148b2074],
7	38	CD	NUMBER	38	num	8	SENT_99	[p5l9t2111r85b2163],
8	cycles	NNS	O	cycle	prep_for	4	SENT_99	[p5l115t2108r320b2176],
9	,	,	O	,	_	0	SENT_99	[p5l115t2108r320b2176],
10	and	CC	O	and	_	0	SENT_99	[p5l349t2108r465b2163],
11	the	DT	O	the	det	13	SENT_99	[p5l493t2108r594b2163],
12	PCR	NN	O	pcr	nn	13	SENT_99	[p5l623t2111r747b2163],
13	products	NNS	O	product	nsubjpass	30	SENT_99	[p5l772t2108r1052b2176],
14	were	VBD	O	be	auxpass	15	SENT_99	[p5l1079t2124r1238b2163],
15	separated	VBN	O	separate	conj_and	4	SENT_99	[p5l1267t2108r1578b2176],
16	by	IN	O	by	_	0	SENT_99	[p5l1606t2108r1682b2176],
17	electrophoresis	NN	O	electrophoresis	agent	15	SENT_99	[p5l1708t2108r2146b2176, p5l11t2197r89b2251],
18	in	IN	O	in	_	0	SENT_99	[p5l111t2197r170b2250],
19	a	DT	O	a	det	23	SENT_99	[p5l191t2212r223b2251],
20	2	CD	PERCENT	2	number	21	SENT_99	[p5l244t2199r324b2251],
21	%	NN	PERCENT	%	amod	23	SENT_99	[p5l244t2199r324b2251],
22	agarose	NN	O	agarose	nn	23	SENT_99	[p5l345t2212r587b2265],
23	gel	NN	O	gel	prep_in	17	SENT_99	[p5l608t2196r699b2265],
24	containing	VBG	O	contain	xcomp	15	SENT_99	[p5l721t2197r1063b2265],
25	0.5	CD	NUMBER	0.5	num	28	SENT_99	[p5l1083t2199r1174b2252],
26	mg/ml	NN	O	mg/ml	nn	28	SENT_99	[p5l1193t2196r1403b2265],
27	ethidium	NN	O	ethidium	nn	28	SENT_99	[p5l1424t2196r1718b2251],
28	bromide	NN	O	bromide	dobj	24	SENT_99	[p5l1738t2196r2009b2251],
29	and	CC	O	and	_	0	SENT_99	[p5l2030t2196r2146b2251],
30	visualized	VBN	O	visualize	conj_and	4	SENT_99	[p5l8t2285r333b2339],
31	under	IN	O	under	_	0	SENT_99	[p5l356t2285r547b2339],
32	UV	NN	O	uv	prep_under	30	SENT_99	[p5l566t2288r675b2340],
33	.	.	O	.	_	0	SENT_99	[p5l566t2288r675b2340],

1	2.5	CD	NUMBER	2.5	_	0	SENT_100	[p5l6t2497r113b2550],
2	.	.	O	.	_	0	SENT_100	[p5l6t2497r113b2550],

1	Statistical	JJ	O	statistical	amod	2	SENT_101	[p5l160t2494r464b2549],
2	analysis	NN	O	analysis	_	0	SENT_101	[p5l485t2494r730b2563],

1	Simon	NNP	PERSON	Simon	poss	7	SENT_102	[p5l112t2674r361b2728],
2	's	POS	O	's	_	0	SENT_102	[p5l112t2674r361b2728],
3	two	CD	NUMBER	two	number	5	SENT_102	[p5l387t2681r706b2741],
4	—	JJ	O	—	dep	5	SENT_102	[p5l387t2681r706b2741],
5	stage	NN	O	stage	amod	7	SENT_102	[p5l387t2681r706b2741],
6	minimax	NN	O	minimax	nn	7	SENT_102	[p5l732t2674r1021b2728],
7	design	NN	O	design	nsubjpass	9	SENT_102	[p5l1045t2673r1253b2741],
8	was	VBD	O	be	auxpass	9	SENT_102	[p5l1277t2689r1400b2728],
9	used	VBN	O	use	_	0	SENT_102	[p5l1426t2673r1575b2728],
10	to	TO	O	to	aux	11	SENT_102	[p5l1600t2681r1661b2728],
11	determine	VB	O	determine	xcomp	9	SENT_102	[p5l1687t2673r2019b2728],
12	the	DT	O	the	det	14	SENT_102	[p5l2044t2673r2146b2728],
13	sample	NN	O	sample	nn	14	SENT_102	[p5l11t2761r239b2830],
14	size	NN	O	size	dobj	11	SENT_102	[p5l273t2762r392b2816],
15	for	IN	O	for	_	0	SENT_102	[p5l426t2761r516b2816],
16	this	DT	O	this	det	19	SENT_102	[p5l546t2761r663b2816],
17	phase	NN	O	phase	nn	19	SENT_102	[p5l698t2761r882b2830],
18	II	CD	NUMBER	ii	num	19	SENT_102	[p5l916t2764r954b2815],
19	study	NN	O	study	prep_for	11	SENT_102	[p5l989t2761r1166b2830],
20	[	CD	NUMBER	[	number	21	SENT_102	[p5l1200t2761r1335b2830],
21	10	CD	NUMBER	10	num	22	SENT_102	[p5l1200t2761r1335b2830],
22	]	NN	O	]	dep	11	SENT_102	[p5l1200t2761r1335b2830],
23	.	.	O	.	_	0	SENT_102	[p5l1200t2761r1335b2830],

1	The	DT	O	the	det	3	SENT_103	[p5l1367t2761r1484b2816],
2	treatment	NN	O	treatment	nn	3	SENT_103	[p5l1517t2769r1841b2816],
3	program	NN	O	program	nsubjpass	5	SENT_103	[p5l1873t2777r2147b2830],
4	was	VBD	O	be	auxpass	5	SENT_103	[p5l9t2866r131b2905],
5	designed	VBN	O	design	_	0	SENT_103	[p5l159t2850r446b2919],
6	to	TO	O	to	aux	7	SENT_103	[p5l472t2858r533b2905],
7	disregard	VB	O	disregard	ccomp	5	SENT_103	[p5l560t2850r859b2919],
8	a	DT	O	a	det	10	SENT_103	[p5l886t2866r918b2905],
9	response	NN	O	response	nn	10	SENT_103	[p5l944t2866r1229b2919],
10	rate	NN	O	rate	nsubj	16	SENT_103	[p5l1256t2858r1377b2905],
11	of	IN	O	of	_	0	SENT_103	[p5l1404t2850r1471b2905],
12	40	CD	PERCENT	40	num	13	SENT_103	[p5l1487t2853r1610b2905],
13	%	NN	PERCENT	%	prep_of	10	SENT_103	[p5l1487t2853r1610b2905],
14	(	CD	NUMBER	(	num	16	SENT_103	[p5l1636t2850r1756b2918],
15	Po	NNP	O	Po	nn	16	SENT_103	[p5l1636t2850r1756b2918],
16	)	NN	O	)	xcomp	7	SENT_103	[p5l1636t2850r1756b2918],
17	and	CC	O	and	_	0	SENT_103	[p5l1782t2850r1898b2905],
18	to	TO	O	to	aux	19	SENT_103	[p5l1924t2858r1985b2905],
19	provide	VB	O	provide	ccomp	5	SENT_103	[p5l2012t2866r2146b2919, p5l8t2939r144b2994],
20	a	DT	O	a	det	22	SENT_103	[p5l175t2955r207b2994],
21	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_103	[p5l238t2939r573b3008],
22	level	NN	O	level	dobj	19	SENT_103	[p5l603t2939r750b2994],
23	of	IN	O	of	_	0	SENT_103	[p5l782t2939r848b2994],
24	0.05	CD	NUMBER	0.05	prep_of	22	SENT_103	[p5l871t2942r1003b2995],
25	with	IN	O	with	_	0	SENT_103	[p5l1035t2939r1183b2994],
26	a	DT	O	a	det	28	SENT_103	[p5l1213t2955r1245b2994],
27	statistical	JJ	O	statistical	amod	28	SENT_103	[p5l1277t2939r1582b2994],
28	power	NN	O	power	prep_with	19	SENT_103	[p5l1614t2955r1818b3008],
29	of	IN	O	of	_	0	SENT_103	[p5l1846t2939r1913b2994],
30	80	CD	PERCENT	80	num	31	SENT_103	[p5l1936t2942r2057b2994],
31	%	NN	PERCENT	%	prep_of	28	SENT_103	[p5l1936t2942r2057b2994],
32	in	IN	O	in	_	0	SENT_103	[p5l2088t2940r2147b2994],
33	assessing	VBG	O	assess	prepc_in	31	SENT_103	[p5l10t3029r309b3097],
34	the	DT	O	the	det	35	SENT_103	[p5l336t3028r437b3083],
35	activity	NN	O	activity	dobj	33	SENT_103	[p5l466t3029r705b3097],
36	of	IN	O	of	_	0	SENT_103	[p5l732t3028r798b3083],
37	the	DT	O	the	det	38	SENT_103	[p5l819t3028r920b3083],
38	regimen	NN	O	regimen	prep_of	35	SENT_103	[p5l949t3029r1215b3097],
39	as	IN	O	as	_	0	SENT_103	[p5l1243t3044r1305b3083],
40	a	DT	O	a	det	44	SENT_103	[p5l1335t3044r1367b3083],
41	70	CD	PERCENT	70	number	42	SENT_103	[p5l1397t3031r1516b3083],
42	%	NN	PERCENT	%	amod	44	SENT_103	[p5l1397t3031r1516b3083],
43	response	NN	O	response	nn	44	SENT_103	[p5l1544t3044r1829b3097],
44	rate	NN	O	rate	prep_as	33	SENT_103	[p5l1859t3036r1980b3083],
45	(	CD	NUMBER	(	num	47	SENT_103	[p5l2009t3028r2145b3097],
46	P1	NN	O	p1	nn	47	SENT_103	[p5l2009t3028r2145b3097],
47	)	NN	O	)	dep	44	SENT_103	[p5l2009t3028r2145b3097],
48	.	.	O	.	_	0	SENT_103	[p5l2009t3028r2145b3097],

1	We	PRP	O	we	nsubj	2	SENT_104	[p5l8t3121r113b3173],
2	needed	VBD	O	need	_	0	SENT_104	[p5l149t3118r383b3173],
3	16	CD	NUMBER	16	num	5	SENT_104	[p5l422t3120r490b3173],
4	evaluable	JJ	O	evaluable	amod	5	SENT_104	[p5l527t3117r831b3173],
5	patients	NNS	O	patient	dobj	2	SENT_104	[p5l866t3118r1125b3186],
6	to	TO	O	to	aux	7	SENT_104	[p5l1160t3126r1221b3173],
7	accept	VB	O	accept	xcomp	2	SENT_104	[p5l1257t3126r1463b3186],
8	the	DT	O	the	det	9	SENT_104	[p5l1496t3118r1598b3173],
9	hypothesis	NN	O	hypothesis	dobj	7	SENT_104	[p5l1634t3118r1996b3186],
10	.	.	O	.	_	0	SENT_104	[p5l1634t3118r1996b3186],

1	The	DT	O	the	det	3	SENT_105	[p5l2029t3118r2146b3173],
2	chi	NN	O	chus	nn	3	SENT_105	[p5l10t3207r347b3275],
3	—	NN	O	—	nsubjpass	7	SENT_105	[p5l10t3207r347b3275],
4	square	JJ	O	square	amod	5	SENT_105	[p5l10t3207r347b3275],
5	test	NN	O	test	dep	3	SENT_105	[p5l372t3215r489b3262],
6	was	VBD	O	be	auxpass	7	SENT_105	[p5l511t3223r634b3262],
7	used	VBN	O	use	_	0	SENT_105	[p5l661t3207r809b3262],
8	to	TO	O	to	aux	9	SENT_105	[p5l835t3215r895b3262],
9	assess	VB	O	assess	xcomp	7	SENT_105	[p5l921t3223r1115b3262],
10	the	DT	O	the	det	11	SENT_105	[p5l1141t3207r1243b3262],
11	relationship	NN	O	relationship	dobj	9	SENT_105	[p5l1269t3207r1655b3275],
12	between	IN	O	between	_	0	SENT_105	[p5l1680t3207r1957b3262],
13	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_105	[p5l1982t3210r2149b3262],
14	gene	NN	O	gene	nn	15	SENT_105	[p5l9t3311r160b3364],
15	mutations	NNS	O	mutation	prep_between	11	SENT_105	[p5l190t3296r517b3350],
16	and	CC	O	and	_	0	SENT_105	[p5l547t3295r663b3350],
17	each	DT	O	each	dobj	9	SENT_105	[p5l694t3295r839b3350],
18	of	IN	O	of	_	0	SENT_105	[p5l869t3295r935b3350],
19	the	DT	O	the	det	21	SENT_105	[p5l957t3295r1058b3350],
20	clinicopathological	JJ	O	clinicopathological	amod	21	SENT_105	[p5l1089t3295r1698b3364],
21	features	NNS	O	feature	prep_of	17	SENT_105	[p5l1728t3295r2001b3351],
22	.	.	O	.	_	0	SENT_105	[p5l1728t3295r2001b3351],

1	The	DT	O	the	det	2	SENT_106	[p5l2029t3295r2146b3350],
2	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_106	[p5l11t3384r464b3453],
3	.	.	O	.	_	0	SENT_106	[p5l11t3384r464b3453],

1	—	NN	O	—	_	0	SENT_107	[p5l11t3384r464b3453],
2	.	.	O	.	_	0	SENT_107	[p5l11t3384r464b3453],

1	Meier	JJR	PERSON	meier	amod	2	SENT_108	[p5l11t3384r464b3453],
2	method	NN	O	method	nsubjpass	4	SENT_108	[p5l484t3384r732b3439],
3	was	VBD	O	be	auxpass	4	SENT_108	[p5l752t3400r875b3439],
4	used	VBN	O	use	_	0	SENT_108	[p5l897t3384r1046b3439],
5	to	TO	O	to	aux	6	SENT_108	[p5l1067t3392r1128b3439],
6	estimate	VB	O	estimate	xcomp	4	SENT_108	[p5l1150t3385r1425b3439],
7	the	DT	O	the	det	8	SENT_108	[p5l1446t3384r1547b3439],
8	probability	NN	O	probability	dobj	6	SENT_108	[p5l1570t3384r1924b3453],
9	of	IN	O	of	_	0	SENT_108	[p5l1943t3384r2010b3439],
10	survival	NN	O	survival	prep_of	8	SENT_108	[p5l2024t3400r2146b3439, p5l8t3473r174b3537],
11	,	,	O	,	_	0	SENT_108	[p5l2024t3400r2146b3439, p5l8t3473r174b3537],
12	and	CC	O	and	_	0	SENT_108	[p5l200t3473r316b3528],
13	survival	NN	O	survival	nn	14	SENT_108	[p5l344t3473r593b3528],
14	differences	NNS	O	difference	nsubjpass	16	SENT_108	[p5l619t3473r971b3528],
15	were	VBD	O	be	auxpass	16	SENT_108	[p5l997t3489r1155b3528],
16	analyzed	VBN	O	analyze	conj_and	4	SENT_108	[p5l1181t3473r1466b3542],
17	by	IN	O	by	_	0	SENT_108	[p5l1491t3473r1568b3542],
18	the	DT	O	the	det	21	SENT_108	[p5l1591t3473r1693b3528],
19	log	NN	O	log	nn	21	SENT_108	[p5l1719t3473r1991b3542],
20	—	CD	NUMBER	—	num	21	SENT_108	[p5l1719t3473r1991b3542],
21	ranl	NN	O	ranl	agent	16	SENT_108	[p5l1719t3473r1991b3542],
22	<	JJR	O	<	amod	23	SENT_108	[p5l1719t3473r1991b3542],
23	test	NN	O	test	dep	21	SENT_108	[p5l2014t3481r2145b3529],
24	.	.	O	.	_	0	SENT_108	[p5l2014t3481r2145b3529],

1	All	DT	O	all	det	3	SENT_109	[p5l8t3562r94b3617],
2	statistical	JJ	O	statistical	amod	3	SENT_109	[p5l122t3562r427b3617],
3	tests	NNS	O	test	nsubj	5	SENT_109	[p5l454t3570r600b3617],
4	were	VBD	O	be	cop	5	SENT_109	[p5l626t3578r785b3617],
5	two	CD	NUMBER	two	_	0	SENT_109	[p5l811t3570r932b3617],
6	sided	VBD	O	side	rcmod	5	SENT_109	[p5l961t3562r1145b3626],
7	,	,	O	,	_	0	SENT_109	[p5l961t3562r1145b3626],
8	and	CC	O	and	_	0	SENT_109	[p5l1173t3562r1289b3617],
9	p	NN	O	p	nn	11	SENT_109	[p5l1312t3562r1584b3631],
10	—	NN	O	—	nn	11	SENT_109	[p5l1312t3562r1584b3631],
11	values	NNS	O	value	nsubjpass	17	SENT_109	[p5l1312t3562r1584b3631],
12	of	IN	O	of	_	0	SENT_109	[p5l1613t3562r1679b3617],
13	less	JJR	O	less	mwe	14	SENT_109	[p5l1699t3562r1813b3617],
14	than	IN	O	than	quantmod	15	SENT_109	[p5l1841t3562r1985b3617],
15	0.05	CD	NUMBER	0.05	prep_of	11	SENT_109	[p5l2012t3565r2144b3618],
16	were	VBD	O	be	auxpass	17	SENT_109	[p5l9t3667r167b3707],
17	considered	VBN	O	consider	conj_and	5	SENT_109	[p5l186t3652r537b3707],
18	statistically	RB	O	statistically	advmod	19	SENT_109	[p5l558t3652r924b3720],
19	signiﬁcant	JJ	O	signiﬁcant	acomp	17	SENT_109	[p5l942t3651r1291b3720],
20	.	.	O	.	_	0	SENT_109	[p5l942t3651r1291b3720],

1	One	CD	NUMBER	one	_	0	SENT_110	[p5l1311t3654r1436b3707],
2	of	IN	O	of	_	0	SENT_110	[p5l1456t3651r1522b3707],
3	the	DT	O	the	det	5	SENT_110	[p5l1533t3652r1634b3707],
4	secondary	JJ	O	secondary	amod	5	SENT_110	[p5l1654t3652r1983b3720],
5	endpoints	NNS	O	endpoint	prep_of	1	SENT_110	[p5l2000t3652r2146b3707, p6l11t18r209b85],

1	was	VBD	O	be	cop	2	SENT_111	[p6l234t33r357b72],
2	PFS	NNP	O	PFS	_	0	SENT_111	[p6l384t20r508b72],
3	.	.	O	.	_	0	SENT_111	[p6l384t20r508b72],

1	PFS	NN	O	pf	nsubjpass	3	SENT_112	[p6l535t20r642b72],
2	was	VBD	O	be	auxpass	3	SENT_112	[p6l667t33r790b72],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_112	[p6l817t17r1058b72],
4	as	IN	O	as	_	0	SENT_112	[p6l1084t33r1146b72],
5	the	DT	O	the	det	6	SENT_112	[p6l1173t17r1275b72],
6	interval	NN	O	interval	prep_as	3	SENT_112	[p6l1302t17r1546b72],
7	between	IN	O	between	_	0	SENT_112	[p6l1572t17r1849b72],
8	the	DT	O	the	det	9	SENT_112	[p6l1874t17r1976b72],
9	start	NN	O	start	prep_between	6	SENT_112	[p6l2003t25r2148b72],
10	of	IN	O	of	_	0	SENT_112	[p6l10t105r77b160],
11	the	DT	O	the	det	13	SENT_112	[p6l97t105r198b160],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_112	[p6l226t105r493b174],
13	treatment	NN	O	treatment	prep_of	9	SENT_112	[p6l521t113r845b160],
14	and	CC	O	and	_	0	SENT_112	[p6l872t105r988b160],
15	the	DT	O	the	det	16	SENT_112	[p6l1016t105r1118b160],
16	date	NN	O	date	prep_between	6	SENT_112	[p6l1146t105r1282b160],
17	of	IN	O	of	_	0	SENT_112	[p6l1311t105r1377b160],
18	the	DT	O	the	det	20	SENT_112	[p6l1398t105r1499b160],
19	ﬁrst	JJ	O	ﬁrst	amod	20	SENT_112	[p6l1529t105r1655b160],
20	observation	NN	O	observation	prep_of	16	SENT_112	[p6l1682t105r2060b160],
21	of	IN	O	of	_	0	SENT_112	[p6l2088t105r2154b160],
22	disease	NN	O	disease	nn	23	SENT_112	[p6l10t194r242b249],
23	progression	NN	O	progression	prep_of	20	SENT_112	[p6l266t195r657b263],
24	.	.	O	.	_	0	SENT_112	[p6l266t195r657b263],

1	3	LS	NUMBER	3	_	0	SENT_113	[p6l8t416r65b468],
2	.	.	O	.	_	0	SENT_113	[p6l8t416r65b468],

1	Results	NNS	O	result	_	0	SENT_114	[p6l111t414r352b468],

1	3.1	CD	NUMBER	3.1	_	0	SENT_115	[p6l7t594r102b646],
2	.	.	O	.	_	0	SENT_115	[p6l7t594r102b646],

1	Patient	NN	O	patient	nn	2	SENT_116	[p6l150t592r372b645],
2	characteristics	NNS	O	characteristic	_	0	SENT_116	[p6l390t591r832b645],
3	and	CC	O	and	_	0	SENT_116	[p6l853t591r967b645],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_116	[p6l986t594r1145b645],
5	mutations	NNS	O	mutation	conj_and	2	SENT_116	[p6l1167t592r1480b645],

1	From	IN	O	from	_	0	SENT_117	[p6l113t772r276b823],
2	January	NNP	DATE	January	prep_from	14	SENT_117	[p6l288t772r542b837],
3	2005	CD	DATE	2005	num	2	SENT_117	[p6l561t771r719b823],
4	to	TO	O	to	_	0	SENT_117	[p6l742t776r802b823],
5	August	NNP	DATE	August	prep_to	2	SENT_117	[p6l821t771r1046b837],
6	2007	CD	DATE	2007	num	5	SENT_117	[p6l1065t771r1234b832],
7	,	,	O	,	_	0	SENT_117	[p6l1065t771r1234b832],
8	48	CD	NUMBER	48	num	11	SENT_117	[p6l1253t771r1332b823],
9	primary	JJ	O	primary	amod	11	SENT_117	[p6l1355t769r1614b837],
10	eligible	JJ	O	eligible	amod	11	SENT_117	[p6l1633t768r1866b837],
11	patients	NNS	O	patient	nsubj	14	SENT_117	[p6l1887t769r2145b837],
12	with	IN	O	with	_	0	SENT_117	[p6l9t857r157b912],
13	NSCLC	NN	ORGANIZATION	nsclc	prep_with	11	SENT_117	[p6l194t860r400b912],
14	underwent	VBD	O	undergo	_	0	SENT_117	[p6l437t857r793b912],
15	analysis	NN	O	analysis	dobj	14	SENT_117	[p6l829t857r1081b926],
16	of	IN	O	of	_	0	SENT_117	[p6l1120t857r1186b912],
17	their	PRP$	O	they	poss	20	SENT_117	[p6l1215t857r1370b912],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_117	[p6l1405t860r1572b912],
19	mutation	NN	O	mutation	nn	20	SENT_117	[p6l1607t858r1904b912],
20	status	NN	O	status	prep_of	15	SENT_117	[p6l1942t865r2145b913],
21	.	.	O	.	_	0	SENT_117	[p6l1942t865r2145b913],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_118	[p6l11t949r177b1002],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_118	[p6l209t947r536b1002],
3	were	VBD	O	be	auxpass	4	SENT_118	[p6l570t962r728b1002],
4	detected	VBN	O	detect	_	0	SENT_118	[p6l763t947r1038b1002],
5	in	IN	O	in	_	0	SENT_118	[p6l1073t947r1132b1001],
6	20	CD	NUMBER	20	num	7	SENT_118	[p6l1166t949r1243b1002],
7	patients	NNS	O	patient	prep_in	4	SENT_118	[p6l1278t947r1536b1015],
8	(	IN	O	(	_	0	SENT_118	[p6l1571t947r1791b1015],
9	41.7	CD	PERCENT	41.7	num	10	SENT_118	[p6l1571t947r1791b1015],
10	%	NN	PERCENT	%	prep_(	4	SENT_118	[p6l1571t947r1791b1015],
11	)	CD	NUMBER	)	npadvmod	4	SENT_118	[p6l1571t947r1791b1015],
12	with	IN	O	with	_	0	SENT_118	[p6l1824t947r1973b1002],
13	adenocarcinoma	NN	O	adenocarcinoma	prep_with	4	SENT_118	[p6l2006t947r2146b1002, p6l11t1037r442b1091],
14	.	.	O	.	_	0	SENT_118	[p6l2006t947r2146b1002, p6l11t1037r442b1091],

1	The	DT	O	the	det	2	SENT_119	[p6l475t1036r592b1091],
2	subjects	NNS	O	subject	nsubj	3	SENT_119	[p6l628t1036r887b1104],
3	consisted	VBD	O	consist	_	0	SENT_119	[p6l923t1036r1223b1091],
4	of	IN	O	of	_	0	SENT_119	[p6l1258t1036r1324b1091],
5	11	CD	NUMBER	11	num	6	SENT_119	[p6l1355t1039r1412b1090],
6	males	NNS	O	male	prep_of	3	SENT_119	[p6l1456t1036r1641b1091],
7	and	CC	O	and	_	0	SENT_119	[p6l1677t1036r1793b1091],
8	9	CD	NUMBER	9	num	9	SENT_119	[p6l1828t1039r1863b1091],
9	females	NNS	O	female	prep_of	3	SENT_119	[p6l1900t1036r2145b1091],
10	and	CC	O	and	_	0	SENT_119	[p6l10t1124r126b1179],
11	the	DT	O	the	det	13	SENT_119	[p6l159t1124r260b1179],
12	median	JJ	O	median	amod	13	SENT_119	[p6l293t1124r534b1179],
13	age	NN	O	age	nsubj	16	SENT_119	[p6l566t1140r672b1193],
14	was	VBD	O	be	cop	16	SENT_119	[p6l703t1140r826b1179],
15	64.9	CD	DURATION	64.9	num	16	SENT_119	[p6l860t1127r994b1180],
16	years	NNS	NUMBER	year	conj_and	3	SENT_119	[p6l1025t1140r1193b1193],
17	(	JJ	O	(	amod	18	SENT_119	[p6l1226t1124r1445b1193],
18	range	NN	O	range	attr	16	SENT_119	[p6l1226t1124r1445b1193],
19	,	,	O	,	_	0	SENT_119	[p6l1226t1124r1445b1193],
20	48-84	CD	NUMBER	48-84	num	21	SENT_119	[p6l1476t1127r1680b1179],
21	years	NNS	NUMBER	year	tmod	22	SENT_119	[p6l1710t1124r1920b1193],
22	)	RB	O	)	amod	18	SENT_119	[p6l1710t1124r1920b1193],
23	.	.	O	.	_	0	SENT_119	[p6l1710t1124r1920b1193],

1	In	IN	O	in	_	0	SENT_120	[p6l1953t1127r2013b1178],
2	the	DT	O	the	det	4	SENT_120	[p6l2044t1124r2146b1179],
3	20	CD	NUMBER	20	num	4	SENT_120	[p6l10t1216r87b1268],
4	patients	NNS	O	patient	pobj	1	SENT_120	[p6l117t1214r376b1282],
5	with	IN	O	with	_	0	SENT_120	[p6l405t1213r553b1268],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_120	[p6l583t1216r750b1268],
7	mutations	NNS	O	mutation	prep_with	4	SENT_120	[p6l778t1214r1121b1277],
8	,	,	O	,	_	0	SENT_120	[p6l778t1214r1121b1277],
9	7	CD	NUMBER	7	nsubj	10	SENT_120	[p6l1153t1217r1186b1268],
10	had	VBD	O	have	dep	4	SENT_120	[p6l1218t1213r1334b1268],
11	the	DT	O	the	det	12	SENT_120	[p6l1364t1213r1465b1268],
12	deletion	NN	O	deletion	dobj	10	SENT_120	[p6l1496t1213r1759b1268],
13	of	IN	O	of	_	0	SENT_120	[p6l1788t1213r1855b1268],
14	exon	NN	O	exon	prep_of	12	SENT_120	[p6l1877t1229r2028b1268],
15	19	CD	NUMBER	19	num	14	SENT_120	[p6l2061t1216r2146b1277],
16	,	,	O	,	_	0	SENT_120	[p6l2061t1216r2146b1277],

1	316	CD	NUMBER	316	num	3	SENT_121	[p6l396t1358r439b1379],
2	K.	NNP	PERSON	K.	nn	3	SENT_121	[p6l1195t1358r1216b1379],
3	Sugio	NNP	PERSON	Sugio	_	0	SENT_121	[p6l1225t1357r1291b1384],
4	et	FW	O	et	nn	5	SENT_121	[p6l1299t1360r1322b1379],
5	al.	FW	O	al.	dep	3	SENT_121	[p6l1329t1357r1355b1379],
6	/	:	O	/	punct	3	SENT_121	[p6l1362t1357r1374b1384],
7	Lung	NN	O	lung	nn	8	SENT_121	[p6l1380t1358r1439b1384],
8	Cancer	NN	O	cancer	dep	3	SENT_121	[p6l1447t1358r1530b1379],
9	64	CD	NUMBER	64	number	10	SENT_121	[p6l1537t1358r1566b1379],
10	(	CD	NUMBER	(	num	11	SENT_121	[p6l1574t1357r1655b1384],
11	2009	CD	DATE	2009	dep	8	SENT_121	[p6l1574t1357r1655b1384],
12	)	CD	NUMBER	)	number	13	SENT_121	[p6l1574t1357r1655b1384],
13	314-318	CD	NUMBER	314-318	num	11	SENT_121	[p6l1663t1358r1763b1379],

1	Table	NNP	O	Table	_	0	SENT_122	[p6l6t1486r149b1530],
2	1	CD	NUMBER	1	num	3	SENT_122	[p6l167t1488r191b1529],
3	Patients	NNPS	O	Patients	dep	1	SENT_122	[p6l9t1559r213b1602],
4	characteristic	JJ	O	characteristic	amod	10	SENT_122	[p6l231t1558r577b1602],
5	in	IN	O	in	_	0	SENT_122	[p6l595t1559r642b1602],
6	relation	NN	O	relation	prep_in	4	SENT_122	[p6l661t1559r859b1602],
7	to	TO	O	to	_	0	SENT_122	[p6l876t1565r925b1602],
8	the	DT	O	the	det	9	SENT_122	[p6l943t1559r1024b1602],
9	EGFR	NN	ORGANIZATION	egfr	prep_to	4	SENT_122	[p6l1043t1561r1177b1602],
10	mutations	NNS	O	mutation	dep	3	SENT_122	[p6l1193t1559r1467b1602],
11	.	.	O	.	_	0	SENT_122	[p6l1193t1559r1467b1602],

1	Factors	NNS	O	factor	_	0	SENT_123	[p6l9t1685r188b1726],
2	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_123	[p6l700t1685r833b1726],
3	mutation	NN	O	mutation	nn	6	SENT_123	[p6l849t1683r1087b1726],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_123	[p6l1318t1685r1451b1726],
5	mutation	NN	O	mutation	nn	6	SENT_123	[p6l1467t1683r1704b1726],
6	p-value	NN	O	p-value	dep	1	SENT_123	[p6l1931t1682r2125b1737],
7	positive	JJ	O	positive	amod	8	SENT_123	[p6l700t1754r900b1808],
8	negative	JJ	O	negative	amod	6	SENT_123	[p6l1318t1754r1533b1808],

1	All	DT	O	all	det	2	SENT_124	[p6l6t1865r75b1908],
2	cases	NNS	O	case	_	0	SENT_124	[p6l94t1878r225b1909],
3	20	CD	NUMBER	20	num	4	SENT_124	[p6l700t1867r761b1909],
4	28	CD	NUMBER	28	dep	2	SENT_124	[p6l1317t1867r1377b1909],

1	Sex	NN	O	sex	_	0	SENT_125	[p6l9t1982r96b2024],

1	Male	JJ	O	male	amod	2	SENT_126	[p6l63t2052r187b2096],
2	11	CD	NUMBER	11	_	0	SENT_126	[p6l708t2055r754b2096],
3	21	CD	NUMBER	21	number	4	SENT_126	[p6l1320t2055r1372b2096],
4	0.1473	CD	NUMBER	0.1473	num	5	SENT_126	[p6l1935t2055r2098b2097],
5	Female	JJ	O	female	dep	2	SENT_126	[p6l63t2125r245b2169],
6	9	CD	NUMBER	9	number	7	SENT_126	[p6l732t2127r760b2169],
7	7	CD	NUMBER	7	amod	5	SENT_126	[p6l1351t2128r1378b2168],

1	Age	NN	O	age	_	0	SENT_127	[p6l6t2242r101b2294],

1	Histology	NNP	O	Histology	_	0	SENT_128	[p6l9t2499r253b2554],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_129	[p6l60t2572r496b2616],
2	20	CD	NUMBER	20	number	3	SENT_129	[p6l700t2574r761b2616],
3	21	CD	NUMBER	21	dep	1	SENT_129	[p6l1320t2574r1372b2615],
4	0.0155	CD	NUMBER	0.0155	num	6	SENT_129	[p6l1935t2574r2101b2616],
5	Non-adeno	NN	O	non-adeno	nn	6	SENT_129	[p6l63t2644r348b2688],
6	o	NN	O	o	dep	3	SENT_129	[p6l732t2646r761b2688],
7	7	CD	NUMBER	7	dep	1	SENT_129	[p6l1351t2647r1377b2687],

1	Smoking	NN	O	smoking	nn	2	SENT_130	[p6l9t2759r233b2814],
2	status	NN	O	status	_	0	SENT_130	[p6l250t2766r400b2803],

1	Never	RB	O	never	advmod	5	SENT_131	[p6l63t2834r214b2875],
2	10	CD	NUMBER	10	pobj	1	SENT_131	[p6l706t2834r761b2875],
3	1	CD	NUMBER	1	number	4	SENT_131	[p6l1353t2834r1372b2875],
4	0.00023	CD	NUMBER	0.00023	num	5	SENT_131	[p6l1935t2834r2133b2876],
5	Former	JJ	O	former	_	0	SENT_131	[p6l63t2907r249b2948],
6	2	CD	NUMBER	2	number	7	SENT_131	[p6l732t2906r759b2947],
7	9	CD	NUMBER	9	num	8	SENT_131	[p6l1350t2906r1378b2948],
8	Current	JJ	DATE	current	dep	5	SENT_131	[p6l63t2979r259b3020],
9	8	CD	NUMBER	8	number	10	SENT_131	[p6l732t2979r759b3020],
10	18	CD	NUMBER	18	amod	8	SENT_131	[p6l1324t2979r1377b3020],

1	Smoking	NN	MISC	smoking	nn	2	SENT_132	[p6l9t3091r233b3146],
2	index	NN	O	index	_	0	SENT_132	[p6l250t3091r392b3135],
3	(	CD	NUMBER	(	num	5	SENT_132	[p6l409t3091r549b3146],
4	pack	NN	O	pack	nn	5	SENT_132	[p6l409t3091r549b3146],
5	year	NN	DURATION	year	dep	2	SENT_132	[p6l563t3091r694b3146],
6	)	IN	O	)	amod	5	SENT_132	[p6l563t3091r694b3146],

1	3	CD	NUMBER	3	_	0	SENT_133	[p6l59t3521r78b3543],
2	Never	RB	O	never	advmod	3	SENT_133	[p6l110t3522r261b3563],
3	smoker	NN	O	smoker	dep	1	SENT_133	[p6l278t3520r469b3563],
4	vs.	CC	O	vs.	prep	3	SENT_133	[p6l484t3532r549b3563],
5	former/current	JJ	O	former/current	amod	6	SENT_133	[p6l568t3519r956b3574],
6	smoker	NN	O	smoker	dep	4	SENT_133	[p6l974t3519r1172b3563],
7	.	.	O	.	_	0	SENT_133	[p6l974t3519r1172b3563],

1	b	NN	O	b	nn	3	SENT_134	[p6l57t3590r77b3621],
2	Smoking	NN	MISC	smoking	nn	3	SENT_134	[p6l110t3597r335b3651],
3	index	NN	O	index	_	0	SENT_134	[p6l352t3597r509b3641],
4	:	:	O	:	_	0	SENT_134	[p6l352t3597r509b3641],
5	(	CD	NUMBER	(	number	6	SENT_134	[p6l531t3597r696b3651],
6	0-10	CD	NUMBER	0-10	num	7	SENT_134	[p6l531t3597r696b3651],
7	)	CD	NUMBER	)	dep	3	SENT_134	[p6l531t3597r696b3651],
8	vs.	IN	O	vs.	_	0	SENT_134	[p6l713t3610r778b3641],
9	(	CD	NUMBER	(	num	10	SENT_134	[p6l797t3597r940b3651],
10	>	JJR	O	>	prep_vs.	7	SENT_134	[p6l797t3597r940b3651],
11	10	CD	NUMBER	10	num	12	SENT_134	[p6l797t3597r940b3651],
12	)	NN	O	)	dep	10	SENT_134	[p6l797t3597r940b3651],
13	.	.	O	.	_	0	SENT_134	[p6l797t3597r940b3651],

1	11	CD	NUMBER	11	nsubj	2	SENT_135	[p7l12t87r70b139],
2	had	VBD	O	have	dep	25	SENT_135	[p7l105t84r220b139],
3	the	DT	O	the	det	5	SENT_135	[p7l246t84r348b139],
4	missense	NN	O	missense	nn	5	SENT_135	[p7l375t85r667b139],
5	mutation	NN	O	mutation	dobj	2	SENT_135	[p7l694t85r991b139],
6	in	IN	O	in	_	0	SENT_135	[p7l1017t85r1076b139],
7	exon	NN	O	exon	prep_in	5	SENT_135	[p7l1101t100r1252b139],
8	21	CD	NUMBER	21	number	9	SENT_135	[p7l1278t87r1343b139],
9	(	CD	NUMBER	(	num	11	SENT_135	[p7l1377t85r1642b153],
10	L858R	NN	O	l858r	nn	11	SENT_135	[p7l1377t85r1642b153],
11	)	NN	O	)	nsubj	14	SENT_135	[p7l1377t85r1642b153],
12	,	,	O	,	_	0	SENT_135	[p7l1377t85r1642b153],
13	1	CD	NUMBER	1	appos	11	SENT_135	[p7l1673t87r1697b139],
14	had	VBD	O	have	rcmod	5	SENT_135	[p7l1731t84r1847b139],
15	both	CC	O	both	preconj	19	SENT_135	[p7l1872t84r2018b139],
16	the	DT	O	the	det	19	SENT_135	[p7l2043t84r2145b139],
17	exon	NN	O	exon	nn	19	SENT_135	[p7l9t188r160b227],
18	19	CD	NUMBER	19	num	19	SENT_135	[p7l192t175r260b227],
19	deletion	NN	O	deletion	dobj	14	SENT_135	[p7l290t173r553b227],
20	and	CC	O	and	_	0	SENT_135	[p7l581t173r697b227],
21	L858R	NN	O	l858r	dobj	14	SENT_135	[p7l727t175r939b235],
22	,	,	O	,	_	0	SENT_135	[p7l727t175r939b235],
23	and	CC	O	and	_	0	SENT_135	[p7l969t173r1086b227],
24	1	CD	NUMBER	1	conj_and	21	SENT_135	[p7l1118t176r1143b226],
25	had	VBD	O	have	_	0	SENT_135	[p7l1180t173r1296b227],
26	the	DT	O	the	det	29	SENT_135	[p7l1325t173r1427b227],
27	exon	NN	O	exon	nn	29	SENT_135	[p7l1456t188r1607b227],
28	19	CD	NUMBER	19	num	29	SENT_135	[p7l1639t175r1707b227],
29	deletion	NN	O	deletion	dobj	25	SENT_135	[p7l1737t173r2000b227],
30	and	CC	O	and	_	0	SENT_135	[p7l2028t173r2144b227],
31	the	DT	O	the	det	33	SENT_135	[p7l8t261r110b316],
32	missense	NN	O	missense	nn	33	SENT_135	[p7l141t262r433b316],
33	mutation	NN	O	mutation	dobj	25	SENT_135	[p7l464t262r760b316],
34	in	IN	O	in	_	0	SENT_135	[p7l790t262r849b315],
35	exon	NN	O	exon	prep_in	25	SENT_135	[p7l879t277r1030b316],
36	20	CD	NUMBER	20	num	35	SENT_135	[p7l1059t264r1136b316],
37	(	CD	NUMBER	(	num	39	SENT_135	[p7l1166t261r1448b329],
38	G796A	NN	O	g796a	nn	39	SENT_135	[p7l1166t261r1448b329],
39	)	NN	O	)	nsubj	25	SENT_135	[p7l1166t261r1448b329],
40	.	.	O	.	_	0	SENT_135	[p7l1166t261r1448b329],

1	The	DT	O	the	det	3	SENT_136	[p7l1476t261r1592b316],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_136	[p7l1624t264r1790b316],
3	mutations	NNS	O	mutation	nsubjpass	6	SENT_136	[p7l1818t262r2144b316],
4	were	VBD	O	be	auxpass	6	SENT_136	[p7l7t365r166b404],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_136	[p7l194t349r588b418],
6	associated	VBN	O	associate	_	0	SENT_136	[p7l614t349r945b404],
7	with	IN	O	with	_	0	SENT_136	[p7l972t349r1120b404],
8	adenocarcinoma	NN	O	adenocarcinoma	nn	9	SENT_136	[p7l1147t349r1680b404],
9	histology	NN	O	histology	prep_with	6	SENT_136	[p7l1708t349r2003b418],
10	and	CC	O	and	_	0	SENT_136	[p7l2028t349r2144b404],
11	never/non	NN	O	never/non	nn	13	SENT_136	[p7l9t438r647b507],
12	—	CD	NUMBER	—	num	13	SENT_136	[p7l9t438r647b507],
13	smol	NN	O	smol	dep	14	SENT_136	[p7l9t438r647b507],
14	<	JJR	O	<	prep_with	6	SENT_136	[p7l9t438r647b507],
15	ing	CD	NUMBER	ing	num	16	SENT_136	[p7l9t438r647b507],
16	status	NN	O	status	dep	14	SENT_136	[p7l682t446r886b494],
17	.	.	O	.	_	0	SENT_136	[p7l682t446r886b494],

1	The	DT	O	the	det	3	SENT_137	[p7l920t438r1037b493],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_137	[p7l1074t441r1240b493],
3	mutations	NNS	O	mutation	nsubjpass	26	SENT_137	[p7l1274t439r1601b493],
4	were	VBD	O	be	auxpass	7	SENT_137	[p7l1636t454r1794b493],
5	more	RBR	O	more	advmod	6	SENT_137	[p7l1831t454r1996b493],
6	frequently	RB	O	frequently	advmod	7	SENT_137	[p7l2033t438r2145b493, p7l9t527r254b596],
7	detected	VBN	O	detect	_	0	SENT_137	[p7l277t527r552b582],
8	in	IN	O	in	_	0	SENT_137	[p7l578t528r637b582],
9	females	NNS	O	female	prep_in	7	SENT_137	[p7l662t527r908b582],
10	(	CD	NUMBER	(	number	11	SENT_137	[p7l933t528r995b596],
11	9	CD	TIME	9	nsubj	18	SENT_137	[p7l933t528r995b596],
12	of	IN	TIME	of	_	0	SENT_137	[p7l1021t527r1087b582],
13	16	CD	TIME	16	num	14	SENT_137	[p7l1108t528r1202b596],
14	)	NN	O	)	prep_of	11	SENT_137	[p7l1108t528r1202b596],
15	than	IN	O	than	advmod	18	SENT_137	[p7l1227t527r1371b582],
16	in	IN	O	in	_	0	SENT_137	[p7l1396t528r1455b582],
17	males	NNS	O	male	prep_in	15	SENT_137	[p7l1480t527r1666b582],
18	(	VBP	O	(	rcmod	9	SENT_137	[p7l1692t527r1779b596],
19	11	CD	NUMBER	11	dobj	18	SENT_137	[p7l1692t527r1779b596],
20	of	IN	O	of	_	0	SENT_137	[p7l1812t527r1879b582],
21	32	CD	NUMBER	32	num	22	SENT_137	[p7l1895t527r2014b596],
22	)	CD	NUMBER	)	prep_of	19	SENT_137	[p7l1895t527r2014b596],
23	,	,	O	,	_	0	SENT_137	[p7l1895t527r2014b596],
24	but	CC	O	but	_	0	SENT_137	[p7l2039t527r2146b582],
25	there	EX	O	there	expl	26	SENT_137	[p7l8t616r175b671],
26	was	VBD	O	be	conj_but	7	SENT_137	[p7l196t632r319b671],
27	no	DT	O	no	det	28	SENT_137	[p7l343t632r421b671],
28	signiﬁcant	NN	O	signiﬁcant	iobj	26	SENT_137	[p7l445t616r779b685],
29	difference	NN	O	difference	nn	31	SENT_137	[p7l800t616r1122b671],
30	(	CD	NUMBER	(	num	31	SENT_137	[p7l1145t616r1337b685],
31	Table	NNP	O	Table	dep	28	SENT_137	[p7l1145t616r1337b685],
32	1	CD	NUMBER	1	number	33	SENT_137	[p7l1364t617r1438b685],
33	)	CD	NUMBER	)	dep	31	SENT_137	[p7l1364t617r1438b685],
34	.	.	O	.	_	0	SENT_137	[p7l1364t617r1438b685],

1	3.2	CD	NUMBER	3.2	_	0	SENT_138	[p7l6t808r111b860],
2	.	.	O	.	_	0	SENT_138	[p7l6t808r111b860],

1	Response	NN	O	response	_	0	SENT_139	[p7l159t808r441b874],
2	to	TO	O	to	_	0	SENT_139	[p7l465t813r519b860],
3	geﬁtinib	NN	O	geﬁtinib	prep_to	1	SENT_139	[p7l537t805r792b874],
4	in	IN	O	in	dep	1	SENT_139	[p7l815t806r871b860],
5	patients	NNS	O	patient	pobj	4	SENT_139	[p7l889t806r1140b874],
6	with	IN	O	with	dep	1	SENT_139	[p7l1160t805r1299b860],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_139	[p7l1320t808r1478b860],
8	mutations	NNS	O	mutation	pobj	6	SENT_139	[p7l1500t806r1813b860],

1	Of	IN	O	of	_	0	SENT_140	[p7l111t983r188b1038],
2	the	DT	O	the	det	4	SENT_140	[p7l212t984r313b1038],
3	20	CD	NUMBER	20	num	4	SENT_140	[p7l347t986r423b1038],
4	patients	NNS	O	patient	nsubj	5	SENT_140	[p7l456t984r714b1052],
5	harboring	VBG	O	harbor	prepc_of	15	SENT_140	[p7l748t983r1065b1052],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_140	[p7l1097t986r1263b1038],
7	mutations	NNS	O	mutation	dobj	5	SENT_140	[p7l1293t984r1636b1047],
8	,	,	O	,	_	0	SENT_140	[p7l1293t984r1636b1047],
9	1	CD	NUMBER	1	num	10	SENT_140	[p7l1674t986r1698b1038],
10	patient	NN	O	patient	nsubjpass	15	SENT_140	[p7l1739t984r1968b1052],
11	with	IN	O	with	_	0	SENT_140	[p7l1997t984r2145b1038],
12	L858R	NN	O	l858r	prep_with	10	SENT_140	[p7l9t1075r209b1127],
13	was	VBD	O	be	auxpass	15	SENT_140	[p7l229t1088r352b1127],
14	not	RB	O	not	neg	15	SENT_140	[p7l379t1081r483b1127],
15	enrolled	VBN	O	enrol	_	0	SENT_140	[p7l507t1072r772b1127],
16	in	IN	O	in	_	0	SENT_140	[p7l798t1073r857b1127],
17	the	DT	O	the	det	21	SENT_140	[p7l881t1072r983b1127],
18	subsequent	JJ	O	subsequent	amod	21	SENT_140	[p7l1010t1072r1378b1141],
19	phase	NN	O	phase	nn	21	SENT_140	[p7l1402t1072r1586b1141],
20	II	CD	NUMBER	ii	num	21	SENT_140	[p7l1612t1076r1650b1127],
21	study	NN	O	study	prep_in	15	SENT_140	[p7l1677t1072r1864b1141],
22	,	,	O	,	_	0	SENT_140	[p7l1677t1072r1864b1141],
23	because	IN	O	because	mark	25	SENT_140	[p7l1890t1072r2145b1127],
24	she	PRP	O	she	nsubj	25	SENT_140	[p7l10t1162r115b1217],
25	withdrew	VBD	O	withdraw	advcl	15	SENT_140	[p7l135t1162r451b1217],
26	her	PRP$	O	she	poss	27	SENT_140	[p7l470t1162r576b1217],
27	consent	NN	O	consent	dobj	25	SENT_140	[p7l595t1170r846b1217],
28	before	IN	O	before	_	0	SENT_140	[p7l864t1161r1067b1217],
29	treatment	NN	O	treatment	prep_before	25	SENT_140	[p7l1088t1170r1426b1217],
30	.	.	O	.	_	0	SENT_140	[p7l1088t1170r1426b1217],

1	Therefore	RB	O	therefore	advmod	6	SENT_141	[p7l1445t1161r1771b1225],
2	,	,	O	,	_	0	SENT_141	[p7l1445t1161r1771b1225],
3	19	CD	NUMBER	19	num	4	SENT_141	[p7l1797t1164r1864b1217],
4	patients	NNS	O	patient	nsubjpass	6	SENT_141	[p7l1886t1162r2144b1230],
5	were	VBD	O	be	auxpass	6	SENT_141	[p7l7t1267r165b1306],
6	treated	VBN	O	treat	_	0	SENT_141	[p7l210t1251r439b1306],
7	with	IN	O	with	_	0	SENT_141	[p7l482t1251r630b1306],
8	geﬁtinib	NN	O	geﬁtinib	prep_with	6	SENT_141	[p7l673t1251r941b1319],
9	and	CC	O	and	_	0	SENT_141	[p7l985t1251r1101b1306],
10	were	VBD	O	be	cop	11	SENT_141	[p7l1145t1267r1303b1306],
11	assessable	JJ	O	assessable	conj_and	6	SENT_141	[p7l1348t1251r1678b1306],
12	for	IN	O	for	_	0	SENT_141	[p7l1724t1251r1813b1306],
13	objective	JJ	O	objective	amod	14	SENT_141	[p7l1856t1251r2145b1319],
14	responses	NNS	O	response	prep_for	11	SENT_141	[p7l9t1355r342b1408],
15	.	.	O	.	_	0	SENT_141	[p7l9t1355r342b1408],

1	Six	CD	NUMBER	six	num	2	SENT_142	[p7l362t1340r456b1394],
2	patients	NNS	O	patient	nsubj	3	SENT_142	[p7l473t1340r731b1408],
3	had	VBD	O	have	ccomp	9	SENT_142	[p7l752t1339r867b1394],
4	stage	NN	O	stage	nn	6	SENT_142	[p7l887t1347r1049b1408],
5	IIIB	NN	O	iiib	nn	6	SENT_142	[p7l1069t1342r1171b1393],
6	disease	NN	O	disease	dobj	3	SENT_142	[p7l1191t1339r1438b1402],
7	,	,	O	,	_	0	SENT_142	[p7l1191t1339r1438b1402],
8	2	CD	NUMBER	2	nsubj	9	SENT_142	[p7l1458t1342r1492b1393],
9	had	VBD	O	have	_	0	SENT_142	[p7l1513t1339r1629b1394],
10	stage	NN	O	stage	dobj	9	SENT_142	[p7l1649t1347r1811b1408],
11	IV	CD	NUMBER	iv	num	12	SENT_142	[p7l1830t1342r1896b1393],
12	disease	NN	O	disease	nsubj	15	SENT_142	[p7l1913t1339r2145b1394],
13	and	CC	O	and	_	0	SENT_142	[p7l9t1428r125b1483],
14	11	CD	NUMBER	11	conj_and	12	SENT_142	[p7l154t1431r212b1483],
15	had	VBD	O	have	rcmod	10	SENT_142	[p7l245t1428r360b1483],
16	recurrent	JJ	O	recurrent	amod	17	SENT_142	[p7l387t1436r688b1483],
17	disease	NN	O	disease	dobj	15	SENT_142	[p7l711t1428r943b1483],
18	after	IN	O	after	_	0	SENT_142	[p7l968t1428r1118b1483],
19	surgery	NN	O	surgery	prep_after	15	SENT_142	[p7l1142t1444r1393b1497],
20	.	.	O	.	_	0	SENT_142	[p7l1142t1444r1393b1497],

1	Nine	CD	NUMBER	nine	num	2	SENT_143	[p7l1419t1429r1567b1483],
2	patients	NNS	O	patient	nsubj	3	SENT_143	[p7l1593t1429r1850b1497],
3	received	VBD	O	receive	_	0	SENT_143	[p7l1877t1428r2144b1483],
4	geﬁtinib	NN	O	geﬁtinib	nn	5	SENT_143	[p7l8t1517r275b1586],
5	treatment	NN	O	treatment	dobj	3	SENT_143	[p7l309t1525r632b1572],
6	as	IN	O	as	_	0	SENT_143	[p7l665t1533r727b1572],
7	the	DT	O	the	det	11	SENT_143	[p7l761t1517r863b1572],
8	ﬁrst	JJ	O	ﬁrst	amod	11	SENT_143	[p7l898t1517r1174b1572],
9	—	NN	O	—	nn	11	SENT_143	[p7l898t1517r1174b1572],
10	line	NN	O	line	nn	11	SENT_143	[p7l898t1517r1174b1572],
11	chemotherapy	NN	O	chemotherapy	prep_as	3	SENT_143	[p7l1208t1518r1683b1586],
12	,	,	O	,	_	0	SENT_143	[p7l1208t1518r1683b1586],
13	6	CD	NUMBER	6	num	14	SENT_143	[p7l1719t1520r1754b1572],
14	patients	NNS	O	patient	prep_as	3	SENT_143	[p7l1789t1518r2047b1586],
15	as	IN	O	as	_	0	SENT_143	[p7l2082t1533r2144b1572],
16	the	DT	O	the	det	20	SENT_143	[p7l8t1607r110b1662],
17	second	JJ	ORDINAL	second	amod	20	SENT_143	[p7l140t1607r513b1662],
18	—	NN	O	—	nn	20	SENT_143	[p7l140t1607r513b1662],
19	line	NN	O	line	nn	20	SENT_143	[p7l140t1607r513b1662],
20	treatment	NN	O	treatment	prep_as	14	SENT_143	[p7l541t1615r879b1670],
21	,	,	O	,	_	0	SENT_143	[p7l541t1615r879b1670],
22	and	CC	O	and	_	0	SENT_143	[p7l909t1607r1025b1662],
23	4	CD	NUMBER	4	num	24	SENT_143	[p7l1053t1609r1091b1661],
24	patients	NNS	O	patient	conj_and	11	SENT_143	[p7l1120t1607r1378b1675],
25	as	IN	O	as	_	0	SENT_143	[p7l1408t1622r1470b1662],
26	the	DT	O	the	det	29	SENT_143	[p7l1500t1607r1601b1662],
27	third	JJ	ORDINAL	third	amod	29	SENT_143	[p7l1630t1607r1937b1662],
28	—	NN	O	—	nn	29	SENT_143	[p7l1630t1607r1937b1662],
29	line	NN	O	line	prep_as	3	SENT_143	[p7l1630t1607r1937b1662],
30	treatment	NN	O	treatment	nn	32	SENT_143	[p7l1966t1615r2144b1662, p7l9t1704r177b1751],
31	(	CD	NUMBER	(	num	32	SENT_143	[p7l203t1696r395b1764],
32	Table	NNP	O	Table	dep	29	SENT_143	[p7l203t1696r395b1764],
33	2	CD	NUMBER	2	number	34	SENT_143	[p7l422t1696r500b1764],
34	)	CD	NUMBER	)	dep	32	SENT_143	[p7l422t1696r500b1764],
35	.	.	O	.	_	0	SENT_143	[p7l422t1696r500b1764],

1	Of	IN	O	of	_	0	SENT_144	[p7l528t1695r605b1751],
2	the	DT	O	the	det	3	SENT_144	[p7l623t1696r725b1751],
3	19	CD	NUMBER	19	prep_of	8	SENT_144	[p7l755t1698r823b1751],
4	enrolled	VBN	O	enrol	partmod	3	SENT_144	[p7l851t1696r1116b1751],
5	patients	NNS	O	patient	dobj	4	SENT_144	[p7l1143t1696r1418b1764],
6	,	,	O	,	_	0	SENT_144	[p7l1143t1696r1418b1764],
7	12	CD	NUMBER	12	nsubj	8	SENT_144	[p7l1449t1698r1517b1750],
8	achieved	VBD	O	achieve	_	0	SENT_144	[p7l1546t1696r1828b1751],
9	objective	JJ	O	objective	amod	10	SENT_144	[p7l1856t1696r2145b1764],
10	responses	NNS	O	response	nsubj	11	SENT_144	[p7l9t1801r325b1853],
11	(	VBP	O	(	ccomp	8	SENT_144	[p7l368t1785r466b1853],
12	12	CD	NUMBER	12	num	14	SENT_144	[p7l368t1785r466b1853],
13	PR	NN	O	pr	nn	14	SENT_144	[p7l510t1785r615b1853],
14	)	NN	O	)	dobj	11	SENT_144	[p7l510t1785r615b1853],
15	with	IN	O	with	_	0	SENT_144	[p7l656t1785r804b1840],
16	an	DT	O	a	det	19	SENT_144	[p7l845t1801r920b1840],
17	overall	JJ	O	overall	amod	19	SENT_144	[p7l963t1785r1177b1840],
18	response	NN	O	response	nn	19	SENT_144	[p7l1221t1801r1505b1853],
19	rate	NN	O	rate	prep_with	11	SENT_144	[p7l1549t1793r1670b1840],
20	of	IN	O	of	_	0	SENT_144	[p7l1713t1785r1780b1840],
21	63.2	CD	PERCENT	63.2	num	22	SENT_144	[p7l1814t1788r1992b1840],
22	%	NN	PERCENT	%	prep_of	19	SENT_144	[p7l1814t1788r1992b1840],
23	(	CD	NUMBER	(	num	24	SENT_144	[p7l2034t1785r2140b1853],
24	CI	NN	O	ci	dep	22	SENT_144	[p7l2034t1785r2140b1853],
25	:	:	O	:	_	0	SENT_144	[p7l2034t1785r2140b1853],
26	38.4	CD	PERCENT	38.4	number	27	SENT_144	[p7l8t1873r409b1941],
27	—	CD	PERCENT	—	dep	22	SENT_144	[p7l8t1873r409b1941],
28	83.7	CD	PERCENT	83.7	num	29	SENT_144	[p7l8t1873r409b1941],
29	%	NN	PERCENT	%	dep	27	SENT_144	[p7l8t1873r409b1941],
30	)	CD	NUMBER	)	dep	27	SENT_144	[p7l8t1873r409b1941],
31	.	.	O	.	_	0	SENT_144	[p7l8t1873r409b1941],

1	Five	CD	NUMBER	five	num	2	SENT_145	[p7l442t1874r566b1928],
2	patients	NNS	O	patient	nsubj	3	SENT_145	[p7l598t1874r857b1942],
3	had	VBD	O	have	_	0	SENT_145	[p7l890t1873r1005b1928],
4	stable	JJ	O	stable	amod	5	SENT_145	[p7l1038t1873r1225b1928],
5	disease	NN	O	disease	nsubj	8	SENT_145	[p7l1257t1873r1505b1937],
6	,	,	O	,	_	0	SENT_145	[p7l1257t1873r1505b1937],
7	thus	RB	O	thus	advmod	5	SENT_145	[p7l1537t1873r1674b1928],
8	resulting	VBG	O	result	ccomp	3	SENT_145	[p7l1708t1873r1993b1942],
9	in	IN	O	in	_	0	SENT_145	[p7l2023t1874r2082b1927],
10	a	DT	O	a	det	13	SENT_145	[p7l2113t1889r2145b1928],
11	disease	NN	O	disease	nn	13	SENT_145	[p7l9t1962r241b2017],
12	control	NN	O	control	nn	13	SENT_145	[p7l270t1962r496b2017],
13	rate	NN	O	rate	prep_in	8	SENT_145	[p7l527t1970r648b2017],
14	of	IN	O	of	_	0	SENT_145	[p7l677t1962r743b2017],
15	89.5	CD	PERCENT	89.5	num	16	SENT_145	[p7l765t1965r943b2018],
16	%	NN	PERCENT	%	prep_of	13	SENT_145	[p7l765t1965r943b2018],
17	(	CD	NUMBER	(	num	18	SENT_145	[p7l971t1962r1164b2030],
18	Table	NNP	O	Table	tmod	3	SENT_145	[p7l971t1962r1164b2030],
19	3	CD	NUMBER	3	num	18	SENT_145	[p7l1191t1962r1270b2031],
20	)	NN	O	)	dep	18	SENT_145	[p7l1191t1962r1270b2031],
21	.	.	O	.	_	0	SENT_145	[p7l1191t1962r1270b2031],

1	According	VBG	O	accord	_	0	SENT_146	[p7l1297t1962r1622b2031],
2	to	TO	O	to	prepc_according_to	29	SENT_146	[p7l1649t1970r1709b2017],
3	the	DT	O	the	det	4	SENT_146	[p7l1738t1962r1840b2017],
4	status	NN	O	status	pobj	29	SENT_146	[p7l1869t1970r2057b2017],
5	of	IN	O	of	_	0	SENT_146	[p7l2086t1962r2153b2017],
6	the	DT	O	the	det	8	SENT_146	[p7l8t2051r110b2106],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_146	[p7l141t2054r308b2106],
8	mutation	NN	O	mutation	prep_of	4	SENT_146	[p7l335t2052r647b2115],
9	,	,	O	,	_	0	SENT_146	[p7l335t2052r647b2115],
10	the	DT	O	the	det	12	SENT_146	[p7l677t2051r779b2106],
11	response	NN	O	response	nn	12	SENT_146	[p7l810t2067r1094b2120],
12	rates	NNS	O	rate	nsubj	29	SENT_146	[p7l1125t2060r1277b2106],
13	of	IN	O	of	_	0	SENT_146	[p7l1309t2051r1375b2106],
14	patients	NNS	O	patient	prep_of	12	SENT_146	[p7l1398t2052r1656b2120],
15	with	IN	O	with	_	0	SENT_146	[p7l1685t2051r1833b2106],
16	the	DT	O	the	det	19	SENT_146	[p7l1862t2051r1964b2106],
17	exon	NN	O	exon	nn	19	SENT_146	[p7l1994t2067r2146b2106],
18	19	CD	NUMBER	19	num	19	SENT_146	[p7l12t2143r80b2196],
19	deletion	NN	O	deletion	prep_with	14	SENT_146	[p7l111t2141r374b2196],
20	and	CC	O	and	_	0	SENT_146	[p7l403t2141r519b2196],
21	those	DT	O	those	conj_and	14	SENT_146	[p7l549t2141r722b2196],
22	with	IN	O	with	_	0	SENT_146	[p7l750t2141r899b2196],
23	L858R	NN	O	l858r	prep_with	21	SENT_146	[p7l928t2143r1128b2196],
24	were	VBD	O	be	cop	29	SENT_146	[p7l1153t2156r1311b2196],
25	71.4	CD	PERCENT	71.4	number	29	SENT_146	[p7l1342t2143r1511b2196],
26	%	NN	PERCENT	%	dep	29	SENT_146	[p7l1342t2143r1511b2196],
27	and	CC	O	and	_	0	SENT_146	[p7l1540t2141r1656b2196],
28	60.0	CD	PERCENT	60.0	conj_and	29	SENT_146	[p7l1687t2143r1880b2204],
29	%	NN	PERCENT	%	_	0	SENT_146	[p7l1687t2143r1880b2204],
30	,	,	O	,	_	0	SENT_146	[p7l1687t2143r1880b2204],
31	respectively	RB	O	respectively	advmod	29	SENT_146	[p7l1911t2156r2144b2209, p7l8t2230r196b2298],
32	,	,	O	,	_	0	SENT_146	[p7l1911t2156r2144b2209, p7l8t2230r196b2298],
33	which	WDT	O	which	nsubj	36	SENT_146	[p7l214t2230r412b2285],
34	did	VBD	O	do	aux	36	SENT_146	[p7l431t2230r530b2285],
35	not	RB	O	not	neg	36	SENT_146	[p7l551t2238r655b2285],
36	show	VB	O	show	rcmod	29	SENT_146	[p7l673t2230r843b2285],
37	a	DT	O	a	det	39	SENT_146	[p7l860t2246r892b2285],
38	signiﬁcant	NN	O	signiﬁcant	nn	39	SENT_146	[p7l912t2230r1247b2298],
39	difference	NN	O	difference	dobj	36	SENT_146	[p7l1264t2230r1602b2285],
40	.	.	O	.	_	0	SENT_146	[p7l1264t2230r1602b2285],

1	A	DT	O	a	det	2	SENT_147	[p7l1619t2232r1666b2284],
2	case	NN	O	case	nsubj	11	SENT_147	[p7l1682t2246r1816b2285],
3	with	IN	O	with	_	0	SENT_147	[p7l1834t2230r1982b2285],
4	both	CC	O	both	preconj	8	SENT_147	[p7l2000t2230r2145b2285],
5	the	DT	O	the	det	8	SENT_147	[p7l8t2318r110b2372],
6	exon	NN	O	exon	nn	8	SENT_147	[p7l139t2334r290b2372],
7	19	CD	NUMBER	19	num	8	SENT_147	[p7l321t2321r389b2372],
8	deletion	NN	O	deletion	prep_with	2	SENT_147	[p7l418t2318r682b2372],
9	and	CC	O	and	_	0	SENT_147	[p7l709t2318r825b2372],
10	L858R	NN	O	l858r	conj_and	8	SENT_147	[p7l854t2321r1054b2372],
11	showed	VBD	O	show	_	0	SENT_147	[p7l1080t2318r1326b2372],
12	PR	NN	O	pr	dobj	11	SENT_147	[p7l1356t2321r1449b2380],
13	,	,	O	,	_	0	SENT_147	[p7l1356t2321r1449b2380],
14	whereas	IN	O	whereas	mark	25	SENT_147	[p7l1477t2318r1747b2372],
15	a	DT	O	a	det	16	SENT_147	[p7l1776t2334r1808b2372],
16	case	NN	O	case	nsubj	25	SENT_147	[p7l1836t2334r1970b2372],
17	with	IN	O	with	_	0	SENT_147	[p7l1997t2318r2145b2372],
18	both	CC	O	both	preconj	22	SENT_147	[p7l8t2405r154b2460],
19	the	DT	O	the	det	22	SENT_147	[p7l187t2405r289b2460],
20	exon	NN	O	exon	nn	22	SENT_147	[p7l324t2421r475b2460],
21	19	CD	NUMBER	19	num	22	SENT_147	[p7l512t2408r580b2460],
22	deletion	NN	O	deletion	prep_with	16	SENT_147	[p7l616t2405r879b2460],
23	and	CC	O	and	_	0	SENT_147	[p7l913t2405r1029b2460],
24	G796A	NN	O	g796a	conj_and	22	SENT_147	[p7l1064t2407r1280b2460],
25	showed	VBD	O	show	advcl	11	SENT_147	[p7l1314t2405r1560b2460],
26	SD	NN	O	sd	dobj	25	SENT_147	[p7l1595t2408r1693b2461],
27	.	.	O	.	_	0	SENT_147	[p7l1595t2408r1693b2461],

1	According	VBG	O	accord	_	0	SENT_148	[p7l1726t2405r2051b2474],
2	to	TO	O	to	prepc_according_to	17	SENT_148	[p7l2084t2413r2144b2460],
3	the	DT	O	the	det	5	SENT_148	[p7l8t2494r110b2549],
4	treatment	NN	O	treatment	nn	5	SENT_148	[p7l140t2502r463b2549],
5	status	NN	O	status	pobj	17	SENT_148	[p7l492t2502r696b2558],
6	,	,	O	,	_	0	SENT_148	[p7l492t2502r696b2558],
7	the	DT	O	the	det	9	SENT_148	[p7l726t2494r828b2549],
8	response	NN	O	response	nn	9	SENT_148	[p7l858t2510r1143b2563],
9	rate	NN	O	rate	nsubj	17	SENT_148	[p7l1174t2502r1296b2549],
10	of	IN	O	of	_	0	SENT_148	[p7l1326t2494r1392b2549],
11	patients	NNS	O	patient	prep_of	9	SENT_148	[p7l1415t2495r1672b2563],
12	without	IN	O	without	_	0	SENT_148	[p7l1702t2494r1960b2549],
13	prior	JJ	O	prior	amod	14	SENT_148	[p7l1989t2495r2147b2563],
14	chemotherapy	NN	O	chemotherapy	prep_without	11	SENT_148	[p7l9t2583r474b2652],
15	was	VBD	O	be	cop	17	SENT_148	[p7l502t2599r624b2638],
16	77.8	CD	PERCENT	77.8	num	17	SENT_148	[p7l658t2586r828b2639],
17	%	NN	PERCENT	%	_	0	SENT_148	[p7l658t2586r828b2639],
18	(	CD	NUMBER	(	number	19	SENT_148	[p7l859t2583r1029b2652],
19	7/9	CD	NUMBER	7/9	num	20	SENT_148	[p7l859t2583r1029b2652],
20	)	NN	O	)	attr	17	SENT_148	[p7l859t2583r1029b2652],
21	,	,	O	,	_	0	SENT_148	[p7l859t2583r1029b2652],
22	in	IN	O	in	_	0	SENT_148	[p7l1062t2584r1121b2638],
23	comparison	NN	O	comparison	prep_in	20	SENT_148	[p7l1152t2584r1530b2652],
24	to	TO	O	to	_	0	SENT_148	[p7l1560t2592r1620b2638],
25	that	DT	O	that	prep_to	23	SENT_148	[p7l1652t2583r1781b2638],
26	with	IN	O	with	_	0	SENT_148	[p7l1809t2583r1958b2638],
27	prior	JJ	O	prior	amod	28	SENT_148	[p7l1989t2584r2147b2652],
28	chemotherapy	NN	O	chemotherapy	prep_with	25	SENT_148	[p7l9t2673r474b2741],
29	of	IN	O	of	_	0	SENT_148	[p7l495t2672r561b2728],
30	50.0	CD	PERCENT	50.0	num	31	SENT_148	[p7l577t2675r754b2728],
31	%	NN	PERCENT	%	prep_of	28	SENT_148	[p7l577t2675r754b2728],
32	(	CD	NUMBER	(	dep	31	SENT_148	[p7l777t2672r967b2741],
33	5/10	CD	NUMBER	5/10	number	34	SENT_148	[p7l777t2672r967b2741],
34	)	CD	NUMBER	)	num	39	SENT_148	[p7l777t2672r967b2741],
35	(	NN	O	(	nn	39	SENT_148	[p7l990t2673r1050b2741],
36	p	NN	O	p	nn	39	SENT_148	[p7l990t2673r1050b2741],
37	=	JJ	O	=	amod	39	SENT_148	[p7l1067t2696r1100b2712],
38	0.210	CD	NUMBER	0.210	num	39	SENT_148	[p7l1116t2673r1325b2741],
39	)	NN	O	)	dep	32	SENT_148	[p7l1116t2673r1325b2741],
40	.	.	O	.	_	0	SENT_148	[p7l1116t2673r1325b2741],

1	The	DT	O	the	det	2	SENT_149	[p7l108t2762r225b2817],
2	median	NN	O	median	nsubj	9	SENT_149	[p7l255t2762r496b2817],
3	follow	VB	O	follow	dep	2	SENT_149	[p7l525t2762r837b2830],
4	—	RB	O	—	advmod	3	SENT_149	[p7l525t2762r837b2830],
5	up	RP	O	up	prep	3	SENT_149	[p7l525t2762r837b2830],
6	time	NN	O	time	dep	5	SENT_149	[p7l867t2763r1012b2817],
7	was	VBD	O	be	cop	9	SENT_149	[p7l1040t2778r1163b2817],
8	13.1	CD	DURATION	13.1	num	9	SENT_149	[p7l1196t2765r1310b2817],
9	months	NNS	NUMBER	month	_	0	SENT_149	[p7l1347t2762r1590b2817],
10	(	JJ	O	(	amod	11	SENT_149	[p7l1621t2762r1843b2830],
11	range	NN	O	range	dep	9	SENT_149	[p7l1621t2762r1843b2830],
12	:	:	O	:	_	0	SENT_149	[p7l1621t2762r1843b2830],
13	1.7	CD	NUMBER	1.7	number	14	SENT_149	[p7l1881t2765r2142b2817],
14	—	CD	NUMBER	—	dep	9	SENT_149	[p7l1881t2765r2142b2817],
15	30.3	CD	DURATION	30.3	num	16	SENT_149	[p7l1881t2765r2142b2817],
16	months	NNS	NUMBER	month	tmod	14	SENT_149	[p7l9t2850r295b2918],
17	)	RB	O	)	advmod	9	SENT_149	[p7l9t2850r295b2918],
18	.	.	O	.	_	0	SENT_149	[p7l9t2850r295b2918],

1	The	DT	O	the	det	3	SENT_150	[p7l318t2850r435b2905],
2	median	JJ	O	median	amod	3	SENT_150	[p7l460t2850r701b2905],
3	PFS	NN	O	pf	nsubj	6	SENT_150	[p7l725t2853r832b2905],
4	was	VBD	O	be	cop	6	SENT_150	[p7l856t2866r979b2905],
5	7.1	CD	DURATION	7.1	num	6	SENT_150	[p7l1006t2853r1078b2906],
6	months	NNS	NUMBER	month	_	0	SENT_150	[p7l1112t2850r1371b2914],
7	,	,	O	,	_	0	SENT_150	[p7l1112t2850r1371b2914],
8	and	CC	O	and	_	0	SENT_150	[p7l1397t2850r1513b2905],
9	the	DT	O	the	det	13	SENT_150	[p7l1537t2850r1639b2905],
10	median	JJ	O	median	amod	13	SENT_150	[p7l1665t2850r1905b2905],
11	overall	JJ	O	overall	amod	13	SENT_150	[p7l1930t2850r2144b2905],
12	survival	NN	O	survival	nn	13	SENT_150	[p7l10t2939r259b2994],
13	time	NN	O	time	nsubj	16	SENT_150	[p7l276t2940r422b2994],
14	was	VBD	O	be	cop	16	SENT_150	[p7l438t2955r561b2994],
15	20.0	CD	DURATION	20.0	num	16	SENT_150	[p7l579t2942r713b2995],
16	months	NNS	NUMBER	month	conj_and	6	SENT_150	[p7l731t2939r974b2994],
17	(	CD	NUMBER	(	num	18	SENT_150	[p7l992t2939r1124b3008],
18	Fig	NN	O	fig	dep	16	SENT_150	[p7l992t2939r1124b3008],
19	.	.	O	.	_	0	SENT_150	[p7l992t2939r1124b3008],

1	1	CD	NUMBER	1	_	0	SENT_151	[p7l1146t2939r1220b3008],
2	)	NN	O	)	dep	1	SENT_151	[p7l1146t2939r1220b3008],
3	.	.	O	.	_	0	SENT_151	[p7l1146t2939r1220b3008],

1	Subset	NN	O	subset	nn	2	SENT_152	[p7l1239t2939r1450b2994],
2	analyses	NNS	O	analysis	nsubj	3	SENT_152	[p7l1466t2939r1734b3008],
3	showed	VBD	O	show	_	0	SENT_152	[p7l1754t2939r2000b2994],
4	that	IN	O	that	complm	20	SENT_152	[p7l2017t2939r2146b2994],
5	no	DT	O	no	det	7	SENT_152	[p7l9t3044r86b3083],
6	signiﬁcant	NN	O	signiﬁcant	nn	7	SENT_152	[p7l116t3028r451b3097],
7	difference	NN	O	difference	nsubj	20	SENT_152	[p7l479t3028r800b3083],
8	of	IN	O	of	_	0	SENT_152	[p7l829t3028r896b3083],
9	PFS	NN	O	pf	prep_of	7	SENT_152	[p7l917t3031r1024b3083],
10	was	VBD	O	be	cop	20	SENT_152	[p7l1052t3044r1175b3083],
11	evident	JJ	O	evident	amod	20	SENT_152	[p7l1205t3028r1446b3083],
12	between	IN	O	between	_	0	SENT_152	[p7l1473t3028r1750b3083],
13	the	DT	O	the	det	15	SENT_152	[p7l1778t3028r1880b3083],
14	2	CD	NUMBER	2	num	15	SENT_152	[p7l1909t3031r1942b3083],
15	types	NNS	O	type	prep_between	11	SENT_152	[p7l1973t3036r2144b3097],
16	of	IN	O	of	_	0	SENT_152	[p7l9t3117r76b3172],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_152	[p7l96t3120r263b3172],
18	mutation	NN	O	mutation	prep_of	15	SENT_152	[p7l288t3118r584b3172],
19	(	CD	NUMBER	(	num	20	SENT_152	[p7l612t3117r810b3186],
20	19del	CD	NUMBER	19del	ccomp	3	SENT_152	[p7l612t3117r810b3186],
21	vs.	IN	O	vs.	_	0	SENT_152	[p7l836t3133r918b3173],
22	21	CD	NUMBER	21	num	23	SENT_152	[p7l946t3120r1012b3172],
23	L858R	NN	O	l858r	prep_vs.	20	SENT_152	[p7l1049t3120r1265b3181],
24	;	:	O	;	_	0	SENT_152	[p7l1049t3120r1265b3181],
25	p	NN	O	p	dep	20	SENT_152	[p7l1293t3133r1331b3186],
26	=	JJ	O	=	amod	25	SENT_152	[p7l1348t3141r1382b3157],
27	0.526	CD	NUMBER	0.526	num	28	SENT_152	[p7l1399t3117r1615b3186],
28	)	NN	O	)	tmod	26	SENT_152	[p7l1399t3117r1615b3186],
29	,	,	O	,	_	0	SENT_152	[p7l1399t3117r1615b3186],
30	between	IN	O	between	_	0	SENT_152	[p7l1643t3117r1921b3172],
31	smoking	NN	O	smoking	nn	32	SENT_152	[p7l1949t3117r2144b3172, p7l9t3208r108b3275],
32	status	NN	O	status	prep_between	28	SENT_152	[p7l131t3215r318b3262],
33	(	CD	NUMBER	(	num	32	SENT_152	[p7l343t3207r549b3275],
34	never	RB	O	never	advmod	25	SENT_152	[p7l343t3207r549b3275],
35	vs.	FW	O	vs.	nn	36	SENT_152	[p7l569t3222r650b3262],
36	former/current	FW	O	former/current	dep	25	SENT_152	[p7l675t3206r1177b3275],
37	;	:	O	;	_	0	SENT_152	[p7l675t3206r1177b3275],
38	p	NN	O	p	dep	20	SENT_152	[p7l1201t3222r1240b3275],
39	=	JJ	O	=	amod	41	SENT_152	[p7l1257t3230r1290b3246],
40	0.923	CD	NUMBER	0.923	tmod	39	SENT_152	[p7l1307t3207r1524b3275],
41	)	NN	O	)	dep	38	SENT_152	[p7l1307t3207r1524b3275],
42	,	,	O	,	_	0	SENT_152	[p7l1307t3207r1524b3275],
43	and	CC	O	and	_	0	SENT_152	[p7l1548t3207r1664b3262],
44	between	IN	O	between	conj_and	20	SENT_152	[p7l1688t3207r1965b3262],
45	prior	JJ	O	prior	amod	46	SENT_152	[p7l1988t3207r2147b3275],
46	chemotherapy	NN	O	chemotherapy	pobj	44	SENT_152	[p7l9t3296r474b3364],
47	(	CD	NUMBER	(	dep	20	SENT_152	[p7l516t3296r619b3364],
48	no	DT	O	no	det	49	SENT_152	[p7l516t3296r619b3364],
49	chemotherapy	NN	O	chemotherapy	dep	47	SENT_152	[p7l664t3296r1129b3364],
50	vs.	FW	O	vs.	prep	49	SENT_152	[p7l1169t3312r1250b3351],
51	chemotherapy	NN	O	chemotherapy	pobj	50	SENT_152	[p7l1295t3296r1777b3364],
52	;	:	O	;	_	0	SENT_152	[p7l1295t3296r1777b3364],
53	p	NN	O	p	dep	49	SENT_152	[p7l1821t3296r2144b3364],
54	=	JJ	O	=	amod	56	SENT_152	[p7l1821t3296r2144b3364],
55	0.394	CD	NUMBER	0.394	tmod	54	SENT_152	[p7l1821t3296r2144b3364],
56	)	NN	O	)	dep	53	SENT_152	[p7l1821t3296r2144b3364],
57	.	.	O	.	_	0	SENT_152	[p7l1821t3296r2144b3364],

1	Three	CD	NUMBER	three	num	2	SENT_153	[p7l6t3384r188b3439],
2	patients	NNS	O	patient	nsubj	3	SENT_153	[p7l210t3385r468b3453],
3	continue	VBP	O	continue	_	0	SENT_153	[p7l490t3385r771b3439],
4	to	TO	O	to	aux	5	SENT_153	[p7l792t3392r853b3439],
5	receive	VB	O	receive	xcomp	3	SENT_153	[p7l875t3385r1099b3439],
6	geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_153	[p7l1119t3384r1387b3453],
7	treatment	NN	O	treatment	dobj	5	SENT_153	[p7l1407t3392r1731b3439],
8	without	IN	O	without	_	0	SENT_153	[p7l1749t3384r2007b3439],
9	disease	NN	O	disease	nn	10	SENT_153	[p7l2026t3384r2144b3439, p7l9t3489r146b3528],
10	progression	NN	O	progression	prep_without	5	SENT_153	[p7l169t3474r561b3542],
11	,	,	O	,	_	0	SENT_153	[p7l169t3474r561b3542],
12	at	IN	O	at	_	0	SENT_153	[p7l584t3481r644b3528],
13	the	DT	O	the	det	14	SENT_153	[p7l665t3473r766b3528],
14	time	NN	O	time	prep_at	5	SENT_153	[p7l789t3474r934b3528],
15	of	IN	O	of	_	0	SENT_153	[p7l957t3473r1023b3528],
16	this	DT	O	this	det	17	SENT_153	[p7l1038t3473r1154b3528],
17	analysis	NN	O	analysis	prep_of	14	SENT_153	[p7l1178t3473r1447b3542],
18	.	.	O	.	_	0	SENT_153	[p7l1178t3473r1447b3542],

1	:	:	O	:	_	0	SENT_154	[p8l1816t106r1874b427],
2	o_mmo	NN	O	o_mmo	_	0	SENT_154	[p8l1816t106r1874b427],
3	.	.	O	.	_	0	SENT_154	[p8l1816t106r1874b427],

1	.	.	O	.	_	0	SENT_155	[p8l1816t106r1874b427],

1	moE	VB	O	moe	_	0	SENT_156	[p8l1816t106r1874b427],
2	oz	NN	O	oz	dep	1	SENT_156	[p8l1818t447r1862b520],
3	ooﬁmoomoa	NN	O	ooﬁmoomoa	nn	5	SENT_156	[p8l1738t106r1796b427],
4	oz	NN	O	oz	nn	5	SENT_156	[p8l1741t447r1784b520],
5	ooﬁmoomooo	NN	O	ooﬁmoomooo	dep	2	SENT_156	[p8l1660t106r1718b427],
6	oz	NN	O	oz	amod	5	SENT_156	[p8l1662t447r1706b520],

1	DZ	NNP	O	DZ	nn	2	SENT_157	[p8l1585t438r1628b520],
2	DZ	NNP	O	DZ	_	0	SENT_157	[p8l1507t438r1550b520],
3	zoo	NN	O	zoo	dep	2	SENT_157	[p8l1429t178r1473b370],
4	?	.	O	?	_	0	SENT_157	[p8l1429t178r1473b370],

1	omxm	NN	O	omxm	nn	3	SENT_158	[p8l1429t387r1473b520],
2	DZ	NN	O	dz	nn	3	SENT_158	[p8l1351t438r1395b520],
3	couﬁsﬁ	NN	O	couﬁsﬁ	_	0	SENT_158	[p8l1271t174r1317b427],
4	OZ	NNP	O	OZ	nn	6	SENT_158	[p8l1273t447r1317b520],
5	DZ	NNP	O	DZ	nn	6	SENT_158	[p8l1196t438r1239b520],
6	Q2	NNP	O	Q2	dep	3	SENT_158	[p8l1118t438r1161b520],
7	2005	CD	DATE	2005	dep	6	SENT_158	[p8l1039t178r1084b371],
8	.	.	O	.	_	0	SENT_158	[p8l1039t178r1084b371],

1	omxm	NN	O	omxm	nn	4	SENT_159	[p8l1039t388r1084b520],
2	DZ	NN	O	dz	nn	4	SENT_159	[p8l962t438r1006b520],
3	DZ	NN	O	dz	nn	4	SENT_159	[p8l884t438r928b520],
4	zoo	NN	O	zoo	_	0	SENT_159	[p8l806t178r851b371],
5	?	.	O	?	_	0	SENT_159	[p8l806t178r851b371],

1	omxm	NN	O	omxm	nn	4	SENT_160	[p8l806t387r851b520],
2	DZ	NN	O	dz	nn	4	SENT_160	[p8l729t437r772b520],
3	QZ	NN	O	qz	nn	4	SENT_160	[p8l651t438r695b520],
4	DZ	NN	O	dz	_	0	SENT_160	[p8l573t438r617b520],
5	DZ	NN	O	dz	nn	8	SENT_160	[p8l495t438r539b520],
6	Eommh	NN	O	eommh	nn	8	SENT_160	[p8l417t178r461b370],
7	omxm	NN	O	omxm	nn	8	SENT_160	[p8l417t387r462b520],
8	uooumooﬁ	NN	O	uooumooﬁ	dep	4	SENT_160	[p8l295t246r341b520],

1	_	NN	O	_	nn	2	SENT_161	[p8l216t277r275b523],
2	oo	NN	O	oo	_	0	SENT_161	[p8l216t277r275b523],
3	:	:	O	:	_	0	SENT_161	[p8l216t277r275b523],
4	=	JJ	O	=	amod	5	SENT_161	[p8l216t277r275b523],
5	co	NN	O	co	dep	6	SENT_161	[p8l216t277r275b523],
6	<	JJR	O	<	dep	2	SENT_161	[p8l216t277r275b523],

1	+	CC	O	+	cc	2	SENT_162	[p8l1815t850r1862b1020],
2	o	NN	O	o	dep	18	SENT_162	[p8l1815t850r1862b1020],
3	>	JJR	O	>	dep	2	SENT_162	[p8l1815t850r1862b1020],
4	=	JJ	O	=	amod	3	SENT_162	[p8l1815t850r1862b1020],
5	<	JJR	O	<	dep	4	SENT_162	[p8l1815t850r1862b1020],
6	+	CC	O	+	_	0	SENT_162	[p8l1738t850r1784b1019],
7	o	NN	O	o	conj_+	3	SENT_162	[p8l1738t850r1784b1019],
8	>	JJR	O	>	dep	9	SENT_162	[p8l1738t850r1784b1019],
9	=	JJ	O	=	amod	10	SENT_162	[p8l1738t850r1784b1019],
10	<	JJR	O	<	dep	7	SENT_162	[p8l1738t850r1784b1019],
11	+	CC	O	+	_	0	SENT_162	[p8l1660t850r1706b1020],
12	m	NN	O	m	conj_+	3	SENT_162	[p8l1660t850r1706b1020],
13	>	JJR	O	>	dep	14	SENT_162	[p8l1660t850r1706b1020],
14	=	JJ	O	=	amod	15	SENT_162	[p8l1660t850r1706b1020],
15	<	JJR	O	<	dep	12	SENT_162	[p8l1660t850r1706b1020],
16	_	CD	NUMBER	_	num	17	SENT_162	[p8l1582t880r1629b1017],
17	o8o	NN	O	o8o	dep	18	SENT_162	[p8l1582t880r1629b1017],
18	o	NN	O	o	dep	27	SENT_162	[p8l1504t883r1551b1019],
19	>	JJR	O	>	dep	20	SENT_162	[p8l1504t883r1551b1019],
20	=	JJ	O	=	amod	22	SENT_162	[p8l1504t883r1551b1019],
21	<	JJR	O	<	amod	22	SENT_162	[p8l1504t883r1551b1019],
22	m	NN	O	m	dep	18	SENT_162	[p8l1426t883r1473b1020],
23	>	JJR	O	>	dep	24	SENT_162	[p8l1426t883r1473b1020],
24	=	JJ	O	=	amod	22	SENT_162	[p8l1426t883r1473b1020],
25	<	JJR	O	<	amod	27	SENT_162	[p8l1426t883r1473b1020],
26	ammo	NN	O	ammo	nn	27	SENT_162	[p8l1348t880r1395b1017],
27	m	NN	O	m	dep	51	SENT_162	[p8l1271t883r1317b1020],
28	>	JJR	O	>	dep	29	SENT_162	[p8l1271t883r1317b1020],
29	=	JJ	O	=	amod	36	SENT_162	[p8l1271t883r1317b1020],
30	<	JJR	O	<	amod	32	SENT_162	[p8l1271t883r1317b1020],
31	ammo	NN	O	ammo	nn	32	SENT_162	[p8l1193t880r1240b1017],
32	m	NN	O	m	npadvmod	35	SENT_162	[p8l1115t883r1161b1020],
33	>	JJR	O	>	dep	34	SENT_162	[p8l1115t883r1161b1020],
34	=	JJ	O	=	amod	32	SENT_162	[p8l1115t883r1161b1020],
35	<	JJR	O	<	amod	36	SENT_162	[p8l1115t883r1161b1020],
36	m	NN	O	m	dep	27	SENT_162	[p8l1037t883r1084b1020],
37	>	JJR	O	>	dep	36	SENT_162	[p8l1037t883r1084b1020],
38	:	:	O	:	_	0	SENT_162	[p8l1037t883r1084b1020],
39	<	JJR	O	<	dep	36	SENT_162	[p8l1037t883r1084b1020],
40	U30	CD	NUMBER	u30	num	42	SENT_162	[p8l959t880r1006b1017],
41	Ego	NN	O	ego	nn	42	SENT_162	[p8l881t879r928b1017],
42	mayo	NN	O	mayo	dep	39	SENT_162	[p8l804t879r851b1017],
43	23	CD	NUMBER	23	num	44	SENT_162	[p8l726t879r772b1016],
44	o	NN	O	o	npadvmod	47	SENT_162	[p8l648t883r695b1019],
45	>	JJR	O	>	dep	46	SENT_162	[p8l648t883r695b1019],
46	=	JJ	O	=	amod	44	SENT_162	[p8l648t883r695b1019],
47	<	JJR	O	<	amod	42	SENT_162	[p8l648t883r695b1019],
48	Eon	NNP	O	Eon	nn	51	SENT_162	[p8l570t879r617b1017],
49	Ego	NNP	O	Ego	nn	51	SENT_162	[p8l492t879r539b1017],
50	ammo	NN	O	ammo	nn	51	SENT_162	[p8l415t879r462b1017],
51	n_@HCOUuSO	NN	O	n_@hcouuso	_	0	SENT_162	[p8l209t744r263b1017],

1	VN	NN	O	vn	nn	2	SENT_163	[p8l1584t1391r1628b1457],
2	mﬁ	NN	O	mﬁ	_	0	SENT_163	[p8l1507t1394r1551b1486],
3	EN	IN	O	en	dep	2	SENT_163	[p8l1429t1393r1473b1485],
4	EN	NNP	O	EN	nn	6	SENT_163	[p8l1351t1393r1395b1493],
5	mom	NN	O	mom	nn	6	SENT_163	[p8l1273t1394r1317b1493],
6	V	NN	O	v	pobj	3	SENT_163	[p8l1195t1391r1239b1479],
7	:	:	O	:	_	0	SENT_163	[p8l1195t1391r1239b1479],
8	mow	VB	O	mow	dep	6	SENT_163	[p8l1117t1392r1161b1495],
9	mmm	NN	O	mmm	nn	12	SENT_163	[p8l1039t1394r1084b1493],
10	mo	NN	DURATION	mo	nn	12	SENT_163	[p8l962t1393r1006b1458],
11	om	NN	O	om	nn	12	SENT_163	[p8l884t1392r928b1457],
12	Q3	NN	O	q3	dobj	8	SENT_163	[p8l806t1392r851b1479],
13	mam	NN	O	mam	nn	17	SENT_163	[p8l728t1393r772b1493],
14	Em	NNP	O	Em	nn	17	SENT_163	[p8l650t1394r695b1486],
15	mm	NN	O	mm	nn	17	SENT_163	[p8l573t1393r617b1456],
16	mmm	NN	O	mmm	nn	17	SENT_163	[p8l495t1393r539b1492],
17	V5	NN	O	v5	dep	8	SENT_163	[p8l417t1391r461b1480],

1	323	CD	NUMBER	323	_	0	SENT_164	[p8l216t1237r275b1376],
2	.	.	O	.	_	0	SENT_164	[p8l219t1394r263b1495],

1	E	NN	O	e	_	0	SENT_165	[p8l219t1394r263b1495],

1	ME	NNP	O	ME	nn	4	SENT_166	[p8l1818t1898r1861b1967],
2	ME	NNP	O	ME	nn	4	SENT_166	[p8l1741t1898r1784b1967],
3	ME	NNP	O	ME	nn	4	SENT_166	[p8l1662t1898r1706b1967],
4	Om	NNP	O	Om	_	0	SENT_166	[p8l1585t1895r1628b1967],
5	om	NN	O	om	nn	12	SENT_166	[p8l1507t1898r1551b1967],
6	om	NN	O	om	nn	12	SENT_166	[p8l1429t1897r1473b1967],
7	ME	NN	O	me	nn	12	SENT_166	[p8l1351t1898r1395b1967],
8	ME	NN	O	me	nn	12	SENT_166	[p8l1273t1898r1317b1967],
9	om	NN	O	om	nn	12	SENT_166	[p8l1195t1897r1240b1967],
10	E	NN	O	e	nn	12	SENT_166	[p8l1118t1898r1161b1967],
11	ME	NN	O	me	nn	12	SENT_166	[p8l1040t1898r1083b1968],
12	mm	NN	O	mm	dep	4	SENT_166	[p8l962t1897r1006b1967],
13	on	IN	O	on	prep	12	SENT_166	[p8l884t1895r928b1967],
14	.	.	O	.	_	0	SENT_166	[p8l884t1895r928b1967],

1	Mm	NN	O	mm	nn	2	SENT_167	[p8l807t1898r850b1967],
2	E	NN	O	e	_	0	SENT_167	[p8l729t1898r772b1967],
3	E	NN	O	e	nn	6	SENT_167	[p8l651t1898r694b1967],
4	om	NN	O	om	nn	6	SENT_167	[p8l573t1897r617b1967],
5	E	NN	O	e	nn	6	SENT_167	[p8l495t1898r539b1967],
6	ME	NN	O	me	dep	2	SENT_167	[p8l418t1898r461b1967],

1	omooomom	NN	O	omooomom	_	0	SENT_168	[p8l219t1712r275b1967],

1	«	NN	O	«	nn	2	SENT_169	[p8l1818t2700r1862b2870],
2	mm	NN	O	mm	_	0	SENT_169	[p8l1818t2700r1862b2870],
3	:	:	O	:	_	0	SENT_169	[p8l1818t2700r1862b2870],
4	Hm	NN	O	hm	dep	2	SENT_169	[p8l1818t2896r1861b2953],
5	«	CD	NUMBER	«	num	6	SENT_169	[p8l1740t2700r1784b2870],
6	mm	NN	O	mm	dep	4	SENT_169	[p8l1740t2700r1784b2870],
7	:	:	O	:	_	0	SENT_169	[p8l1740t2700r1784b2870],
8	HN	NNP	O	HN	dep	4	SENT_169	[p8l1740t2897r1784b2953],
9	mom	NN	O	mom	dep	8	SENT_169	[p8l1662t2700r1706b2870],
10	:	:	O	:	_	0	SENT_169	[p8l1662t2700r1706b2870],
11	Hm	NN	O	hm	nn	12	SENT_169	[p8l1662t2897r1706b2953],
12	ombwovﬁ	NN	O	ombwovﬁ	dep	4	SENT_169	[p8l1584t2488r1629b2786],
13	32	CD	NUMBER	32	num	14	SENT_169	[p8l1582t2807r1629b2950],
14	moms	NNS	O	mom	dep	12	SENT_169	[p8l1507t2700r1551b2870],
15	Hm	NN	O	hm	nn	17	SENT_169	[p8l1507t2897r1550b2953],
16	mwmmo	NN	O	mwmmo	nn	17	SENT_169	[p8l1429t2700r1473b2870],
17	Hm	NN	O	hm	dep	57	SENT_169	[p8l1429t2896r1472b2953],
18	«	CD	NUMBER	«	num	21	SENT_169	[p8l1351t2700r1395b2870],
19	$	$	MONEY	$	amod	21	SENT_169	[p8l1351t2700r1395b2870],
20	3	CD	MONEY	3	number	19	SENT_169	[p8l1351t2700r1395b2870],
21	R	NN	O	r	dep	17	SENT_169	[p8l1351t2897r1395b2953],
22	Nam	NNP	O	Nam	dep	21	SENT_169	[p8l1273t2700r1317b2870],
23	”	CD	NUMBER	”	num	22	SENT_169	[p8l1273t2700r1317b2870],
24	:	:	O	:	_	0	SENT_169	[p8l1273t2700r1317b2870],
25	~	CD	NUMBER	~	num	27	SENT_169	[p8l1273t2897r1317b2953],
26	N	NN	O	n	nn	27	SENT_169	[p8l1273t2897r1317b2953],
27	omK	NN	O	omk	dep	21	SENT_169	[p8l1195t2488r1240b2787],
28	<	JJR	O	<	dep	27	SENT_169	[p8l1195t2488r1240b2787],
29	-	:	O	-	_	0	SENT_169	[p8l1195t2488r1240b2787],
30	o	NN	O	o	nn	35	SENT_169	[p8l1195t2488r1240b2787],
31	§	NN	O	§	nn	35	SENT_169	[p8l1195t2488r1240b2787],
32	m	NN	O	m	nn	35	SENT_169	[p8l1195t2488r1240b2787],
33	_	CD	NUMBER	_	num	35	SENT_169	[p8l1193t2807r1240b2950],
34	o_om	NN	O	o_om	nn	35	SENT_169	[p8l1193t2807r1240b2950],
35	~	NN	O	~	dep	21	SENT_169	[p8l1193t2807r1240b2950],
36	mwmmo	NN	O	mwmmo	nn	38	SENT_169	[p8l1117t2700r1162b2870],
37	R	NN	O	r	nn	38	SENT_169	[p8l1117t2897r1161b2953],
38	mwE-oEm	NN	O	mwe-oem	dep	35	SENT_169	[p8l1039t2497r1084b2786],
39	_	CD	NUMBER	_	number	40	SENT_169	[p8l1039t2497r1084b2786],
40	32	CD	NUMBER	32	dep	35	SENT_169	[p8l1037t2806r1084b2950],
41	mmmmo	NN	O	mmmmo	nn	43	SENT_169	[p8l962t2700r1006b2870],
42	Hm	NN	O	hm	nn	43	SENT_169	[p8l962t2897r1006b2953],
43	mmmm	NN	O	mmmm	dep	40	SENT_169	[p8l884t2700r928b2870],
44	:	:	O	:	_	0	SENT_169	[p8l884t2700r928b2870],
45	R	NN	O	r	nn	46	SENT_169	[p8l884t2896r928b2953],
46	omn	NN	O	omn	dep	21	SENT_169	[p8l806t2488r851b2786],
47	<	JJR	O	<	dep	46	SENT_169	[p8l806t2488r851b2786],
48	-	:	O	-	_	0	SENT_169	[p8l806t2488r851b2786],
49	o	NN	O	o	nn	51	SENT_169	[p8l806t2488r851b2786],
50	§	NN	O	§	nn	51	SENT_169	[p8l806t2488r851b2786],
51	m	NN	O	m	dep	21	SENT_169	[p8l806t2488r851b2786],
52	_	CD	NUMBER	_	num	54	SENT_169	[p8l806t2488r851b2786],
53	E2	NN	O	e2	nn	54	SENT_169	[p8l804t2807r851b2950],
54	omE-oEm	NN	O	ome-oem	dep	51	SENT_169	[p8l728t2488r772b2786],
55	_	CD	PERCENT	_	num	56	SENT_169	[p8l726t2806r772b2950],
56	%	NN	PERCENT	%	dep	57	SENT_169	[p8l726t2806r772b2950],
57	m	NN	O	m	dep	2	SENT_169	[p8l726t2806r772b2950],
58	_	IN	O	_	prep	57	SENT_169	[p8l726t2806r772b2950],

1	«	NN	O	«	nn	2	SENT_170	[p8l650t2202r695b2372],
2	ammo	NN	O	ammo	nsubj	3	SENT_170	[p8l650t2202r695b2372],
3	S	NN	O	s	_	0	SENT_170	[p8l650t2398r694b2454],
4	.	.	O	.	_	0	SENT_170	[p8l650t2474r702b2786],

1	omn	NN	O	omn	_	0	SENT_171	[p8l650t2474r702b2786],
2	<	JJR	O	<	dep	1	SENT_171	[p8l650t2474r702b2786],
3	-	:	O	-	_	0	SENT_171	[p8l650t2474r702b2786],
4	ovE	NN	O	ove	nn	5	SENT_171	[p8l650t2474r702b2786],
5	E69	NN	O	e69	dep	6	SENT_171	[p8l648t2806r695b2950],
6	<	JJR	O	<	dep	1	SENT_171	[p8l572t2185r617b2369],
7	35	CD	NUMBER	35	num	8	SENT_171	[p8l572t2185r617b2369],
8	om	NN	O	om	dep	6	SENT_171	[p8l573t2389r617b2454],
9	.	.	O	.	_	0	SENT_171	[p8l572t2474r624b2786],

1	omK	NN	O	omk	dep	2	SENT_172	[p8l572t2474r624b2786],
2	<	JJR	O	<	_	0	SENT_172	[p8l572t2474r624b2786],
3	-	:	O	-	_	0	SENT_172	[p8l572t2474r624b2786],
4	oEm	NN	O	oem	nn	6	SENT_172	[p8l572t2474r624b2786],
5	_	NN	O	_	nn	6	SENT_172	[p8l572t2474r624b2786],
6	E9	NN	O	e9	dep	2	SENT_172	[p8l570t2806r617b2950],

1	omK	NN	O	omk	_	0	SENT_173	[p8l494t2488r539b2786],
2	<	JJR	O	<	dep	1	SENT_173	[p8l494t2488r539b2786],
3	-	:	O	-	_	0	SENT_173	[p8l494t2488r539b2786],
4	oEm	NN	O	oem	nn	6	SENT_173	[p8l494t2488r539b2786],
5	E5	NN	O	e5	nn	6	SENT_173	[p8l492t2806r539b2950],
6	omK	NN	O	omk	dep	1	SENT_173	[p8l417t2488r462b2786],
7	<	JJR	O	<	dep	6	SENT_173	[p8l417t2488r462b2786],
8	-	:	O	-	_	0	SENT_173	[p8l417t2488r462b2786],
9	oEm	NN	O	oem	dep	6	SENT_173	[p8l417t2488r462b2786],
10	_	CD	NUMBER	_	number	11	SENT_173	[p8l417t2488r462b2786],
11	:62	CD	NUMBER	:62	num	13	SENT_173	[p8l415t2806r462b2950],
12	moosmosﬁ	NN	O	moosmosﬁ	nn	13	SENT_173	[p8l217t2515r263b2793],
13	mmum	NN	O	mmum	dep	9	SENT_173	[p8l219t2810r263b2952],

1	©	NN	O	©	_	0	SENT_174	[p8l417t3626r1862b3657],
2	C	NN	O	c	dep	1	SENT_174	[p8l417t3626r1862b3657],
3	'	''	O	'	_	0	SENT_174	[p8l417t3626r1862b3657],
4	\	CD	NUMBER	\	num	5	SENT_174	[p8l417t3626r1862b3657],
5	lC	NN	O	lc	dep	2	SENT_174	[p8l417t3626r1862b3657],
6	\	CD	NUMBER	\	num	7	SENT_174	[p8l417t3626r1862b3657],
7	l1	NN	O	l1	dep	2	SENT_174	[p8l417t3626r1862b3657],
8	.	.	O	.	_	0	SENT_174	[p8l417t3626r1862b3657],

1	—	NN	O	—	_	0	SENT_175	[p8l417t3626r1862b3657],
2	.	.	O	.	_	0	SENT_175	[p8l417t3626r1862b3657],

1	*	NN	O	*	nn	4	SENT_176	[p8l417t3626r1862b3657],
2	C	NN	O	c	nn	4	SENT_176	[p8l417t3626r1862b3657],
3	\	NN	O	\	nn	4	SENT_176	[p8l417t3626r1862b3657],
4	l	NN	O	l	_	0	SENT_176	[p8l417t3626r1862b3657],
5	©	CD	NUMBER	©	num	6	SENT_176	[p8l417t3626r1862b3657],
6	1	CD	NUMBER	1	dep	4	SENT_176	[p8l417t3626r1862b3657],
7	.	.	O	.	_	0	SENT_176	[p8l417t3626r1862b3657],

1	—	NN	O	—	_	0	SENT_177	[p8l417t3626r1862b3657],
2	.	.	O	.	_	0	SENT_177	[p8l417t3626r1862b3657],

1	*	NN	O	*	_	0	SENT_178	[p8l417t3626r1862b3657],
2	1	CD	NUMBER	1	dep	1	SENT_178	[p8l417t3626r1862b3657],
3	.	.	O	.	_	0	SENT_178	[p8l417t3626r1862b3657],

1	—	NN	O	—	_	0	SENT_179	[p8l417t3626r1862b3657],
2	.	.	O	.	_	0	SENT_179	[p8l417t3626r1862b3657],
3	'	''	O	'	_	0	SENT_179	[p8l417t3626r1862b3657],

1	C	NN	O	c	nn	3	SENT_180	[p8l417t3626r1862b3657],
2	\	NN	O	\	nn	3	SENT_180	[p8l417t3626r1862b3657],
3	l	NN	O	l	_	0	SENT_180	[p8l417t3626r1862b3657],
4	©	CD	NUMBER	©	number	5	SENT_180	[p8l417t3626r1862b3657],
5	©	CD	NUMBER	©	num	6	SENT_180	[p8l417t3626r1862b3657],
6	©	NN	O	©	dep	3	SENT_180	[p8l417t3626r1862b3657],
7	©	CD	NUMBER	©	number	8	SENT_180	[p8l417t3626r1862b3657],
8	©	CD	NUMBER	©	num	9	SENT_180	[p8l417t3626r1862b3657],
9	\	NN	O	\	dep	6	SENT_180	[p8l417t3626r1862b3657],
10	.	.	O	.	_	0	SENT_180	[p8l417t3626r1862b3657],

1	—	NN	O	—	_	0	SENT_181	[p8l417t3626r1862b3657],
2	.	.	O	.	_	0	SENT_181	[p8l417t3626r1862b3657],

1	*	NN	O	*	_	0	SENT_182	[p8l417t3626r1862b3657],
2	\	NN	O	\	dep	1	SENT_182	[p8l417t3626r1862b3657],
3	.	.	O	.	_	0	SENT_182	[p8l417t3626r1862b3657],

1	—	NN	O	—	_	0	SENT_183	[p8l417t3626r1862b3657],
2	.	.	O	.	_	0	SENT_183	[p8l417t3626r1862b3657],

1	‘	NN	O	‘	nn	2	SENT_184	[p8l417t3626r1862b3657],
2	©	NN	O	©	_	0	SENT_184	[p8l417t3626r1862b3657],
3	1	CD	NUMBER	1	dep	2	SENT_184	[p8l417t3626r1862b3657],
4	.	.	O	.	_	0	SENT_184	[p8l417t3626r1862b3657],

1	—	NN	O	—	_	0	SENT_185	[p8l417t3626r1862b3657],
2	.	.	O	.	_	0	SENT_185	[p8l417t3626r1862b3657],
3	'	''	O	'	_	0	SENT_185	[p8l417t3626r1862b3657],

1	©	NN	O	©	_	0	SENT_186	[p8l417t3626r1862b3657],

1	>	JJR	O	>	_	0	SENT_187	[p8l294t3260r353b3657],
2	om	NN	O	om	dep	1	SENT_187	[p8l294t3260r353b3657],
3	.	.	O	.	_	0	SENT_187	[p8l294t3260r353b3657],

1	_	NN	O	_	nn	2	SENT_188	[p8l294t3260r353b3657],
2	oEoEo	NN	O	oeoeo	_	0	SENT_188	[p8l294t3260r353b3657],
3	:	:	O	:	_	0	SENT_188	[p8l294t3260r353b3657],
4	o	NN	O	o	nn	5	SENT_188	[p8l294t3260r353b3657],
5	SE	NN	O	se	dep	2	SENT_188	[p8l217t3210r275b3345],
6	.	.	O	.	_	0	SENT_188	[p8l217t3210r275b3345],

1	ho	NN	O	ho	nn	2	SENT_189	[p8l216t3358r263b3415],
2	omn_E	NN	O	omn_e	_	0	SENT_189	[p8l216t3432r263b3656],
3	=	JJ	O	=	dep	2	SENT_189	[p8l216t3432r263b3656],
4	z	SYM	O	z	dep	2	SENT_189	[p8l216t3432r263b3656],

1	>	JJR	O	>	_	0	SENT_190	[p9l1818t422r1861b479],
2	_	CD	NUMBER	_	num	3	SENT_190	[p9l1818t422r1861b479],
3	Eotsuum	NN	MISC	eotsuum	rcmod	1	SENT_190	[p9l1741t209r1784b478],
4	Emtsumm	NNP	MISC	Emtsumm	nn	6	SENT_190	[p9l1662t209r1706b478],
5	Embsumm	NNP	MISC	Embsumm	nn	6	SENT_190	[p9l1585t209r1629b479],
6	m	NN	O	m	dep	3	SENT_190	[p9l1507t391r1550b478],
7	:	:	O	:	_	0	SENT_190	[p9l1507t391r1550b478],
8	:	:	O	:	_	0	SENT_190	[p9l1507t391r1550b478],
9	Embsumm	NNP	MISC	Embsumm	nn	10	SENT_190	[p9l1429t209r1473b478],
10	Eotsuum	NNP	MISC	Eotsuum	dep	12	SENT_190	[p9l1351t209r1395b478],
11	Embsuum	NNP	MISC	Embsuum	nn	12	SENT_190	[p9l1273t209r1317b478],
12	Embsuom	NNP	MISC	Embsuom	dep	6	SENT_190	[p9l1196t209r1240b479],
13	m	NN	O	m	dep	12	SENT_190	[p9l1118t391r1161b478],
14	:	:	O	:	_	0	SENT_190	[p9l1118t391r1161b478],
15	:	:	O	:	_	0	SENT_190	[p9l1118t391r1161b478],
16	Embsumm	NNP	ORGANIZATION	Embsumm	dep	3	SENT_190	[p9l1040t209r1084b478],
17	m	NN	O	m	dep	16	SENT_190	[p9l962t391r1006b479],
18	:	:	O	:	_	0	SENT_190	[p9l962t391r1006b479],
19	=	JJ	O	=	amod	20	SENT_190	[p9l962t391r1006b479],
20	>	JJR	O	>	dep	3	SENT_190	[p9l884t422r928b478],
21	_	CD	NUMBER	_	num	22	SENT_190	[p9l884t422r928b478],
22	E	NN	O	e	dep	20	SENT_190	[p9l807t391r850b479],
23	:	:	O	:	_	0	SENT_190	[p9l807t391r850b479],
24	m	NN	O	m	dep	3	SENT_190	[p9l729t391r772b478],
25	:	:	O	:	_	0	SENT_190	[p9l729t391r772b478],
26	:	:	O	:	_	0	SENT_190	[p9l729t391r772b478],
27	Embsumm	NNP	O	Embsumm	nn	29	SENT_190	[p9l651t209r695b478],
28	uC	NNP	O	uC	nn	29	SENT_190	[p9l573t209r617b478],
29	®	NNP	O	®	dep	1	SENT_190	[p9l573t209r617b478],
30	.	.	O	.	_	0	SENT_190	[p9l573t209r617b478],

1	CSUQM	NNP	O	CSUQM	_	0	SENT_191	[p9l573t209r617b478],
2	_	CD	NUMBER	_	num	3	SENT_191	[p9l573t209r617b478],
3	m	NN	O	m	dep	1	SENT_191	[p9l495t391r539b478],
4	=	JJ	O	=	amod	6	SENT_191	[p9l495t391r539b478],
5	=	JJ	O	=	amod	6	SENT_191	[p9l495t391r539b478],
6	Embsumm	NN	O	embsumm	dep	1	SENT_191	[p9l418t209r462b478],

1	«	NN	O	«	nn	2	SENT_192	[p9l301t266r353b404],
2	mm	NN	O	mm	_	0	SENT_192	[p9l301t266r353b404],
3	:	:	O	:	_	0	SENT_192	[p9l301t266r353b404],
4	.5	CD	NUMBER	.5	dep	2	SENT_192	[p9l308t422r341b479],

1	msuﬁm	NN	O	msuﬁm	nn	2	SENT_193	[p9l224t94r263b253],
2	ommmmﬁ	NN	O	ommmmﬁ	_	0	SENT_193	[p9l217t273r263b478],
3	2	CD	NUMBER	2	num	6	SENT_193	[p9l495t911r539b969],
4	o	NN	O	o	nn	6	SENT_193	[p9l417t911r462b941],
5	mane	NN	O	mane	nn	6	SENT_193	[p9l294t803r341b976],
6	w	NN	O	w	dep	2	SENT_193	[p9l216t737r275b976],
7	:	:	O	:	_	0	SENT_193	[p9l216t737r275b976],
8	_	CD	NUMBER	_	num	9	SENT_193	[p9l216t737r275b976],
9	v_oEm	NN	O	v_oem	dep	6	SENT_193	[p9l216t737r275b976],

1	Embsu	NNP	O	Embsu	nn	3	SENT_194	[p9l1818t1254r1862b1463],
2	35	CD	NUMBER	35	num	3	SENT_194	[p9l1751t1302r1784b1419],
3	Z	NN	O	z	_	0	SENT_194	[p9l1740t1423r1784b1463],
4	.85	CD	NUMBER	.85	num	7	SENT_194	[p9l1673t1302r1706b1419],
5	Z	NN	O	z	nn	7	SENT_194	[p9l1662t1423r1706b1463],
6	Eobsu	NN	O	eobsu	nn	7	SENT_194	[p9l1584t1254r1629b1463],
7	Eobsu	NN	O	eobsu	dep	3	SENT_194	[p9l1507t1254r1551b1463],
8	35	CD	NUMBER	35	num	9	SENT_194	[p9l1440t1302r1473b1419],
9	Z	NN	O	z	dep	7	SENT_194	[p9l1429t1423r1473b1463],
10	Baton	NNP	O	Baton	dep	3	SENT_194	[p9l1351t1264r1395b1463],
11	.8	CD	NUMBER	.8	num	10	SENT_194	[p9l1284t1302r1317b1419],
12	>	JJR	O	>	amod	14	SENT_194	[p9l1284t1302r1317b1419],
13	m	NN	O	m	nn	14	SENT_194	[p9l1284t1302r1317b1419],
14	Z	NN	O	z	dep	10	SENT_194	[p9l1273t1423r1317b1463],
15	Embsu	NNP	MISC	Embsu	nn	18	SENT_194	[p9l1195t1254r1240b1463],
16	Emtsu	NNP	MISC	Emtsu	nn	18	SENT_194	[p9l1117t1254r1162b1463],
17	Embsu	NNP	MISC	Embsu	nn	18	SENT_194	[p9l1039t1254r1084b1463],
18	Eotsu	NNP	MISC	Eotsu	dep	3	SENT_194	[p9l962t1254r1006b1463],
19	$	$	MONEY	$	dep	20	SENT_194	[p9l895t1302r928b1419],
20	>	JJR	MONEY	>	dep	18	SENT_194	[p9l895t1302r928b1419],
21	m	NN	O	m	nn	23	SENT_194	[p9l895t1302r928b1419],
22	Z	NN	O	z	nn	23	SENT_194	[p9l884t1423r928b1463],
23	Embsu	NN	O	embsu	dep	3	SENT_194	[p9l806t1254r851b1463],
24	35	CD	NUMBER	35	num	25	SENT_194	[p9l739t1302r772b1419],
25	Z	NN	O	z	dep	23	SENT_194	[p9l729t1423r772b1463],
26	.	.	O	.	_	0	SENT_194	[p9l662t1302r695b1419],

1	_	NN	O	_	nn	2	SENT_195	[p9l662t1302r695b1419],
2	m	NN	O	m	dep	10	SENT_195	[p9l662t1302r695b1419],
3	>	JJR	O	>	amod	5	SENT_195	[p9l662t1302r695b1419],
4	m	NN	O	m	nn	5	SENT_195	[p9l662t1302r695b1419],
5	Z	NN	O	z	dep	2	SENT_195	[p9l651t1423r695b1463],
6	.55	CD	NUMBER	.55	num	7	SENT_195	[p9l584t1302r617b1419],
7	Z	NN	O	z	dep	10	SENT_195	[p9l573t1423r617b1463],
8	58:0	CD	NUMBER	58:0	num	10	SENT_195	[p9l495t1264r539b1463],
9	;	:	O	;	_	0	SENT_195	[p9l495t1264r539b1463],
10	35	CD	NUMBER	35	_	0	SENT_195	[p9l428t1302r462b1419],
11	Z	NN	O	z	dep	10	SENT_195	[p9l418t1423r461b1463],

1	\	NN	O	\	_	0	SENT_196	[p9l294t1270r353b1463],
2	C8mE	NN	O	c8me	nn	3	SENT_196	[p9l294t1270r353b1463],
3	mEv_oEm	NN	O	mev_oem	dep	1	SENT_196	[p9l216t1224r275b1463],

1	.	.	O	.	_	0	SENT_197	[p9l2106t1640r2153b1894],

1	_	NN	O	_	nn	4	SENT_198	[p9l2106t1640r2153b1894],
2	uoEmEo	NN	O	uoemeo	nn	4	SENT_198	[p9l2106t1640r2153b1894],
3	SE3	NN	O	se3	nn	4	SENT_198	[p9l2113t1911r2152b2083],
4	o	NN	O	o	_	0	SENT_198	[p9l2119t2102r2152b2168],
5	:	:	O	:	_	0	SENT_198	[p9l2119t2102r2152b2168],
6	“	CD	NUMBER	“	num	8	SENT_198	[p9l2109t2191r2153b2291],
7	Dz	NN	O	dz	nn	8	SENT_198	[p9l2109t2191r2153b2291],
8	U	NN	O	u	dep	4	SENT_198	[p9l2108t2327r2131b2344],

1	.	.	O	.	_	0	SENT_199	[p9l2022t1258r2080b1592],

1	:	:	O	:	_	0	SENT_200	[p9l2022t1258r2080b1592],
2	o_mm2wEn	NN	O	o_mm2wen	nn	3	SENT_200	[p9l2022t1258r2080b1592],
3	_	NN	O	_	_	0	SENT_200	[p9l2022t1258r2080b1592],
4	on	IN	O	on	prep	3	SENT_200	[p9l2035t1612r2068b1677],
5	53	CD	NUMBER	53	num	7	SENT_200	[p9l2021t1697r2068b1823],
6	>	JJR	O	>	amod	7	SENT_200	[p9l2021t1697r2068b1823],
7	m	NN	O	m	dep	4	SENT_200	[p9l2021t1841r2068b1966],
8	>	JJR	O	>	dep	7	SENT_200	[p9l2021t1841r2068b1966],
9	:	:	O	:	_	0	SENT_200	[p9l2021t1841r2068b1966],
10	m	NN	O	m	dep	8	SENT_200	[p9l2021t1841r2068b1966],
11	=	JJ	O	=	amod	10	SENT_200	[p9l2021t1986r2068b2084],
12	:	:	O	:	_	0	SENT_200	[p9l2021t1986r2068b2084],
13	m	NN	O	m	nn	14	SENT_200	[p9l2021t1986r2068b2084],
14	”	NN	O	”	dep	8	SENT_200	[p9l2021t2108r2068b2294],
15	+	CC	O	+	_	0	SENT_200	[p9l2021t2108r2068b2294],
16	m	NN	O	m	conj_+	3	SENT_200	[p9l2021t2108r2068b2294],
17	>	JJR	O	>	dep	16	SENT_200	[p9l2021t2108r2068b2294],
18	:	:	O	:	_	0	SENT_200	[p9l2021t2108r2068b2294],
19	<	JJR	O	<	amod	20	SENT_200	[p9l2021t2108r2068b2294],
20	n	NN	O	n	dep	3	SENT_200	[p9l2014t2327r2047b2349],
21	_	IN	O	_	amod	20	SENT_200	[p9l2014t2327r2047b2349],

1	.53	CD	PERCENT	.53	number	2	SENT_201	[p9l1950t1575r1995b1701],
2	5	CD	PERCENT	5	dep	3	SENT_201	[p9l1937t1718r1995b1844],
3	%	NN	PERCENT	%	dep	5	SENT_201	[p9l1937t1718r1995b1844],
4	uxmuﬁ	NN	O	uxmuﬁ	nn	5	SENT_201	[p9l1937t1868r1984b2034],
5	m	NN	O	m	_	0	SENT_201	[p9l1937t2052r1995b2292],
6	:	:	O	:	_	0	SENT_201	[p9l1937t2052r1995b2292],
7	EoEm	NN	O	eoem	nn	8	SENT_201	[p9l1937t2052r1995b2292],
8	_	NN	O	_	dep	5	SENT_201	[p9l1939t2327r1962b2346],
9	.	.	O	.	_	0	SENT_201	[p9l1939t2327r1962b2346],

1	.	.	O	.	_	0	SENT_202	[p9l1939t2327r1962b2346],

1	mm	NN	O	mm	nn	3	SENT_203	[p9l1818t2029r1862b2092],
2	mm	NN	O	mm	nn	3	SENT_203	[p9l1740t2029r1784b2090],
3	mm	NN	O	mm	_	0	SENT_203	[p9l1662t2030r1706b2090],
4	we	PRP	O	we	dep	3	SENT_203	[p9l1584t2029r1629b2094],
5	9	CD	NUMBER	9	number	6	SENT_203	[p9l1507t2029r1551b2095],
6	»	CD	NUMBER	»	num	7	SENT_203	[p9l1507t2029r1551b2095],
7	mm	NN	O	mm	dep	4	SENT_203	[p9l1429t2029r1473b2090],
8	no	DT	O	no	det	11	SENT_203	[p9l1351t2029r1395b2093],
9	3	CD	NUMBER	3	num	11	SENT_203	[p9l1273t2027r1317b2093],
10	mm	NN	O	mm	nn	11	SENT_203	[p9l1196t2029r1239b2091],
11	mm	NN	O	mm	dep	3	SENT_203	[p9l1117t2030r1161b2092],
12	mm	NN	O	mm	nn	15	SENT_203	[p9l1039t2030r1084b2092],
13	8	CD	NUMBER	8	num	15	SENT_203	[p9l962t2027r1006b2093],
14	mm	NN	O	mm	nn	15	SENT_203	[p9l884t2030r928b2090],
15	mm	NN	O	mm	dep	11	SENT_203	[p9l806t2029r851b2093],
16	we	PRP	O	we	dep	3	SENT_203	[p9l728t2029r772b2096],
17	mm	NN	O	mm	dep	16	SENT_203	[p9l651t2029r695b2092],
18	.	.	O	.	_	0	SENT_203	[p9l651t2029r695b2092],

1	K	NNP	O	K	_	0	SENT_204	[p9l573t2034r617b2089],
2	mm	NN	O	mm	nn	4	SENT_204	[p9l495t2030r539b2093],
3	mm	NN	O	mm	nn	4	SENT_204	[p9l418t2029r462b2092],
4	EEu	NN	O	eeu	dep	1	SENT_204	[p9l418t1723r1861b1773],
5	.	.	O	.	_	0	SENT_204	[p9l418t1723r1861b1773],

1	EEu	NN	O	eeu	_	0	SENT_205	[p9l418t1723r1861b1773],
2	.	.	O	.	_	0	SENT_205	[p9l418t1723r1861b1773],

1	u.	NNP	O	u.	nn	2	SENT_206	[p9l418t1723r1861b1773],
2	EEu	NNP	O	EEu	_	0	SENT_206	[p9l418t1723r1861b1773],
3	.	.	O	.	_	0	SENT_206	[p9l418t1723r1861b1773],

1	Eu_Eu	NN	O	eu_eu	_	0	SENT_207	[p9l418t1723r1861b1773],
2	.2	NN	NUMBER	.2	nn	3	SENT_207	[p9l418t1723r1861b1773],
3	Eu_u	NN	O	eu_u	dep	1	SENT_207	[p9l418t1723r1861b1773],
4	.	.	O	.	_	0	SENT_207	[p9l418t1723r1861b1773],

1	E	NN	O	e	_	0	SENT_208	[p9l418t1723r1861b1773],

1	xmm	CD	PERCENT	xmm	num	2	SENT_209	[p9l219t1681r263b1774],
2	%	NN	PERCENT	%	_	0	SENT_209	[p9l218t1994r275b2095],
3	<	JJR	O	<	dep	2	SENT_209	[p9l218t1994r275b2095],

1	2	CD	NUMBER	2	num	2	SENT_210	[p9l1818t2335r1862b2393],
2	M	NN	O	m	_	0	SENT_210	[p9l1740t2336r1784b2393],
3	:	:	O	:	_	0	SENT_210	[p9l1740t2336r1784b2393],
4	D	NN	O	d	dep	2	SENT_210	[p9l1662t2336r1706b2392],
5	2	CD	NUMBER	2	number	4	SENT_210	[p9l1584t2335r1629b2393],
6	2	CD	NUMBER	2	number	4	SENT_210	[p9l1507t2337r1551b2393],
7	3	CD	NUMBER	3	number	4	SENT_210	[p9l1428t2334r1472b2393],
8	2	CD	NUMBER	2	num	9	SENT_210	[p9l1351t2337r1395b2393],
9	Nw	NN	O	nw	dep	4	SENT_210	[p9l1273t2336r1317b2394],
10	3	CD	NUMBER	3	dep	4	SENT_210	[p9l1195t2342r1239b2391],

1	1	CD	NUMBER	1	number	2	SENT_211	[p9l417t2334r1161b2393],
2	—	CD	NUMBER	—	num	4	SENT_211	[p9l417t2334r1161b2393],
3	1C	NN	O	1c	nn	4	SENT_211	[p9l417t2334r1161b2393],
4	\	NN	O	\	_	0	SENT_211	[p9l417t2334r1161b2393],
5	l	NN	O	l	amod	4	SENT_211	[p9l417t2334r1161b2393],
6	<	JJR	O	<	dep	5	SENT_211	[p9l417t2334r1161b2393],
7	‘	CD	NUMBER	‘	num	10	SENT_211	[p9l417t2334r1161b2393],
8	0Vl	NN	O	0vl	nn	10	SENT_211	[p9l417t2334r1161b2393],
9	"	''	O	"	punct	10	SENT_211	[p9l417t2334r1161b2393],
10	LDLDl	NNP	O	LDLDl	dep	4	SENT_211	[p9l417t2334r1161b2393],
11	\	NNP	O	\	nn	13	SENT_211	[p9l417t2334r1161b2393],
12	OO	NNP	O	OO	nn	13	SENT_211	[p9l417t2334r1161b2393],
13	®	NN	O	®	dep	10	SENT_211	[p9l417t2334r1161b2393],
14	2	CD	NUMBER	2	num	13	SENT_211	[p9l417t2334r1161b2393],

1	.	.	O	.	_	0	SENT_212	[p9l219t2313r264b2400],

1	oZ	NN	O	oz	_	0	SENT_213	[p9l219t2313r264b2400],

1	.	.	O	.	_	0	SENT_214	[p9l83t215r130b338],

1	_	NN	O	_	nn	3	SENT_215	[p9l83t215r130b338],
2	m_b	NN	O	m_b	nn	3	SENT_215	[p9l83t215r130b338],
3	m	NN	O	m	_	0	SENT_215	[p9l84t357r142b673],
4	>	JJR	O	>	amod	5	SENT_215	[p9l84t357r142b673],
5	Uumn_moE	NN	O	uumn_moe	dep	3	SENT_215	[p9l84t357r142b673],
6	2	CD	NUMBER	2	dep	5	SENT_215	[p9l83t693r130b779],
7	:	:	O	:	_	0	SENT_215	[p9l83t693r130b779],
8	E	NN	O	e	nn	10	SENT_215	[p9l84t798r130b848],
9	_	CD	NUMBER	_	num	10	SENT_215	[p9l83t868r130b1094],
10	om	NN	O	om	dep	5	SENT_215	[p9l83t868r130b1094],
11	=	JJ	O	=	amod	13	SENT_215	[p9l83t868r130b1094],
12	oEm	NN	O	oem	nn	13	SENT_215	[p9l83t868r130b1094],
13	o	NN	O	o	dep	10	SENT_215	[p9l83t1114r130b1233],
14	:	:	O	:	_	0	SENT_215	[p9l83t1114r130b1233],
15	>>	CD	NUMBER	>>	num	18	SENT_215	[p9l83t1114r130b1233],
16	nzcummm	NN	O	nzcummm	nn	18	SENT_215	[p9l83t1251r142b1478],
17	H8	NN	O	h8	nn	18	SENT_215	[p9l83t1495r130b1571],
18	mmcommmg	NN	O	mmcommmg	dep	5	SENT_215	[p9l97t1591r142b1833],
19	cam	NN	O	cam	nn	21	SENT_215	[p9l83t1853r130b1953],
20	2:08	CD	TIME	2:08	num	21	SENT_215	[p9l83t1972r142b2148],
21	.3	NN	NUMBER	.3	dep	18	SENT_215	[p9l84t2169r130b2400],
22	:	:	O	:	_	0	SENT_215	[p9l84t2169r130b2400],
23	mBwn	JJ	O	mbwn	dep	5	SENT_215	[p9l84t2169r130b2400],
24	_	NN	O	_	dep	23	SENT_215	[p9l84t2169r130b2400],

1	N	NN	O	n	_	0	SENT_216	[p9l8t2201r52b2233],
2	o_n_w	NN	O	o_n_w	dep	1	SENT_216	[p9l6t2251r52b2403],
3	.	.	O	.	_	0	SENT_216	[p9l6t2251r52b2403],

1	.	.	O	.	_	0	SENT_217	[p9l6t2251r52b2403],

1	—	NN	O	—	_	0	SENT_218	[p9l6t2251r52b2403],
2	.	.	O	.	_	0	SENT_218	[p9l6t2251r52b2403],

1	.	.	O	.	_	0	SENT_219	[p9l6t2251r52b2403],

1	317	CD	NUMBER	317	_	0	SENT_220	[p9l2112t2479r2154b2500],

1	K.	NNP	PERSON	K.	nn	2	SENT_221	[p9l786t2479r807b2500],
2	Sugio	NNP	PERSON	Sugio	_	0	SENT_221	[p9l816t2478r881b2505],
3	et	FW	O	et	nn	4	SENT_221	[p9l890t2481r913b2500],
4	al.	FW	O	al.	dep	2	SENT_221	[p9l920t2478r946b2500],
5	/	:	O	/	punct	2	SENT_221	[p9l952t2478r964b2505],
6	Lung	NN	O	lung	nn	7	SENT_221	[p9l970t2479r1030b2505],
7	Cancer	NN	O	cancer	dep	2	SENT_221	[p9l1037t2479r1120b2500],
8	64	CD	NUMBER	64	number	9	SENT_221	[p9l1127t2479r1156b2500],
9	(	CD	NUMBER	(	num	10	SENT_221	[p9l1165t2478r1246b2505],
10	2009	CD	DATE	2009	dep	7	SENT_221	[p9l1165t2478r1246b2505],
11	)	CD	NUMBER	)	number	12	SENT_221	[p9l1165t2478r1246b2505],
12	314-318	CD	NUMBER	314-318	num	10	SENT_221	[p9l1253t2479r1354b2500],

1	Table	NNP	O	Table	nn	3	SENT_222	[p9l6t2555r77b2577],
2	3	CD	NUMBER	3	num	3	SENT_222	[p9l84t2556r99b2577],
3	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_222	[p9l6t2588r103b2615],
4	of	IN	O	of	_	0	SENT_222	[p9l111t2588r137b2610],
5	geﬁtinib	NN	O	geﬁtinib	prep_of	3	SENT_222	[p9l142t2588r247b2615],
6	in	IN	O	in	_	0	SENT_222	[p9l256t2588r279b2609],
7	patients	NNS	O	patient	prep_in	3	SENT_222	[p9l287t2588r389b2615],
8	with	IN	O	with	_	0	SENT_222	[p9l397t2588r455b2610],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_222	[p9l464t2589r529b2610],
10	mutations	NNS	O	mutation	prep_with	7	SENT_222	[p9l537t2588r671b2610],
11	.	.	O	.	_	0	SENT_222	[p9l537t2588r671b2610],

1	PD	NN	O	pd	nn	3	SENT_223	[p9l1272t2650r1305b2670],
2	Response	NN	O	response	nn	3	SENT_223	[p9l1474t2650r1591b2676],
3	rate	NN	O	rate	_	0	SENT_223	[p9l1600t2652r1648b2671],
4	(	CD	NUMBER	(	number	5	SENT_223	[p9l1656t2649r1692b2676],
5	96	CD	NUMBER	96	num	9	SENT_223	[p9l1656t2649r1692b2676],
6	)	NN	O	)	nn	9	SENT_223	[p9l1656t2649r1692b2676],
7	Disease	NN	O	disease	nn	9	SENT_223	[p9l1861t2649r1955b2671],
8	control	NN	O	control	nn	9	SENT_223	[p9l1964t2649r2053b2671],
9	rate	NN	O	rate	dep	3	SENT_223	[p9l2062t2652r2109b2671],
10	(	CD	NUMBER	(	number	11	SENT_223	[p9l2118t2649r2154b2676],
11	96	CD	NUMBER	96	num	12	SENT_223	[p9l2118t2649r2154b2676],
12	)	NN	O	)	dep	9	SENT_223	[p9l2118t2649r2154b2676],

1	SD	NN	O	sd	_	0	SENT_224	[p9l1071t2650r1103b2671],
2	PR	NN	O	pr	nn	3	SENT_224	[p9l864t2650r895b2670],
3	CR	NN	O	cr	dep	1	SENT_224	[p9l663t2650r696b2671],

1	Male	JJ	O	male	_	0	SENT_225	[p9l9t2718r128b2760],
2	Female	JJ	O	female	dep	1	SENT_225	[p9l9t2786r183b2828],

1	Never	RB	O	never	neg	2	SENT_226	[p9l9t2899r153b2938],
2	smoker	VB	O	smoker	_	0	SENT_226	[p9l169t2896r352b2938],
3	Former	JJ	O	former	amod	6	SENT_226	[p9l9t2967r187b3006],
4	smoker	NN	O	smoker	nn	6	SENT_226	[p9l203t2964r386b3006],
5	Current	JJ	DATE	current	amod	6	SENT_226	[p9l9t3035r197b3075],
6	smoker	NN	O	smoker	dobj	2	SENT_226	[p9l213t3033r396b3075],

1	Prior	RB	O	prior	_	0	SENT_227	[p9l9t3143r129b3185],
2	chemotherapy	NN	O	chemotherapy	nn	3	SENT_227	[p9l144t3143r500b3195],
3	(	NN	O	(	pobj	1	SENT_227	[p9l516t3143r581b3195],
4	+	CC	O	+	_	0	SENT_227	[p9l516t3143r581b3195],
5	)	CD	NUMBER	)	num	8	SENT_227	[p9l516t3143r581b3195],
6	Prior	JJ	O	prior	amod	8	SENT_227	[p9l9t3213r129b3254],
7	chemotherapy	NN	O	chemotherapy	nn	8	SENT_227	[p9l144t3212r500b3265],
8	(	NN	O	(	conj_+	3	SENT_227	[p9l516t3212r592b3264],
9	.	.	O	.	_	0	SENT_227	[p9l516t3212r592b3264],

1	—	NN	O	—	_	0	SENT_228	[p9l516t3212r592b3264],
2	.	.	O	.	_	0	SENT_228	[p9l516t3212r592b3264],
3	)	SYM	O	)	dep	1	SENT_228	[p9l516t3212r592b3264],

1	Exon	NN	O	exon	_	0	SENT_229	[p9l9t3325r128b3364],
2	19	CD	NUMBER	19	dep	1	SENT_229	[p9l147t3324r199b3364],
3	del	DT	O	del	dep	1	SENT_229	[p9l217t3322r290b3364],

1	Exon	NN	O	exon	nn	4	SENT_230	[p9l9t3393r128b3432],
2	21	CD	NUMBER	21	num	4	SENT_230	[p9l145t3393r195b3432],
3	L858R	NN	O	l858r	nn	4	SENT_230	[p9l219t3393r372b3432],
4	Exon	NN	O	exon	dep	9	SENT_230	[p9l9t3461r128b3500],
5	19	CD	NUMBER	19	num	6	SENT_230	[p9l147t3461r199b3501],
6	de1	NN	O	de1	dep	4	SENT_230	[p9l217t3459r391b3501],
7	+21	CD	NUMBER	+21	num	8	SENT_230	[p9l217t3459r391b3501],
8	L858R	NN	O	l858r	dep	9	SENT_230	[p9l415t3461r568b3501],
9	Exon	NN	O	exon	_	0	SENT_230	[p9l9t3530r128b3569],
10	19	CD	NUMBER	19	num	9	SENT_230	[p9l147t3529r199b3569],
11	del	DT	O	del	det	14	SENT_230	[p9l217t3527r399b3569],
12	+2	CD	NUMBER	+2	num	14	SENT_230	[p9l217t3527r399b3569],
13	O	NN	O	o	nn	14	SENT_230	[p9l217t3527r399b3569],
14	G796A	NN	O	g796a	dep	9	SENT_230	[p9l417t3529r583b3569],

1	All	DT	O	all	_	0	SENT_231	[p9l7t3637r73b3678],
2	cases	NNS	O	case	dep	1	SENT_231	[p9l91t3649r217b3679],

1	3.3	CD	NUMBER	3.3	_	0	SENT_232	[p10l6t1950r111b2002],
2	.	.	O	.	_	0	SENT_232	[p10l6t1950r111b2002],

1	Acquired	VBN	O	acquire	_	0	SENT_233	[p10l155t1947r431b2015],
2	mutation	NN	O	mutation	dobj	1	SENT_233	[p10l452t1948r735b2002],
3	in	IN	O	in	_	0	SENT_233	[p10l758t1948r813b2002],
4	exon	NN	O	exon	prep_in	1	SENT_233	[p10l837t1963r978b2002],
5	20	CD	NUMBER	20	num	4	SENT_233	[p10l998t1950r1077b2002],
6	in	IN	O	in	_	0	SENT_233	[p10l1098t1948r1153b2002],
7	geﬁtinib	NN	O	geﬁtinib	prep_in	1	SENT_233	[p10l1171t1947r1762b2015],
8	—	CD	NUMBER	—	num	10	SENT_233	[p10l1171t1947r1762b2015],
9	refractory	JJ	O	refractory	amod	10	SENT_233	[p10l1171t1947r1762b2015],
10	tumors	NNS	O	tumor	dep	7	SENT_233	[p10l1785t1955r2001b2002],

1	The	DT	O	the	det	2	SENT_234	[p10l108t2125r225b2180],
2	presence	NN	O	presence	nsubjpass	9	SENT_234	[p10l252t2141r536b2194],
3	of	IN	O	of	_	0	SENT_234	[p10l564t2125r630b2180],
4	exon	NN	O	exon	prep_of	2	SENT_234	[p10l650t2141r801b2180],
5	20	CD	NUMBER	20	num	4	SENT_234	[p10l828t2128r904b2180],
6	of	IN	O	of	_	0	SENT_234	[p10l931t2125r998b2180],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_234	[p10l1017t2128r1184b2180],
8	was	VBD	O	be	auxpass	9	SENT_234	[p10l1206t2141r1329b2180],
9	examined	VBN	O	examine	_	0	SENT_234	[p10l1358t2125r1673b2180],
10	in	IN	O	in	_	0	SENT_234	[p10l1701t2126r1760b2179],
11	5	CD	NUMBER	5	num	13	SENT_234	[p10l1787t2128r1820b2180],
12	geﬁtinibrefractory	NN	O	geﬁtinibrefractory	nn	13	SENT_234	[p10l1848t2125r2144b2194, p10l9t2214r326b2283],
13	tumors	NNS	O	tumor	prep_in	9	SENT_234	[p10l363t2222r593b2269],
14	by	IN	O	by	_	0	SENT_234	[p10l632t2214r708b2283],
15	a	DT	O	a	det	18	SENT_234	[p10l746t2230r778b2269],
16	direct	JJ	O	direct	amod	18	SENT_234	[p10l816t2214r1001b2269],
17	sequence	NN	O	sequence	nn	18	SENT_234	[p10l1040t2230r1336b2283],
18	analysis	NN	O	analysis	agent	9	SENT_234	[p10l1375t2214r1644b2283],
19	,	,	O	,	_	0	SENT_234	[p10l1375t2214r1644b2283],
20	and	CC	O	and	_	0	SENT_234	[p10l1684t2214r1800b2269],
21	4	CD	NUMBER	4	num	22	SENT_234	[p10l1838t2217r1876b2269],
22	tumors	NNS	O	tumor	nsubj	23	SENT_234	[p10l1914t2222r2144b2269],
23	showed	VBD	O	show	conj_and	9	SENT_234	[p10l10t2302r256b2357],
24	an	DT	O	a	det	28	SENT_234	[p10l286t2318r361b2356],
25	exon	NN	O	exon	nn	28	SENT_234	[p10l390t2318r541b2357],
26	20	CD	NUMBER	20	num	28	SENT_234	[p10l570t2305r646b2356],
27	T79OM	NN	O	t79om	nn	28	SENT_234	[p10l673t2305r898b2356],
28	mutation	NN	O	mutation	dobj	23	SENT_234	[p10l929t2303r1240b2365],
29	,	,	O	,	_	0	SENT_234	[p10l929t2303r1240b2365],
30	which	WDT	O	which	nsubjpass	33	SENT_234	[p10l1269t2303r1467b2356],
31	was	VBD	O	be	auxpass	33	SENT_234	[p10l1494t2318r1617b2356],
32	not	RB	O	not	neg	33	SENT_234	[p10l1648t2310r1753b2357],
33	detected	VBN	O	detect	rcmod	28	SENT_234	[p10l1780t2302r2056b2357],
34	in	IN	O	in	_	0	SENT_234	[p10l2086t2303r2145b2356],
35	the	DT	O	the	det	36	SENT_234	[p10l8t2391r110b2446],
36	tumors	NNS	O	tumor	prep_in	33	SENT_234	[p10l138t2399r368b2446],
37	before	IN	O	before	_	0	SENT_234	[p10l397t2390r600b2446],
38	geﬁtinib	NN	O	geﬁtinib	nn	39	SENT_234	[p10l628t2390r895b2459],
39	treatment	NN	O	treatment	prep_before	33	SENT_234	[p10l924t2399r1261b2446],
40	.	.	O	.	_	0	SENT_234	[p10l924t2399r1261b2446],

1	No	DT	O	no	det	3	SENT_235	[p10l1292t2394r1377b2446],
2	additional	JJ	O	additional	amod	3	SENT_235	[p10l1406t2391r1731b2446],
3	mutation	NN	O	mutation	nsubjpass	8	SENT_235	[p10l1761t2392r2057b2446],
4	in	IN	O	in	_	0	SENT_235	[p10l2086t2391r2145b2445],
5	exon	NN	O	exon	prep_in	3	SENT_235	[p10l9t2496r160b2535],
6	20	CD	NUMBER	20	num	5	SENT_235	[p10l181t2483r257b2535],
7	was	VBD	O	be	auxpass	8	SENT_235	[p10l277t2496r400b2535],
8	observed	VBN	O	observe	_	0	SENT_235	[p10l422t2480r713b2535],
9	in	IN	O	in	_	0	SENT_235	[p10l736t2481r794b2534],
10	one	CD	NUMBER	one	prep_in	8	SENT_235	[p10l815t2496r930b2535],
11	tumor	NN	O	tumor	nn	13	SENT_235	[p10l951t2488r1152b2535],
12	(	CD	NUMBER	(	num	13	SENT_235	[p10l1172t2480r1364b2548],
13	Table	NNP	O	Table	dep	10	SENT_235	[p10l1172t2480r1364b2548],
14	2	CD	NUMBER	2	number	15	SENT_235	[p10l1386t2480r1463b2548],
15	)	CD	NUMBER	)	dep	13	SENT_235	[p10l1386t2480r1463b2548],
16	.	.	O	.	_	0	SENT_235	[p10l1386t2480r1463b2548],

1	In	IN	O	in	_	0	SENT_236	[p10l1486t2483r1546b2534],
2	4	CD	NUMBER	4	num	3	SENT_236	[p10l1565t2483r1604b2534],
3	tumors	NNS	O	tumor	prep_in	10	SENT_236	[p10l1624t2488r1853b2535],
4	with	IN	O	with	_	0	SENT_236	[p10l1874t2480r2022b2535],
5	the	DT	O	the	det	7	SENT_236	[p10l2043t2480r2144b2535],
6	T79OM	NN	O	t79om	nn	7	SENT_236	[p10l6t2570r231b2621],
7	mutation	NN	O	mutation	prep_with	3	SENT_236	[p10l252t2568r564b2629],
8	,	,	O	,	_	0	SENT_236	[p10l252t2568r564b2629],
9	3	CD	NUMBER	3	nsubj	17	SENT_236	[p10l584t2570r618b2621],
10	had	VBD	O	have	_	0	SENT_236	[p10l641t2567r757b2621],
11	the	DT	O	the	det	14	SENT_236	[p10l776t2567r878b2621],
12	exon	NN	O	exon	nn	14	SENT_236	[p10l899t2583r1050b2621],
13	19	CD	NUMBER	19	num	14	SENT_236	[p10l1073t2570r1141b2621],
14	deletion	NN	O	deletion	dobj	10	SENT_236	[p10l1162t2567r1440b2629],
15	,	,	O	,	_	0	SENT_236	[p10l1162t2567r1440b2629],
16	and	CC	O	and	_	0	SENT_236	[p10l1460t2567r1577b2621],
17	showed	VBD	O	show	conj_and	10	SENT_236	[p10l1598t2567r1844b2621],
18	an	DT	O	a	det	21	SENT_236	[p10l1864t2583r1939b2621],
19	initial	JJ	O	initial	amod	21	SENT_236	[p10l1959t2567r2144b2621],
20	good	JJ	O	good	amod	21	SENT_236	[p10l8t2655r163b2724],
21	response	NN	O	response	iobj	17	SENT_236	[p10l186t2671r471b2724],
22	(	CD	NUMBER	(	num	24	SENT_236	[p10l493t2655r640b2723],
23	PR	NN	O	pr	nn	24	SENT_236	[p10l493t2655r640b2723],
24	)	NN	O	)	dobj	17	SENT_236	[p10l493t2655r640b2723],
25	.	.	O	.	_	0	SENT_236	[p10l493t2655r640b2723],

1	One	CD	NUMBER	one	nsubj	2	SENT_237	[p10l663t2658r788b2710],
2	had	VBD	O	have	_	0	SENT_237	[p10l811t2655r926b2710],
3	an	DT	O	a	det	7	SENT_237	[p10l949t2671r1024b2710],
4	exon	NN	O	exon	nn	7	SENT_237	[p10l1046t2671r1196b2710],
5	21	CD	NUMBER	21	num	7	SENT_237	[p10l1218t2658r1284b2710],
6	L858R	NN	O	l858r	nn	7	SENT_237	[p10l1315t2658r1514b2710],
7	mutation	NN	O	mutation	dobj	2	SENT_237	[p10l1534t2656r1845b2719],
8	,	,	O	,	_	0	SENT_237	[p10l1534t2656r1845b2719],
9	and	CC	O	and	_	0	SENT_237	[p10l1868t2655r1984b2710],
10	thus	RB	O	thus	advmod	2	SENT_237	[p10l2006t2655r2144b2710],
11	showed	VBD	O	show	conj_and	2	SENT_237	[p10l10t2744r256b2799],
12	an	DT	O	a	det	16	SENT_237	[p10l279t2760r354b2799],
13	initial	JJ	O	initial	amod	16	SENT_237	[p10l376t2745r561b2799],
14	long	JJ	O	long	amod	16	SENT_237	[p10l585t2745r723b2813],
15	SD	NN	O	sd	nn	16	SENT_237	[p10l745t2747r827b2799],
16	(	NN	O	(	iobj	11	SENT_237	[p10l850t2745r950b2813],
17	7.1	CD	DURATION	7.1	num	18	SENT_237	[p10l850t2745r950b2813],
18	months	NNS	NUMBER	month	tmod	19	SENT_237	[p10l981t2744r1251b2813],
19	)	RB	O	)	amod	20	SENT_237	[p10l981t2744r1251b2813],
20	response	NN	O	response	dobj	11	SENT_237	[p10l1274t2760r1575b2813],
21	.	.	O	.	_	0	SENT_237	[p10l1274t2760r1575b2813],

1	3.4	CD	NUMBER	3.4	_	0	SENT_238	[p10l6t2933r111b2984],
2	.	.	O	.	_	0	SENT_238	[p10l6t2933r111b2984],

1	Adverse	JJ	O	adverse	amod	2	SENT_239	[p10l155t2930r398b2984],
2	events	NNS	O	event	_	0	SENT_239	[p10l420t2938r613b2984],

1	All	DT	O	all	det	3	SENT_240	[p10l108t3107r194b3161],
2	19	CD	NUMBER	19	num	3	SENT_240	[p10l222t3110r290b3162],
3	patients	NNS	O	patient	nsubjpass	5	SENT_240	[p10l315t3108r572b3176],
4	were	VBD	O	be	auxpass	5	SENT_240	[p10l595t3123r754b3162],
5	evaluated	VBN	O	evaluate	_	0	SENT_240	[p10l778t3107r1088b3162],
6	for	IN	O	for	_	0	SENT_240	[p10l1113t3107r1202b3162],
7	drug	NN	O	drug	nn	8	SENT_240	[p10l1224t3107r1627b3176],
8	—	NN	O	—	prep_for	5	SENT_240	[p10l1224t3107r1627b3176],
9	related	JJ	O	related	amod	11	SENT_240	[p10l1224t3107r1627b3176],
10	adverse	JJ	O	adverse	amod	11	SENT_240	[p10l1651t3107r1897b3162],
11	events	NNS	O	event	dep	8	SENT_240	[p10l1922t3115r2144b3163],
12	.	.	O	.	_	0	SENT_240	[p10l1922t3115r2144b3163],

1	The	DT	O	the	det	4	SENT_241	[p10l6t3196r123b3251],
2	most	RBS	O	most	advmod	3	SENT_241	[p10l153t3204r312b3251],
3	common	JJ	O	common	amod	4	SENT_241	[p10l340t3212r623b3251],
4	geﬁtinib	NN	O	geﬁtinib	_	0	SENT_241	[p10l651t3196r1176b3265],
5	—	NN	O	—	dep	4	SENT_241	[p10l651t3196r1176b3265],
6	related	JJ	O	related	amod	8	SENT_241	[p10l651t3196r1176b3265],
7	adverse	JJ	O	adverse	amod	8	SENT_241	[p10l1205t3196r1451b3251],
8	event	NN	O	event	nsubj	11	SENT_241	[p10l1481t3204r1658b3251],
9	was	VBD	O	be	cop	11	SENT_241	[p10l1684t3212r1807b3251],
10	skin	NN	O	skin	nn	11	SENT_241	[p10l1838t3196r1968b3251],
11	toxicity	NN	O	toxicity	dep	4	SENT_241	[p10l1996t3197r2144b3251, p10l9t3286r136b3354],
12	,	,	O	,	_	0	SENT_241	[p10l1996t3197r2144b3251, p10l9t3286r136b3354],
13	such	JJ	O	such	_	0	SENT_241	[p10l171t3285r315b3340],
14	as	IN	O	as	_	0	SENT_241	[p10l347t3301r409b3340],
15	a	DT	O	a	det	16	SENT_241	[p10l443t3301r475b3340],
16	rash	NN	O	rash	prep_such_as	4	SENT_241	[p10l507t3285r656b3349],
17	,	,	O	,	_	0	SENT_241	[p10l507t3285r656b3349],
18	dry	JJ	O	dry	amod	19	SENT_241	[p10l689t3285r796b3354],
19	skin	NN	O	skin	prep_such_as	4	SENT_241	[p10l828t3285r972b3349],
20	,	,	O	,	_	0	SENT_241	[p10l828t3285r972b3349],
21	or	CC	O	or	_	0	SENT_241	[p10l1006t3301r1072b3340],
22	nail	NN	O	nail	nn	23	SENT_241	[p10l1103t3285r1219b3340],
23	change	NN	O	change	conj_or	16	SENT_241	[p10l1252t3285r1492b3354],
24	.	.	O	.	_	0	SENT_241	[p10l1252t3285r1492b3354],

1	However	RB	O	however	advmod	13	SENT_242	[p10l1526t3289r1824b3349],
2	,	,	O	,	_	0	SENT_242	[p10l1526t3289r1824b3349],
3	no	DT	O	no	det	4	SENT_242	[p10l1858t3301r1935b3340],
4	grade	NN	O	grade	nsubjpass	13	SENT_242	[p10l1967t3285r2144b3354],
5	3/4	CD	NUMBER	3/4	num	7	SENT_242	[p10l8t3374r111b3443],
6	adverse	JJ	O	adverse	amod	7	SENT_242	[p10l134t3375r380b3430],
7	events	NNS	O	event	dep	4	SENT_242	[p10l404t3383r609b3430],
8	or	CC	O	or	_	0	SENT_242	[p10l634t3390r700b3430],
9	interstitial	JJ	O	interstitial	amod	11	SENT_242	[p10l722t3375r1055b3430],
10	lung	NN	O	lung	nn	11	SENT_242	[p10l1080t3375r1221b3443],
11	disease	NN	O	disease	nsubjpass	13	SENT_242	[p10l1243t3375r1475b3430],
12	were	VBD	O	be	auxpass	13	SENT_242	[p10l1497t3390r1656b3430],
13	observed	VBN	O	observe	_	0	SENT_242	[p10l1679t3375r1986b3430],
14	.	.	O	.	_	0	SENT_242	[p10l1679t3375r1986b3430],

1	Two	CD	NUMBER	two	num	2	SENT_243	[p10l2008t3378r2144b3430],
2	patients	NNS	O	patient	nsubj	3	SENT_243	[p10l9t3465r267b3532],
3	required	VBD	O	require	_	0	SENT_243	[p10l288t3464r559b3532],
4	an	DT	O	a	det	5	SENT_243	[p10l580t3480r655b3519],
5	interruption	NN	O	interruption	dobj	3	SENT_243	[p10l675t3465r1068b3532],
6	of	IN	O	of	_	0	SENT_243	[p10l1088t3464r1155b3519],
7	geﬁtinib	NN	O	geﬁtinib	nn	8	SENT_243	[p10l1166t3464r1433b3532],
8	treatment	NN	O	treatment	prep_of	5	SENT_243	[p10l1453t3472r1790b3527],
9	,	,	O	,	_	0	SENT_243	[p10l1453t3472r1790b3527],
10	because	IN	O	because	_	0	SENT_243	[p10l1811t3464r2066b3519],
11	of	IN	O	of	_	0	SENT_243	[p10l2086t3464r2153b3519],
12	grade	NN	O	grade	prep_because_of	3	SENT_243	[p10l8t3552r185b3621],
13	2	CD	NUMBER	2	num	15	SENT_243	[p10l208t3555r242b3606],
14	elevated	JJ	O	elevated	amod	15	SENT_243	[p10l267t3552r535b3607],
15	transaminases	NNS	O	transaminase	dep	12	SENT_243	[p10l558t3553r1038b3615],
16	,	,	O	,	_	0	SENT_243	[p10l558t3553r1038b3615],
17	lasting	VBG	O	last	partmod	12	SENT_243	[p10l1062t3552r1275b3621],
18	2-4	CD	NUMBER	2-4	num	19	SENT_243	[p10l1296t3555r1415b3606],
19	weeks	NNS	NUMBER	week	tmod	17	SENT_243	[p10l1435t3552r1653b3608],
20	.	.	O	.	_	0	SENT_243	[p10l1435t3552r1653b3608],

1	4	LS	NUMBER	4	_	0	SENT_244	[p10l6t3745r63b3796],
2	.	.	O	.	_	0	SENT_244	[p10l6t3745r63b3796],

1	Discussion	NN	O	discussion	_	0	SENT_245	[p10l109t3741r471b3796],

1	Geﬁtinib	NN	O	geﬁtinib	nsubj	9	SENT_246	[p11l111t111r389b166],
2	or	CC	O	or	_	0	SENT_246	[p11l423t127r490b166],
3	erlotinib	NN	O	erlotinib	nsubj	9	SENT_246	[p11l522t111r811b174],
4	,	,	O	,	_	0	SENT_246	[p11l522t111r811b174],
5	as	IN	O	as	_	0	SENT_246	[p11l846t127r908b166],
6	a	DT	O	a	det	7	SENT_246	[p11l943t127r975b166],
7	TKI	NN	O	tkus	prep_as	1	SENT_246	[p11l1007t114r1127b174],
8	,	,	O	,	_	0	SENT_246	[p11l1007t114r1127b174],
9	shows	VBZ	O	show	_	0	SENT_246	[p11l1163t111r1360b166],
10	a	DT	O	a	det	13	SENT_246	[p11l1396t127r1428b166],
11	higher	JJR	O	higher	amod	13	SENT_246	[p11l1462t111r1670b179],
12	response	NN	O	response	nn	13	SENT_246	[p11l1703t127r1988b179],
13	rate	NN	O	rate	dobj	9	SENT_246	[p11l2023t119r2144b166],
14	for	IN	O	for	_	0	SENT_246	[p11l9t199r98b254],
15	patients	NNS	O	patient	prep_for	13	SENT_246	[p11l129t200r387b268],
16	with	IN	O	with	_	0	SENT_246	[p11l417t199r566b254],
17	mutant	JJ	O	mutant	amod	18	SENT_246	[p11l598t207r834b254],
18	EGFR	NN	ORGANIZATION	egfr	prep_with	15	SENT_246	[p11l864t202r1032b254],
19	than	IN	O	than	_	0	SENT_246	[p11l1060t199r1204b254],
20	those	DT	O	those	prep_than	9	SENT_246	[p11l1235t199r1408b254],
21	with	IN	O	with	_	0	SENT_246	[p11l1439t199r1587b254],
22	wild	JJ	O	wild	amod	25	SENT_246	[p11l1617t199r1932b268],
23	—	NN	O	—	nn	25	SENT_246	[p11l1617t199r1932b268],
24	type	NN	O	type	nn	25	SENT_246	[p11l1617t199r1932b268],
25	EGFR	NN	ORGANIZATION	egfr	prep_with	20	SENT_246	[p11l1964t202r2144b255],
26	.	.	O	.	_	0	SENT_246	[p11l1964t202r2144b255],

1	Among	IN	O	among	_	0	SENT_247	[p11l6t291r239b357],
2	the	DT	O	the	det	4	SENT_247	[p11l264t288r365b343],
3	many	JJ	O	many	amod	4	SENT_247	[p11l393t304r571b357],
4	types	NNS	O	type	prep_among	27	SENT_247	[p11l595t296r766b357],
5	of	IN	O	of	_	0	SENT_247	[p11l794t288r861b343],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_247	[p11l880t291r1047b343],
7	mutation	NN	O	mutation	prep_of	4	SENT_247	[p11l1072t289r1383b352],
8	,	,	O	,	_	0	SENT_247	[p11l1072t289r1383b352],
9	exon	NN	O	exon	nn	11	SENT_247	[p11l1411t304r1563b343],
10	19	CD	NUMBER	19	num	11	SENT_247	[p11l1592t291r1660b343],
11	deletion	NN	O	deletion	nsubjpass	27	SENT_247	[p11l1688t288r1966b352],
12	,	,	O	,	_	0	SENT_247	[p11l1688t288r1966b352],
13	exon	NN	O	exon	nn	15	SENT_247	[p11l1994t304r2145b343],
14	21	CD	NUMBER	21	num	15	SENT_247	[p11l9t380r74b432],
15	L858R	NN	O	l858r	appos	11	SENT_247	[p11l108t380r320b441],
16	,	,	O	,	_	0	SENT_247	[p11l108t380r320b441],
17	exon	NN	O	exon	nn	19	SENT_247	[p11l346t393r497b432],
18	18	CD	NUMBER	18	num	19	SENT_247	[p11l525t380r591b432],
19	G719A/S	NN	O	g719a/s	appos	11	SENT_247	[p11l619t377r903b446],
20	,	,	O	,	_	0	SENT_247	[p11l619t377r903b446],
21	and	CC	O	and	_	0	SENT_247	[p11l928t377r1044b432],
22	exon	NN	O	exon	nn	24	SENT_247	[p11l1070t393r1221b432],
23	21	CD	NUMBER	21	num	24	SENT_247	[p11l1246t380r1311b432],
24	L861X	NN	O	l861x	appos	11	SENT_247	[p11l1345t380r1558b441],
25	,	,	O	,	_	0	SENT_247	[p11l1345t380r1558b441],
26	are	VBP	O	be	auxpass	27	SENT_247	[p11l1584t393r1680b432],
27	thought	VBN	O	think	_	0	SENT_247	[p11l1706t377r1962b446],
28	to	TO	O	to	aux	30	SENT_247	[p11l1985t386r2046b432],
29	be	VB	O	be	cop	30	SENT_247	[p11l2070t377r2144b432],
30	TI	NNP	O	TI	xcomp	27	SENT_247	[p11l6t466r425b520],
31	(	CD	NUMBER	(	num	30	SENT_247	[p11l6t466r425b520],
32	I	PRP	O	I	nsubj	33	SENT_247	[p11l6t466r425b520],
33	—	VBP	O	—	rcmod	30	SENT_247	[p11l6t466r425b520],
34	sensitive	JJ	O	sensitive	amod	35	SENT_247	[p11l6t466r425b520],
35	mutations	NNS	O	mutation	dobj	33	SENT_247	[p11l444t466r787b528],
36	,	,	O	,	_	0	SENT_247	[p11l444t466r787b528],
37	and	CC	O	and	_	0	SENT_247	[p11l806t466r923b520],
38	the	DT	O	the	det	41	SENT_247	[p11l941t466r1043b520],
39	exon	NN	O	exon	nn	41	SENT_247	[p11l1062t481r1213b520],
40	19	CD	NUMBER	19	num	41	SENT_247	[p11l1235t468r1303b520],
41	deletion	NN	O	deletion	nsubjpass	47	SENT_247	[p11l1322t466r1585b520],
42	or	CC	O	or	_	0	SENT_247	[p11l1603t481r1670b520],
43	exon	NN	O	exon	nn	45	SENT_247	[p11l1686t481r1838b520],
44	21	CD	NUMBER	21	num	45	SENT_247	[p11l1856t468r1921b519],
45	L858R	NN	O	l858r	conj_or	41	SENT_247	[p11l1948t468r2148b520],
46	are	VBP	O	be	auxpass	47	SENT_247	[p11l9t569r105b609],
47	detected	VBN	O	detect	conj_and	27	SENT_247	[p11l132t554r407b609],
48	in	IN	O	in	_	0	SENT_247	[p11l435t554r494b608],
49	85-90	CD	PERCENT	85-90	num	50	SENT_247	[p11l521t556r764b609],
50	%	NN	PERCENT	%	prep_in	47	SENT_247	[p11l521t556r764b609],
51	of	IN	O	of	_	0	SENT_247	[p11l790t553r857b609],
52	cases	NNS	O	case	prep_of	50	SENT_247	[p11l876t569r1040b609],
53	with	IN	O	with	mark	56	SENT_247	[p11l1066t554r1214b609],
54	EGFR	NN	ORGANIZATION	egfr	nn	55	SENT_247	[p11l1241t556r1407b609],
55	mutations	NNS	O	mutation	nsubj	56	SENT_247	[p11l1432t554r1758b609],
56	[	VBP	O	[	advcl	47	SENT_247	[p11l1789t553r1921b622],
57	11	CD	NUMBER	11	number	58	SENT_247	[p11l1789t553r1921b622],
58	]	CD	NUMBER	]	dobj	56	SENT_247	[p11l1789t553r1921b622],
59	,	,	O	,	_	0	SENT_247	[p11l1789t553r1921b622],
60	which	WDT	O	which	nsubjpass	63	SENT_247	[p11l1947t554r2145b609],
61	were	VBD	O	be	auxpass	63	SENT_247	[p11l7t659r165b698],
62	selectively	RB	O	selectively	advmod	63	SENT_247	[p11l189t643r526b711],
63	evaluated	VBN	O	evaluate	rcmod	58	SENT_247	[p11l547t643r857b698],
64	in	IN	O	in	_	0	SENT_247	[p11l881t644r939b697],
65	this	DT	O	this	det	66	SENT_247	[p11l961t643r1078b698],
66	study	NN	O	study	prep_in	63	SENT_247	[p11l1102t643r1289b711],
67	.	.	O	.	_	0	SENT_247	[p11l1102t643r1289b711],

1	In	IN	O	in	_	0	SENT_248	[p11l111t734r171b785],
2	a	DT	O	a	det	4	SENT_248	[p11l209t747r241b786],
3	retrospective	JJ	O	retrospective	amod	4	SENT_248	[p11l280t732r698b800],
4	analysis	NN	O	analysis	prep_in	14	SENT_248	[p11l737t731r1006b800],
5	,	,	O	,	_	0	SENT_248	[p11l737t731r1006b800],
6	about	IN	O	about	advmod	8	SENT_248	[p11l1046t731r1229b786],
7	70	CD	PERCENT	70	num	8	SENT_248	[p11l1267t734r1385b786],
8	%	NN	PERCENT	%	nsubj	14	SENT_248	[p11l1267t734r1385b786],
9	of	IN	O	of	_	0	SENT_248	[p11l1424t731r1490b786],
10	NSCLCs	NNS	O	nsclc	prep_of	8	SENT_248	[p11l1521t734r1756b786],
11	with	IN	O	with	_	0	SENT_248	[p11l1794t731r1942b786],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_248	[p11l1981t734r2148b786],
13	mutations	NNS	O	mutation	prep_with	10	SENT_248	[p11l9t821r336b875],
14	respond	VBP	O	respond	_	0	SENT_248	[p11l353t820r611b889],
15	to	TO	O	to	_	0	SENT_248	[p11l627t828r688b875],
16	EGFR	NN	ORGANIZATION	egfr	prep_to	14	SENT_248	[p11l704t823r1063b884],
17	.	.	O	.	_	0	SENT_248	[p11l704t823r1063b884],

1	—	NN	O	—	_	0	SENT_249	[p11l704t823r1063b884],
2	.	.	O	.	_	0	SENT_249	[p11l704t823r1063b884],

1	TI	NNP	O	TI	nn	2	SENT_250	[p11l704t823r1063b884],
2	(	NNP	O	(	nsubj	3	SENT_250	[p11l704t823r1063b884],
3	Is	VBZ	O	be	_	0	SENT_250	[p11l704t823r1063b884],
4	,	,	O	,	_	0	SENT_250	[p11l704t823r1063b884],
5	whereas	IN	O	whereas	mark	14	SENT_250	[p11l1078t820r1348b875],
6	only	RB	O	only	quantmod	7	SENT_250	[p11l1365t820r1503b889],
7	10	CD	PERCENT	10	num	8	SENT_250	[p11l1521t823r1634b875],
8	%	NN	PERCENT	%	nsubj	14	SENT_250	[p11l1521t823r1634b875],
9	of	IN	O	of	_	0	SENT_250	[p11l1649t820r1716b875],
10	tumors	NNS	O	tumor	prep_of	8	SENT_250	[p11l1723t828r1953b875],
11	without	IN	O	without	_	0	SENT_250	[p11l1968t820r2144b875, p11l9t918r114b964],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_250	[p11l147t912r313b964],
13	mutations	NNS	O	mutation	prep_without	10	SENT_250	[p11l345t910r671b964],
14	respond	VBP	O	respond	advcl	3	SENT_250	[p11l706t909r964b978],
15	to	TO	O	to	_	0	SENT_250	[p11l997t918r1058b964],
16	them	PRP	O	they	prep_to	14	SENT_250	[p11l1092t909r1259b964],
17	[	RB	O	[	advmod	19	SENT_250	[p11l1296t909r1432b978],
18	12	CD	NUMBER	12	num	19	SENT_250	[p11l1296t909r1432b978],
19	]	NN	O	]	rcmod	16	SENT_250	[p11l1296t909r1432b978],
20	.	.	O	.	_	0	SENT_250	[p11l1296t909r1432b978],

1	Previous	JJ	O	previous	amod	5	SENT_251	[p11l1467t910r1739b964],
2	prospective	JJ	O	prospective	amod	5	SENT_251	[p11l1774t910r2144b978],
3	phase	NN	O	phase	nn	5	SENT_251	[p11l9t999r194b1067],
4	II	CD	NUMBER	ii	num	5	SENT_251	[p11l210t1002r248b1053],
5	studies	NNS	O	study	nsubj	19	SENT_251	[p11l266t999r490b1054],
6	of	IN	O	of	_	0	SENT_251	[p11l507t998r574b1054],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_251	[p11l580t998r847b1067],
8	for	IN	O	for	_	0	SENT_251	[p11l864t998r953b1054],
9	chemotherapy	NN	O	chemotherapy	prep_for	7	SENT_251	[p11l967t999r1432b1067],
10	na	TO	O	na	infmod	9	SENT_251	[p11l1446t1002r1615b1054],
11	'	''	O	'	_	0	SENT_251	[p11l1446t1002r1615b1054],
12	1	CD	NUMBER	1	dep	10	SENT_251	[p11l1446t1002r1615b1054],
13	've	VBP	O	have	aux	19	SENT_251	[p11l1446t1002r1615b1054],
14	patients	NNS	O	patient	dobj	19	SENT_251	[p11l1632t1000r1890b1067],
15	harboring	VBG	O	harbor	partmod	14	SENT_251	[p11l1907t999r2144b1054, p11l9t1089r108b1156],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_251	[p11l130t1091r297b1143],
17	mutations	NNS	O	mutation	dobj	15	SENT_251	[p11l318t1089r661b1151],
18	,	,	O	,	_	0	SENT_251	[p11l318t1089r661b1151],
19	conﬁrmed	VBN	O	conﬁrmed	ccomp	47	SENT_251	[p11l685t1088r1015b1143],
20	high	JJ	O	high	amod	22	SENT_251	[p11l1040t1088r1180b1156],
21	response	NN	O	response	nn	22	SENT_251	[p11l1204t1104r1488b1156],
22	rates	NNS	O	rate	dobj	19	SENT_251	[p11l1513t1096r1665b1143],
23	of	IN	O	of	_	0	SENT_251	[p11l1690t1088r1756b1143],
24	75	CD	PERCENT	75	num	25	SENT_251	[p11l1773t1091r1893b1143],
25	%	NN	PERCENT	%	prep_of	22	SENT_251	[p11l1773t1091r1893b1143],
26	[	CD	NUMBER	[	number	27	SENT_251	[p11l1919t1088r2144b1156],
27	13,14	CD	NUMBER	13,14	num	28	SENT_251	[p11l1919t1088r2144b1156],
28	]	NN	O	]	dep	25	SENT_251	[p11l1919t1088r2144b1156],
29	,	,	O	,	_	0	SENT_251	[p11l1919t1088r2144b1156],
30	and	CC	O	and	_	0	SENT_251	[p11l9t1176r125b1231],
31	a	DT	O	a	det	34	SENT_251	[p11l147t1192r179b1231],
32	phase	NN	O	phase	nn	34	SENT_251	[p11l201t1176r386b1245],
33	II	CD	NUMBER	ii	num	34	SENT_251	[p11l409t1179r446b1230],
34	study	NN	O	study	conj_and	25	SENT_251	[p11l470t1176r647b1245],
35	of	IN	O	of	_	0	SENT_251	[p11l667t1176r733b1231],
36	geﬁtinib	NN	O	geﬁtinib	prep_of	34	SENT_251	[p11l746t1176r1013b1245],
37	in	IN	O	in	_	0	SENT_251	[p11l1036t1177r1095b1230],
38	mixed	JJ	O	mixed	amod	39	SENT_251	[p11l1117t1176r1315b1231],
39	patients	NNS	O	patient	prep_in	19	SENT_251	[p11l1338t1177r1613b1245],
40	,	,	O	,	_	0	SENT_251	[p11l1338t1177r1613b1245],
41	with	IN	O	with	_	0	SENT_251	[p11l1634t1176r1782b1231],
42	or	CC	O	or	_	0	SENT_251	[p11l1804t1192r1870b1231],
43	without	IN	O	without	_	0	SENT_251	[p11l1888t1176r2146b1231],
44	chemotherapy	NN	O	chemotherapy	prep_with	19	SENT_251	[p11l9t1265r484b1334],
45	,	,	O	,	_	0	SENT_251	[p11l9t1265r484b1334],
46	also	RB	O	also	advmod	47	SENT_251	[p11l504t1265r628b1320],
47	showed	VBD	O	show	_	0	SENT_251	[p11l648t1265r895b1320],
48	high	JJ	O	high	amod	50	SENT_251	[p11l915t1265r1055b1334],
49	response	NN	O	response	nn	50	SENT_251	[p11l1074t1281r1359b1334],
50	rates	NNS	O	rate	iobj	47	SENT_251	[p11l1379t1273r1531b1320],
51	of	IN	O	of	_	0	SENT_251	[p11l1551t1265r1618b1320],
52	76-90	CD	PERCENT	76-90	num	53	SENT_251	[p11l1630t1268r1870b1320],
53	%	NN	PERCENT	%	prep_of	50	SENT_251	[p11l1630t1268r1870b1320],
54	[	CD	NUMBER	[	dobj	47	SENT_251	[p11l1892t1265r2144b1334],
55	15	CD	NUMBER	15	num	58	SENT_251	[p11l1892t1265r2144b1334],
56	—	NN	O	—	nn	58	SENT_251	[p11l1892t1265r2144b1334],
57	17	CD	NUMBER	17	num	58	SENT_251	[p11l1892t1265r2144b1334],
58	]	NN	O	]	nsubj	47	SENT_251	[p11l1892t1265r2144b1334],
59	.	.	O	.	_	0	SENT_251	[p11l1892t1265r2144b1334],

1	The	DT	O	the	det	4	SENT_252	[p11l6t1354r123b1409],
2	present	JJ	DATE	present	amod	4	SENT_252	[p11l143t1362r384b1423],
3	prospective	JJ	O	prospective	amod	4	SENT_252	[p11l402t1355r773b1423],
4	study	NN	O	study	nsubj	5	SENT_252	[p11l793t1354r970b1423],
5	demonstrated	VBD	O	demonstrate	ccomp	50	SENT_252	[p11l987t1354r1437b1409],
6	an	DT	O	a	det	12	SENT_252	[p11l1456t1370r1531b1409],
7	objective	JJ	O	objective	amod	12	SENT_252	[p11l1550t1354r1839b1423],
8	response	NN	O	response	nn	12	SENT_252	[p11l1860t1370r2144b1423],
9	rate	NN	O	rate	nn	12	SENT_252	[p11l9t1452r131b1498],
10	(	CD	NUMBER	(	num	12	SENT_252	[p11l162t1444r297b1512],
11	RR	NN	O	rr	nn	12	SENT_252	[p11l162t1444r297b1512],
12	)	NN	O	)	dobj	5	SENT_252	[p11l162t1444r297b1512],
13	of	IN	O	of	_	0	SENT_252	[p11l329t1443r395b1498],
14	63.2	CD	PERCENT	63.2	num	15	SENT_252	[p11l419t1446r613b1507],
15	%	NN	PERCENT	%	prep_of	12	SENT_252	[p11l419t1446r613b1507],
16	,	,	O	,	_	0	SENT_252	[p11l419t1446r613b1507],
17	a	DT	O	a	det	20	SENT_252	[p11l645t1459r677b1498],
18	disease	NN	O	disease	nn	20	SENT_252	[p11l708t1443r940b1498],
19	control	NN	O	control	nn	20	SENT_252	[p11l972t1443r1198b1498],
20	rate	NN	O	rate	nsubj	50	SENT_252	[p11l1231t1452r1353b1498],
21	of	IN	O	of	_	0	SENT_252	[p11l1384t1443r1451b1498],
22	89.5	CD	PERCENT	89.5	num	23	SENT_252	[p11l1475t1446r1668b1507],
23	%	NN	PERCENT	%	prep_of	20	SENT_252	[p11l1475t1446r1668b1507],
24	,	,	O	,	_	0	SENT_252	[p11l1475t1446r1668b1507],
25	a	DT	O	a	det	27	SENT_252	[p11l1701t1459r1733b1498],
26	median	JJ	O	median	amod	27	SENT_252	[p11l1765t1443r2006b1498],
27	PFS	NN	O	pf	conj_and	20	SENT_252	[p11l2037t1446r2144b1498],
28	of	IN	O	of	_	0	SENT_252	[p11l9t1532r75b1588],
29	7.1	CD	DURATION	7.1	num	30	SENT_252	[p11l105t1536r177b1588],
30	months	NNS	NUMBER	month	prep_of	27	SENT_252	[p11l222t1533r481b1596],
31	,	,	O	,	_	0	SENT_252	[p11l222t1533r481b1596],
32	and	CC	O	and	_	0	SENT_252	[p11l518t1533r634b1588],
33	MST	NN	O	mst	conj_and	20	SENT_252	[p11l671t1535r810b1588],
34	of	IN	O	of	_	0	SENT_252	[p11l844t1532r911b1588],
35	20.0	CD	DURATION	20.0	num	36	SENT_252	[p11l939t1535r1073b1588],
36	months	NNS	NUMBER	month	prep_of	33	SENT_252	[p11l1109t1533r1368b1596],
37	,	,	O	,	_	0	SENT_252	[p11l1109t1533r1368b1596],
38	and	CC	O	and	_	0	SENT_252	[p11l1406t1533r1522b1588],
39	1-year	JJ	DURATION	1-year	amod	40	SENT_252	[p11l1562t1536r1765b1601],
40	survival	NN	O	survival	conj_and	20	SENT_252	[p11l1800t1533r2049b1588],
41	of	IN	O	of	_	0	SENT_252	[p11l2086t1532r2153b1588],
42	77	CD	PERCENT	77	num	43	SENT_252	[p11l10t1625r144b1685],
43	%	NN	PERCENT	%	prep_of	40	SENT_252	[p11l10t1625r144b1685],
44	,	,	O	,	_	0	SENT_252	[p11l10t1625r144b1685],
45	consistent	JJ	O	consistent	amod	20	SENT_252	[p11l167t1623r496b1677],
46	with	IN	O	with	_	0	SENT_252	[p11l515t1622r663b1677],
47	previous	JJ	O	previous	amod	49	SENT_252	[p11l686t1623r960b1690],
48	retrospective	JJ	O	retrospective	amod	49	SENT_252	[p11l984t1623r1403b1690],
49	studies	NNS	O	study	prep_with	45	SENT_252	[p11l1426t1622r1651b1677],
50	[	VBP	O	[	_	0	SENT_252	[p11l1678t1622r1922b1690],
51	6,8,18	CD	NUMBER	6,8,18	number	52	SENT_252	[p11l1678t1622r1922b1690],
52	]	CD	NUMBER	]	dobj	50	SENT_252	[p11l1678t1622r1922b1690],
53	.	.	O	.	_	0	SENT_252	[p11l1678t1622r1922b1690],

1	In	IN	O	in	_	0	SENT_253	[p11l1946t1625r2006b1676],
2	this	DT	O	this	det	3	SENT_253	[p11l2027t1622r2144b1677],
3	study	NN	O	study	prep_in	15	SENT_253	[p11l10t1710r186b1779],
4	of	IN	O	of	_	0	SENT_253	[p11l208t1710r274b1765],
5	patients	NNS	O	patient	prep_of	3	SENT_253	[p11l290t1711r548b1779],
6	with	IN	O	with	_	0	SENT_253	[p11l571t1710r719b1765],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_253	[p11l743t1713r910b1765],
8	mutations	NNS	O	mutation	prep_with	5	SENT_253	[p11l931t1711r1274b1773],
9	,	,	O	,	_	0	SENT_253	[p11l931t1711r1274b1773],
10	no	DT	O	no	det	11	SENT_253	[p11l1299t1726r1376b1765],
11	differences	NNS	O	difference	nsubjpass	15	SENT_253	[p11l1400t1710r1752b1765],
12	in	IN	O	in	_	0	SENT_253	[p11l1777t1711r1836b1764],
13	response	NN	O	response	prep_in	11	SENT_253	[p11l1860t1726r2145b1779],
14	were	VBD	O	be	auxpass	15	SENT_253	[p11l7t1814r165b1852],
15	observed	VBN	O	observe	_	0	SENT_253	[p11l190t1798r480b1852],
16	between	IN	O	between	_	0	SENT_253	[p11l504t1798r782b1852],
17	males	NNS	O	male	prep_between	15	SENT_253	[p11l806t1798r991b1852],
18	and	CC	O	and	_	0	SENT_253	[p11l1016t1798r1133b1852],
19	females	NNS	O	female	prep_between	15	SENT_253	[p11l1158t1798r1420b1861],
20	,	,	O	,	_	0	SENT_253	[p11l1158t1798r1420b1861],
21	between	IN	O	between	_	0	SENT_253	[p11l1445t1798r1722b1852],
22	never	RB	O	never	advmod	23	SENT_253	[p11l1746t1814r1926b1852],
23	smokers	NNS	O	smoker	conj_or	17	SENT_253	[p11l1949t1798r2144b1852, p11l9t1902r100b1941],
24	and	CC	O	and	_	0	SENT_253	[p11l133t1886r249b1941],
25	former/current	JJ	O	former/current	amod	26	SENT_253	[p11l282t1886r767b1955],
26	smokers	NNS	O	smoker	conj_and	23	SENT_253	[p11l799t1886r1082b1950],
27	,	,	O	,	_	0	SENT_253	[p11l799t1886r1082b1950],
28	or	CC	O	or	_	0	SENT_253	[p11l1115t1902r1181b1941],
29	between	IN	O	between	_	0	SENT_253	[p11l1210t1886r1487b1941],
30	patients	NNS	O	patient	conj_or	17	SENT_253	[p11l1519t1887r1777b1955],
31	with	IN	O	with	_	0	SENT_253	[p11l1809t1886r1957b1941],
32	prior	JJ	O	prior	amod	33	SENT_253	[p11l1989t1887r2147b1955],
33	chemotherapy	NN	O	chemotherapy	prep_with	30	SENT_253	[p11l9t1975r474b2044],
34	and	CC	O	and	_	0	SENT_253	[p11l494t1975r611b2030],
35	without	IN	O	without	_	0	SENT_253	[p11l632t1975r890b2030],
36	prior	JJ	O	prior	amod	37	SENT_253	[p11l912t1976r1070b2044],
37	chemotherapy	NN	O	chemotherapy	prep_without	30	SENT_253	[p11l1091t1975r1566b2044],
38	.	.	O	.	_	0	SENT_253	[p11l1091t1975r1566b2044],

1	Although	IN	O	although	mark	8	SENT_254	[p11l108t2065r407b2133],
2	the	DT	O	the	det	3	SENT_254	[p11l448t2065r550b2120],
3	number	NN	O	number	nsubj	8	SENT_254	[p11l593t2065r848b2120],
4	of	IN	O	of	_	0	SENT_254	[p11l888t2064r955b2120],
5	patients	NNS	O	patient	prep_of	3	SENT_254	[p11l989t2065r1247b2133],
6	examined	VBN	O	examine	partmod	5	SENT_254	[p11l1291t2065r1606b2120],
7	was	VBD	O	be	cop	8	SENT_254	[p11l1647t2080r1770b2120],
8	small	JJ	O	small	advcl	13	SENT_254	[p11l1814t2065r2000b2128],
9	,	,	O	,	_	0	SENT_254	[p11l1814t2065r2000b2128],
10	the	DT	O	the	det	12	SENT_254	[p11l2043t2065r2144b2120],
11	present	JJ	DATE	present	amod	12	SENT_254	[p11l9t2162r251b2222],
12	study	NN	O	study	nsubj	13	SENT_254	[p11l305t2154r482b2222],
13	showed	VBD	O	show	_	0	SENT_254	[p11l536t2154r782b2209],
14	no	DT	O	no	det	16	SENT_254	[p11l838t2170r915b2209],
15	signiﬁcant	NN	O	signiﬁcant	nn	16	SENT_254	[p11l971t2154r1306b2222],
16	difference	NN	O	difference	dobj	13	SENT_254	[p11l1360t2154r1680b2209],
17	for	IN	O	for	_	0	SENT_254	[p11l1736t2154r1826b2209],
18	geﬁtinib	NN	O	geﬁtinib	nn	19	SENT_254	[p11l1877t2154r2145b2222],
19	response	NN	O	response	prep_for	13	SENT_254	[p11l9t2258r294b2311],
20	and	CC	O	and	_	0	SENT_254	[p11l326t2242r442b2297],
21	survival	NN	O	survival	conj_and	19	SENT_254	[p11l475t2242r724b2297],
22	in	IN	O	in	_	0	SENT_254	[p11l757t2243r816b2296],
23	patients	NNS	O	patient	prep_in	13	SENT_254	[p11l847t2243r1105b2311],
24	with	IN	O	with	_	0	SENT_254	[p11l1136t2242r1284b2297],
25	the	DT	O	the	det	28	SENT_254	[p11l1315t2242r1416b2297],
26	exon	NN	O	exon	nn	28	SENT_254	[p11l1449t2258r1600b2297],
27	19	CD	NUMBER	19	num	28	SENT_254	[p11l1634t2245r1702b2297],
28	deletion	NN	O	deletion	prep_with	23	SENT_254	[p11l1734t2242r1997b2297],
29	and	CC	O	and	_	0	SENT_254	[p11l2028t2242r2144b2297],
30	those	DT	O	those	prep_in	13	SENT_254	[p11l8t2331r181b2386],
31	with	IN	O	with	_	0	SENT_254	[p11l207t2331r355b2386],
32	exon	NN	O	exon	nn	34	SENT_254	[p11l381t2347r532b2386],
33	21	CD	NUMBER	21	num	34	SENT_254	[p11l558t2334r624b2386],
34	L858R	NN	O	l858r	prep_with	30	SENT_254	[p11l659t2334r871b2387],
35	.	.	O	.	_	0	SENT_254	[p11l659t2334r871b2387],

1	Greulich	NNP	O	Greulich	_	0	SENT_255	[p11l899t2331r1170b2386],
2	et	FW	O	et	nn	4	SENT_255	[p11l1196t2339r1255b2386],
3	al.	FW	O	al.	nn	4	SENT_255	[p11l1280t2331r1349b2387],
4	[	FW	O	[	dep	1	SENT_255	[p11l1379t2331r1496b2400],
5	19	CD	NUMBER	19	num	6	SENT_255	[p11l1379t2331r1496b2400],
6	]	NN	O	]	dep	4	SENT_255	[p11l1379t2331r1496b2400],
7	observed	VBN	O	observe	partmod	6	SENT_255	[p11l1526t2331r1816b2386],
8	no	DT	O	no	det	9	SENT_255	[p11l1844t2347r1921b2386],
9	differences	NNS	O	difference	dobj	7	SENT_255	[p11l1948t2331r2144b2386, p11l10t2437r187b2476],
10	between	IN	O	between	_	0	SENT_255	[p11l213t2421r491b2476],
11	the	DT	O	the	det	14	SENT_255	[p11l515t2421r616b2476],
12	exon	NN	O	exon	nn	14	SENT_255	[p11l642t2437r793b2476],
13	19	CD	NUMBER	19	num	14	SENT_255	[p11l822t2424r890b2476],
14	deletion	NN	O	deletion	prep_between	7	SENT_255	[p11l916t2421r1179b2476],
15	and	CC	O	and	_	0	SENT_255	[p11l1204t2421r1320b2476],
16	L858R	NN	O	l858r	prep_between	7	SENT_255	[p11l1347t2424r1546b2476],
17	using	VBG	O	use	xcomp	7	SENT_255	[p11l1569t2422r1742b2489],
18	a	DT	O	a	det	20	SENT_255	[p11l1765t2437r1798b2476],
19	cell	NN	O	cell	nn	20	SENT_255	[p11l1823t2421r2149b2476],
20	—	NN	O	—	dobj	17	SENT_255	[p11l1823t2421r2149b2476],
21	based	VBN	O	base	partmod	20	SENT_255	[p11l1823t2421r2149b2476],
22	assay	NN	O	assay	dobj	21	SENT_255	[p11l10t2525r192b2578],
23	.	.	O	.	_	0	SENT_255	[p11l10t2525r192b2578],

1	On	IN	O	on	dep	9	SENT_256	[p11l224t2512r313b2564],
2	the	DT	O	the	det	4	SENT_256	[p11l343t2509r445b2564],
3	other	JJ	O	other	amod	4	SENT_256	[p11l476t2509r648b2564],
4	hand	NN	O	hand	pobj	1	SENT_256	[p11l677t2509r852b2572],
5	,	,	O	,	_	0	SENT_256	[p11l677t2509r852b2572],
6	in	FW	O	in	nn	7	SENT_256	[p11l884t2510r940b2564],
7	vitro	FW	O	vitro	dep	1	SENT_256	[p11l970t2510r1112b2564],
8	kinase	NN	O	kinase	nn	9	SENT_256	[p11l1144t2509r1348b2564],
9	assays	NNS	O	assay	nsubj	10	SENT_256	[p11l1379t2525r1578b2578],
10	showed	VBD	O	show	_	0	SENT_256	[p11l1611t2509r1858b2564],
11	that	IN	O	that	complm	22	SENT_256	[p11l1889t2509r2018b2564],
12	the	DT	O	the	det	13	SENT_256	[p11l2047t2509r2149b2564],
13	exon	NN	O	exon	nsubj	22	SENT_256	[p11l10t2614r162b2653],
14	19	CD	NUMBER	19	num	15	SENT_256	[p11l205t2601r273b2653],
15	deletion	NN	O	deletion	dep	13	SENT_256	[p11l313t2598r576b2653],
16	(	CD	NUMBER	(	num	17	SENT_256	[p11l616t2598r1051b2667],
17	Del747	NN	O	del747	dep	13	SENT_256	[p11l616t2598r1051b2667],
18	—	NN	O	—	nn	21	SENT_256	[p11l616t2598r1051b2667],
19	753	CD	NUMBER	753	num	21	SENT_256	[p11l616t2598r1051b2667],
20	)	NN	O	)	nn	21	SENT_256	[p11l616t2598r1051b2667],
21	mutant	NN	O	mutant	dep	17	SENT_256	[p11l1091t2606r1328b2653],
22	exhibits	VBZ	O	exhibit	ccomp	10	SENT_256	[p11l1366t2598r1619b2653],
23	increased	VBN	O	increase	amod	25	SENT_256	[p11l1661t2598r1967b2653],
24	geﬁtinib	NN	O	geﬁtinib	nn	25	SENT_256	[p11l2005t2598r2149b2667, p11l10t2687r158b2742],
25	afﬁnity	NN	O	afﬁnity	dobj	22	SENT_256	[p11l192t2687r423b2756],
26	in	IN	O	in	_	0	SENT_256	[p11l456t2688r515b2742],
27	comparison	NN	O	comparison	prep_in	25	SENT_256	[p11l549t2688r927b2756],
28	to	TO	O	to	_	0	SENT_256	[p11l961t2695r1021b2742],
29	the	DT	O	the	det	32	SENT_256	[p11l1055t2687r1157b2742],
30	L858R	NN	O	l858r	nn	32	SENT_256	[p11l1192t2690r1392b2742],
31	mutant	JJ	O	mutant	amod	32	SENT_256	[p11l1423t2695r1659b2742],
32	[	NN	O	[	prep_to	27	SENT_256	[p11l1695t2687r1931b2756],
33	20,21	CD	NUMBER	20,21	num	34	SENT_256	[p11l1695t2687r1931b2756],
34	]	NN	O	]	dep	32	SENT_256	[p11l1695t2687r1931b2756],
35	.	.	O	.	_	0	SENT_256	[p11l1695t2687r1931b2756],

1	These	DT	O	these	det	2	SENT_257	[p11l1963t2687r2149b2742],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_257	[p11l11t2776r268b2845],
3	suggest	VBP	O	suggest	_	0	SENT_257	[p11l308t2785r548b2845],
4	the	DT	O	the	det	7	SENT_257	[p11l584t2776r686b2831],
5	exon	NN	O	exon	nn	7	SENT_257	[p11l725t2792r876b2831],
6	19	CD	NUMBER	19	num	7	SENT_257	[p11l918t2779r985b2831],
7	deletion	NN	O	deletion	nsubj	12	SENT_257	[p11l1025t2776r1288b2831],
8	of	IN	O	of	_	0	SENT_257	[p11l1326t2776r1393b2831],
9	EGFR	NN	ORGANIZATION	egfr	prep_of	7	SENT_257	[p11l1423t2779r1591b2831],
10	might	MD	O	might	aux	12	SENT_257	[p11l1626t2776r1817b2845],
11	therefore	RB	O	therefore	advmod	12	SENT_257	[p11l1853t2776r2149b2831],
12	have	VB	O	have	ccomp	3	SENT_257	[p11l11t2866r158b2921],
13	a	DT	O	a	det	15	SENT_257	[p11l186t2881r218b2921],
14	higher	JJR	O	higher	amod	15	SENT_257	[p11l248t2866r456b2934],
15	sensitivity	NN	O	sensitivity	dobj	12	SENT_257	[p11l483t2866r815b2934],
16	to	TO	O	to	_	0	SENT_257	[p11l841t2874r902b2921],
17	EGFR	NN	ORGANIZATION	egfr	prep_to	12	SENT_257	[p11l932t2868r1275b2921],
18	.	.	O	.	_	0	SENT_257	[p11l932t2868r1275b2921],

1	—	NN	O	—	_	0	SENT_258	[p11l932t2868r1275b2921],
2	.	.	O	.	_	0	SENT_258	[p11l932t2868r1275b2921],

1	TI	NNP	O	TI	nn	2	SENT_259	[p11l932t2868r1275b2921],
2	(	NNP	O	(	nsubj	4	SENT_259	[p11l932t2868r1275b2921],
3	Is	VBZ	O	be	cop	4	SENT_259	[p11l932t2868r1275b2921],
4	treatment	NN	O	treatment	_	0	SENT_259	[p11l1304t2874r1642b2921],
5	.	.	O	.	_	0	SENT_259	[p11l1304t2874r1642b2921],

1	In	IN	O	in	_	0	SENT_260	[p11l1672t2869r1732b2920],
2	some	DT	O	some	det	5	SENT_260	[p11l1761t2881r1930b2921],
3	previous	JJ	O	previous	amod	5	SENT_260	[p11l1959t2866r2149b2934, p11l10t2971r119b3010],
4	clinical	JJ	O	clinical	amod	5	SENT_260	[p11l148t2955r374b3010],
5	reports	NNS	O	report	prep_in	13	SENT_260	[p11l404t2963r649b3023],
6	,	,	O	,	_	0	SENT_260	[p11l404t2963r649b3023],
7	patients	NNS	O	patient	nsubj	13	SENT_260	[p11l678t2956r937b3023],
8	with	IN	O	with	_	0	SENT_260	[p11l964t2955r1113b3010],
9	the	DT	O	the	det	12	SENT_260	[p11l1140t2955r1242b3010],
10	exon	NN	O	exon	nn	12	SENT_260	[p11l1270t2971r1422b3010],
11	19	CD	NUMBER	19	num	12	SENT_260	[p11l1453t2958r1521b3010],
12	deletion	NN	O	deletion	prep_with	7	SENT_260	[p11l1550t2955r1814b3010],
13	showed	VBD	O	show	_	0	SENT_260	[p11l1842t2955r2089b3010],
14	a	DT	O	a	det	17	SENT_260	[p11l2118t2971r2150b3010],
15	higher	JJR	O	higher	amod	17	SENT_260	[p11l11t3043r219b3112],
16	response	NN	O	response	nn	17	SENT_260	[p11l242t3059r527b3112],
17	rate	NN	O	rate	dobj	13	SENT_260	[p11l552t3051r673b3098],
18	than	IN	O	than	_	0	SENT_260	[p11l697t3043r842b3098],
19	those	DT	O	those	prep_than	13	SENT_260	[p11l865t3043r1038b3098],
20	with	IN	O	with	_	0	SENT_260	[p11l1061t3043r1209b3098],
21	the	DT	O	the	det	25	SENT_260	[p11l1232t3043r1334b3098],
22	exon	NN	O	exon	nn	25	SENT_260	[p11l1359t3059r1510b3098],
23	21	CD	NUMBER	21	num	25	SENT_260	[p11l1534t3046r1599b3097],
24	L858R	NN	O	l858r	nn	25	SENT_260	[p11l1632t3046r1831b3098],
25	mutation	NN	O	mutation	prep_with	13	SENT_260	[p11l1853t3044r2150b3098],
26	[	CD	NUMBER	[	number	27	SENT_260	[p11l14t3132r371b3201],
27	12,22	CD	NUMBER	12,22	num	28	SENT_260	[p11l14t3132r371b3201],
28	—	NN	O	—	dep	25	SENT_260	[p11l14t3132r371b3201],
29	24	CD	NUMBER	24	num	30	SENT_260	[p11l14t3132r371b3201],
30	]	NN	O	]	dep	28	SENT_260	[p11l14t3132r371b3201],
31	.	.	O	.	_	0	SENT_260	[p11l14t3132r371b3201],

1	These	DT	O	these	det	3	SENT_261	[p11l389t3132r575b3187],
2	clinical	JJ	O	clinical	amod	3	SENT_261	[p11l596t3132r823b3187],
3	observations	NNS	O	observation	nsubj	4	SENT_261	[p11l844t3132r1252b3187],
4	suggest	VBP	O	suggest	dep	16	SENT_261	[p11l1275t3140r1515b3201],
5	that	IN	O	that	complm	10	SENT_261	[p11l1533t3132r1662b3187],
6	there	EX	O	there	expl	10	SENT_261	[p11l1680t3132r1848b3187],
7	may	MD	O	may	aux	10	SENT_261	[p11l1869t3148r2005b3201],
8	be	VB	O	be	cop	10	SENT_261	[p11l2023t3132r2097b3187],
9	a	DT	O	a	det	10	SENT_261	[p11l2118t3148r2150b3187],
10	difference	NN	O	difference	ccomp	4	SENT_261	[p11l10t3221r332b3276],
11	of	IN	O	of	_	0	SENT_261	[p11l353t3221r419b3276],
12	sensitivity	NN	O	sensitivity	prep_of	10	SENT_261	[p11l433t3222r764b3290],
13	to	TO	O	to	_	0	SENT_261	[p11l782t3230r843b3276],
14	TI	NNP	O	TI	nn	15	SENT_261	[p11l861t3225r996b3276],
15	(	NNP	O	(	prep_to	10	SENT_261	[p11l861t3225r996b3276],
16	Is	VBZ	O	be	_	0	SENT_261	[p11l861t3225r996b3276],
17	between	IN	O	between	_	0	SENT_261	[p11l1017t3221r1295b3276],
18	exon	NN	O	exon	prep_between	16	SENT_261	[p11l1315t3237r1466b3276],
19	19	CD	NUMBER	19	num	20	SENT_261	[p11l1490t3224r1557b3276],
20	deletion	NN	O	deletion	attr	16	SENT_261	[p11l1578t3221r1842b3276],
21	and	CC	O	and	_	0	SENT_261	[p11l1862t3221r1978b3276],
22	exon	NN	O	exon	conj_and	20	SENT_261	[p11l1998t3237r2150b3276],
23	21	CD	NUMBER	21	num	24	SENT_261	[p11l10t3313r76b3365],
24	L858R	NN	O	l858r	nsubj	16	SENT_261	[p11l107t3313r320b3374],
25	,	,	O	,	_	0	SENT_261	[p11l107t3313r320b3374],
26	as	IN	O	as	mark	27	SENT_261	[p11l343t3326r405b3365],
27	observed	VBN	O	observe	dep	24	SENT_261	[p11l429t3310r720b3365],
28	the	DT	O	the	dobj	27	SENT_261	[p11l743t3310r845b3365],
29	in	FW	O	in	nn	30	SENT_261	[p11l868t3312r922b3365],
30	vitro	FW	O	vitro	dep	32	SENT_261	[p11l945t3312r1087b3365],
31	kinase	NN	O	kinase	nn	32	SENT_261	[p11l1111t3310r1314b3365],
32	assay	NN	O	assay	dep	28	SENT_261	[p11l1337t3326r1519b3379],
33	.	.	O	.	_	0	SENT_261	[p11l1337t3326r1519b3379],

1	The	DT	O	the	det	4	SENT_262	[p11l109t3400r227b3455],
2	secondary	JJ	O	secondary	amod	4	SENT_262	[p11l249t3400r577b3468],
3	mutation	NN	O	mutation	nn	4	SENT_262	[p11l597t3401r894b3455],
4	T790M	NN	O	t790m	nsubjpass	10	SENT_262	[p11l911t3402r1136b3455],
5	of	IN	O	of	_	0	SENT_262	[p11l1158t3399r1225b3455],
6	the	DT	O	the	det	8	SENT_262	[p11l1237t3400r1338b3455],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_262	[p11l1360t3402r1527b3455],
8	gene	NN	O	gene	prep_of	4	SENT_262	[p11l1543t3415r1694b3468],
9	was	VBD	O	be	auxpass	10	SENT_262	[p11l1713t3415r1836b3455],
10	observed	VBN	O	observe	_	0	SENT_262	[p11l1858t3400r2149b3455],
11	in	IN	O	in	_	0	SENT_262	[p12l11t18r70b71],
12	4	CD	TIME	4	prep_in	10	SENT_262	[p12l85t20r123b71],
13	of	IN	TIME	of	_	0	SENT_262	[p12l140t17r206b72],
14	5	CD	TIME	5	num	15	SENT_262	[p12l216t20r249b72],
15	tumors	NNS	O	tumor	prep_of	12	SENT_262	[p12l268t25r498b72],
16	with	IN	O	with	_	0	SENT_262	[p12l514t17r662b72],
17	acquired	VBN	O	acquire	amod	18	SENT_262	[p12l679t17r956b85],
18	resistance	NN	O	resistance	prep_with	10	SENT_262	[p12l974t18r1294b72],
19	to	TO	O	to	_	0	SENT_262	[p12l1311t25r1372b72],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	18	SENT_262	[p12l1388t17r1672b85],
21	.	.	O	.	_	0	SENT_262	[p12l1388t17r1672b85],

1	The	DT	O	the	det	4	SENT_263	[p12l1687t17r1804b72],
2	secondary	JJ	O	secondary	amod	4	SENT_263	[p12l1823t17r2151b85],
3	mutation	NN	O	mutation	nn	4	SENT_263	[p12l11t106r307b160],
4	T79OM	NN	O	t79om	nsubj	6	SENT_263	[p12l327t108r552b160],
5	is	VBZ	O	be	cop	6	SENT_263	[p12l577t106r623b160],
6	responsible	JJ	O	responsible	_	0	SENT_263	[p12l648t105r1016b174],
7	for	IN	O	for	_	0	SENT_263	[p12l1040t105r1129b160],
8	some	DT	O	some	prep_for	6	SENT_263	[p12l1151t121r1319b160],
9	with	IN	O	with	_	0	SENT_263	[p12l1341t105r1489b160],
10	acquired	VBN	O	acquire	amod	11	SENT_263	[p12l1511t105r1788b174],
11	resistance	NN	O	resistance	prep_with	8	SENT_263	[p12l1813t106r2149b169],
12	,	,	O	,	_	0	SENT_263	[p12l1813t106r2149b169],
13	based	VBN	O	base	_	0	SENT_263	[p12l10t194r194b249],
14	on	IN	O	on	prepc_based_on	6	SENT_263	[p12l210t210r289b249],
15	a	DT	O	a	det	17	SENT_263	[p12l304t210r336b249],
16	biochemical	JJ	O	biochemical	amod	17	SENT_263	[p12l350t194r740b249],
17	analysis	NN	O	analysis	nsubj	22	SENT_263	[p12l756t194r1008b263],
18	and	CC	O	and	_	0	SENT_263	[p12l1025t194r1142b249],
19	growth	NN	O	growth	nn	21	SENT_263	[p12l1156t194r1388b263],
20	inhibition	NN	O	inhibition	nn	21	SENT_263	[p12l1404t194r1720b249],
21	studies	NNS	O	study	nsubj	22	SENT_263	[p12l1736t194r1961b249],
22	using	VBG	O	use	pcomp	6	SENT_263	[p12l1978t195r2151b263],
23	T79OM	NN	O	t79om	dobj	22	SENT_263	[p12l8t286r233b338],
24	transfected	VBN	O	transfect	partmod	23	SENT_263	[p12l269t283r629b338],
25	lung	NN	O	lung	nn	28	SENT_263	[p12l666t283r807b352],
26	cancer	NN	O	cancer	nn	28	SENT_263	[p12l841t299r1052b338],
27	cell	NN	O	cell	nn	28	SENT_263	[p12l1085t283r1193b338],
28	lines	NNS	O	line	nsubj	29	SENT_263	[p12l1230t283r1377b338],
29	[	VBP	O	[	ccomp	24	SENT_263	[p12l1418t283r1656b352],
30	25,26	CD	NUMBER	25,26	number	31	SENT_263	[p12l1418t283r1656b352],
31	]	CD	NUMBER	]	dobj	29	SENT_263	[p12l1418t283r1656b352],
32	.	.	O	.	_	0	SENT_263	[p12l1418t283r1656b352],

1	After	IN	O	after	_	0	SENT_264	[p12l1691t283r1853b338],
2	the	DT	O	the	det	4	SENT_264	[p12l1886t283r1988b338],
3	ﬁrst	NN	O	ﬁrst	nn	4	SENT_264	[p12l2024t283r2151b338],
4	report	NN	O	report	prep_after	17	SENT_264	[p12l11t381r210b441],
5	of	IN	O	of	_	0	SENT_264	[p12l236t372r302b428],
6	acquired	VBN	O	acquire	amod	8	SENT_264	[p12l322t373r599b441],
7	T79OM	NN	O	t79om	nn	8	SENT_264	[p12l624t375r850b428],
8	mutation	NN	O	mutation	prep_of	4	SENT_264	[p12l879t373r1175b428],
9	[	CD	NUMBER	[	num	11	SENT_264	[p12l1206t372r1444b441],
10	25,26	CD	NUMBER	25,26	num	11	SENT_264	[p12l1206t372r1444b441],
11	]	NN	O	]	dep	8	SENT_264	[p12l1206t372r1444b441],
12	,	,	O	,	_	0	SENT_264	[p12l1206t372r1444b441],
13	the	DT	O	the	det	15	SENT_264	[p12l1472t373r1574b428],
14	T79OM	NN	O	t79om	nn	15	SENT_264	[p12l1599t375r1824b428],
15	mutation	NN	O	mutation	nsubjpass	17	SENT_264	[p12l1853t373r2150b428],
16	was	VBD	O	be	auxpass	17	SENT_264	[p12l9t477r131b517],
17	detected	VBN	O	detect	dep	31	SENT_264	[p12l154t462r430b517],
18	in	IN	O	in	dep	17	SENT_264	[p12l453t462r511b516],
19	about	IN	O	about	_	0	SENT_264	[p12l533t462r716b517],
20	half	NN	O	half	prep_about	17	SENT_264	[p12l736t461r863b517],
21	of	IN	O	of	_	0	SENT_264	[p12l877t461r944b517],
22	the	DT	O	the	det	23	SENT_264	[p12l957t462r1059b517],
23	patients	NNS	O	patient	prep_of	20	SENT_264	[p12l1081t463r1339b530],
24	with	IN	O	with	_	0	SENT_264	[p12l1360t462r1508b517],
25	acquired	VBN	O	acquire	amod	26	SENT_264	[p12l1530t462r1806b530],
26	resistance	NN	O	resistance	prep_with	17	SENT_264	[p12l1829t462r2149b517],
27	to	TO	O	to	_	0	SENT_264	[p12l10t559r71b606],
28	Tl	NN	O	tl	nn	30	SENT_264	[p12l91t554r227b606],
29	(	NN	O	(	nn	30	SENT_264	[p12l91t554r227b606],
30	ls	NNS	O	l	prep_to	26	SENT_264	[p12l91t554r227b606],
31	[	VBP	O	[	_	0	SENT_264	[p12l254t551r515b619],
32	27	CD	NUMBER	27	num	33	SENT_264	[p12l254t551r515b619],
33	—	CD	NUMBER	—	dobj	31	SENT_264	[p12l254t551r515b619],
34	29	CD	NUMBER	29	num	35	SENT_264	[p12l254t551r515b619],
35	]	NN	O	]	nsubj	31	SENT_264	[p12l254t551r515b619],
36	.	.	O	.	_	0	SENT_264	[p12l254t551r515b619],

1	In	IN	O	in	_	0	SENT_265	[p12l540t554r599b605],
2	addition	NN	O	addition	prep_in	9	SENT_265	[p12l622t551r905b614],
3	,	,	O	,	_	0	SENT_265	[p12l622t551r905b614],
4	a	DT	O	a	det	7	SENT_265	[p12l929t567r961b606],
5	novel	JJ	O	novel	amod	7	SENT_265	[p12l984t551r1156b606],
6	G796A	NN	O	g796a	nn	7	SENT_265	[p12l1179t553r1396b606],
7	mutation	NN	O	mutation	nsubjpass	9	SENT_265	[p12l1417t552r1714b606],
8	was	VBD	O	be	auxpass	9	SENT_265	[p12l1735t567r1858b606],
9	found	VBN	O	find	_	0	SENT_265	[p12l1882t551r2067b606],
10	in	IN	O	in	_	0	SENT_265	[p12l2091t552r2150b605],
11	tumors	NNS	O	tumor	prep_in	9	SENT_265	[p12l10t647r240b694],
12	with	IN	O	with	_	0	SENT_265	[p12l268t639r416b694],
13	primary	JJ	O	primary	amod	14	SENT_265	[p12l445t640r705b708],
14	resistance	NN	O	resistance	prep_with	11	SENT_265	[p12l732t640r1053b694],
15	to	TO	O	to	_	0	SENT_265	[p12l1082t647r1142b694],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	9	SENT_265	[p12l1170t639r1438b708],
17	[	CD	NUMBER	[	num	16	SENT_265	[p12l1470t639r1610b708],
18	30	CD	NUMBER	30	num	19	SENT_265	[p12l1470t639r1610b708],
19	]	NN	O	]	dep	16	SENT_265	[p12l1470t639r1610b708],
20	,	,	O	,	_	0	SENT_265	[p12l1470t639r1610b708],
21	and	CC	O	and	_	0	SENT_265	[p12l1640t639r1757b694],
22	other	JJ	O	other	amod	24	SENT_265	[p12l1786t639r1958b694],
23	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_265	[p12l1985t642r2152b694],
24	mutation	NN	O	mutation	nsubjpass	44	SENT_265	[p12l11t729r307b783],
25	such	JJ	O	such	_	0	SENT_265	[p12l343t728r488b783],
26	as	IN	O	as	_	0	SENT_265	[p12l523t744r585b783],
27	D761Y	NN	O	d761y	prep_such_as	24	SENT_265	[p12l622t731r831b783],
28	[	CD	NUMBER	[	number	29	SENT_265	[p12l867t728r1007b797],
29	28	CD	NUMBER	28	num	30	SENT_265	[p12l867t728r1007b797],
30	]	NN	O	]	dep	27	SENT_265	[p12l867t728r1007b797],
31	,	,	O	,	_	0	SENT_265	[p12l867t728r1007b797],
32	L747S	NN	O	l747	prep_such_as	24	SENT_265	[p12l1044t731r1225b783],
33	[	CD	NUMBER	[	num	32	SENT_265	[p12l1265t728r1401b797],
34	31	CD	NUMBER	31	num	35	SENT_265	[p12l1265t728r1401b797],
35	]	NN	O	]	dep	32	SENT_265	[p12l1265t728r1401b797],
36	,	,	O	,	_	0	SENT_265	[p12l1265t728r1401b797],
37	and	CC	O	and	_	0	SENT_265	[p12l1437t728r1554b783],
38	E884I	NN	O	e884us	prep_such_as	24	SENT_265	[p12l1590t731r1796b783],
39	(	CD	NUMBER	(	num	38	SENT_265	[p12l1590t731r1796b783],
40	[	CD	NUMBER	[	number	41	SENT_265	[p12l1832t728r1953b797],
41	32	CD	NUMBER	32	num	42	SENT_265	[p12l1832t728r1953b797],
42	]	NN	O	]	dep	38	SENT_265	[p12l1832t728r1953b797],
43	were	VBD	O	be	auxpass	44	SENT_265	[p12l1991t744r2149b783],
44	reported	VBN	O	report	conj_and	9	SENT_265	[p12l11t817r287b886],
45	as	IN	O	as	_	0	SENT_265	[p12l316t833r378b872],
46	acquired	VBN	O	acquire	amod	47	SENT_265	[p12l408t817r685b886],
47	mutations	NNS	O	mutation	prep_as	44	SENT_265	[p12l715t818r1041b872],
48	which	WDT	O	which	nsubj	49	SENT_265	[p12l1070t817r1268b872],
49	correlate	VBP	O	correlate	rcmod	47	SENT_265	[p12l1296t817r1579b872],
50	with	IN	O	with	_	0	SENT_265	[p12l1607t817r1756b872],
51	resistant	JJ	O	resistant	prep_with	49	SENT_265	[p12l1784t818r2062b872],
52	to	TO	O	to	_	0	SENT_265	[p12l2088t826r2149b872],
53	TKIS	NNS	O	tki	prep_to	49	SENT_265	[p12l8t910r160b961],
54	.	.	O	.	_	0	SENT_265	[p12l8t910r160b961],

1	The	DT	O	the	det	2	SENT_266	[p12l109t995r227b1050],
2	occurrence	NN	O	occurrence	_	0	SENT_266	[p12l251t1011r605b1050],
3	of	IN	O	of	_	0	SENT_266	[p12l629t995r696b1050],
4	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_266	[p12l712t998r879b1050],
5	and	CC	O	and	_	0	SENT_266	[p12l900t995r1017b1050],
6	l	NN	O	l	conj_and	4	SENT_266	[p12l1042t998r1203b1050],
7	(	NN	O	(	prep_of	2	SENT_266	[p12l1042t998r1203b1050],
8	.	.	O	.	_	0	SENT_266	[p12l1042t998r1203b1050],

1	—	NN	O	—	_	0	SENT_267	[p12l1042t998r1203b1050],
2	.	.	O	.	_	0	SENT_267	[p12l1042t998r1203b1050],

1	ras	NN	O	ra	nn	2	SENT_268	[p12l1042t998r1203b1050],
2	mutations	NNS	O	mutation	nsubj	7	SENT_268	[p12l1229t996r1556b1050],
3	are	VBP	O	be	cop	7	SENT_268	[p12l1581t1011r1678b1050],
4	strictly	RB	O	strictly	advmod	7	SENT_268	[p12l1703t995r1926b1063],
5	mutually	RB	O	mutually	advmod	6	SENT_268	[p12l1949t1003r2149b1050, p12l10t1083r124b1152],
6	exclusive	JJ	O	exclusive	amod	7	SENT_268	[p12l144t1083r435b1138],
7	[	NN	O	[	_	0	SENT_268	[p12l460t1083r698b1152],
8	33,34	CD	NUMBER	33,34	num	9	SENT_268	[p12l460t1083r698b1152],
9	]	NN	O	]	dep	7	SENT_268	[p12l460t1083r698b1152],
10	,	,	O	,	_	0	SENT_268	[p12l460t1083r698b1152],
11	and	CC	O	and	_	0	SENT_268	[p12l719t1083r836b1138],
12	lung	NN	O	lung	nn	13	SENT_268	[p12l858t1083r999b1152],
13	cancer	NN	O	cancer	conj_and	7	SENT_268	[p12l1019t1099r1230b1138],
14	with	IN	O	with	_	0	SENT_268	[p12l1247t1083r1396b1138],
15	l	NN	O	l	nn	16	SENT_268	[p12l1417t1086r1577b1138],
16	(	NN	O	(	prep_with	13	SENT_268	[p12l1417t1086r1577b1138],
17	.	.	O	.	_	0	SENT_268	[p12l1417t1086r1577b1138],

1	—	NN	O	—	_	0	SENT_269	[p12l1417t1086r1577b1138],
2	.	.	O	.	_	0	SENT_269	[p12l1417t1086r1577b1138],

1	ras	NN	O	ra	nn	2	SENT_270	[p12l1417t1086r1577b1138],
2	mutations	NNS	O	mutation	nsubj	3	SENT_270	[p12l1601t1084r1928b1138],
3	shows	VBZ	O	show	_	0	SENT_270	[p12l1951t1083r2148b1138],
4	resistance	NN	O	resistance	dobj	3	SENT_270	[p12l11t1173r331b1227],
5	to	TO	O	to	_	0	SENT_270	[p12l375t1180r435b1227],
6	EGFR	NN	ORGANIZATION	egfr	prep_to	3	SENT_270	[p12l480t1175r823b1227],
7	.	.	O	.	_	0	SENT_270	[p12l480t1175r823b1227],

1	—	NN	O	—	_	0	SENT_271	[p12l480t1175r823b1227],
2	.	.	O	.	_	0	SENT_271	[p12l480t1175r823b1227],

1	Tl	NN	O	tl	nsubj	6	SENT_272	[p12l480t1175r823b1227],
2	(	CD	NUMBER	(	num	1	SENT_272	[p12l480t1175r823b1227],
3	Is	VBZ	O	be	cop	6	SENT_272	[p12l480t1175r823b1227],
4	[	CD	NUMBER	[	number	5	SENT_272	[p12l871t1172r1011b1241],
5	34	CD	NUMBER	34	num	6	SENT_272	[p12l871t1172r1011b1241],
6	]	NN	O	]	_	0	SENT_272	[p12l871t1172r1011b1241],
7	.	.	O	.	_	0	SENT_272	[p12l871t1172r1011b1241],

1	In	IN	O	in	_	0	SENT_273	[p12l1056t1175r1116b1226],
2	the	DT	O	the	det	5	SENT_273	[p12l1159t1172r1261b1227],
3	current	JJ	DATE	current	amod	5	SENT_273	[p12l1305t1180r1541b1227],
4	19	CD	NUMBER	19	num	5	SENT_273	[p12l1587t1175r1655b1227],
5	patients	NNS	O	patient	prep_in	12	SENT_273	[p12l1700t1173r1958b1241],
6	with	IN	O	with	_	0	SENT_273	[p12l2001t1172r2150b1227],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_273	[p12l11t1264r178b1316],
8	mutations	NNS	O	mutation	prep_with	5	SENT_273	[p12l219t1262r562b1325],
9	,	,	O	,	_	0	SENT_273	[p12l219t1262r562b1325],
10	no	DT	O	no	det	11	SENT_273	[p12l607t1277r684b1316],
11	I	PRP	O	I	nsubj	12	SENT_273	[p12l728t1265r889b1316],
12	(	VBP	O	(	_	0	SENT_273	[p12l728t1265r889b1316],
13	.	.	O	.	_	0	SENT_273	[p12l728t1265r889b1316],

1	—	NN	O	—	_	0	SENT_274	[p12l728t1265r889b1316],
2	.	.	O	.	_	0	SENT_274	[p12l728t1265r889b1316],

1	ras	NN	O	ra	nn	2	SENT_275	[p12l728t1265r889b1316],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_275	[p12l934t1262r1261b1316],
3	were	VBD	O	be	auxpass	4	SENT_275	[p12l1303t1277r1462b1316],
4	observed	VBN	O	observe	_	0	SENT_275	[p12l1505t1261r1796b1316],
5	(	RB	O	(	advmod	4	SENT_275	[p12l1840t1261r2003b1329],
6	data	NNS	O	datum	npadvmod	7	SENT_275	[p12l1840t1261r2003b1329],
7	not	RB	O	not	neg	4	SENT_275	[p12l2047t1269r2151b1316],
8	shown	VBN	O	show	dep	4	SENT_275	[p12l11t1350r264b1419],
9	)	NN	O	)	dobj	4	SENT_275	[p12l11t1350r264b1419],
10	.	.	O	.	_	0	SENT_275	[p12l11t1350r264b1419],

1	On	IN	O	on	_	0	SENT_276	[p12l294t1353r383b1405],
2	the	DT	O	the	det	4	SENT_276	[p12l411t1350r512b1405],
3	other	JJ	O	other	amod	4	SENT_276	[p12l541t1350r713b1405],
4	hand	NN	O	hand	prep_on	9	SENT_276	[p12l740t1350r914b1414],
5	,	,	O	,	_	0	SENT_276	[p12l740t1350r914b1414],
6	Engelman	NNP	PERSON	Engelman	nsubj	9	SENT_276	[p12l945t1350r1264b1419],
7	et	FW	O	et	nn	8	SENT_276	[p12l1292t1359r1352b1405],
8	al.	FW	O	al.	dep	6	SENT_276	[p12l1378t1350r1447b1406],
9	reported	VBN	O	report	_	0	SENT_276	[p12l1477t1350r1753b1419],
10	that	IN	O	that	complm	17	SENT_276	[p12l1782t1350r1911b1405],
11	ampliﬁcation	NN	O	ampliﬁcation	nsubjpass	17	SENT_276	[p12l1939t1350r2149b1419, p12l11t1439r251b1495],
12	of	IN	O	of	_	0	SENT_276	[p12l293t1439r360b1495],
13	the	DT	O	the	det	15	SENT_276	[p12l393t1440r495b1495],
14	MET	NN	O	met	nn	15	SENT_276	[p12l539t1443r681b1494],
15	gene	NN	O	gene	prep_of	11	SENT_276	[p12l719t1455r870b1508],
16	is	VBZ	O	be	auxpass	17	SENT_276	[p12l913t1440r959b1495],
17	detected	VBN	O	detect	ccomp	9	SENT_276	[p12l1003t1440r1278b1495],
18	in	IN	O	in	_	0	SENT_276	[p12l1322t1440r1381b1494],
19	22	CD	PERCENT	22	num	20	SENT_276	[p12l1422t1442r1544b1495],
20	%	NN	PERCENT	%	prep_in	17	SENT_276	[p12l1422t1442r1544b1495],
21	(	CD	NUMBER	(	number	22	SENT_276	[p12l1586t1439r1775b1508],
22	4/18	CD	NUMBER	4/18	num	23	SENT_276	[p12l1586t1439r1775b1508],
23	)	NN	O	)	dobj	17	SENT_276	[p12l1586t1439r1775b1508],
24	of	IN	O	of	_	0	SENT_276	[p12l1818t1439r1885b1495],
25	tumors	NNS	O	tumor	prep_of	23	SENT_276	[p12l1918t1448r2148b1495],
26	with	IN	O	with	_	0	SENT_276	[p12l9t1529r157b1584],
27	acquired	VBN	O	acquire	amod	28	SENT_276	[p12l195t1529r472b1597],
28	resistance	NN	O	resistance	prep_with	25	SENT_276	[p12l512t1530r832b1584],
29	to	TO	O	to	_	0	SENT_276	[p12l871t1537r932b1584],
30	EGFR	NN	ORGANIZATION	egfr	prep_to	28	SENT_276	[p12l972t1532r1331b1592],
31	.	.	O	.	_	0	SENT_276	[p12l972t1532r1331b1592],

1	—	NN	O	—	_	0	SENT_277	[p12l972t1532r1331b1592],
2	.	.	O	.	_	0	SENT_277	[p12l972t1532r1331b1592],

1	TI	NNP	O	TI	nn	2	SENT_278	[p12l972t1532r1331b1592],
2	(	NNP	O	(	nsubj	3	SENT_278	[p12l972t1532r1331b1592],
3	Is	VBZ	O	be	_	0	SENT_278	[p12l972t1532r1331b1592],
4	,	,	O	,	_	0	SENT_278	[p12l972t1532r1331b1592],
5	which	WDT	O	which	nsubj	6	SENT_278	[p12l1369t1529r1567b1584],
6	indicate	VBP	O	indicate	ccomp	3	SENT_278	[p12l1606t1529r1861b1584],
7	another	DT	O	another	det	8	SENT_278	[p12l1900t1529r2152b1584],
8	mechanism	NN	O	mechanism	dobj	6	SENT_278	[p12l11t1617r382b1672],
9	of	IN	O	of	_	0	SENT_278	[p12l424t1617r491b1672],
10	resistance	NN	O	resistance	prep_of	8	SENT_278	[p12l525t1618r846b1672],
11	to	TO	O	to	_	0	SENT_278	[p12l887t1625r948b1672],
12	EGFR	NN	ORGANIZATION	egfr	prep_to	3	SENT_278	[p12l992t1620r1334b1672],
13	.	.	O	.	_	0	SENT_278	[p12l992t1620r1334b1672],

1	—	NN	O	—	_	0	SENT_279	[p12l992t1620r1334b1672],
2	.	.	O	.	_	0	SENT_279	[p12l992t1620r1334b1672],

1	TKIs	NNS	O	tki	_	0	SENT_280	[p12l992t1620r1334b1672],
2	[	CD	NUMBER	[	number	3	SENT_280	[p12l1380t1617r1519b1686],
3	27	CD	NUMBER	27	dep	1	SENT_280	[p12l1380t1617r1519b1686],
4	]	NN	O	]	dep	3	SENT_280	[p12l1380t1617r1519b1686],
5	.	.	O	.	_	0	SENT_280	[p12l1380t1617r1519b1686],

1	Notably	RB	O	notably	advmod	7	SENT_281	[p12l1562t1617r1822b1686],
2	,	,	O	,	_	0	SENT_281	[p12l1562t1617r1822b1686],
3	the	DT	O	the	det	5	SENT_281	[p12l1865t1617r1967b1672],
4	MET	NN	O	met	nn	5	SENT_281	[p12l2009t1620r2152b1671],
5	ampliﬁcation	NN	O	ampliﬁcation	nsubj	7	SENT_281	[p12l10t1706r438b1775],
6	can	MD	O	can	aux	7	SENT_281	[p12l461t1722r570b1761],
7	occur	VB	O	occur	_	0	SENT_281	[p12l593t1722r770b1761],
8	concurrently	RB	O	concurrently	advmod	7	SENT_281	[p12l792t1706r1205b1775],
9	with	IN	O	with	mark	20	SENT_281	[p12l1225t1706r1373b1761],
10	the	DT	O	the	det	12	SENT_281	[p12l1396t1706r1498b1761],
11	T79OM	NN	O	t79om	nn	12	SENT_281	[p12l1519t1709r1745b1761],
12	mutation	NN	O	mutation	nsubj	20	SENT_281	[p12l1770t1707r2067b1761],
13	in	IN	O	in	_	0	SENT_281	[p12l2091t1707r2150b1761],
14	some	DT	O	some	det	16	SENT_281	[p12l11t1811r179b1850],
15	TI	NNP	O	TI	nn	16	SENT_281	[p12l194t1796r643b1850],
16	(	NNP	O	(	prep_in	12	SENT_281	[p12l194t1796r643b1850],
17	Is	VBZ	O	be	cop	20	SENT_281	[p12l194t1796r643b1850],
18	—	CD	NUMBER	—	num	20	SENT_281	[p12l194t1796r643b1850],
19	resistant	JJ	O	resistant	amod	20	SENT_281	[p12l194t1796r643b1850],
20	tumors	NNS	O	tumor	advcl	7	SENT_281	[p12l659t1803r888b1850],
21	[	VBP	O	[	rcmod	20	SENT_281	[p12l910t1795r1048b1864],
22	27	CD	NUMBER	27	num	23	SENT_281	[p12l910t1795r1048b1864],
23	]	CD	NUMBER	]	dobj	21	SENT_281	[p12l910t1795r1048b1864],
24	.	.	O	.	_	0	SENT_281	[p12l910t1795r1048b1864],

1	Recently	RB	DATE	recently	dep	4	SENT_282	[p12l1067t1795r1353b1864],
2	,	,	O	,	_	0	SENT_282	[p12l1067t1795r1353b1864],
3	irreversible	JJ	O	irreversible	amod	4	SENT_282	[p12l1372t1795r1737b1850],
4	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_282	[p12l1755t1798r2067b1850],
5	.	.	O	.	_	0	SENT_282	[p12l1755t1798r2067b1850],

1	—	NN	O	—	_	0	SENT_283	[p12l1755t1798r2067b1850],
2	.	.	O	.	_	0	SENT_283	[p12l1755t1798r2067b1850],

1	TKI	NN	O	tkus	nn	4	SENT_284	[p12l1755t1798r2067b1850],
2	or	CC	O	or	_	0	SENT_284	[p12l2085t1811r2151b1850],
3	MET	NN	O	met	nn	4	SENT_284	[p12l11t1888r153b1939],
4	inhibitors	NNS	O	inhibitor	nsubjpass	7	SENT_284	[p12l169t1884r479b1939],
5	have	VBP	O	have	aux	7	SENT_284	[p12l498t1884r645b1939],
6	been	VBN	O	be	auxpass	7	SENT_284	[p12l662t1884r817b1939],
7	developed	VBN	O	develop	_	0	SENT_284	[p12l835t1884r1166b1953],
8	for	IN	O	for	mark	16	SENT_284	[p12l1185t1884r1274b1939],
9	treatment	NN	O	treatment	nsubj	16	SENT_284	[p12l1289t1892r1613b1939],
10	of	IN	O	of	_	0	SENT_284	[p12l1629t1884r1695b1939],
11	TI	NNP	O	TI	nn	12	SENT_284	[p12l1702t1885r2151b1939],
12	(	NNP	O	(	prep_of	9	SENT_284	[p12l1702t1885r2151b1939],
13	Is	VBZ	O	be	cop	16	SENT_284	[p12l1702t1885r2151b1939],
14	—	CD	NUMBER	—	npadvmod	15	SENT_284	[p12l1702t1885r2151b1939],
15	resistant	JJ	O	resistant	amod	16	SENT_284	[p12l1702t1885r2151b1939],
16	tumors	NNS	O	tumor	advcl	7	SENT_284	[p12l10t1982r256b2029],
17	.	.	O	.	_	0	SENT_284	[p12l10t1982r256b2029],

1	These	DT	O	these	det	2	SENT_285	[p12l282t1974r468b2029],
2	studies	NNS	O	study	nsubj	3	SENT_285	[p12l498t1974r723b2029],
3	suggest	VBP	O	suggest	_	0	SENT_285	[p12l753t1982r993b2042],
4	the	DT	O	the	det	5	SENT_285	[p12l1019t1974r1121b2029],
5	development	NN	O	development	dobj	3	SENT_285	[p12l1150t1974r1576b2042],
6	of	IN	O	of	_	0	SENT_285	[p12l1602t1973r1669b2029],
7	individualized	JJ	O	individualized	amod	8	SENT_285	[p12l1690t1974r2149b2029],
8	therapy	NN	O	therapy	prep_of	5	SENT_285	[p12l10t2063r258b2131],
9	according	VBG	O	accord	_	0	SENT_285	[p12l278t2063r592b2131],
10	to	TO	O	to	prepc_according_to	3	SENT_285	[p12l613t2071r674b2118],
11	genotype	NN	O	genotype	nn	12	SENT_285	[p12l696t2071r993b2131],
12	information	NN	O	information	pobj	3	SENT_285	[p12l1017t2063r1416b2118],
13	.	.	O	.	_	0	SENT_285	[p12l1017t2063r1416b2118],

1	In	IN	O	in	_	0	SENT_286	[p12l113t2154r173b2206],
2	conclusion	NN	O	conclusion	prep_in	13	SENT_286	[p12l200t2151r561b2214],
3	,	,	O	,	_	0	SENT_286	[p12l200t2151r561b2214],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_286	[p12l590t2154r757b2206],
5	mutations	NNS	O	mutation	nsubjpass	13	SENT_286	[p12l783t2152r1109b2206],
6	in	IN	O	in	_	0	SENT_286	[p12l1139t2152r1198b2205],
7	exons	NNS	O	exon	prep_in	5	SENT_286	[p12l1225t2167r1407b2206],
8	19	CD	NUMBER	19	num	7	SENT_286	[p12l1439t2154r1507b2206],
9	or	CC	O	or	_	0	SENT_286	[p12l1536t2167r1602b2206],
10	21	CD	NUMBER	21	prep_in	5	SENT_286	[p12l1627t2154r1693b2205],
11	are	VBP	O	be	auxpass	13	SENT_286	[p12l1729t2167r1826b2206],
12	therefore	RB	O	therefore	advmod	13	SENT_286	[p12l1854t2151r2149b2206],
13	considered	VBN	O	consider	_	0	SENT_286	[p12l10t2240r362b2295],
14	to	TO	O	to	aux	18	SENT_286	[p12l385t2248r445b2295],
15	be	VB	O	be	cop	18	SENT_286	[p12l468t2240r542b2295],
16	a	DT	O	a	det	18	SENT_286	[p12l565t2256r597b2295],
17	good	JJ	O	good	amod	18	SENT_286	[p12l618t2240r774b2309],
18	predictor	NN	O	predictor	xcomp	13	SENT_286	[p12l797t2240r1094b2309],
19	of	IN	O	of	_	0	SENT_286	[p12l1115t2240r1182b2295],
20	the	DT	O	the	det	21	SENT_286	[p12l1196t2240r1297b2295],
21	efﬁcacy	NN	O	efﬁcacy	prep_of	18	SENT_286	[p12l1321t2240r1566b2309],
22	of	IN	O	of	_	0	SENT_286	[p12l1587t2240r1654b2295],
23	geﬁtinib	NN	O	geﬁtinib	prep_of	21	SENT_286	[p12l1667t2240r1950b2309],
24	.	.	O	.	_	0	SENT_286	[p12l1667t2240r1950b2309],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_287	[p12l9t2427r272b2482],
2	of	IN	O	of	_	0	SENT_287	[p12l292t2427r364b2482],
3	interest	NN	O	interest	prep_of	1	SENT_287	[p12l379t2428r642b2482],

1	None	NN	O	none	nsubj	2	SENT_288	[p12l113t2609r279b2660],
2	declared	VBD	O	declare	_	0	SENT_288	[p12l302t2606r591b2661],
3	.	.	O	.	_	0	SENT_288	[p12l302t2606r591b2661],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_289	[p12l7t2793r676b2862],

1	We	PRP	O	we	nsubj	2	SENT_290	[p12l109t2975r215b3026],
2	thank	VBP	O	thank	_	0	SENT_290	[p12l230t2972r416b3026],
3	Ms.	NNP	O	Ms.	nn	5	SENT_290	[p12l430t2975r538b3027],
4	Misako	NNP	PERSON	Misako	nn	5	SENT_290	[p12l555t2972r784b3026],
5	Fukumoto	NNP	PERSON	Fukumoto	dobj	2	SENT_290	[p12l800t2972r1124b3026],
6	for	IN	O	for	_	0	SENT_290	[p12l1141t2972r1230b3026],
7	her	PRP$	O	she	poss	10	SENT_290	[p12l1244t2972r1350b3026],
8	excellent	JJ	O	excellent	amod	10	SENT_290	[p12l1364t2972r1653b3026],
9	technical	JJ	O	technical	amod	10	SENT_290	[p12l1666t2972r1956b3026],
10	assistance	NN	O	assistance	prep_for	5	SENT_290	[p12l1972t2973r2149b3026, p12l10t3068r182b3115],
11	for	IN	O	for	_	0	SENT_290	[p12l222t3060r311b3115],
12	the	DT	O	the	det	14	SENT_290	[p12l347t3060r449b3115],
13	genetic	JJ	O	genetic	amod	14	SENT_290	[p12l487t3061r719b3129],
14	analyses	NNS	O	analysis	prep_for	10	SENT_290	[p12l757t3060r1042b3129],
15	,	,	O	,	_	0	SENT_290	[p12l757t3060r1042b3129],
16	and	CC	O	and	_	0	SENT_290	[p12l1082t3060r1199b3115],
17	Dr.	NNP	O	Dr.	nn	19	SENT_290	[p12l1239t3063r1325b3116],
18	Brian	NNP	PERSON	Brian	nn	19	SENT_290	[p12l1365t3061r1532b3115],
19	Quinn	NNP	PERSON	Quinn	dobj	2	SENT_290	[p12l1571t3061r1767b3126],
20	for	IN	O	for	_	0	SENT_290	[p12l1805t3060r1895b3115],
21	critical	JJ	O	critical	amod	22	SENT_290	[p12l1931t3060r2149b3115],
22	comments	NNS	O	comment	prep_for	19	SENT_290	[p12l10t3157r347b3204],
23	in	IN	O	in	_	0	SENT_290	[p12l373t3150r431b3204],
24	preparing	VBG	O	prepare	prepc_in	2	SENT_290	[p12l455t3150r769b3218],
25	this	DT	O	this	det	26	SENT_290	[p12l790t3149r906b3204],
26	manuscript	NN	O	manuscript	dobj	24	SENT_290	[p12l931t3150r1313b3218],
27	.	.	O	.	_	0	SENT_290	[p12l931t3150r1313b3218],

1	This	DT	O	this	det	2	SENT_291	[p12l1334t3149r1466b3204],
2	work	NN	O	work	nsubjpass	4	SENT_291	[p12l1488t3149r1654b3204],
3	was	VBD	O	be	auxpass	4	SENT_291	[p12l1673t3165r1797b3204],
4	supported	VBN	O	support	_	0	SENT_291	[p12l1822t3149r2149b3218],

1	318	CD	NUMBER	318	num	3	SENT_292	[p12l396t3294r439b3315],
2	K.	NNP	PERSON	K.	nn	3	SENT_292	[p12l1195t3294r1216b3315],
3	Sugio	NNP	PERSON	Sugio	_	0	SENT_292	[p12l1225t3293r1291b3320],
4	et	FW	O	et	nn	5	SENT_292	[p12l1299t3296r1322b3315],
5	al.	FW	O	al.	dep	3	SENT_292	[p12l1329t3293r1355b3315],
6	/	:	O	/	punct	3	SENT_292	[p12l1362t3293r1374b3320],
7	Lung	NN	O	lung	nn	8	SENT_292	[p12l1380t3294r1439b3320],
8	Cancer	NN	O	cancer	dep	3	SENT_292	[p12l1447t3294r1530b3315],
9	64	CD	NUMBER	64	number	10	SENT_292	[p12l1537t3294r1566b3315],
10	(	CD	NUMBER	(	num	11	SENT_292	[p12l1574t3293r1655b3320],
11	2009	CD	DATE	2009	dep	8	SENT_292	[p12l1574t3293r1655b3320],
12	)	CD	NUMBER	)	number	13	SENT_292	[p12l1574t3293r1655b3320],
13	314-318	CD	NUMBER	314-318	num	11	SENT_292	[p12l1663t3294r1763b3315],

1	by	IN	O	by	dep	24	SENT_293	[p12l6t3427r83b3496],
2	a	DT	O	a	det	4	SENT_293	[p12l103t3443r135b3482],
3	Grand	NNP	MISC	Grand	nn	4	SENT_293	[p12l157t3427r446b3482],
4	—	NN	MISC	—	pobj	1	SENT_293	[p12l157t3427r446b3482],
5	in	IN	O	in	_	0	SENT_293	[p12l157t3427r446b3482],
6	Aid	NN	O	aid	prep_in	4	SENT_293	[p12l464t3427r572b3482],
7	for	IN	O	for	_	0	SENT_293	[p12l595t3427r685b3482],
8	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	9	SENT_293	[p12l704t3427r999b3482],
9	Research	NNP	ORGANIZATION	Research	prep_for	6	SENT_293	[p12l1020t3427r1305b3482],
10	from	IN	O	from	_	0	SENT_293	[p12l1327t3427r1480b3482],
11	the	DT	O	the	det	12	SENT_293	[p12l1501t3427r1603b3482],
12	Ministry	NNP	ORGANIZATION	Ministry	prep_from	9	SENT_293	[p12l1626t3428r1900b3496],
13	of	IN	ORGANIZATION	of	_	0	SENT_293	[p12l1920t3427r1987b3482],
14	Education	NNP	ORGANIZATION	Education	prep_of	12	SENT_293	[p12l2002t3427r2149b3482, p12l7t3517r219b3580],
15	,	,	O	,	_	0	SENT_293	[p12l2002t3427r2149b3482, p12l7t3517r219b3580],
16	Culture	NNP	O	Culture	prep_of	12	SENT_293	[p12l243t3516r495b3580],
17	,	,	O	,	_	0	SENT_293	[p12l243t3516r495b3580],
18	Sports	NNP	O	Sports	prep_of	12	SENT_293	[p12l518t3519r736b3585],
19	,	,	O	,	_	0	SENT_293	[p12l518t3519r736b3585],
20	Science	NNP	O	Science	prep_of	12	SENT_293	[p12l760t3517r998b3571],
21	and	CC	O	and	_	0	SENT_293	[p12l1021t3516r1138b3571],
22	Technology	NNP	O	Technology	conj_and	14	SENT_293	[p12l1158t3516r1539b3585],
23	,	,	O	,	_	0	SENT_293	[p12l1158t3516r1539b3585],
24	Japan	NNP	LOCATION	Japan	_	0	SENT_293	[p12l1554t3520r1754b3585],
25	.	.	O	.	_	0	SENT_293	[p12l1554t3520r1754b3585],

1	References	NNS	O	reference	_	0	SENT_294	[p12l6t3699r373b3753],

1	Ohe	NNP	O	Ohe	nn	2	SENT_295	[p13l135t78r236b122],
2	Y	NN	O	y	_	0	SENT_295	[p13l251t81r293b128],
3	,	,	O	,	_	0	SENT_295	[p13l251t81r293b128],
4	Ohashi	NNP	PERSON	Ohashi	nn	5	SENT_295	[p13l311t78r488b122],
5	Y	NN	PERSON	y	appos	2	SENT_295	[p13l504t81r545b128],
6	,	,	O	,	_	0	SENT_295	[p13l504t81r545b128],
7	Kubota	NNP	ORGANIZATION	Kubota	nn	8	SENT_295	[p13l564t78r744b122],
8	K	NNP	ORGANIZATION	K	appos	5	SENT_295	[p13l761t81r806b128],
9	,	,	O	,	_	0	SENT_295	[p13l761t81r806b128],
10	Tamura	NNP	ORGANIZATION	Tamura	nn	11	SENT_295	[p13l822t81r1017b122],
11	T	NN	ORGANIZATION	t	appos	5	SENT_295	[p13l1032t81r1071b128],
12	,	,	O	,	_	0	SENT_295	[p13l1032t81r1071b128],
13	Nakagawa	NNP	PERSON	Nakagawa	nn	14	SENT_295	[p13l1090t78r1352b132],
14	K	NNP	PERSON	K	appos	5	SENT_295	[p13l1369t81r1414b128],
15	,	,	O	,	_	0	SENT_295	[p13l1369t81r1414b128],
16	Negoro	NNP	PERSON	Negoro	nn	17	SENT_295	[p13l1432t81r1616b132],
17	S	NNP	O	S	appos	5	SENT_295	[p13l1634t80r1672b128],
18	,	,	O	,	_	0	SENT_295	[p13l1634t80r1672b128],
19	et	FW	O	et	nn	20	SENT_295	[p13l1690t84r1738b122],
20	al.	FW	O	al.	appos	5	SENT_295	[p13l1754t78r1809b122],
21	.	.	O	.	_	0	SENT_295	[p13l1754t78r1809b122],

1	Randomized	VBN	O	randomize	_	0	SENT_296	[p13l1827t78r2150b122],
2	phase	NN	O	phase	nn	4	SENT_296	[p13l135t143r284b198],
3	III	CD	NUMBER	iii	num	4	SENT_296	[p13l318t146r366b187],
4	study	NN	O	study	dobj	1	SENT_296	[p13l401t143r543b198],
5	of	IN	O	of	_	0	SENT_296	[p13l575t143r628b187],
6	cisplatin	NN	O	cisplatin	prep_of	4	SENT_296	[p13l656t143r874b198],
7	plus	CC	O	plus	_	0	SENT_296	[p13l908t143r1013b198],
8	irinotecan	NN	O	irinotecan	dobj	1	SENT_296	[p13l1048t144r1308b187],
9	versus	CC	O	versus	prep	8	SENT_296	[p13l1340t156r1505b187],
10	carboplatin	NN	O	carboplatin	dep	9	SENT_296	[p13l1539t143r1833b198],
11	plus	CC	O	plus	_	0	SENT_296	[p13l1867t143r1972b198],
12	paclitaxel	NN	O	paclitaxel	dep	9	SENT_296	[p13l2007t143r2150b198, p13l135t210r271b260],
13	,	,	O	,	_	0	SENT_296	[p13l2007t143r2150b198, p13l135t210r271b260],
14	cisplatin	NN	O	cisplatin	conj_plus	10	SENT_296	[p13l294t210r512b264],
15	plus	CC	O	plus	_	0	SENT_296	[p13l535t210r640b264],
16	gemcitabine	NN	O	gemcitabine	conj_plus	10	SENT_296	[p13l661t210r992b264],
17	,	,	O	,	_	0	SENT_296	[p13l661t210r992b264],
18	and	CC	O	and	_	0	SENT_296	[p13l1015t210r1108b253],
19	cisplatin	NN	O	cisplatin	conj_and	4	SENT_296	[p13l1130t210r1349b264],
20	plus	CC	O	plus	prep	19	SENT_296	[p13l1371t210r1476b264],
21	vinorelbine	NN	O	vinorelbine	dep	20	SENT_296	[p13l1498t210r1793b253],
22	for	IN	O	for	_	0	SENT_296	[p13l1815t210r1887b253],
23	advanced	JJ	O	advanced	amod	28	SENT_296	[p13l1907t210r2150b253],
24	non	JJ	O	non	amod	28	SENT_296	[p13l135t276r510b320],
25	—	NN	O	—	nn	28	SENT_296	[p13l135t276r510b320],
26	small-cell	NN	O	small-cell	nn	28	SENT_296	[p13l135t276r510b320],
27	lung	NN	O	lung	nn	28	SENT_296	[p13l532t276r646b331],
28	cancer	NN	O	cancer	prep_for	21	SENT_296	[p13l665t289r848b320],
29	:	:	O	:	_	0	SENT_296	[p13l665t289r848b320],
30	Four-Arm	NN	O	four-arm	nn	32	SENT_296	[p13l873t278r1121b320],
31	Cooperative	NNP	O	Cooperative	nn	32	SENT_296	[p13l1142t277r1448b331],
32	Study	NNP	O	Study	dep	19	SENT_296	[p13l1470t276r1616b331],
33	in	IN	O	in	_	0	SENT_296	[p13l1636t277r1684b319],
34	Japan	NNP	LOCATION	Japan	prep_in	32	SENT_296	[p13l1698t279r1858b331],
35	.	.	O	.	_	0	SENT_296	[p13l1698t279r1858b331],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_297	[p13l1878t278r1983b319],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_297	[p13l2003t276r2150b320],
3	2007	CD	DATE	2007	num	2	SENT_297	[p13l135t344r566b392],
4	;	:	O	;	_	0	SENT_297	[p13l135t344r566b392],
5	18:317	CD	NUMBER	18:317	number	6	SENT_297	[p13l135t344r566b392],
6	—	CD	NUMBER	—	dep	2	SENT_297	[p13l135t344r566b392],
7	23	CD	NUMBER	23	dep	6	SENT_297	[p13l135t344r566b392],
8	.	.	O	.	_	0	SENT_297	[p13l135t344r566b392],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_298	[p13l135t411r250b452],
2	JG	NNP	O	JG	_	0	SENT_298	[p13l264t410r337b462],
3	,	,	O	,	_	0	SENT_298	[p13l264t410r337b462],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_298	[p13l351t411r499b462],
5	PA	NN	PERSON	pa	appos	2	SENT_298	[p13l520t410r595b458],
6	,	,	O	,	_	0	SENT_298	[p13l520t410r595b458],
7	Lee	NNP	PERSON	Lee	nn	9	SENT_298	[p13l617t411r700b452],
8	]	CD	NUMBER	]	num	9	SENT_298	[p13l714t410r781b462],
9	C	NN	O	c	appos	5	SENT_298	[p13l714t410r781b462],
10	,	,	O	,	_	0	SENT_298	[p13l714t410r781b462],
11	Tracy	NNP	PERSON	Tracy	nn	12	SENT_298	[p13l800t411r940b462],
12	S	NNP	PERSON	S	appos	5	SENT_298	[p13l959t410r997b458],
13	,	,	O	,	_	0	SENT_298	[p13l959t410r997b458],
14	Greulich	NNP	PERSON	Greulich	nn	15	SENT_298	[p13l1018t408r1236b452],
15	H	NNP	PERSON	H	appos	5	SENT_298	[p13l1256t411r1306b458],
16	,	,	O	,	_	0	SENT_298	[p13l1256t411r1306b458],
17	Gabriel	NNP	PERSON	Gabriel	nn	18	SENT_298	[p13l1328t408r1512b452],
18	S	NNP	PERSON	S	appos	5	SENT_298	[p13l1533t410r1571b458],
19	,	,	O	,	_	0	SENT_298	[p13l1533t410r1571b458],
20	et	FW	O	et	nn	21	SENT_298	[p13l1592t414r1640b452],
21	al.	FW	O	al.	appos	5	SENT_298	[p13l1659t408r1714b452],
22	.	.	O	.	_	0	SENT_298	[p13l1659t408r1714b452],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_299	[p13l1735t410r1870b452],
2	mutations	NNS	O	mutation	_	0	SENT_299	[p13l1887t409r2150b452],
3	in	IN	O	in	_	0	SENT_299	[p13l135t474r183b517],
4	lung	NN	O	lung	nn	5	SENT_299	[p13l202t473r316b528],
5	cancer	NN	O	cancer	prep_in	2	SENT_299	[p13l334t486r517b517],
6	:	:	O	:	_	0	SENT_299	[p13l334t486r517b517],
7	correlation	NN	O	correlation	dep	2	SENT_299	[p13l541t473r823b517],
8	with	IN	O	with	_	0	SENT_299	[p13l841t473r960b517],
9	clinical	JJ	O	clinical	amod	10	SENT_299	[p13l979t473r1161b517],
10	response	NN	O	response	prep_with	7	SENT_299	[p13l1181t486r1410b528],
11	to	TO	O	to	_	0	SENT_299	[p13l1430t480r1479b517],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_299	[p13l1498t473r1712b528],
13	therapy	NN	O	therapy	prep_to	10	SENT_299	[p13l1731t474r1939b528],
14	.	.	O	.	_	0	SENT_299	[p13l1731t474r1939b528],

1	Science	NNP	O	Science	_	0	SENT_300	[p13l1960t474r2150b517],
2	2004	CD	DATE	2004	num	1	SENT_300	[p13l135t542r677b590],
3	;	:	O	;	_	0	SENT_300	[p13l135t542r677b590],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_300	[p13l135t542r677b590],
5	—	CD	NUMBER	—	dep	1	SENT_300	[p13l135t542r677b590],
6	500	CD	NUMBER	500	dep	5	SENT_300	[p13l135t542r677b590],
7	.	.	O	.	_	0	SENT_300	[p13l135t542r677b590],

1	Pao	NNP	O	Pao	nn	2	SENT_301	[p13l135t609r224b650],
2	W	NNP	O	W	_	0	SENT_301	[p13l242t609r308b656],
3	,	,	O	,	_	0	SENT_301	[p13l242t609r308b656],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_301	[p13l329t606r484b650],
5	V	NNP	O	V	appos	2	SENT_301	[p13l499t609r548b657],
6	,	,	O	,	_	0	SENT_301	[p13l499t609r548b657],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_301	[p13l567t606r809b650],
8	M	NNP	O	M	appos	5	SENT_301	[p13l829t609r891b657],
9	,	,	O	,	_	0	SENT_301	[p13l829t609r891b657],
10	Doherty	NNP	PERSON	Doherty	nn	11	SENT_301	[p13l911t606r1121b661],
11	J	NNP	PERSON	J	appos	5	SENT_301	[p13l1133t609r1166b661],
12	,	,	O	,	_	0	SENT_301	[p13l1133t609r1166b661],
13	Politi	NNP	PERSON	Politi	nn	14	SENT_301	[p13l1186t606r1317b650],
14	K	NNP	PERSON	K	appos	5	SENT_301	[p13l1338t609r1383b656],
15	,	,	O	,	_	0	SENT_301	[p13l1338t609r1383b656],
16	Sarkaria	NNP	O	Sarkaria	appos	5	SENT_301	[p13l1403t606r1612b650],
17	I	PRP	O	I	dep	16	SENT_301	[p13l1632t609r1658b657],
18	,	,	O	,	_	0	SENT_301	[p13l1632t609r1658b657],
19	et	FW	O	et	nn	20	SENT_301	[p13l1678t613r1726b650],
20	al.	FW	O	al.	appos	5	SENT_301	[p13l1744t606r1799b650],
21	.	.	O	.	_	0	SENT_301	[p13l1744t606r1799b650],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_302	[p13l1820t608r1918b650],
2	receptor	NN	O	receptor	nn	4	SENT_302	[p13l1936t613r2152b661],
3	gene	NN	O	gene	nn	4	SENT_302	[p13l134t684r255b726],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_302	[p13l281t672r543b715],
5	are	VBP	O	be	cop	6	SENT_302	[p13l568t684r646b715],
6	common	JJ	O	common	_	0	SENT_302	[p13l671t684r899b715],
7	in	IN	O	in	_	0	SENT_302	[p13l924t672r971b715],
8	lung	NN	O	lung	nn	9	SENT_302	[p13l996t672r1109b726],
9	cancers	NNS	O	cancer	prep_in	6	SENT_302	[p13l1133t684r1325b715],
10	from	IN	O	from	_	0	SENT_302	[p13l1351t672r1473b715],
11	“	CD	NUMBER	“	prep_from	9	SENT_302	[p13l1498t674r1667b715],
12	never	RB	O	never	advmod	9	SENT_302	[p13l1498t674r1667b715],
13	smokers	NNS	O	smoker	dep	9	SENT_302	[p13l1690t672r1928b715],
14	”	CD	NUMBER	”	tmod	6	SENT_302	[p13l1690t672r1928b715],
15	and	CC	O	and	_	0	SENT_302	[p13l1954t672r2047b715],
16	are	VBP	O	be	auxpass	17	SENT_302	[p13l2073t684r2150b715],
17	associated	VBN	O	associate	conj_and	6	SENT_302	[p13l135t738r401b782],
18	with	IN	O	with	_	0	SENT_302	[p13l419t738r538b782],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_302	[p13l558t739r823b792],
20	of	IN	O	of	_	0	SENT_302	[p13l841t738r894b782],
21	tumors	NNS	O	tumor	prep_of	19	SENT_302	[p13l906t744r1091b782],
22	to	TO	O	to	_	0	SENT_302	[p13l1110t744r1159b782],
23	geﬁtinib	NN	O	geﬁtinib	prep_to	17	SENT_302	[p13l1177t738r1392b792],
24	and	CC	O	and	_	0	SENT_302	[p13l1411t738r1504b782],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_302	[p13l1524t738r1756b782],
26	.	.	O	.	_	0	SENT_302	[p13l1524t738r1756b782],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_303	[p13l1776t741r1886b782],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_303	[p13l1904t738r2008b782],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_303	[p13l2025t738r2150b782],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_303	[p13l135t804r205b847],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_303	[p13l223t806r329b847],
6	2004	CD	DATE	2004	num	5	SENT_303	[p13l345t806r581b854],
7	;	:	O	;	_	0	SENT_303	[p13l345t806r581b854],
8	101 213306	CD	NUMBER	101 213306	number	9	SENT_303	[p13l595t806r868b848],[p13l345t806r581b854],
9	-11	CD	NUMBER	-11	dep	5	SENT_303	[p13l595t806r868b848],
10	.	.	O	.	_	0	SENT_303	[p13l595t806r868b848],

1	Lynch	NNP	PERSON	Lynch	_	0	SENT_304	[p13l135t870r284b924],
2	T	NN	O	t	nn	3	SENT_304	[p13l301t873r362b924],
3	]	NN	O	]	dep	1	SENT_304	[p13l301t873r362b924],
4	,	,	O	,	_	0	SENT_304	[p13l301t873r362b924],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_304	[p13l382t870r475b914],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_304	[p13l495t873r598b920],
7	,	,	O	,	_	0	SENT_304	[p13l495t873r598b920],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_304	[p13l618t870r826b914],
9	R	NNP	PERSON	R	appos	3	SENT_304	[p13l845t873r888b920],
10	,	,	O	,	_	0	SENT_304	[p13l845t873r888b920],
11	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	12	SENT_304	[p13l908t870r1351b924],
12	S	NNP	LOCATION	S	appos	3	SENT_304	[p13l1370t872r1409b920],
13	,	,	O	,	_	0	SENT_304	[p13l1370t872r1409b920],
14	Okimoto	NNP	PERSON	Okimoto	nn	15	SENT_304	[p13l1429t870r1650b914],
15	RA	NN	O	ra	appos	3	SENT_304	[p13l1669t872r1752b920],
16	,	,	O	,	_	0	SENT_304	[p13l1669t872r1752b920],
17	Brannigan	NNP	PERSON	Brannigan	nn	18	SENT_304	[p13l1772t871r2034b924],
18	BW	NN	O	bw	appos	3	SENT_304	[p13l2053t873r2150b920],
19	,	,	O	,	_	0	SENT_304	[p13l2053t873r2150b920],
20	et	FW	O	et	nn	21	SENT_304	[p13l135t942r183b979],
21	al.	FW	O	al.	appos	3	SENT_304	[p13l205t936r260b979],
22	.	.	O	.	_	0	SENT_304	[p13l205t936r260b979],

1	Activating	VBG	O	activate	amod	2	SENT_305	[p13l282t936r544b990],
2	mutations	NNS	O	mutation	_	0	SENT_305	[p13l567t936r829b979],
3	in	IN	O	in	_	0	SENT_305	[p13l853t936r901b979],
4	the	DT	O	the	det	7	SENT_305	[p13l923t935r1005b979],
5	epidermal	JJ	O	epidermal	amod	7	SENT_305	[p13l1028t935r1291b990],
6	growth	NN	O	growth	nn	7	SENT_305	[p13l1313t936r1499b990],
7	factor	NN	O	factor	prep_in	2	SENT_305	[p13l1522t935r1671b979],
8	receptor	NN	O	receptor	nn	10	SENT_305	[p13l1693t942r1909b990],
9	underlying	VBG	O	underlie	amod	10	SENT_305	[p13l1930t935r2150b990, p13l135t1003r215b1056],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_305	[p13l241t1003r629b1056],
11	of	IN	O	of	_	0	SENT_305	[p13l657t1002r710b1045],
12	non	JJ	O	non	amod	16	SENT_305	[p13l731t1002r1106b1045],
13	—	JJ	O	—	amod	16	SENT_305	[p13l731t1002r1106b1045],
14	small-cell	NN	O	small-cell	nn	16	SENT_305	[p13l731t1002r1106b1045],
15	lung	NN	O	lung	nn	16	SENT_305	[p13l1133t1002r1247b1056],
16	cancer	NN	O	cancer	prep_of	10	SENT_305	[p13l1272t1014r1441b1045],
17	to	TO	O	to	_	0	SENT_305	[p13l1466t1008r1515b1045],
18	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_305	[p13l1541t1002r1768b1056],
19	.	.	O	.	_	0	SENT_305	[p13l1541t1002r1768b1056],

1	N	NN	O	n	nn	3	SENT_306	[p13l1796t1005r1833b1045],
2	Engl	NNP	O	Engl	nn	3	SENT_306	[p13l1860t1002r2011b1056],
3	]	NNP	O	]	nsubj	4	SENT_306	[p13l1860t1002r2011b1056],
4	Med	VBD	O	med	_	0	SENT_306	[p13l2038t1002r2150b1045],
5	2004	CD	DATE	2004	dobj	4	SENT_306	[p13l135t1070r640b1118],
6	;	:	O	;	_	0	SENT_306	[p13l135t1070r640b1118],
7	350:2129	CD	NUMBER	350:2129	number	8	SENT_306	[p13l135t1070r640b1118],
8	—	CD	NUMBER	—	dep	5	SENT_306	[p13l135t1070r640b1118],
9	39	CD	NUMBER	39	dep	8	SENT_306	[p13l135t1070r640b1118],
10	.	.	O	.	_	0	SENT_306	[p13l135t1070r640b1118],

1	Tokumo	NNP	O	Tokumo	nn	2	SENT_307	[p13l133t1134r342b1177],
2	M	NNP	O	M	_	0	SENT_307	[p13l382t1136r444b1184],
3	,	,	O	,	_	0	SENT_307	[p13l382t1136r444b1184],
4	Toyooka	NNP	PERSON	Toyooka	nn	5	SENT_307	[p13l481t1134r695b1188],
5	S	NNP	PERSON	S	appos	2	SENT_307	[p13l735t1136r773b1184],
6	,	,	O	,	_	0	SENT_307	[p13l735t1136r773b1184],
7	Kiura	NNP	PERSON	Kiura	nn	8	SENT_307	[p13l814t1134r949b1177],
8	K	NNP	PERSON	K	appos	5	SENT_307	[p13l989t1136r1034b1184],
9	,	,	O	,	_	0	SENT_307	[p13l989t1136r1034b1184],
10	Shigematsu	NNP	PERSON	Shigematsu	nn	11	SENT_307	[p13l1074t1134r1374b1188],
11	H	NNP	PERSON	H	appos	5	SENT_307	[p13l1414t1136r1464b1184],
12	,	,	O	,	_	0	SENT_307	[p13l1414t1136r1464b1184],
13	Tomii	NNP	PERSON	Tomii	nn	14	SENT_307	[p13l1502t1134r1647b1177],
14	K	NNP	PERSON	K	appos	5	SENT_307	[p13l1688t1136r1732b1184],
15	,	,	O	,	_	0	SENT_307	[p13l1688t1136r1732b1184],
16	Aoe	NNP	O	Aoe	nn	17	SENT_307	[p13l1771t1136r1867b1177],
17	M	NNP	O	M	appos	5	SENT_307	[p13l1907t1136r1968b1184],
18	,	,	O	,	_	0	SENT_307	[p13l1907t1136r1968b1184],
19	et	FW	O	et	nn	20	SENT_307	[p13l2009t1140r2057b1177],
20	al.	FW	O	al.	appos	5	SENT_307	[p13l2095t1134r2150b1178],
21	.	.	O	.	_	0	SENT_307	[p13l2095t1134r2150b1178],

1	The	DT	O	the	det	2	SENT_308	[p13l133t1200r227b1244],
2	relationship	NN	O	relationship	_	0	SENT_308	[p13l256t1200r565b1254],
3	between	IN	O	between	_	0	SENT_308	[p13l593t1200r816b1244],
4	epidermal	JJ	O	epidermal	amod	8	SENT_308	[p13l844t1200r1106b1254],
5	growth	NN	O	growth	nn	8	SENT_308	[p13l1133t1200r1320b1254],
6	factor	NN	O	factor	nn	8	SENT_308	[p13l1348t1200r1496b1244],
7	receptor	NN	O	receptor	nn	8	SENT_308	[p13l1523t1206r1739b1254],
8	mutations	NNS	O	mutation	prep_between	2	SENT_308	[p13l1766t1201r2028b1244],
9	and	CC	O	and	_	0	SENT_308	[p13l2057t1200r2150b1244],
10	clinicopathologic	JJ	O	clinicopathologic	amod	11	SENT_308	[p13l135t1265r579b1320],
11	features	NNS	O	feature	prep_between	2	SENT_308	[p13l611t1265r817b1309],
12	in	IN	O	in	_	0	SENT_308	[p13l851t1266r898b1309],
13	non-small	JJ	O	non-small	amod	16	SENT_308	[p13l931t1265r1191b1309],
14	cell	NN	O	cell	nn	16	SENT_308	[p13l1225t1265r1311b1309],
15	lung	NN	O	lung	nn	16	SENT_308	[p13l1344t1265r1457b1320],
16	cancers	NNS	O	cancer	prep_in	2	SENT_308	[p13l1489t1278r1694b1309],
17	.	.	O	.	_	0	SENT_308	[p13l1489t1278r1694b1309],

1	Clin	NNP	O	Clin	nn	3	SENT_309	[p13l1728t1265r1827b1309],
2	Cancer	NNP	O	Cancer	nn	3	SENT_309	[p13l1859t1268r2035b1309],
3	Res	NNP	O	Res	_	0	SENT_309	[p13l2066t1268r2150b1309],
4	2005	CD	DATE	2005	num	3	SENT_309	[p13l135t1334r594b1382],
5	;	:	O	;	_	0	SENT_309	[p13l135t1334r594b1382],
6	11:1167	CD	NUMBER	11:1167	number	7	SENT_309	[p13l135t1334r594b1382],
7	—	CD	NUMBER	—	dep	3	SENT_309	[p13l135t1334r594b1382],
8	73	CD	NUMBER	73	dep	7	SENT_309	[p13l135t1334r594b1382],
9	.	.	O	.	_	0	SENT_309	[p13l135t1334r594b1382],

1	Mitsudomi	JJ	ORGANIZATION	mitsudomi	amod	2	SENT_310	[p13l135t1398r417b1442],
2	T	NN	ORGANIZATION	t	_	0	SENT_310	[p13l432t1401r471b1448],
3	,	,	O	,	_	0	SENT_310	[p13l432t1401r471b1448],
4	Kosaka	NNP	PERSON	Kosaka	nn	5	SENT_310	[p13l489t1398r668b1442],
5	T	NN	PERSON	t	appos	2	SENT_310	[p13l682t1401r721b1448],
6	,	,	O	,	_	0	SENT_310	[p13l682t1401r721b1448],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_310	[p13l739t1398r902b1442],
8	H	NN	PERSON	h	appos	5	SENT_310	[p13l919t1401r969b1449],
9	,	,	O	,	_	0	SENT_310	[p13l919t1401r969b1449],
10	Horio	NNP	ORGANIZATION	Horio	nn	11	SENT_310	[p13l987t1399r1130b1442],
11	Y	NN	ORGANIZATION	y	appos	5	SENT_310	[p13l1145t1401r1187b1448],
12	,	,	O	,	_	0	SENT_310	[p13l1145t1401r1187b1448],
13	Hida	NN	LOCATION	hida	nn	14	SENT_310	[p13l1205t1398r1323b1442],
14	T	NN	LOCATION	t	appos	5	SENT_310	[p13l1337t1401r1377b1448],
15	,	,	O	,	_	0	SENT_310	[p13l1337t1401r1377b1448],
16	Mori	NNP	LOCATION	Mori	nn	17	SENT_310	[p13l1394t1399r1515b1442],
17	S	NNP	LOCATION	S	appos	5	SENT_310	[p13l1533t1400r1571b1448],
18	,	,	O	,	_	0	SENT_310	[p13l1533t1400r1571b1448],
19	et	FW	O	et	nn	20	SENT_310	[p13l1589t1405r1637b1442],
20	al.	FW	O	al.	appos	5	SENT_310	[p13l1652t1398r1707b1442],
21	.	.	O	.	_	0	SENT_310	[p13l1652t1398r1707b1442],

1	Mutations	NNS	O	mutation	nsubj	9	SENT_311	[p13l1725t1399r1987b1442],
2	of	IN	O	of	_	0	SENT_311	[p13l2005t1398r2059b1442],
3	the	DT	O	the	det	8	SENT_311	[p13l2069t1398r2150b1442],
4	epidermal	JJ	O	epidermal	amod	8	SENT_311	[p13l135t1464r397b1518],
5	growth	NN	O	growth	nn	8	SENT_311	[p13l420t1464r606b1518],
6	factor	NN	O	factor	nn	8	SENT_311	[p13l629t1463r777b1507],
7	receptor	NN	O	receptor	nn	8	SENT_311	[p13l799t1470r1015b1518],
8	gene	NN	O	gene	prep_of	1	SENT_311	[p13l1035t1476r1156b1518],
9	predict	VBP	O	predict	_	0	SENT_311	[p13l1180t1464r1363b1518],
10	prolonged	JJ	O	prolonged	amod	11	SENT_311	[p13l1385t1464r1647b1518],
11	survival	NN	O	survival	dobj	9	SENT_311	[p13l1670t1464r1871b1507],
12	after	IN	O	after	prep	11	SENT_311	[p13l1894t1464r2015b1507],
13	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_311	[p13l2035t1463r2150b1518, p13l135t1530r254b1574],
14	treatment	NN	O	treatment	dep	22	SENT_311	[p13l269t1537r529b1574],
15	in	IN	O	in	_	0	SENT_311	[p13l543t1531r591b1573],
16	patients	NNS	O	patient	prep_in	14	SENT_311	[p13l606t1531r813b1585],
17	with	IN	O	with	_	0	SENT_311	[p13l829t1530r948b1574],
18	non	JJ	O	non	amod	20	SENT_311	[p13l963t1530r1338b1574],
19	—	JJ	O	—	amod	20	SENT_311	[p13l963t1530r1338b1574],
20	small-cell	NN	O	small-cell	prep_with	16	SENT_311	[p13l963t1530r1338b1574],
21	lung	NN	O	lung	nn	22	SENT_311	[p13l1355t1530r1468b1585],
22	cancer	NN	O	cancer	dep	12	SENT_311	[p13l1482t1543r1652b1574],
23	with	IN	O	with	_	0	SENT_311	[p13l1664t1530r1783b1574],
24	postoperative	JJ	O	postoperative	amod	25	SENT_311	[p13l1799t1531r2150b1585],
25	recurrence	NN	O	recurrence	prep_with	22	SENT_311	[p13l136t1598r457b1650],
26	.	.	O	.	_	0	SENT_311	[p13l136t1598r457b1650],
27	]	SYM	O	]	dep	11	SENT_311	[p13l136t1598r457b1650],

1	Clin	NNP	O	Clin	nn	2	SENT_312	[p13l475t1596r574b1639],
2	Oncol	NNP	O	Oncol	_	0	SENT_312	[p13l592t1596r739b1639],
3	2005	CD	DATE	2005	num	2	SENT_312	[p13l757t1598r1228b1646],
4	;	:	O	;	_	0	SENT_312	[p13l757t1598r1228b1646],
5	23:2513	CD	NUMBER	23:2513	number	6	SENT_312	[p13l757t1598r1228b1646],
6	—	CD	NUMBER	—	dep	2	SENT_312	[p13l757t1598r1228b1646],
7	20	CD	NUMBER	20	dep	6	SENT_312	[p13l757t1598r1228b1646],
8	.	.	O	.	_	0	SENT_312	[p13l757t1598r1228b1646],

1	Chou	NNP	PERSON	Chou	nn	2	SENT_313	[p13l135t1662r266b1706],
2	TY	NNP	PERSON	TY	_	0	SENT_313	[p13l287t1665r363b1712],
3	,	,	O	,	_	0	SENT_313	[p13l287t1665r363b1712],
4	Chiu	NNP	PERSON	Chiu	nn	5	SENT_313	[p13l387t1662r502b1706],
5	CH	NN	O	ch	appos	2	SENT_313	[p13l526t1664r611b1712],
6	,	,	O	,	_	0	SENT_313	[p13l526t1664r611b1712],
7	Li	NNP	PERSON	Li	nn	8	SENT_313	[p13l635t1663r676b1705],
8	LH	NNP	PERSON	LH	appos	5	SENT_313	[p13l700t1665r778b1712],
9	,	,	O	,	_	0	SENT_313	[p13l700t1665r778b1712],
10	Hsiao	NNP	O	Hsiao	nn	11	SENT_313	[p13l803t1663r945b1706],
11	CY	NNP	O	CY	appos	5	SENT_313	[p13l968t1664r1042b1712],
12	,	,	O	,	_	0	SENT_313	[p13l968t1664r1042b1712],
13	Tzen	NNP	PERSON	Tzen	nn	14	SENT_313	[p13l1063t1665r1187b1706],
14	CY	NNP	O	CY	appos	5	SENT_313	[p13l1210t1664r1283b1712],
15	,	,	O	,	_	0	SENT_313	[p13l1210t1664r1283b1712],
16	Chang	NNP	PERSON	Chang	nn	17	SENT_313	[p13l1307t1662r1467b1716],
17	KT	NNP	O	KT	appos	5	SENT_313	[p13l1490t1665r1564b1712],
18	,	,	O	,	_	0	SENT_313	[p13l1490t1665r1564b1712],
19	et	FW	O	et	nn	20	SENT_313	[p13l1588t1668r1636b1706],
20	al.	FW	O	al.	appos	5	SENT_313	[p13l1658t1662r1713b1706],
21	.	.	O	.	_	0	SENT_313	[p13l1658t1662r1713b1706],

1	Mutation	NN	O	mutation	nsubj	17	SENT_314	[p13l1737t1663r1976b1706],
2	in	IN	O	in	_	0	SENT_314	[p13l1999t1663r2046b1705],
3	the	DT	O	the	det	6	SENT_314	[p13l2069t1662r2150b1706],
4	tyrosine	NN	O	tyrosine	nn	6	SENT_314	[p13l135t1728r344b1782],
5	kinase	NN	O	kinase	nn	6	SENT_314	[p13l361t1728r524b1771],
6	domain	NN	O	domain	prep_in	1	SENT_314	[p13l540t1727r736b1771],
7	of	IN	O	of	_	0	SENT_314	[p13l751t1727r805b1771],
8	epidermal	JJ	O	epidermal	amod	11	SENT_314	[p13l815t1727r1077b1782],
9	growth	NN	O	growth	nn	11	SENT_314	[p13l1092t1727r1278b1782],
10	factor	NN	O	factor	nn	11	SENT_314	[p13l1294t1727r1443b1771],
11	receptor	NN	O	receptor	prep_of	6	SENT_314	[p13l1457t1734r1673b1782],
12	is	VBZ	O	be	cop	17	SENT_314	[p13l1688t1728r1725b1771],
13	a	DT	O	a	det	17	SENT_314	[p13l1741t1740r1768b1771],
14	predictive	JJ	O	predictive	amod	17	SENT_314	[p13l1783t1727r2041b1782],
15	and	CC	O	and	_	0	SENT_314	[p13l2057t1727r2150b1771],
16	prognostic	JJ	O	prognostic	conj_and	14	SENT_314	[p13l135t1795r408b1848],
17	factor	NN	O	factor	_	0	SENT_314	[p13l430t1794r578b1837],
18	for	IN	O	for	_	0	SENT_314	[p13l598t1794r671b1837],
19	geﬁtinib	NN	O	geﬁtinib	nn	20	SENT_314	[p13l690t1794r905b1848],
20	treatment	NN	O	treatment	prep_for	17	SENT_314	[p13l926t1800r1186b1837],
21	in	IN	O	in	_	0	SENT_314	[p13l1207t1795r1254b1837],
22	patients	NNS	O	patient	prep_in	20	SENT_314	[p13l1276t1795r1484b1848],
23	with	IN	O	with	_	0	SENT_314	[p13l1505t1794r1624b1837],
24	non-small	JJ	O	non-small	amod	27	SENT_314	[p13l1646t1794r1907b1837],
25	cell	NN	O	cell	nn	27	SENT_314	[p13l1929t1794r2016b1837],
26	lung	NN	O	lung	nn	27	SENT_314	[p13l2039t1794r2152b1848],
27	cancer	NN	O	cancer	prep_with	22	SENT_314	[p13l135t1873r312b1904],
28	.	.	O	.	_	0	SENT_314	[p13l135t1873r312b1904],

1	Clin	NNP	O	Clin	nn	3	SENT_315	[p13l331t1860r430b1904],
2	Cancer	NNP	O	Cancer	nn	3	SENT_315	[p13l448t1862r624b1904],
3	Res	NNP	O	Res	_	0	SENT_315	[p13l640t1863r724b1904],
4	2005	CD	DATE	2005	num	3	SENT_315	[p13l743t1862r1175b1911],
5	;	:	O	;	_	0	SENT_315	[p13l743t1862r1175b1911],
6	11:3750	CD	NUMBER	11:3750	num	7	SENT_315	[p13l743t1862r1175b1911],
7	—	NN	O	—	dep	3	SENT_315	[p13l743t1862r1175b1911],
8	7	CD	NUMBER	7	dep	7	SENT_315	[p13l743t1862r1175b1911],
9	.	.	O	.	_	0	SENT_315	[p13l743t1862r1175b1911],

1	Uramoto	NNP	O	Uramoto	nn	2	SENT_316	[p13l134t1928r358b1969],
2	H	NNP	O	H	_	0	SENT_316	[p13l377t1928r427b1976],
3	,	,	O	,	_	0	SENT_316	[p13l377t1928r427b1976],
4	Sugio	NNP	ORGANIZATION	Sugio	nn	5	SENT_316	[p13l446t1926r585b1980],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_316	[p13l603t1928r649b1976],
6	,	,	O	,	_	0	SENT_316	[p13l603t1928r649b1976],
7	Oyama	NNP	PERSON	Oyama	nn	8	SENT_316	[p13l667t1928r845b1980],
8	T	NN	O	t	appos	5	SENT_316	[p13l860t1928r899b1976],
9	,	,	O	,	_	0	SENT_316	[p13l860t1928r899b1976],
10	Ono	NNP	PERSON	Ono	nn	11	SENT_316	[p13l918t1928r1020b1969],
11	K	NNP	PERSON	K	appos	5	SENT_316	[p13l1039t1928r1083b1976],
12	,	,	O	,	_	0	SENT_316	[p13l1039t1928r1083b1976],
13	Sugaya	NNP	ORGANIZATION	Sugaya	nn	14	SENT_316	[p13l1102t1928r1280b1980],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_316	[p13l1298t1928r1359b1976],
15	,	,	O	,	_	0	SENT_316	[p13l1298t1928r1359b1976],
16	Yoshimatsu	NNP	PERSON	Yoshimatsu	nn	17	SENT_316	[p13l1375t1926r1676b1969],
17	T	NN	PERSON	t	appos	5	SENT_316	[p13l1691t1928r1730b1976],
18	,	,	O	,	_	0	SENT_316	[p13l1691t1928r1730b1976],
19	et	FW	O	et	nn	20	SENT_316	[p13l1748t1932r1796b1969],
20	al.	FW	O	al.	appos	5	SENT_316	[p13l1812t1926r1868b1970],
21	.	.	O	.	_	0	SENT_316	[p13l1812t1926r1868b1970],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_317	[p13l1886t1926r2150b1980],
2	growth	NN	O	growth	nn	5	SENT_317	[p13l134t1992r320b2046],
3	factor	NN	O	factor	nn	5	SENT_317	[p13l345t1992r493b2036],
4	receptor	NN	O	receptor	nn	5	SENT_317	[p13l515t1998r731b2046],
5	mutations	NNS	O	mutation	nsubjpass	7	SENT_317	[p13l754t1993r1016b2036],
6	are	VBP	O	be	auxpass	7	SENT_317	[p13l1041t2005r1119b2036],
7	associated	VBN	O	associate	_	0	SENT_317	[p13l1143t1992r1410b2036],
8	with	IN	O	with	_	0	SENT_317	[p13l1433t1992r1552b2036],
9	geﬁtinib	NN	O	geﬁtinib	nn	10	SENT_317	[p13l1575t1992r1790b2046],
10	sensitivity	NN	O	sensitivity	prep_with	7	SENT_317	[p13l1814t1993r2080b2046],
11	in	IN	O	in	_	0	SENT_317	[p13l2104t1993r2151b2035],
12	non-small	JJ	O	non-small	amod	15	SENT_317	[p13l135t2057r396b2101],
13	cell	NN	O	cell	nn	15	SENT_317	[p13l415t2057r501b2101],
14	lung	NN	O	lung	nn	15	SENT_317	[p13l520t2058r633b2112],
15	cancer	NN	O	cancer	prep_in	7	SENT_317	[p13l650t2070r819b2101],
16	in	IN	O	in	_	0	SENT_317	[p13l836t2058r884b2101],
17	Japanese	JJ	MISC	japanese	prep_in	15	SENT_317	[p13l894t2060r1140b2112],
18	.	.	O	.	_	0	SENT_317	[p13l894t2060r1140b2112],

1	Lung	NN	O	lung	nn	2	SENT_318	[p13l1159t2060r1284b2112],
2	Cancer	NN	O	cancer	_	0	SENT_318	[p13l1301t2060r1476b2101],
3	2006	CD	DATE	2006	dep	2	SENT_318	[p13l1493t2060r1698b2108],
4	;	:	O	;	_	0	SENT_318	[p13l1493t2060r1698b2108],
5	51	CD	NUMBER	51	number	6	SENT_318	[p13l1493t2060r1698b2108],
6	:71	CD	NUMBER	:71	dep	2	SENT_318	[p13l1712t2060r1781b2101],
7	-7	CD	NUMBER	-7	dep	6	SENT_318	[p13l1793t2060r1862b2101],
8	.	.	O	.	_	0	SENT_318	[p13l1793t2060r1862b2101],

1	Sugio	NNP	O	Sugio	nn	2	SENT_319	[p13l135t2124r275b2178],
2	K	NNP	O	K	_	0	SENT_319	[p13l298t2127r344b2174],
3	,	,	O	,	_	0	SENT_319	[p13l298t2127r344b2174],
4	Uramoto	NNP	O	Uramoto	nn	5	SENT_319	[p13l367t2127r591b2167],
5	H	NNP	O	H	appos	2	SENT_319	[p13l615t2127r665b2174],
6	,	,	O	,	_	0	SENT_319	[p13l615t2127r665b2174],
7	Ono	NNP	PERSON	Ono	nn	8	SENT_319	[p13l690t2126r793b2167],
8	K	NNP	PERSON	K	appos	5	SENT_319	[p13l816t2127r861b2174],
9	,	,	O	,	_	0	SENT_319	[p13l816t2127r861b2174],
10	Oyama	NNP	ORGANIZATION	Oyama	nn	11	SENT_319	[p13l886t2126r1064b2178],
11	T	NN	ORGANIZATION	t	appos	5	SENT_319	[p13l1084t2126r1123b2174],
12	,	,	O	,	_	0	SENT_319	[p13l1084t2126r1123b2174],
13	Hanagiri	NN	ORGANIZATION	hanagirus	nn	14	SENT_319	[p13l1148t2125r1367b2178],
14	T	NN	ORGANIZATION	t	appos	5	SENT_319	[p13l1388t2127r1427b2174],
15	,	,	O	,	_	0	SENT_319	[p13l1388t2127r1427b2174],
16	Sugaya	NNP	PERSON	Sugaya	nn	17	SENT_319	[p13l1451t2126r1630b2178],
17	M	NNP	O	M	appos	5	SENT_319	[p13l1653t2127r1714b2174],
18	,	,	O	,	_	0	SENT_319	[p13l1653t2127r1714b2174],
19	et	FW	O	et	nn	20	SENT_319	[p13l1738t2130r1786b2167],
20	al.	FW	O	al.	appos	5	SENT_319	[p13l1808t2124r1863b2168],
21	.	.	O	.	_	0	SENT_319	[p13l1808t2124r1863b2168],

1	Mutations	NNS	O	mutation	nsubj	11	SENT_320	[p13l1887t2125r2150b2167],
2	within	IN	O	within	_	0	SENT_320	[p13l134t2190r304b2234],
3	the	DT	O	the	det	6	SENT_320	[p13l320t2190r402b2234],
4	tyrosine	NN	O	tyrosine	nn	6	SENT_320	[p13l418t2191r628b2245],
5	kinase	NN	O	kinase	nn	6	SENT_320	[p13l645t2190r808b2234],
6	domain	NN	O	domain	prep_within	1	SENT_320	[p13l825t2190r1021b2234],
7	of	IN	O	of	_	0	SENT_320	[p13l1037t2190r1090b2234],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_320	[p13l1101t2192r1235b2234],
9	gene	NN	O	gene	prep_of	6	SENT_320	[p13l1248t2203r1369b2245],
10	speciﬁcally	RB	O	speciﬁcally	advmod	11	SENT_320	[p13l1387t2190r1674b2245],
11	occur	VBP	O	occur	_	0	SENT_320	[p13l1689t2203r1830b2234],
12	in	IN	O	in	_	0	SENT_320	[p13l1845t2191r1893b2233],
13	lung	NN	O	lung	nn	15	SENT_320	[p13l1910t2190r2023b2245],
14	adenocarcinoma	NN	O	adenocarcinoma	nn	15	SENT_320	[p13l2038t2190r2150b2234, p13l136t2256r470b2299],
15	patients	NNS	O	patient	prep_in	11	SENT_320	[p13l496t2256r702b2310],
16	with	IN	O	with	_	0	SENT_320	[p13l728t2256r847b2299],
17	a	DT	O	a	det	19	SENT_320	[p13l872t2268r898b2299],
18	low	JJ	O	low	amod	19	SENT_320	[p13l924t2256r1018b2299],
19	exposure	NN	O	exposure	prep_with	11	SENT_320	[p13l1043t2268r1276b2310],
20	of	IN	O	of	_	0	SENT_320	[p13l1302t2255r1356b2299],
21	tobacco	NN	O	tobacco	nn	22	SENT_320	[p13l1375t2256r1572b2299],
22	smoking	NN	O	smoking	prep_of	19	SENT_320	[p13l1599t2256r1831b2310],
23	.	.	O	.	_	0	SENT_320	[p13l1599t2256r1831b2310],

1	Br	NN	O	br	_	0	SENT_321	[p13l1858t2258r1951b2310],
2	]	CD	NUMBER	]	num	1	SENT_321	[p13l1858t2258r1951b2310],
3	Cancer	NN	O	cancer	dep	1	SENT_321	[p13l1976t2258r2152b2299],
4	2006	CD	DATE	2006	num	3	SENT_321	[p13l135t2324r614b2372],
5	;	:	O	;	_	0	SENT_321	[p13l135t2324r614b2372],
6	94:896	CD	NUMBER	94:896	num	7	SENT_321	[p13l135t2324r614b2372],
7	-903	CD	NUMBER	-903	dep	1	SENT_321	[p13l135t2324r614b2372],
8	.	.	O	.	_	0	SENT_321	[p13l135t2324r614b2372],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_322	[p13l135t2388r298b2431],
2	R.	NNP	PERSON	R.	_	0	SENT_322	[p13l310t2390r353b2432],
3	Optimal	JJ	PERSON	optimal	amod	5	SENT_322	[p13l367t2388r573b2442],
4	two-stage	JJ	O	two-stage	amod	5	SENT_322	[p13l586t2394r842b2442],
5	designs	NNS	O	design	dep	2	SENT_322	[p13l855t2388r1047b2442],
6	for	IN	O	for	_	0	SENT_322	[p13l1061t2387r1133b2431],
7	phase	NN	O	phase	prep_for	5	SENT_322	[p13l1144t2388r1292b2442],
8	II	CD	NUMBER	ii	num	10	SENT_322	[p13l1305t2390r1336b2431],
9	clinical	JJ	O	clinical	amod	10	SENT_322	[p13l1349t2388r1531b2431],
10	trials	NNS	O	trial	dep	5	SENT_322	[p13l1543t2388r1685b2432],
11	.	.	O	.	_	0	SENT_322	[p13l1543t2388r1685b2432],

1	Control	NNP	O	Control	nn	3	SENT_323	[p13l1699t2388r1888b2431],
2	Clin	NNP	O	Clin	nn	3	SENT_323	[p13l1901t2388r2000b2431],
3	Trials	NNPS	O	Trials	_	0	SENT_323	[p13l2010t2388r2150b2431],
4	1989	CD	DATE	1989	dep	3	SENT_323	[p13l138t2456r501b2504],
5	;	:	O	;	_	0	SENT_323	[p13l138t2456r501b2504],
6	10:1	CD	NUMBER	10:1	number	7	SENT_323	[p13l138t2456r501b2504],
7	—	CD	NUMBER	—	dep	3	SENT_323	[p13l138t2456r501b2504],
8	10	CD	NUMBER	10	dep	7	SENT_323	[p13l138t2456r501b2504],
9	.	.	O	.	_	0	SENT_323	[p13l138t2456r501b2504],

1	Riely	NNP	PERSON	Riely	nn	3	SENT_324	[p13l135t2520r262b2574],
2	G	NNP	O	G	nn	3	SENT_324	[p13l273t2522r339b2574],
3	]	NNS	O	]	_	0	SENT_324	[p13l273t2522r339b2574],
4	,	,	O	,	_	0	SENT_324	[p13l273t2522r339b2574],
5	Politi	NNP	PERSON	Politi	nn	6	SENT_324	[p13l352t2519r484b2563],
6	KA	NN	O	ka	appos	3	SENT_324	[p13l497t2521r580b2570],
7	,	,	O	,	_	0	SENT_324	[p13l497t2521r580b2570],
8	Miller	NNP	ORGANIZATION	Miller	nn	9	SENT_324	[p13l593t2519r748b2563],
9	VA	NNP	ORGANIZATION	VA	appos	3	SENT_324	[p13l756t2521r843b2570],
10	,	,	O	,	_	0	SENT_324	[p13l756t2521r843b2570],
11	Pao	NNP	O	Pao	nn	13	SENT_324	[p13l857t2522r945b2563],
12	W.	NNP	O	W.	nn	13	SENT_324	[p13l955t2522r1022b2563],
13	Update	NNP	O	Update	appos	3	SENT_324	[p13l1034t2519r1218b2574],
14	on	IN	O	on	_	0	SENT_324	[p13l1230t2532r1293b2563],
15	epidermal	JJ	O	epidermal	amod	19	SENT_324	[p13l1305t2519r1567b2574],
16	growth	NN	O	growth	nn	19	SENT_324	[p13l1579t2520r1765b2574],
17	factor	NN	O	factor	nn	19	SENT_324	[p13l1777t2519r1926b2563],
18	receptor	NN	O	receptor	nn	19	SENT_324	[p13l1936t2526r2152b2574],
19	mutations	NNS	O	mutation	prep_on	13	SENT_324	[p13l135t2587r398b2629],
20	in	IN	O	in	_	0	SENT_324	[p13l417t2587r464b2629],
21	non-small	JJ	O	non-small	amod	24	SENT_324	[p13l482t2586r743b2629],
22	cell	NN	O	cell	nn	24	SENT_324	[p13l762t2586r848b2629],
23	lung	NN	O	lung	nn	24	SENT_324	[p13l867t2586r981b2640],
24	cancer	NN	O	cancer	prep_in	19	SENT_324	[p13l997t2598r1174b2630],
25	.	.	O	.	_	0	SENT_324	[p13l997t2598r1174b2630],

1	Clin	NNP	O	Clin	nn	3	SENT_325	[p13l1193t2586r1292b2629],
2	Cancer	NNP	O	Cancer	nn	3	SENT_325	[p13l1310t2588r1486b2629],
3	Res	NNP	O	Res	_	0	SENT_325	[p13l1502t2589r1586b2629],
4	2006	CD	DATE	2006	num	3	SENT_325	[p13l1605t2588r2071b2636],
5	;	:	O	;	_	0	SENT_325	[p13l1605t2588r2071b2636],
6	12:7232	CD	NUMBER	12:7232	number	7	SENT_325	[p13l1605t2588r2071b2636],
7	—	CD	NUMBER	—	dep	3	SENT_325	[p13l1605t2588r2071b2636],
8	41	CD	NUMBER	41	dep	7	SENT_325	[p13l1605t2588r2071b2636],
9	.	.	O	.	_	0	SENT_325	[p13l1605t2588r2071b2636],

1	Mitsudomi	JJ	ORGANIZATION	mitsudomi	amod	2	SENT_326	[p13l135t2652r417b2696],
2	T	NN	ORGANIZATION	t	_	0	SENT_326	[p13l430t2655r469b2702],
3	,	,	O	,	_	0	SENT_326	[p13l430t2655r469b2702],
4	Yatabe	NNP	PERSON	Yatabe	nn	6	SENT_326	[p13l482t2652r654b2696],
5	Y.	NNP	O	Y.	nn	6	SENT_326	[p13l668t2655r710b2696],
6	Mutations	NNS	O	mutation	appos	2	SENT_326	[p13l726t2653r988b2696],
7	of	IN	O	of	_	0	SENT_326	[p13l1004t2652r1058b2696],
8	the	DT	O	the	det	13	SENT_326	[p13l1065t2652r1147b2696],
9	epidermal	JJ	O	epidermal	amod	13	SENT_326	[p13l1162t2652r1424b2707],
10	growth	NN	O	growth	nn	13	SENT_326	[p13l1439t2652r1625b2707],
11	factor	NN	O	factor	nn	13	SENT_326	[p13l1640t2652r1788b2696],
12	receptor	NN	O	receptor	nn	13	SENT_326	[p13l1802t2659r2018b2707],
13	gene	NN	O	gene	prep_of	6	SENT_326	[p13l2030t2665r2150b2707],
14	and	CC	O	and	_	0	SENT_326	[p13l135t2718r228b2761],
15	related	JJ	O	related	amod	16	SENT_326	[p13l243t2718r421b2761],
16	genes	NNS	O	gene	conj_and	6	SENT_326	[p13l434t2730r580b2772],
17	as	IN	O	as	_	0	SENT_326	[p13l594t2730r644b2761],
18	determinants	NNS	O	determinant	prep_as	16	SENT_326	[p13l658t2718r1004b2761],
19	of	IN	O	of	_	0	SENT_326	[p13l1018t2717r1072b2761],
20	epidermal	JJ	O	epidermal	amod	27	SENT_326	[p13l1079t2718r1341b2772],
21	growth	NN	O	growth	nn	27	SENT_326	[p13l1354t2718r1540b2772],
22	factor	NN	O	factor	nn	27	SENT_326	[p13l1553t2717r1702b2761],
23	receptor	NN	O	receptor	nn	27	SENT_326	[p13l1713t2724r1929b2772],
24	tyrosine	NN	O	tyrosine	nn	27	SENT_326	[p13l1940t2718r2150b2772],
25	kinase	NN	O	kinase	nn	27	SENT_326	[p13l135t2784r299b2828],
26	inhibitors	NNS	O	inhibitor	nn	27	SENT_326	[p13l317t2784r566b2828],
27	sensitivity	NN	O	sensitivity	prep_of	18	SENT_326	[p13l585t2785r851b2838],
28	in	IN	O	in	_	0	SENT_326	[p13l868t2785r916b2827],
29	lung	NN	O	lung	nn	30	SENT_326	[p13l934t2784r1047b2838],
30	cancer	NN	O	cancer	prep_in	16	SENT_326	[p13l1064t2797r1241b2828],
31	.	.	O	.	_	0	SENT_326	[p13l1064t2797r1241b2828],

1	Cancer	NN	O	cancer	_	0	SENT_327	[p13l1260t2786r1436b2828],
2	Sci	NNP	O	Sci	dep	1	SENT_327	[p13l1453t2785r1522b2828],
3	2007	CD	DATE	2007	num	2	SENT_327	[p13l1540t2786r2007b2834],
4	;	:	O	;	_	0	SENT_327	[p13l1540t2786r2007b2834],
5	98:1817	CD	NUMBER	98:1817	number	6	SENT_327	[p13l1540t2786r2007b2834],
6	—	CD	NUMBER	—	dep	1	SENT_327	[p13l1540t2786r2007b2834],
7	24	CD	NUMBER	24	dep	6	SENT_327	[p13l1540t2786r2007b2834],
8	.	.	O	.	_	0	SENT_327	[p13l1540t2786r2007b2834],

1	Asahina	NNP	PERSON	Asahina	nn	2	SENT_328	[p13l133t2849r339b2893],
2	H	NNP	PERSON	H	_	0	SENT_328	[p13l366t2852r417b2900],
3	,	,	O	,	_	0	SENT_328	[p13l366t2852r417b2900],
4	Yamazaki	NNP	PERSON	Yamazaki	nn	5	SENT_328	[p13l443t2849r689b2893],
5	K	NNP	PERSON	K	appos	2	SENT_328	[p13l717t2852r763b2900],
6	,	,	O	,	_	0	SENT_328	[p13l717t2852r763b2900],
7	Kinoshita	NNP	PERSON	Kinoshita	nn	8	SENT_328	[p13l791t2850r1035b2893],
8	I	NNP	O	I	appos	5	SENT_328	[p13l1062t2852r1088b2900],
9	,	,	O	,	_	0	SENT_328	[p13l1062t2852r1088b2900],
10	Sukoh	NNP	O	Sukoh	nn	11	SENT_328	[p13l1116t2849r1274b2893],
11	N	NNP	O	N	appos	5	SENT_328	[p13l1302t2852r1351b2900],
12	,	,	O	,	_	0	SENT_328	[p13l1302t2852r1351b2900],
13	Harada	NNP	PERSON	Harada	nn	14	SENT_328	[p13l1380t2849r1563b2893],
14	M	NNP	O	M	appos	5	SENT_328	[p13l1590t2852r1651b2900],
15	,	,	O	,	_	0	SENT_328	[p13l1590t2852r1651b2900],
16	Yokouchi	NNP	PERSON	Yokouchi	nn	17	SENT_328	[p13l1677t2849r1914b2893],
17	H	NNP	O	H	appos	5	SENT_328	[p13l1942t2852r1993b2900],
18	,	,	O	,	_	0	SENT_328	[p13l1942t2852r1993b2900],
19	et	FW	O	et	nn	20	SENT_328	[p13l2021t2856r2069b2893],
20	al.	FW	O	al.	appos	5	SENT_328	[p13l2094t2849r2150b2893],
21	.	.	O	.	_	0	SENT_328	[p13l2094t2849r2150b2893],

1	A	DT	O	a	det	4	SENT_329	[p13l133t2918r171b2959],
2	phase	NN	O	phase	nn	4	SENT_329	[p13l194t2916r343b2970],
3	II	CD	NUMBER	ii	num	4	SENT_329	[p13l368t2919r399b2959],
4	trial	NN	O	trial	_	0	SENT_329	[p13l424t2916r528b2959],
5	of	IN	O	of	_	0	SENT_329	[p13l554t2916r608b2959],
6	geﬁtinib	NN	O	geﬁtinib	prep_of	4	SENT_329	[p13l626t2916r840b2970],
7	as	IN	O	as	_	0	SENT_329	[p13l865t2928r916b2959],
8	ﬁrst	NN	O	ﬁrst	nn	11	SENT_329	[p13l942t2916r1164b2959],
9	—	CD	NUMBER	—	num	11	SENT_329	[p13l942t2916r1164b2959],
10	line	NN	O	line	nn	11	SENT_329	[p13l942t2916r1164b2959],
11	therapy	NN	O	therapy	prep_as	6	SENT_329	[p13l1189t2916r1388b2970],
12	for	IN	O	for	_	0	SENT_329	[p13l1412t2916r1484b2959],
13	advanced	JJ	O	advanced	amod	17	SENT_329	[p13l1507t2916r1751b2959],
14	non-small	JJ	O	non-small	amod	17	SENT_329	[p13l1777t2916r2038b2959],
15	cell	NN	O	cell	nn	17	SENT_329	[p13l2064t2916r2150b2959],
16	lung	NN	O	lung	nn	17	SENT_329	[p13l135t2982r249b3037],
17	cancer	NN	O	cancer	prep_for	4	SENT_329	[p13l277t2995r446b3026],
18	with	IN	O	with	_	0	SENT_329	[p13l472t2982r591b3026],
19	epidermal	JJ	O	epidermal	amod	23	SENT_329	[p13l620t2982r882b3037],
20	growth	NN	O	growth	nn	23	SENT_329	[p13l910t2982r1097b3037],
21	factor	NN	O	factor	nn	23	SENT_329	[p13l1126t2982r1274b3026],
22	receptor	NN	O	receptor	nn	23	SENT_329	[p13l1302t2989r1518b3037],
23	mutations	NNS	O	mutation	prep_with	4	SENT_329	[p13l1545t2983r1821b3026],
24	.	.	O	.	_	0	SENT_329	[p13l1545t2983r1821b3026],

1	Br	NN	O	br	_	0	SENT_330	[p13l1851t2985r1947b3037],
2	]	CD	NUMBER	]	num	1	SENT_330	[p13l1851t2985r1947b3037],
3	Cancer	NN	O	cancer	dep	1	SENT_330	[p13l1976t2984r2152b3026],
4	2006	CD	DATE	2006	num	3	SENT_330	[p13l135t3050r645b3098],
5	;	:	O	;	_	0	SENT_330	[p13l135t3050r645b3098],
6	95:998	CD	NUMBER	95:998	number	7	SENT_330	[p13l135t3050r645b3098],
7	—	CD	NUMBER	—	dep	1	SENT_330	[p13l135t3050r645b3098],
8	1004	CD	DATE	1004	dep	7	SENT_330	[p13l135t3050r645b3098],
9	.	.	O	.	_	0	SENT_330	[p13l135t3050r645b3098],

1	Inoue	NNP	PERSON	Inoue	nn	2	SENT_331	[p13l135t3117r279b3158],
2	A	NNP	O	A	_	0	SENT_331	[p13l304t3116r353b3164],
3	,	,	O	,	_	0	SENT_331	[p13l304t3116r353b3164],
4	Suzuki	NNP	ORGANIZATION	Suzuki	nn	5	SENT_331	[p13l380t3114r550b3158],
5	T	NN	ORGANIZATION	t	appos	2	SENT_331	[p13l575t3117r614b3164],
6	,	,	O	,	_	0	SENT_331	[p13l575t3117r614b3164],
7	Fukuhara	NNP	ORGANIZATION	Fukuhara	nn	8	SENT_331	[p13l641t3114r881b3158],
8	T	NN	ORGANIZATION	t	appos	5	SENT_331	[p13l905t3117r944b3165],
9	,	,	O	,	_	0	SENT_331	[p13l905t3117r944b3165],
10	Maemondo	NNP	O	Maemondo	nn	11	SENT_331	[p13l971t3114r1264b3158],
11	M	NNP	O	M	appos	5	SENT_331	[p13l1291t3117r1352b3164],
12	,	,	O	,	_	0	SENT_331	[p13l1291t3117r1352b3164],
13	Kimura	NNP	PERSON	Kimura	nn	14	SENT_331	[p13l1380t3115r1568b3158],
14	Y	NN	PERSON	y	appos	5	SENT_331	[p13l1591t3117r1634b3164],
15	,	,	O	,	_	0	SENT_331	[p13l1591t3117r1634b3164],
16	Morikawa	NNP	PERSON	Morikawa	nn	17	SENT_331	[p13l1661t3114r1918b3158],
17	N	NNP	O	N	appos	5	SENT_331	[p13l1945t3117r1995b3164],
18	,	,	O	,	_	0	SENT_331	[p13l1945t3117r1995b3164],
19	et	FW	O	et	nn	20	SENT_331	[p13l2022t3121r2070b3158],
20	al.	FW	O	al.	appos	5	SENT_331	[p13l2094t3114r2150b3158],
21	.	.	O	.	_	0	SENT_331	[p13l2094t3114r2150b3158],

1	Prospective	JJ	O	prospective	amod	2	SENT_332	[p13l135t3180r431b3234],
2	phase	NN	O	phase	nsubj	24	SENT_332	[p13l454t3180r603b3234],
3	II	CD	NUMBER	ii	num	4	SENT_332	[p13l626t3182r657b3223],
4	study	NN	O	study	npadvmod	2	SENT_332	[p13l681t3180r823b3234],
5	of	IN	O	of	_	0	SENT_332	[p13l845t3179r898b3223],
6	geﬁtinib	NN	O	geﬁtinib	prep_of	4	SENT_332	[p13l914t3179r1128b3234],
7	for	IN	O	for	_	0	SENT_332	[p13l1152t3180r1224b3223],
8	chemotherapy-naive	JJ	O	chemotherapy-naive	amod	9	SENT_332	[p13l1245t3180r1779b3234],
9	patients	NNS	O	patient	prep_for	6	SENT_332	[p13l1802t3180r2009b3234],
10	with	IN	O	with	_	0	SENT_332	[p13l2032t3180r2151b3223],
11	advanced	JJ	O	advanced	amod	12	SENT_332	[p13l135t3246r379b3290],
12	non	JJ	O	non	amod	16	SENT_332	[p13l403t3246r778b3290],
13	—	NN	O	—	nn	16	SENT_332	[p13l403t3246r778b3290],
14	small-cell	NN	O	small-cell	nn	16	SENT_332	[p13l403t3246r778b3290],
15	lung	NN	O	lung	nn	16	SENT_332	[p13l803t3246r916b3300],
16	cancer	NN	O	cancer	prep_with	2	SENT_332	[p13l938t3259r1107b3290],
17	with	IN	O	with	_	0	SENT_332	[p13l1128t3246r1247b3290],
18	epidermal	JJ	O	epidermal	amod	23	SENT_332	[p13l1271t3246r1533b3300],
19	growth	NN	O	growth	nn	23	SENT_332	[p13l1556t3246r1742b3300],
20	factor	NN	O	factor	nn	23	SENT_332	[p13l1766t3246r1914b3290],
21	receptor	NN	O	receptor	nn	23	SENT_332	[p13l1936t3252r2152b3300],
22	gene	NN	O	gene	nn	23	SENT_332	[p13l134t3324r255b3366],
23	mutations	NNS	O	mutation	prep_with	2	SENT_332	[p13l274t3312r582b3366],
24	]	VBP	O	]	_	0	SENT_332	[p13l274t3312r582b3366],
25	Clin	NNP	O	Clin	nn	26	SENT_332	[p13l600t3312r699b3355],
26	Oncol	NNP	O	Oncol	dobj	24	SENT_332	[p13l717t3311r864b3355],
27	2006	CD	DATE	2006	dep	26	SENT_332	[p13l882t3314r1326b3362],
28	;	:	O	;	_	0	SENT_332	[p13l882t3314r1326b3362],
29	24:3340	CD	NUMBER	24:3340	number	30	SENT_332	[p13l882t3314r1326b3362],
30	—	CD	NUMBER	—	dep	26	SENT_332	[p13l882t3314r1326b3362],
31	6	CD	NUMBER	6	dep	30	SENT_332	[p13l882t3314r1326b3362],
32	.	.	O	.	_	0	SENT_332	[p13l882t3314r1326b3362],

1	Sunaga	FW	O	sunaga	_	0	SENT_333	[p13l135t3380r319b3432],
2	N	NN	O	n	dep	1	SENT_333	[p13l339t3381r389b3428],
3	,	,	O	,	_	0	SENT_333	[p13l339t3381r389b3428],
4	Tomizawa	NNP	PERSON	Tomizawa	nn	5	SENT_333	[p13l407t3379r669b3421],
5	Y	NN	PERSON	y	appos	2	SENT_333	[p13l687t3381r728b3428],
6	,	,	O	,	_	0	SENT_333	[p13l687t3381r728b3428],
7	Yanagitani	JJ	ORGANIZATION	yanagitani	amod	8	SENT_333	[p13l747t3379r1019b3432],
8	N	NN	ORGANIZATION	n	appos	2	SENT_333	[p13l1040t3381r1090b3428],
9	,	,	O	,	_	0	SENT_333	[p13l1040t3381r1090b3428],
10	Iijima	NNP	PERSON	Iijima	nn	11	SENT_333	[p13l1111t3379r1256b3432],
11	H	NNP	O	H	appos	2	SENT_333	[p13l1276t3381r1327b3428],
12	,	,	O	,	_	0	SENT_333	[p13l1276t3381r1327b3428],
13	Kaira	NNP	PERSON	Kaira	nn	14	SENT_333	[p13l1348t3379r1479b3421],
14	K	NNP	PERSON	K	appos	2	SENT_333	[p13l1499t3381r1544b3428],
15	,	,	O	,	_	0	SENT_333	[p13l1499t3381r1544b3428],
16	Shimizu	NNP	PERSON	Shimizu	nn	17	SENT_333	[p13l1566t3378r1775b3421],
17	K	NNP	PERSON	K	appos	2	SENT_333	[p13l1795t3381r1840b3428],
18	,	,	O	,	_	0	SENT_333	[p13l1795t3381r1840b3428],
19	et	FW	O	et	nn	20	SENT_333	[p13l1861t3384r1909b3421],
20	al.	FW	O	al.	appos	2	SENT_333	[p13l1927t3378r1983b3422],
21	.	.	O	.	_	0	SENT_333	[p13l1927t3378r1983b3422],

1	Phase	NN	O	phase	_	0	SENT_334	[p13l2004t3378r2150b3421],
2	II	CD	NUMBER	ii	num	4	SENT_334	[p13l135t3447r166b3487],
3	prospective	JJ	O	prospective	amod	4	SENT_334	[p13l198t3445r495b3499],
4	study	NN	O	study	dep	1	SENT_334	[p13l527t3444r669b3499],
5	of	IN	O	of	_	0	SENT_334	[p13l698t3444r752b3488],
6	the	DT	O	the	det	7	SENT_334	[p13l776t3444r857b3488],
7	efﬁcacy	NN	O	efﬁcacy	prep_of	4	SENT_334	[p13l889t3444r1086b3499],
8	of	IN	O	of	_	0	SENT_334	[p13l1116t3444r1169b3488],
9	geﬁtinib	NN	O	geﬁtinib	prep_of	7	SENT_334	[p13l1193t3444r1407b3499],
10	for	IN	O	for	_	0	SENT_334	[p13l1439t3444r1511b3488],
11	the	DT	O	the	det	12	SENT_334	[p13l1539t3444r1621b3488],
12	treatment	NN	O	treatment	prep_for	9	SENT_334	[p13l1652t3451r1912b3488],
13	of	IN	O	of	_	0	SENT_334	[p13l1941t3444r1995b3488],
14	stage	NN	O	stage	nn	15	SENT_334	[p13l2020t3451r2150b3499],
15	III/IV	NN	O	iii/iv	prep_of	12	SENT_334	[p13l135t3509r261b3564],
16	non-small	JJ	O	non-small	amod	19	SENT_334	[p13l276t3510r537b3553],
17	cell	NN	O	cell	nn	19	SENT_334	[p13l554t3510r641b3553],
18	lung	NN	O	lung	nn	19	SENT_334	[p13l658t3510r771b3564],
19	cancer	NN	O	cancer	dep	1	SENT_334	[p13l787t3522r956b3553],
20	with	IN	O	with	_	0	SENT_334	[p13l969t3510r1088b3553],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_334	[p13l1105t3512r1239b3553],
22	mutations	NNS	O	mutation	prep_with	19	SENT_334	[p13l1254t3510r1529b3560],
23	,	,	O	,	_	0	SENT_334	[p13l1254t3510r1529b3560],
24	irrespective	RB	O	irrespective	_	0	SENT_334	[p13l1547t3510r1848b3564],
25	of	IN	O	of	_	0	SENT_334	[p13l1865t3510r1919b3553],
26	previous	JJ	O	previous	amod	27	SENT_334	[p13l1929t3510r2150b3564],
27	chemotherapy	NN	O	chemotherapy	prep_irrespective_of	22	SENT_334	[p13l135t3576r517b3630],
28	.	.	O	.	_	0	SENT_334	[p13l135t3576r517b3630],

1	Lung	NN	O	lung	nn	2	SENT_335	[p13l536t3579r661b3630],
2	Cancer	NN	O	cancer	_	0	SENT_335	[p13l678t3578r853b3620],
3	2007	CD	DATE	2007	dep	2	SENT_335	[p13l870t3578r1280b3626],
4	;	:	O	;	_	0	SENT_335	[p13l870t3578r1280b3626],
5	56:383	CD	NUMBER	56:383	number	6	SENT_335	[p13l870t3578r1280b3626],
6	—	CD	NUMBER	—	dep	2	SENT_335	[p13l870t3578r1280b3626],
7	9	CD	NUMBER	9	dep	6	SENT_335	[p13l870t3578r1280b3626],
8	.	.	O	.	_	0	SENT_335	[p13l870t3578r1280b3626],

1	Sutani	NNP	MISC	Sutani	nn	2	SENT_336	[p13l135t3642r297b3685],
2	A	NNP	MISC	A	_	0	SENT_336	[p13l311t3643r360b3692],
3	,	,	O	,	_	0	SENT_336	[p13l311t3643r360b3692],
4	Nagai	NNP	PERSON	Nagai	nn	5	SENT_336	[p13l378t3642r520b3696],
5	Y	NN	PERSON	y	appos	2	SENT_336	[p13l535t3644r576b3692],
6	,	,	O	,	_	0	SENT_336	[p13l535t3644r576b3692],
7	Udagawa	NNP	PERSON	Udagawa	nn	8	SENT_336	[p13l593t3641r828b3696],
8	K	NNP	PERSON	K	appos	5	SENT_336	[p13l844t3644r889b3692],
9	,	,	O	,	_	0	SENT_336	[p13l844t3644r889b3692],
10	Uchida	NNP	LOCATION	Uchida	nn	11	SENT_336	[p13l905t3641r1084b3685],
11	Y	NN	LOCATION	y	appos	5	SENT_336	[p13l1098t3644r1140b3692],
12	,	,	O	,	_	0	SENT_336	[p13l1098t3644r1140b3692],
13	Koyama	NNP	PERSON	Koyama	nn	14	SENT_336	[p13l1157t3644r1361b3696],
14	N	NNP	O	N	appos	5	SENT_336	[p13l1377t3644r1427b3692],
15	,	,	O	,	_	0	SENT_336	[p13l1377t3644r1427b3692],
16	Murayama	NNP	PERSON	Murayama	nn	17	SENT_336	[p13l1444t3644r1720b3696],
17	Y	NN	PERSON	y	appos	5	SENT_336	[p13l1734t3644r1775b3692],
18	,	,	O	,	_	0	SENT_336	[p13l1734t3644r1775b3692],
19	et	FW	O	et	nn	20	SENT_336	[p13l1792t3648r1840b3685],
20	al.	FW	O	al.	appos	5	SENT_336	[p13l1855t3642r1910b3685],
21	.	.	O	.	_	0	SENT_336	[p13l1855t3642r1910b3685],

1	Geﬁtinib	NNP	O	Geﬁtinib	_	0	SENT_337	[p13l1927t3641r2150b3685],
2	for	IN	O	for	dep	1	SENT_337	[p13l135t3708r207b3751],
3	non	JJ	O	non	amod	8	SENT_337	[p13l229t3708r604b3751],
4	—	JJ	O	—	amod	8	SENT_337	[p13l229t3708r604b3751],
5	small-cell	NN	O	small-cell	nn	8	SENT_337	[p13l229t3708r604b3751],
6	lung	NN	O	lung	nn	8	SENT_337	[p13l628t3708r741b3762],
7	cancer	NN	O	cancer	nn	8	SENT_337	[p13l763t3720r931b3751],
8	patients	NNS	O	patient	pobj	2	SENT_337	[p13l953t3709r1160b3762],
9	with	IN	O	with	_	0	SENT_337	[p13l1183t3708r1302b3751],
10	epidermal	JJ	O	epidermal	amod	15	SENT_337	[p13l1325t3708r1587b3762],
11	growth	NN	O	growth	nn	15	SENT_337	[p13l1609t3708r1795b3762],
12	factor	NN	O	factor	nn	15	SENT_337	[p13l1818t3708r1967b3751],
13	receptor	NN	O	receptor	nn	15	SENT_337	[p13l1988t3720r2150b3762, p13l135t3780r209b3817],
14	gene	NN	O	gene	nn	15	SENT_337	[p13l228t3786r348b3828],
15	mutations	NNS	O	mutation	prep_with	8	SENT_337	[p13l370t3774r632b3817],
16	screened	VBN	O	screen	partmod	15	SENT_337	[p13l655t3773r883b3817],
17	by	IN	O	by	_	0	SENT_337	[p13l904t3773r966b3828],
18	peptide	NN	O	peptide	nn	23	SENT_337	[p13l986t3773r1180b3828],
19	nucleic	JJ	O	nucleic	amod	23	SENT_337	[p13l1202t3773r1385b3817],
20	acid-locked	JJ	O	acid-locked	amod	23	SENT_337	[p13l1405t3773r1703b3817],
21	nucleic	JJ	O	nucleic	amod	23	SENT_337	[p13l1725t3774r1908b3817],
22	acid	NN	O	acid	nn	23	SENT_337	[p13l1928t3773r2032b3817],
23	PCR	NN	O	pcr	agent	16	SENT_337	[p13l2054t3776r2153b3817],

1	clamp	NN	O	clamp	_	0	SENT_338	[p14l135t16r303b70],
2	.	.	O	.	_	0	SENT_338	[p14l135t16r303b70],

1	BrJ	NN	O	brj	nn	2	SENT_339	[p14l323t19r408b70],
2	Cancer	NN	O	cancer	_	0	SENT_339	[p14l426t18r602b59],
3	2006	CD	DATE	2006	dep	2	SENT_339	[p14l618t18r1061b66],
4	;	:	O	;	_	0	SENT_339	[p14l618t18r1061b66],
5	95:1483	CD	NUMBER	95:1483	number	6	SENT_339	[p14l618t18r1061b66],
6	—	CD	NUMBER	—	dep	2	SENT_339	[p14l618t18r1061b66],
7	9	CD	NUMBER	9	dep	6	SENT_339	[p14l618t18r1061b66],
8	.	.	O	.	_	0	SENT_339	[p14l618t18r1061b66],

1	[	NN	O	[	nn	5	SENT_340	[p14l12t81r104b136],
2	17	CD	NUMBER	17	num	5	SENT_340	[p14l12t81r104b136],
3	]	CD	NUMBER	]	num	5	SENT_340	[p14l12t81r104b136],
4	Yoshida	NNP	PERSON	Yoshida	nn	5	SENT_340	[p14l136t81r338b125],
5	K	NNP	PERSON	K	_	0	SENT_340	[p14l361t84r406b132],
6	,	,	O	,	_	0	SENT_340	[p14l361t84r406b132],
7	Yatabe	NNP	PERSON	Yatabe	nn	8	SENT_340	[p14l428t81r600b125],
8	Y	NN	PERSON	y	appos	5	SENT_340	[p14l622t84r664b132],
9	,	,	O	,	_	0	SENT_340	[p14l622t84r664b132],
10	Park	NNP	O	Park	nn	11	SENT_340	[p14l689t81r801b125],
11	JY	NN	O	jy	appos	8	SENT_340	[p14l816t84r880b136],
12	,	,	O	,	_	0	SENT_340	[p14l816t84r880b136],
13	Shimizu	NNP	PERSON	Shimizu	nn	14	SENT_340	[p14l905t82r1113b125],
14	J	NNP	PERSON	J	appos	8	SENT_340	[p14l1130t84r1163b136],
15	,	,	O	,	_	0	SENT_340	[p14l1130t84r1163b136],
16	Horio	NNP	O	Horio	nn	17	SENT_340	[p14l1188t82r1330b125],
17	Y	NN	O	y	appos	8	SENT_340	[p14l1352t84r1394b132],
18	,	,	O	,	_	0	SENT_340	[p14l1352t84r1394b132],
19	Matsuo	NNP	PERSON	Matsuo	nn	20	SENT_340	[p14l1419t84r1609b125],
20	K	NNP	PERSON	K	appos	8	SENT_340	[p14l1633t84r1678b132],
21	,	,	O	,	_	0	SENT_340	[p14l1633t84r1678b132],
22	et	FW	O	et	nn	23	SENT_340	[p14l1703t88r1750b125],
23	al.	FW	O	al.	appos	8	SENT_340	[p14l1773t81r1828b125],
24	.	.	O	.	_	0	SENT_340	[p14l1773t81r1828b125],

1	Prospective	JJ	O	prospective	amod	2	SENT_341	[p14l1853t82r2147b136],
2	validation	NN	O	validation	_	0	SENT_341	[p14l137t148r395b191],
3	for	IN	O	for	_	0	SENT_341	[p14l421t148r493b191],
4	prediction	NN	O	prediction	prep_for	2	SENT_341	[p14l518t148r783b202],
5	of	IN	O	of	_	0	SENT_341	[p14l810t148r864b191],
6	geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_341	[p14l883t148r1097b202],
7	sensitivity	NN	O	sensitivity	prep_of	2	SENT_341	[p14l1124t149r1390b202],
8	by	IN	O	by	_	0	SENT_341	[p14l1414t148r1476b202],
9	epidermal	JJ	O	epidermal	amod	14	SENT_341	[p14l1501t148r1762b202],
10	growth	NN	O	growth	nn	14	SENT_341	[p14l1789t148r1974b202],
11	factor	NN	O	factor	nn	14	SENT_341	[p14l2001t148r2149b191],
12	receptor	NN	O	receptor	nn	14	SENT_341	[p14l139t220r354b268],
13	gene	NN	O	gene	nn	14	SENT_341	[p14l373t226r494b268],
14	mutation	NN	O	mutation	prep_by	2	SENT_341	[p14l516t214r754b257],
15	in	IN	O	in	_	0	SENT_341	[p14l776t214r823b257],
16	patients	NNS	O	patient	prep_in	14	SENT_341	[p14l845t214r1052b268],
17	with	IN	O	with	_	0	SENT_341	[p14l1073t214r1192b257],
18	non-small	JJ	O	non-small	amod	21	SENT_341	[p14l1214t213r1474b257],
19	cell	NN	O	cell	nn	21	SENT_341	[p14l1497t213r1583b257],
20	lung	NN	O	lung	nn	21	SENT_341	[p14l1605t213r1718b268],
21	cancer	NN	O	cancer	prep_with	16	SENT_341	[p14l1739t216r1952b268],
22	.	.	O	.	_	0	SENT_341	[p14l1739t216r1952b268],

1	J	NNP	O	J	nn	3	SENT_342	[p14l1739t216r1952b268],
2	Thorac	NNP	O	Thorac	nn	3	SENT_342	[p14l1972t213r2148b257],
3	Oncol	NNP	O	Oncol	_	0	SENT_342	[p14l139t280r285b323],
4	2007	CD	DATE	2007	num	3	SENT_342	[p14l303t282r647b330],
5	;	:	O	;	_	0	SENT_342	[p14l303t282r647b330],
6	2:22	CD	TIME	2:22	number	7	SENT_342	[p14l303t282r647b330],
7	—	CD	NUMBER	—	dep	3	SENT_342	[p14l303t282r647b330],
8	8	CD	NUMBER	8	dep	7	SENT_342	[p14l303t282r647b330],
9	.	.	O	.	_	0	SENT_342	[p14l303t282r647b330],

1	[	NN	O	[	_	0	SENT_343	[p14l11t346r103b401],
2	18	CD	NUMBER	18	num	1	SENT_343	[p14l11t346r103b401],
3	]	CD	NUMBER	]	num	5	SENT_343	[p14l11t346r103b401],
4	Takano	NNP	PERSON	Takano	nn	5	SENT_343	[p14l136t346r319b390],
5	T	NN	PERSON	t	dep	1	SENT_343	[p14l337t349r377b396],
6	,	,	O	,	_	0	SENT_343	[p14l337t349r377b396],
7	Ohe	NN	O	ohe	nn	8	SENT_343	[p14l398t346r498b390],
8	Y	NN	O	y	appos	5	SENT_343	[p14l517t349r559b396],
9	,	,	O	,	_	0	SENT_343	[p14l517t349r559b396],
10	Sakamoto	NNP	PERSON	Sakamoto	nn	11	SENT_343	[p14l581t346r832b390],
11	H	NNP	O	H	appos	5	SENT_343	[p14l853t349r904b396],
12	,	,	O	,	_	0	SENT_343	[p14l853t349r904b396],
13	Tsuta	NNP	LOCATION	Tsuta	nn	14	SENT_343	[p14l923t349r1060b390],
14	K	NNP	LOCATION	K	appos	5	SENT_343	[p14l1081t349r1126b396],
15	,	,	O	,	_	0	SENT_343	[p14l1081t349r1126b396],
16	Matsuno	NNP	PERSON	Matsuno	nn	17	SENT_343	[p14l1147t349r1371b390],
17	Y	NN	PERSON	y	appos	5	SENT_343	[p14l1390t349r1432b396],
18	,	,	O	,	_	0	SENT_343	[p14l1390t349r1432b396],
19	Tateishi	NNP	PERSON	Tateishi	nn	20	SENT_343	[p14l1451t346r1651b390],
20	U	NNP	PERSON	U	appos	5	SENT_343	[p14l1671t349r1718b397],
21	,	,	O	,	_	0	SENT_343	[p14l1671t349r1718b397],
22	et	FW	O	et	nn	23	SENT_343	[p14l1740t353r1788b390],
23	al.	FW	O	al.	appos	5	SENT_343	[p14l1807t346r1862b390],
24	.	.	O	.	_	0	SENT_343	[p14l1807t346r1862b390],

1	Epidermal	JJ	O	epidermal	amod	6	SENT_344	[p14l1884t346r2147b401],
2	growth	NN	O	growth	nn	6	SENT_344	[p14l138t412r323b466],
3	factor	NN	O	factor	nn	6	SENT_344	[p14l347t411r495b455],
4	receptor	NN	O	receptor	nn	6	SENT_344	[p14l517t418r733b466],
5	gene	NN	O	gene	nn	6	SENT_344	[p14l754t424r874b466],
6	mutations	NNS	O	mutation	nsubj	11	SENT_344	[p14l898t412r1160b455],
7	and	CC	O	and	_	0	SENT_344	[p14l1185t412r1277b455],
8	increased	VBD	O	increase	amod	9	SENT_344	[p14l1302t412r1546b455],
9	copy	NN	O	copy	nsubj	11	SENT_344	[p14l1571t424r1691b466],
10	numbers	NNS	O	number	dep	6	SENT_344	[p14l1714t412r1941b455],
11	predict	VBP	O	predict	_	0	SENT_344	[p14l1966t412r2148b466],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_344	[p14l138t478r351b532],
13	sensitivity	NN	O	sensitivity	dobj	11	SENT_344	[p14l366t479r631b532],
14	in	IN	O	in	_	0	SENT_344	[p14l645t479r692b521],
15	patients	NNS	O	patient	prep_in	11	SENT_344	[p14l706t479r913b532],
16	with	IN	O	with	_	0	SENT_344	[p14l927t478r1046b522],
17	recurrent	JJ	O	recurrent	amod	20	SENT_344	[p14l1060t484r1301b522],
18	non-small-cell	JJ	O	non-small-cell	amod	20	SENT_344	[p14l1314t478r1688b522],
19	lung	NN	O	lung	nn	20	SENT_344	[p14l1703t478r1816b532],
20	cancer	NN	O	cancer	prep_with	15	SENT_344	[p14l1829t481r2034b532],
21	.	.	O	.	_	0	SENT_344	[p14l1829t481r2034b532],

1	J	NNP	O	J	nn	3	SENT_345	[p14l1829t481r2034b532],
2	Clin	NNP	O	Clin	nn	3	SENT_345	[p14l2049t478r2147b522],
3	Oncol	NNP	O	Oncol	_	0	SENT_345	[p14l139t543r285b587],
4	2005	CD	DATE	2005	num	3	SENT_345	[p14l303t546r773b594],
5	;	:	O	;	_	0	SENT_345	[p14l303t546r773b594],
6	23:6829	CD	NUMBER	23:6829	number	7	SENT_345	[p14l303t546r773b594],
7	—	CD	NUMBER	—	dep	3	SENT_345	[p14l303t546r773b594],
8	37	CD	NUMBER	37	dep	7	SENT_345	[p14l303t546r773b594],
9	.	.	O	.	_	0	SENT_345	[p14l303t546r773b594],

1	[	NN	O	[	nn	4	SENT_346	[p14l10t610r104b664],
2	19	CD	NUMBER	19	num	4	SENT_346	[p14l10t610r104b664],
3	]	NN	O	]	nn	4	SENT_346	[p14l10t610r104b664],
4	Greulich	NN	O	greulich	_	0	SENT_346	[p14l139t610r355b653],
5	H	NN	O	h	dep	4	SENT_346	[p14l375t613r426b660],
6	,	,	O	,	_	0	SENT_346	[p14l375t613r426b660],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_346	[p14l447t610r575b653],
8	TH	NN	O	th	appos	5	SENT_346	[p14l592t613r677b660],
9	,	,	O	,	_	0	SENT_346	[p14l592t613r677b660],
10	Feng	NNP	O	Feng	nn	11	SENT_346	[p14l698t613r817b664],
11	W	NNP	O	W	appos	5	SENT_346	[p14l834t613r900b660],
12	,	,	O	,	_	0	SENT_346	[p14l834t613r900b660],
13	Janne	NNP	ORGANIZATION	Janne	nn	14	SENT_346	[p14l914t613r1062b664],
14	PA	NN	ORGANIZATION	pa	appos	5	SENT_346	[p14l1082t612r1157b660],
15	,	,	O	,	_	0	SENT_346	[p14l1082t612r1157b660],
16	Alvarez	NNP	PERSON	Alvarez	nn	17	SENT_346	[p14l1176t610r1366b653],
17	JV	NNP	O	JV	appos	5	SENT_346	[p14l1380t613r1450b664],
18	,	,	O	,	_	0	SENT_346	[p14l1380t613r1450b664],
19	Zappaterra	NNP	O	Zappaterra	nn	20	SENT_346	[p14l1470t613r1751b664],
20	M	NNP	O	M	appos	5	SENT_346	[p14l1770t613r1832b660],
21	,	,	O	,	_	0	SENT_346	[p14l1770t613r1832b660],
22	et	FW	O	et	nn	23	SENT_346	[p14l1852t616r1900b653],
23	al.	FW	O	al.	appos	5	SENT_346	[p14l1918t610r1973b654],
24	.	.	O	.	_	0	SENT_346	[p14l1918t610r1973b654],

1	Oncogenic	JJ	MISC	oncogenic	amod	2	SENT_347	[p14l1994t612r2147b653, p14l138t677r273b731],
2	transformation	NN	O	transformation	_	0	SENT_347	[p14l289t676r679b720],
3	by	IN	O	by	_	0	SENT_347	[p14l696t676r757b731],
4	inhibitor-sensitive	JJ	O	inhibitor-sensitive	prep_by	2	SENT_347	[p14l773t676r1244b720],
5	and	CC	O	and	cc	2	SENT_347	[p14l1262t676r1356b720],
6	-	:	O	-	_	0	SENT_347	[p14l1374t677r1619b720],
7	resistant	JJ	O	resistant	amod	9	SENT_347	[p14l1374t677r1619b720],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_347	[p14l1636t678r1769b720],
9	mutants	NNS	O	mutant	dep	2	SENT_347	[p14l1785t683r2011b720],
10	.	.	O	.	_	0	SENT_347	[p14l1785t683r2011b720],

1	PLoS	NNP	O	PLoS	nn	2	SENT_348	[p14l2030t678r2147b720],
2	Med	NNP	O	Med	_	0	SENT_348	[p14l139t742r251b785],
3	2005	CD	DATE	2005	num	5	SENT_348	[p14l269t744r605b792],
4	;	:	O	;	_	0	SENT_348	[p14l269t744r605b792],
5	2	CD	NUMBER	2	dep	2	SENT_348	[p14l269t744r605b792],
6	:	:	O	:	_	0	SENT_348	[p14l269t744r605b792],
7	e313	NN	O	e313	dep	2	SENT_348	[p14l269t744r605b792],
8	.	.	O	.	_	0	SENT_348	[p14l269t744r605b792],

1	[	RB	O	[	advmod	2	SENT_349	[p14l7t808r104b862],
2	20	CD	NUMBER	20	_	0	SENT_349	[p14l7t808r104b862],
3	]	CD	NUMBER	]	num	5	SENT_349	[p14l7t808r104b862],
4	Mulloy	NN	PERSON	mulloy	nn	5	SENT_349	[p14l139t808r319b862],
5	R	NN	PERSON	r	dep	2	SENT_349	[p14l354t811r397b858],
6	,	,	O	,	_	0	SENT_349	[p14l354t811r397b858],
7	Ferrand	NNP	PERSON	Ferrand	nn	8	SENT_349	[p14l434t808r630b852],
8	A	NNP	O	A	appos	5	SENT_349	[p14l665t810r713b858],
9	,	,	O	,	_	0	SENT_349	[p14l665t810r713b858],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_349	[p14l751t809r853b851],
11	Y	NN	PERSON	y	appos	5	SENT_349	[p14l887t811r928b858],
12	,	,	O	,	_	0	SENT_349	[p14l887t811r928b858],
13	Sordella	NN	PERSON	sordellum	nn	14	SENT_349	[p14l966t808r1172b852],
14	R	NN	PERSON	r	appos	5	SENT_349	[p14l1208t811r1252b858],
15	,	,	O	,	_	0	SENT_349	[p14l1208t811r1252b858],
16	Bell	NNP	ORGANIZATION	Bell	nn	17	SENT_349	[p14l1289t808r1382b852],
17	DW	NNP	ORGANIZATION	DW	appos	5	SENT_349	[p14l1419t811r1522b858],
18	,	,	O	,	_	0	SENT_349	[p14l1419t811r1522b858],
19	Haber	NNP	ORGANIZATION	Haber	nn	20	SENT_349	[p14l1559t808r1714b852],
20	DA	NNP	ORGANIZATION	DA	appos	5	SENT_349	[p14l1749t810r1834b858],
21	,	,	O	,	_	0	SENT_349	[p14l1749t810r1834b858],
22	et	FW	O	et	nn	23	SENT_349	[p14l1871t814r1918b852],
23	al.	FW	O	al.	appos	5	SENT_349	[p14l1953t808r2008b852],
24	.	.	O	.	_	0	SENT_349	[p14l1953t808r2008b852],

1	Epidermal	JJ	O	epidermal	amod	5	SENT_350	[p14l2045t809r2147b862, p14l139t873r319b917],
2	growth	NN	O	growth	nn	5	SENT_350	[p14l350t874r536b928],
3	factor	NN	O	factor	nn	5	SENT_350	[p14l568t873r715b917],
4	receptor	NN	O	receptor	nn	5	SENT_350	[p14l746t880r961b928],
5	mutants	NNS	O	mutant	nsubj	10	SENT_350	[p14l991t880r1204b917],
6	from	IN	O	from	_	0	SENT_350	[p14l1237t873r1358b917],
7	human	JJ	O	human	amod	9	SENT_350	[p14l1390t873r1570b917],
8	lung	NN	O	lung	nn	9	SENT_350	[p14l1602t873r1715b928],
9	cancers	NNS	O	cancer	prep_from	5	SENT_350	[p14l1746t886r1936b917],
10	exhibit	VBP	O	exhibit	_	0	SENT_350	[p14l1969t873r2148b917],
11	enhanced	VBN	O	enhance	amod	13	SENT_350	[p14l139t940r387b984],
12	catalytic	JJ	O	catalytic	amod	13	SENT_350	[p14l412t940r627b994],
13	activity	NN	O	activity	dobj	10	SENT_350	[p14l651t941r842b994],
14	and	CC	O	and	_	0	SENT_350	[p14l865t940r958b984],
15	increased	VBD	O	increase	amod	16	SENT_350	[p14l983t940r1227b984],
16	sensitivity	NN	O	sensitivity	conj_and	13	SENT_350	[p14l1252t941r1518b994],
17	to	TO	O	to	_	0	SENT_350	[p14l1540t946r1589b984],
18	geﬁtinib	NN	O	geﬁtinib	prep_to	16	SENT_350	[p14l1613t940r1839b994],
19	.	.	O	.	_	0	SENT_350	[p14l1613t940r1839b994],

1	Cancer	NN	O	cancer	_	0	SENT_351	[p14l1864t942r2040b984],
2	Res	NNP	O	Res	dep	1	SENT_351	[p14l2063t943r2146b984],
3	2007	CD	DATE	2007	num	2	SENT_351	[p14l138t1008r608b1056],
4	;	:	O	;	_	0	SENT_351	[p14l138t1008r608b1056],
5	67:2325	CD	NUMBER	67:2325	number	6	SENT_351	[p14l138t1008r608b1056],
6	—	CD	NUMBER	—	dep	1	SENT_351	[p14l138t1008r608b1056],
7	30	CD	NUMBER	30	dep	6	SENT_351	[p14l138t1008r608b1056],
8	.	.	O	.	_	0	SENT_351	[p14l138t1008r608b1056],

1	[	NN	O	[	_	0	SENT_352	[p14l9t1072r104b1126],
2	21	CD	NUMBER	21	num	1	SENT_352	[p14l9t1072r104b1126],
3	]	CD	NUMBER	]	num	5	SENT_352	[p14l9t1072r104b1126],
4	Carey	NNP	PERSON	Carey	nn	5	SENT_352	[p14l139t1074r282b1126],
5	KD	NN	O	kd	dep	1	SENT_352	[p14l306t1075r391b1122],
6	,	,	O	,	_	0	SENT_352	[p14l306t1075r391b1122],
7	Garton	NNP	PERSON	Garton	nn	9	SENT_352	[p14l417t1074r592b1115],
8	A	NNP	O	A	nn	9	SENT_352	[p14l615t1074r680b1126],
9	]	NN	O	]	appos	5	SENT_352	[p14l615t1074r680b1126],
10	,	,	O	,	_	0	SENT_352	[p14l615t1074r680b1126],
11	Romero	NNP	PERSON	Romero	nn	12	SENT_352	[p14l706t1075r904b1115],
12	MS	NN	O	m	appos	5	SENT_352	[p14l929t1074r1020b1122],
13	,	,	O	,	_	0	SENT_352	[p14l929t1074r1020b1122],
14	Kahler	NNP	PERSON	Kahler	nn	15	SENT_352	[p14l1046t1072r1214b1115],
15	J	NNP	PERSON	J	appos	5	SENT_352	[p14l1230t1075r1263b1126],
16	,	,	O	,	_	0	SENT_352	[p14l1230t1075r1263b1126],
17	Thomson	NNP	PERSON	Thomson	nn	18	SENT_352	[p14l1286t1072r1527b1115],
18	S	NN	O	s	appos	5	SENT_352	[p14l1552t1074r1590b1122],
19	,	,	O	,	_	0	SENT_352	[p14l1552t1074r1590b1122],
20	Ross	NNP	PERSON	Ross	nn	21	SENT_352	[p14l1616t1075r1727b1115],
21	S	NNP	O	S	appos	5	SENT_352	[p14l1753t1074r1791b1122],
22	,	,	O	,	_	0	SENT_352	[p14l1753t1074r1791b1122],
23	et	FW	O	et	nn	24	SENT_352	[p14l1817t1078r1865b1115],
24	al.	FW	O	al.	appos	5	SENT_352	[p14l1888t1072r1943b1116],
25	.	.	O	.	_	0	SENT_352	[p14l1888t1072r1943b1116],

1	Kinetic	JJ	O	kinetic	amod	2	SENT_353	[p14l1969t1072r2148b1115],
2	analysis	NN	O	analysis	nsubj	11	SENT_353	[p14l138t1138r340b1193],
3	of	IN	O	of	_	0	SENT_353	[p14l363t1138r416b1182],
4	epidermal	JJ	O	epidermal	amod	7	SENT_353	[p14l431t1138r693b1193],
5	growth	NN	O	growth	nn	7	SENT_353	[p14l714t1138r899b1193],
6	factor	NN	O	factor	nn	7	SENT_353	[p14l921t1138r1069b1182],
7	receptor	NN	O	receptor	prep_of	2	SENT_353	[p14l1089t1145r1304b1193],
8	somatic	JJ	O	somatic	amod	10	SENT_353	[p14l1325t1139r1525b1182],
9	mutant	JJ	O	mutant	amod	10	SENT_353	[p14l1546t1145r1736b1182],
10	proteins	NNS	O	protein	dep	7	SENT_353	[p14l1756t1139r1965b1193],
11	shows	VBZ	O	show	_	0	SENT_353	[p14l1988t1138r2146b1182],
12	increased	VBN	O	increase	amod	13	SENT_353	[p14l139t1204r383b1247],
13	sensitivity	NN	O	sensitivity	dobj	11	SENT_353	[p14l405t1204r670b1258],
14	to	TO	O	to	_	0	SENT_353	[p14l690t1210r738b1247],
15	the	DT	O	the	det	22	SENT_353	[p14l760t1204r841b1247],
16	epidermal	JJ	O	epidermal	amod	22	SENT_353	[p14l863t1204r1124b1258],
17	growth	NN	O	growth	nn	22	SENT_353	[p14l1145t1204r1330b1258],
18	factor	NN	O	factor	nn	22	SENT_353	[p14l1352t1203r1499b1247],
19	receptor	NN	O	receptor	nn	22	SENT_353	[p14l1519t1210r1734b1258],
20	tyrosine	NN	O	tyrosine	nn	22	SENT_353	[p14l1754t1204r1963b1258],
21	kinase	NN	O	kinase	nn	22	SENT_353	[p14l1984t1204r2147b1247],
22	inhibitor	NN	O	inhibitor	prep_to	11	SENT_353	[p14l139t1270r371b1320],
23	,	,	O	,	_	0	SENT_353	[p14l139t1270r371b1320],
24	erlotinib	NN	O	erlotinib	appos	22	SENT_353	[p14l391t1270r621b1314],
25	.	.	O	.	_	0	SENT_353	[p14l391t1270r621b1314],

1	Cancer	NN	O	cancer	_	0	SENT_354	[p14l640t1272r816b1314],
2	Res	NNP	O	Res	dep	1	SENT_354	[p14l832t1273r916b1314],
3	2006	CD	DATE	2006	num	2	SENT_354	[p14l935t1272r1401b1320],
4	;	:	O	;	_	0	SENT_354	[p14l935t1272r1401b1320],
5	66:8163	CD	NUMBER	66:8163	number	6	SENT_354	[p14l935t1272r1401b1320],
6	—	CD	NUMBER	—	dep	1	SENT_354	[p14l935t1272r1401b1320],
7	71	CD	NUMBER	71	dep	6	SENT_354	[p14l935t1272r1401b1320],
8	.	.	O	.	_	0	SENT_354	[p14l935t1272r1401b1320],

1	[	NN	O	[	nn	5	SENT_355	[p14l7t1335r104b1390],
2	22	CD	NUMBER	22	num	5	SENT_355	[p14l7t1335r104b1390],
3	]	CD	NUMBER	]	num	5	SENT_355	[p14l7t1335r104b1390],
4	Riely	NNP	O	Riely	nn	5	SENT_355	[p14l139t1335r265b1390],
5	GJ	NNP	O	GJ	_	0	SENT_355	[p14l279t1338r345b1390],
6	,	,	O	,	_	0	SENT_355	[p14l279t1338r345b1390],
7	Pao	NNP	O	Pao	nn	8	SENT_355	[p14l362t1338r449b1379],
8	W	NNP	O	W	appos	5	SENT_355	[p14l463t1338r530b1386],
9	,	,	O	,	_	0	SENT_355	[p14l463t1338r530b1386],
10	Pham	NNP	PERSON	Pham	nn	11	SENT_355	[p14l546t1335r691b1379],
11	D	NNP	PERSON	D	appos	8	SENT_355	[p14l706t1338r755b1386],
12	,	,	O	,	_	0	SENT_355	[p14l706t1338r755b1386],
13	Li	NNP	PERSON	Li	nn	14	SENT_355	[p14l771t1336r812b1379],
14	AR	NNS	PERSON	ar	appos	8	SENT_355	[p14l826t1337r909b1386],
15	,	,	O	,	_	0	SENT_355	[p14l826t1337r909b1386],
16	Rizvi	NNP	PERSON	Rizvi	nn	17	SENT_355	[p14l925t1336r1048b1379],
17	N	NNP	PERSON	N	appos	8	SENT_355	[p14l1065t1338r1114b1386],
18	,	,	O	,	_	0	SENT_355	[p14l1065t1338r1114b1386],
19	Venl	NNP	O	Venl	appos	8	SENT_355	[p14l1128t1335r1478b1379],
20	<	JJR	O	<	amod	22	SENT_355	[p14l1128t1335r1478b1379],
21	atraman	NN	O	atraman	nn	22	SENT_355	[p14l1128t1335r1478b1379],
22	ES	NN	O	e	dep	19	SENT_355	[p14l1494t1338r1564b1386],
23	,	,	O	,	_	0	SENT_355	[p14l1494t1338r1564b1386],
24	et	FW	O	et	nn	25	SENT_355	[p14l1580t1342r1628b1379],
25	al.	FW	O	al.	appos	8	SENT_355	[p14l1642t1335r1697b1379],
26	.	.	O	.	_	0	SENT_355	[p14l1642t1335r1697b1379],

1	Clinical	JJ	O	clinical	amod	2	SENT_356	[p14l1713t1335r1901b1379],
2	course	NN	O	course	nsubj	21	SENT_356	[p14l1917t1348r2084b1379],
3	of	IN	O	of	_	0	SENT_356	[p14l2100t1335r2153b1379],
4	patients	NNS	O	patient	prep_of	2	SENT_356	[p14l139t1402r345b1456],
5	with	IN	O	with	_	0	SENT_356	[p14l360t1402r479b1445],
6	non-small	JJ	O	non-small	amod	9	SENT_356	[p14l495t1402r755b1445],
7	cell	NN	O	cell	nn	9	SENT_356	[p14l771t1402r858b1445],
8	lung	NN	O	lung	nn	9	SENT_356	[p14l874t1402r987b1456],
9	cancer	NN	O	cancer	prep_with	4	SENT_356	[p14l1002t1414r1170b1445],
10	and	CC	O	and	_	0	SENT_356	[p14l1184t1402r1277b1445],
11	epidermal	JJ	O	epidermal	amod	14	SENT_356	[p14l1293t1402r1555b1456],
12	growth	NN	O	growth	nn	14	SENT_356	[p14l1570t1402r1756b1456],
13	factor	NN	O	factor	nn	14	SENT_356	[p14l1771t1402r1919b1445],
14	receptor	NN	O	receptor	conj_and	4	SENT_356	[p14l1934t1408r2149b1456],
15	exon	NN	O	exon	num	20	SENT_356	[p14l139t1481r260b1512],
16	19	CD	NUMBER	19	num	15	SENT_356	[p14l281t1470r335b1512],
17	and	CC	O	and	_	0	SENT_356	[p14l355t1468r447b1512],
18	exon	NN	O	exon	num	20	SENT_356	[p14l467t1481r588b1512],
19	21	CD	NUMBER	21	num	18	SENT_356	[p14l606t1470r659b1511],
20	mutations	NNS	O	mutation	dep	14	SENT_356	[p14l685t1469r946b1512],
21	treated	VBN	O	treat	_	0	SENT_356	[p14l965t1468r1148b1512],
22	with	IN	O	with	_	0	SENT_356	[p14l1166t1468r1285b1512],
23	geﬁtinib	NN	O	geﬁtinib	prep_with	21	SENT_356	[p14l1302t1468r1517b1523],
24	or	CC	O	or	_	0	SENT_356	[p14l1536t1481r1588b1512],
25	erlotinib	NN	O	erlotinib	prep_with	21	SENT_356	[p14l1606t1468r1837b1512],
26	.	.	O	.	_	0	SENT_356	[p14l1606t1468r1837b1512],

1	Clin	NNP	O	Clin	nn	3	SENT_357	[p14l1856t1468r1955b1512],
2	Cancer	NNP	O	Cancer	nn	3	SENT_357	[p14l1974t1471r2149b1512],
3	Res	NNP	O	Res	_	0	SENT_357	[p14l139t1536r222b1577],
4	2006	CD	DATE	2006	num	3	SENT_357	[p14l241t1536r684b1584],
5	;	:	O	;	_	0	SENT_357	[p14l241t1536r684b1584],
6	12:839	CD	NUMBER	12:839	number	7	SENT_357	[p14l241t1536r684b1584],
7	—	CD	NUMBER	—	dep	3	SENT_357	[p14l241t1536r684b1584],
8	44	CD	NUMBER	44	dep	7	SENT_357	[p14l241t1536r684b1584],
9	.	.	O	.	_	0	SENT_357	[p14l241t1536r684b1584],

1	[	NN	O	[	_	0	SENT_358	[p14l7t1600r104b1654],
2	23	CD	NUMBER	23	num	1	SENT_358	[p14l7t1600r104b1654],
3	]	CD	NUMBER	]	num	5	SENT_358	[p14l7t1600r104b1654],
4	Jackman	NNP	O	Jackman	nn	5	SENT_358	[p14l132t1600r355b1654],
5	DM	NN	O	dm	dep	1	SENT_358	[p14l373t1603r474b1650],
6	,	,	O	,	_	0	SENT_358	[p14l373t1603r474b1650],
7	Yeap	NNP	PERSON	Yeap	nn	8	SENT_358	[p14l490t1603r612b1654],
8	BY	NNP	O	BY	appos	5	SENT_358	[p14l630t1603r702b1650],
9	,	,	O	,	_	0	SENT_358	[p14l630t1603r702b1650],
10	Sequist	NNP	ORGANIZATION	Sequist	nn	11	SENT_358	[p14l720t1601r906b1654],
11	LV	NNP	ORGANIZATION	LV	appos	5	SENT_358	[p14l922t1603r993b1650],
12	,	,	O	,	_	0	SENT_358	[p14l922t1603r993b1650],
13	Lindeman	NNP	PERSON	Lindeman	nn	14	SENT_358	[p14l1011t1600r1266b1644],
14	N	NNP	O	N	appos	5	SENT_358	[p14l1283t1603r1333b1650],
15	,	,	O	,	_	0	SENT_358	[p14l1283t1603r1333b1650],
16	Holmes	NNP	PERSON	Holmes	nn	17	SENT_358	[p14l1351t1600r1545b1644],
17	AJ	NNP	PERSON	AJ	appos	5	SENT_358	[p14l1560t1602r1626b1654],
18	,	,	O	,	_	0	SENT_358	[p14l1560t1602r1626b1654],
19	Joshi	NNP	ORGANIZATION	Joshi	nn	20	SENT_358	[p14l1638t1600r1766b1654],
20	VA	NNP	ORGANIZATION	VA	appos	5	SENT_358	[p14l1781t1602r1868b1650],
21	,	,	O	,	_	0	SENT_358	[p14l1781t1602r1868b1650],
22	et	FW	O	et	nn	23	SENT_358	[p14l1887t1606r1934b1644],
23	al.	FW	O	al.	appos	5	SENT_358	[p14l1950t1600r2005b1644],
24	.	.	O	.	_	0	SENT_358	[p14l1950t1600r2005b1644],

1	Exon	NN	O	exon	nsubjpass	11	SENT_359	[p14l2023t1603r2147b1644],
2	19	CD	NUMBER	19	num	4	SENT_359	[p14l141t1668r195b1709],
3	deletion	NN	O	deletion	nn	4	SENT_359	[p14l213t1666r423b1709],
4	mutations	NNS	O	mutation	dep	1	SENT_359	[p14l440t1666r701b1709],
5	of	IN	O	of	_	0	SENT_359	[p14l718t1666r772b1709],
6	epidermal	JJ	O	epidermal	amod	9	SENT_359	[p14l782t1666r1043b1720],
7	growth	NN	O	growth	nn	9	SENT_359	[p14l1059t1666r1244b1720],
8	factor	NN	O	factor	nn	9	SENT_359	[p14l1261t1665r1409b1709],
9	receptor	NN	O	receptor	prep_of	1	SENT_359	[p14l1424t1672r1639b1720],
10	are	VBP	O	be	auxpass	11	SENT_359	[p14l1654t1678r1731b1709],
11	associated	VBN	O	associate	_	0	SENT_359	[p14l1748t1666r2013b1709],
12	with	IN	O	with	_	0	SENT_359	[p14l2029t1666r2147b1709],
13	prolonged	JJ	O	prolonged	amod	14	SENT_359	[p14l139t1732r399b1786],
14	survival	NN	O	survival	prep_with	11	SENT_359	[p14l416t1732r615b1776],
15	in	IN	O	in	_	0	SENT_359	[p14l631t1733r679b1775],
16	non-small	JJ	O	non-small	amod	20	SENT_359	[p14l694t1732r954b1776],
17	cell	NN	O	cell	nn	20	SENT_359	[p14l970t1732r1056b1776],
18	lung	NN	O	lung	nn	20	SENT_359	[p14l1072t1732r1185b1786],
19	cancer	NN	O	cancer	nn	20	SENT_359	[p14l1199t1745r1367b1776],
20	patients	NNS	O	patient	prep_in	11	SENT_359	[p14l1381t1733r1587b1786],
21	treated	VBN	O	treat	partmod	20	SENT_359	[p14l1603t1732r1786b1776],
22	with	IN	O	with	_	0	SENT_359	[p14l1801t1732r1919b1776],
23	geﬁtinib	NN	O	geﬁtinib	prep_with	21	SENT_359	[p14l1933t1732r2147b1786],
24	or	CC	O	or	_	0	SENT_359	[p14l139t1810r191b1841],
25	erlotinib	NN	O	erlotinib	prep_with	21	SENT_359	[p14l208t1797r439b1841],
26	.	.	O	.	_	0	SENT_359	[p14l208t1797r439b1841],

1	Clin	NNP	O	Clin	nn	3	SENT_360	[p14l458t1797r556b1841],
2	Cancer	NNP	O	Cancer	nn	3	SENT_360	[p14l574t1800r749b1841],
3	Res	NNP	O	Res	_	0	SENT_360	[p14l766t1800r850b1841],
4	2006	CD	DATE	2006	num	3	SENT_360	[p14l868t1800r1338b1848],
5	;	:	O	;	_	0	SENT_360	[p14l868t1800r1338b1848],
6	12:3908	CD	NUMBER	12:3908	number	7	SENT_360	[p14l868t1800r1338b1848],
7	—	CD	NUMBER	—	dep	3	SENT_360	[p14l868t1800r1338b1848],
8	14	CD	NUMBER	14	dep	7	SENT_360	[p14l868t1800r1338b1848],
9	.	.	O	.	_	0	SENT_360	[p14l868t1800r1338b1848],

1	[	NN	O	[	nn	5	SENT_361	[p14l7t1864r104b1918],
2	24	CD	NUMBER	24	num	5	SENT_361	[p14l7t1864r104b1918],
3	]	CD	NUMBER	]	num	5	SENT_361	[p14l7t1864r104b1918],
4	Tamura	NNP	PERSON	Tamura	nn	5	SENT_361	[p14l136t1867r331b1907],
5	K	NNP	PERSON	K	_	0	SENT_361	[p14l357t1866r401b1914],
6	,	,	O	,	_	0	SENT_361	[p14l357t1866r401b1914],
7	Okamoto	NNP	PERSON	Okamoto	nn	8	SENT_361	[p14l428t1864r661b1907],
8	I	NNP	O	I	appos	5	SENT_361	[p14l688t1867r714b1914],
9	,	,	O	,	_	0	SENT_361	[p14l688t1867r714b1914],
10	Kashii	NNP	LOCATION	Kashii	nn	11	SENT_361	[p14l741t1864r895b1907],
11	T	NN	LOCATION	t	appos	8	SENT_361	[p14l920t1867r959b1914],
12	,	,	O	,	_	0	SENT_361	[p14l920t1867r959b1914],
13	Negoro	NNP	LOCATION	Negoro	nn	14	SENT_361	[p14l985t1867r1168b1918],
14	S	NNP	LOCATION	S	appos	8	SENT_361	[p14l1195t1866r1233b1914],
15	,	,	O	,	_	0	SENT_361	[p14l1195t1866r1233b1914],
16	Hirashima	NNP	ORGANIZATION	Hirashima	nn	17	SENT_361	[p14l1260t1864r1525b1907],
17	T	NN	ORGANIZATION	t	appos	8	SENT_361	[p14l1548t1867r1587b1914],
18	,	,	O	,	_	0	SENT_361	[p14l1548t1867r1587b1914],
19	Kudoh	NNP	PERSON	Kudoh	nn	20	SENT_361	[p14l1614t1864r1780b1907],
20	S	NNP	PERSON	S	appos	8	SENT_361	[p14l1805t1866r1843b1914],
21	,	,	O	,	_	0	SENT_361	[p14l1805t1866r1843b1914],
22	et	FW	O	et	nn	23	SENT_361	[p14l1870t1870r1918b1907],
23	al.	FW	O	al.	appos	8	SENT_361	[p14l1942t1864r1997b1908],
24	.	.	O	.	_	0	SENT_361	[p14l1942t1864r1997b1908],

1	Multicentre	JJ	O	multicentre	amod	3	SENT_362	[p14l2024t1864r2147b1907, p14l138t1931r337b1974],
2	prospective	JJ	O	prospective	amod	3	SENT_362	[p14l368t1931r664b1985],
3	phase	NN	O	phase	_	0	SENT_362	[p14l696t1930r844b1985],
4	II	CD	NUMBER	ii	num	5	SENT_362	[p14l876t1933r906b1973],
5	trial	NN	O	trial	dep	3	SENT_362	[p14l937t1930r1040b1974],
6	of	IN	O	of	_	0	SENT_362	[p14l1072t1930r1125b1974],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_362	[p14l1149t1930r1362b1985],
8	for	IN	O	for	_	0	SENT_362	[p14l1394t1930r1465b1974],
9	advanced	JJ	O	advanced	amod	13	SENT_362	[p14l1495t1930r1738b1974],
10	non-small	JJ	O	non-small	amod	13	SENT_362	[p14l1769t1930r2029b1974],
11	cell	NN	O	cell	nn	13	SENT_362	[p14l2061t1930r2147b1974],
12	lung	NN	O	lung	nn	13	SENT_362	[p14l139t1996r252b2050],
13	cancer	NN	O	cancer	prep_for	7	SENT_362	[p14l273t2008r441b2039],
14	with	IN	O	with	_	0	SENT_362	[p14l461t1996r579b2039],
15	epidermal	JJ	O	epidermal	amod	19	SENT_362	[p14l602t1996r863b2050],
16	growth	NN	O	growth	nn	19	SENT_362	[p14l885t1996r1070b2050],
17	factor	NN	O	factor	nn	19	SENT_362	[p14l1093t1995r1241b2039],
18	receptor	NN	O	receptor	nn	19	SENT_362	[p14l1262t2002r1478b2050],
19	mutations	NNS	O	mutation	prep_with	5	SENT_362	[p14l1499t1996r1777b2040],
20	:	:	O	:	_	0	SENT_362	[p14l1499t1996r1777b2040],
21	results	NNS	O	result	dep	3	SENT_362	[p14l1804t1996r1973b2039],
22	of	IN	O	of	_	0	SENT_362	[p14l1996t1996r2050b2039],
23	the	DT	O	the	det	28	SENT_362	[p14l2066t1996r2147b2039],
24	West	NNP	LOCATION	West	nn	28	SENT_362	[p14l136t2065r268b2106],
25	Japan	NNP	LOCATION	Japan	nn	28	SENT_362	[p14l277t2065r425b2116],
26	Thoracic	NNP	O	Thoracic	nn	28	SENT_362	[p14l440t2062r659b2106],
27	Oncology	NNP	O	Oncology	nn	28	SENT_362	[p14l676t2062r918b2116],
28	Group	NNP	O	Group	prep_of	21	SENT_362	[p14l934t2064r1092b2116],
29	trial	NN	O	trial	nn	32	SENT_362	[p14l1109t2062r1213b2106],
30	(	CD	NUMBER	(	num	32	SENT_362	[p14l1231t2062r1601b2116],
31	WJTOGO403	NN	O	wjtogo403	nn	32	SENT_362	[p14l1231t2062r1601b2116],
32	)	NN	O	)	dep	21	SENT_362	[p14l1231t2062r1601b2116],
33	.	.	O	.	_	0	SENT_362	[p14l1231t2062r1601b2116],

1	BrJ	NN	O	brj	nn	2	SENT_363	[p14l1620t2065r1704b2116],
2	Cancer	NN	O	cancer	_	0	SENT_363	[p14l1722t2064r1897b2106],
3	2008	CD	DATE	2008	dep	2	SENT_363	[p14l1912t2064r2143b2112],
4	;	:	O	;	_	0	SENT_363	[p14l1912t2064r2143b2112],
5	98	CD	NUMBER	98	num	7	SENT_363	[p14l1912t2064r2143b2112],
6	:	:	O	:	_	0	SENT_363	[p14l1912t2064r2143b2112],
7	907-14	CD	NUMBER	907-14	dep	2	SENT_363	[p14l138t2131r338b2172],
8	.	.	O	.	_	0	SENT_363	[p14l138t2131r338b2172],

1	[	NN	O	[	_	0	SENT_364	[p14l7t2195r104b2249],
2	25	CD	NUMBER	25	num	1	SENT_364	[p14l7t2195r104b2249],
3	]	CD	NUMBER	]	num	5	SENT_364	[p14l7t2195r104b2249],
4	Kobayashi	NNP	LOCATION	Kobayashi	nn	5	SENT_364	[p14l139t2195r398b2249],
5	S	NN	LOCATION	s	dep	1	SENT_364	[p14l413t2197r451b2245],
6	,	,	O	,	_	0	SENT_364	[p14l413t2197r451b2245],
7	Boggon	NNP	ORGANIZATION	Boggon	nn	8	SENT_364	[p14l466t2198r656b2249],
8	TJ	NNP	ORGANIZATION	TJ	appos	5	SENT_364	[p14l668t2198r729b2249],
9	,	,	O	,	_	0	SENT_364	[p14l668t2198r729b2249],
10	Dayaram	NNP	ORGANIZATION	Dayaram	nn	11	SENT_364	[p14l744t2198r972b2249],
11	T	NN	ORGANIZATION	t	appos	5	SENT_364	[p14l984t2198r1180b2249],
12	,	,	O	,	_	0	SENT_364	[p14l984t2198r1180b2249],
13	Janne	NNP	ORGANIZATION	Janne	nn	14	SENT_364	[p14l984t2198r1180b2249],
14	PA	NN	ORGANIZATION	pa	appos	5	SENT_364	[p14l1195t2197r1270b2245],
15	,	,	O	,	_	0	SENT_364	[p14l1195t2197r1270b2245],
16	Kocher	NNP	PERSON	Kocher	nn	17	SENT_364	[p14l1285t2195r1464b2238],
17	O	NNP	O	O	appos	5	SENT_364	[p14l1477t2197r1526b2245],
18	,	,	O	,	_	0	SENT_364	[p14l1477t2197r1526b2245],
19	Meyerson	NNP	PERSON	Meyerson	nn	20	SENT_364	[p14l1541t2198r1794b2249],
20	M	NNP	O	M	appos	5	SENT_364	[p14l1808t2198r1869b2245],
21	,	,	O	,	_	0	SENT_364	[p14l1808t2198r1869b2245],
22	et	FW	O	et	nn	23	SENT_364	[p14l1885t2201r1932b2238],
23	al.	FW	O	al.	appos	5	SENT_364	[p14l1945t2195r2000b2239],
24	.	.	O	.	_	0	SENT_364	[p14l1945t2195r2000b2239],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_365	[p14l2016t2197r2149b2238],
2	mutation	NN	O	mutation	_	0	SENT_365	[p14l139t2262r376b2305],
3	and	CC	O	and	_	0	SENT_365	[p14l390t2261r483b2305],
4	resistance	NN	O	resistance	conj_and	2	SENT_365	[p14l498t2262r754b2305],
5	of	IN	O	of	_	0	SENT_365	[p14l769t2261r822b2305],
6	non-small-cell	JJ	O	non-small-cell	amod	8	SENT_365	[p14l831t2261r1204b2305],
7	lung	NN	O	lung	nn	8	SENT_365	[p14l1219t2261r1332b2316],
8	cancer	NN	O	cancer	prep_of	2	SENT_365	[p14l1345t2274r1514b2305],
9	to	TO	O	to	_	0	SENT_365	[p14l1526t2268r1575b2305],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	2	SENT_365	[p14l1588t2261r1815b2316],
11	.	.	O	.	_	0	SENT_365	[p14l1588t2261r1815b2316],

1	N	NN	O	n	nn	2	SENT_366	[p14l1830t2264r1868b2304],
2	EnglJ	NN	O	englj	nsubj	3	SENT_366	[p14l1883t2261r2020b2316],
3	Med	VBD	O	med	_	0	SENT_366	[p14l2035t2261r2147b2305],
4	2005	CD	DATE	2005	dobj	3	SENT_366	[p14l138t2329r613b2377],
5	;	:	O	;	_	0	SENT_366	[p14l138t2329r613b2377],
6	352:786	CD	NUMBER	352:786	number	7	SENT_366	[p14l138t2329r613b2377],
7	—	CD	NUMBER	—	dep	4	SENT_366	[p14l138t2329r613b2377],
8	92	CD	NUMBER	92	dep	7	SENT_366	[p14l138t2329r613b2377],
9	.	.	O	.	_	0	SENT_366	[p14l138t2329r613b2377],

1	[	NN	O	[	nn	5	SENT_367	[p14l7t2393r104b2447],
2	26	CD	NUMBER	26	num	5	SENT_367	[p14l7t2393r104b2447],
3	]	CD	NUMBER	]	num	5	SENT_367	[p14l7t2393r104b2447],
4	Pao	NNP	O	Pao	nn	5	SENT_367	[p14l139t2396r227b2437],
5	W	NNP	O	W	_	0	SENT_367	[p14l246t2396r313b2443],
6	,	,	O	,	_	0	SENT_367	[p14l246t2396r313b2443],
7	Miller	NNP	ORGANIZATION	Miller	nn	8	SENT_367	[p14l335t2393r489b2437],
8	VA	NNP	ORGANIZATION	VA	appos	5	SENT_367	[p14l506t2395r593b2443],
9	,	,	O	,	_	0	SENT_367	[p14l506t2395r593b2443],
10	Politi	NNP	PERSON	Politi	nn	11	SENT_367	[p14l616t2393r746b2437],
11	KA	NN	O	ka	appos	8	SENT_367	[p14l768t2395r852b2443],
12	,	,	O	,	_	0	SENT_367	[p14l768t2395r852b2443],
13	Riely	NNP	PERSON	Riely	nn	14	SENT_367	[p14l874t2393r1000b2447],
14	GJ	NNP	O	GJ	appos	8	SENT_367	[p14l1020t2395r1086b2447],
15	,	,	O	,	_	0	SENT_367	[p14l1020t2395r1086b2447],
16	Somwar	NNP	ORGANIZATION	Somwar	nn	17	SENT_367	[p14l1108t2395r1318b2437],
17	R	NNP	ORGANIZATION	R	appos	8	SENT_367	[p14l1338t2396r1381b2443],
18	,	,	O	,	_	0	SENT_367	[p14l1338t2396r1381b2443],
19	Zakowski	NNP	O	Zakowski	nn	20	SENT_367	[p14l1402t2393r1643b2437],
20	MF	NN	O	mf	appos	8	SENT_367	[p14l1665t2396r1752b2443],
21	,	,	O	,	_	0	SENT_367	[p14l1665t2396r1752b2443],
22	et	FW	O	et	nn	23	SENT_367	[p14l1774t2399r1822b2437],
23	al.	FW	O	al.	appos	8	SENT_367	[p14l1842t2393r1896b2437],
24	.	.	O	.	_	0	SENT_367	[p14l1842t2393r1896b2437],

1	Acquired	VBN	O	acquire	csubjpass	11	SENT_368	[p14l1916t2393r2147b2447],
2	resistance	NN	O	resistance	dobj	1	SENT_368	[p14l139t2459r395b2502],
3	of	IN	O	of	_	0	SENT_368	[p14l414t2458r467b2502],
4	lung	NN	O	lung	nn	5	SENT_368	[p14l480t2459r593b2513],
5	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	2	SENT_368	[p14l611t2459r1061b2502],
6	to	TO	O	to	_	0	SENT_368	[p14l1080t2465r1129b2502],
7	geﬁtinib	NN	O	geﬁtinib	prep_to	1	SENT_368	[p14l1148t2458r1361b2513],
8	or	CC	O	or	_	0	SENT_368	[p14l1380t2471r1434b2502],
9	erlotinib	NN	O	erlotinib	prep_to	1	SENT_368	[p14l1451t2459r1669b2502],
10	is	VBZ	O	be	auxpass	11	SENT_368	[p14l1689t2459r1726b2502],
11	associated	VBN	O	associate	_	0	SENT_368	[p14l1745t2459r2011b2502],
12	with	IN	O	with	_	0	SENT_368	[p14l2029t2459r2148b2502],
13	a	DT	DURATION	a	det	15	SENT_368	[p14l138t2538r164b2569],
14	second	JJ	DURATION	second	amod	15	SENT_368	[p14l183t2525r359b2569],
15	mutation	NN	O	mutation	prep_with	11	SENT_368	[p14l378t2526r616b2569],
16	in	IN	O	in	_	0	SENT_368	[p14l634t2526r681b2568],
17	the	DT	O	the	det	20	SENT_368	[p14l698t2525r780b2569],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_368	[p14l798t2527r932b2569],
19	kinase	NN	O	kinase	nn	20	SENT_368	[p14l948t2525r1110b2569],
20	domain	NN	O	domain	prep_in	15	SENT_368	[p14l1128t2525r1336b2569],
21	.	.	O	.	_	0	SENT_368	[p14l1128t2525r1336b2569],

1	PLoS	NNP	O	PLoS	nn	2	SENT_369	[p14l1355t2527r1472b2569],
2	Med	NNP	O	Med	_	0	SENT_369	[p14l1491t2525r1603b2569],
3	2005	CD	DATE	2005	num	5	SENT_369	[p14l1622t2527r1929b2575],
4	;	:	O	;	_	0	SENT_369	[p14l1622t2527r1929b2575],
5	2	CD	NUMBER	2	dep	2	SENT_369	[p14l1622t2527r1929b2575],
6	:	:	O	:	_	0	SENT_369	[p14l1622t2527r1929b2575],
7	e73	NN	O	e73	dep	2	SENT_369	[p14l1622t2527r1929b2575],
8	.	.	O	.	_	0	SENT_369	[p14l1622t2527r1929b2575],

1	[	NN	O	[	nn	5	SENT_370	[p14l9t2590r103b2645],
2	27	CD	NUMBER	27	num	5	SENT_370	[p14l9t2590r103b2645],
3	]	CD	NUMBER	]	num	5	SENT_370	[p14l9t2590r103b2645],
4	Engelman	NNP	O	Engelman	nn	5	SENT_370	[p14l139t2590r394b2645],
5	JA	NNP	O	JA	_	0	SENT_370	[p14l406t2592r477b2645],
6	,	,	O	,	_	0	SENT_370	[p14l406t2592r477b2645],
7	Zejnullahu	NNP	PERSON	Zejnullahu	nn	8	SENT_370	[p14l496t2590r772b2645],
8	K	NNP	PERSON	K	appos	5	SENT_370	[p14l791t2593r836b2641],
9	,	,	O	,	_	0	SENT_370	[p14l791t2593r836b2641],
10	Mitsudomi	NNP	ORGANIZATION	Mitsudomi	nn	11	SENT_370	[p14l856t2591r1136b2634],
11	T	NN	ORGANIZATION	t	appos	8	SENT_370	[p14l1154t2593r1192b2641],
12	,	,	O	,	_	0	SENT_370	[p14l1154t2593r1192b2641],
13	Song	NN	O	song	nn	14	SENT_370	[p14l1213t2593r1337b2645],
14	Y	NN	O	y	appos	8	SENT_370	[p14l1352t2593r1394b2641],
15	,	,	O	,	_	0	SENT_370	[p14l1352t2593r1394b2641],
16	Hyland	NN	PERSON	hyland	nn	17	SENT_370	[p14l1414t2590r1596b2645],
17	C	NN	O	c	appos	8	SENT_370	[p14l1616t2593r1658b2641],
18	,	,	O	,	_	0	SENT_370	[p14l1616t2593r1658b2641],
19	Park	NNP	O	Park	nn	20	SENT_370	[p14l1679t2590r1790b2634],
20	JO	NNP	O	JO	appos	8	SENT_370	[p14l1801t2593r1875b2645],
21	,	,	O	,	_	0	SENT_370	[p14l1801t2593r1875b2645],
22	et	FW	O	et	nn	23	SENT_370	[p14l1894t2597r1942b2634],
23	al.	FW	O	al.	appos	8	SENT_370	[p14l1960t2590r2015b2634],
24	.	.	O	.	_	0	SENT_370	[p14l1960t2590r2015b2634],

1	MET	NN	O	met	nn	2	SENT_371	[p14l2035t2593r2149b2634],
2	ampliﬁcation	NN	O	ampliﬁcation	nsubj	3	SENT_371	[p14l138t2657r480b2711],
3	leads	VBZ	O	lead	_	0	SENT_371	[p14l502t2657r631b2700],
4	to	TO	O	to	_	0	SENT_371	[p14l654t2663r702b2700],
5	geﬁtinib	JJ	O	geﬁtinib	amod	6	SENT_371	[p14l723t2657r937b2711],
6	resistance	NN	O	resistance	prep_to	3	SENT_371	[p14l960t2658r1216b2700],
7	in	IN	O	in	_	0	SENT_371	[p14l1238t2658r1285b2700],
8	lung	NN	O	lung	nn	9	SENT_371	[p14l1307t2657r1420b2711],
9	cancer	NN	O	cancer	prep_in	6	SENT_371	[p14l1441t2669r1609b2700],
10	by	IN	O	by	_	0	SENT_371	[p14l1629t2657r1690b2711],
11	activating	VBG	O	activate	prepc_by	3	SENT_371	[p14l1710t2658r1963b2711],
12	ERBB3	NN	O	erbb3	nn	13	SENT_371	[p14l1983t2659r2145b2700],
13	signaling	NN	O	signaling	dobj	11	SENT_371	[p14l139t2723r382b2778],
14	.	.	O	.	_	0	SENT_371	[p14l139t2723r382b2778],

1	Science	NNP	O	Science	_	0	SENT_372	[p14l401t2724r591b2767],
2	2007	CD	DATE	2007	num	1	SENT_372	[p14l610t2725r1107b2774],
3	;	:	O	;	_	0	SENT_372	[p14l610t2725r1107b2774],
4	316:1039	CD	NUMBER	316:1039	number	5	SENT_372	[p14l610t2725r1107b2774],
5	—	CD	NUMBER	—	dep	1	SENT_372	[p14l610t2725r1107b2774],
6	43	CD	NUMBER	43	dep	5	SENT_372	[p14l610t2725r1107b2774],
7	.	.	O	.	_	0	SENT_372	[p14l610t2725r1107b2774],

1	[	NN	O	[	_	0	SENT_373	[p14l7t2788r104b2843],
2	28	CD	NUMBER	28	num	1	SENT_373	[p14l7t2788r104b2843],
3	]	CD	NUMBER	]	num	5	SENT_373	[p14l7t2788r104b2843],
4	Balak	NNP	O	Balak	nn	5	SENT_373	[p14l139t2789r277b2832],
5	MN	NN	O	mn	dep	1	SENT_373	[p14l295t2791r398b2839],
6	,	,	O	,	_	0	SENT_373	[p14l295t2791r398b2839],
7	Gong	NNP	PERSON	Gong	nn	8	SENT_373	[p14l418t2791r552b2843],
8	Y	NN	PERSON	y	appos	5	SENT_373	[p14l568t2791r609b2839],
9	,	,	O	,	_	0	SENT_373	[p14l568t2791r609b2839],
10	Riely	NNP	PERSON	Riely	nn	11	SENT_373	[p14l629t2789r756b2843],
11	GJ	NNP	O	GJ	appos	5	SENT_373	[p14l773t2791r839b2843],
12	,	,	O	,	_	0	SENT_373	[p14l773t2791r839b2843],
13	Somwar	NNP	O	Somwar	nn	14	SENT_373	[p14l859t2791r1069b2832],
14	R	NNP	O	R	appos	5	SENT_373	[p14l1087t2791r1130b2839],
15	,	,	O	,	_	0	SENT_373	[p14l1087t2791r1130b2839],
16	Li	NNP	PERSON	Li	nn	17	SENT_373	[p14l1150t2789r1190b2832],
17	AR	NNS	PERSON	ar	appos	5	SENT_373	[p14l1208t2791r1291b2839],
18	,	,	O	,	_	0	SENT_373	[p14l1208t2791r1291b2839],
19	Zakowski	NNP	O	Zakowski	nn	20	SENT_373	[p14l1310t2789r1551b2832],
20	MF	NN	O	mf	appos	5	SENT_373	[p14l1571t2791r1658b2839],
21	,	,	O	,	_	0	SENT_373	[p14l1571t2791r1658b2839],
22	et	FW	O	et	nn	23	SENT_373	[p14l1678t2795r1725b2832],
23	al.	FW	O	al.	appos	5	SENT_373	[p14l1743t2789r1798b2833],
24	.	.	O	.	_	0	SENT_373	[p14l1743t2789r1798b2833],

1	Novel	JJ	O	novel	amod	2	SENT_374	[p14l1818t2789r1962b2832],
2	D761Y	NN	O	d761y	_	0	SENT_374	[p14l1982t2791r2150b2832],
3	and	CC	O	and	_	0	SENT_374	[p14l138t2855r231b2899],
4	common	JJ	O	common	amod	7	SENT_374	[p14l244t2868r471b2899],
5	secondary	JJ	O	secondary	amod	7	SENT_374	[p14l484t2855r747b2909],
6	T79OM	NN	O	t79om	nn	7	SENT_374	[p14l755t2857r936b2899],
7	mutations	NNS	O	mutation	conj_and	2	SENT_374	[p14l949t2856r1211b2899],
8	in	IN	O	in	_	0	SENT_374	[p14l1224t2856r1271b2898],
9	epidermal	JJ	O	epidermal	amod	14	SENT_374	[p14l1284t2855r1545b2909],
10	growth	NN	O	growth	nn	14	SENT_374	[p14l1557t2855r1743b2909],
11	factor	NN	O	factor	nn	14	SENT_374	[p14l1755t2855r1903b2899],
12	receptormutant	JJ	O	receptormutant	amod	14	SENT_374	[p14l1914t2861r2147b2909, p14l139t2927r328b2964],
13	lung	NN	O	lung	nn	14	SENT_374	[p14l351t2920r463b2975],
14	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	2	SENT_374	[p14l486t2920r936b2964],
15	with	IN	O	with	_	0	SENT_374	[p14l959t2920r1078b2964],
16	acquired	VBN	O	acquire	amod	17	SENT_374	[p14l1101t2920r1322b2975],
17	resistance	NN	O	resistance	prep_with	14	SENT_374	[p14l1346t2921r1603b2964],
18	to	TO	O	to	_	0	SENT_374	[p14l1626t2927r1674b2964],
19	kinase	NN	O	kinase	nn	20	SENT_374	[p14l1698t2920r1861b2964],
20	inhibitors	NNS	O	inhibitor	prep_to	17	SENT_374	[p14l1885t2920r2146b2964],
21	.	.	O	.	_	0	SENT_374	[p14l1885t2920r2146b2964],

1	Clin	NNP	O	Clin	nn	3	SENT_375	[p14l139t2987r237b3030],
2	Cancer	NNP	O	Cancer	nn	3	SENT_375	[p14l255t2989r430b3030],
3	Res	NNP	O	Res	_	0	SENT_375	[p14l447t2990r530b3030],
4	2006	CD	DATE	2006	num	3	SENT_375	[p14l549t2989r1051b3037],
5	;	:	O	;	_	0	SENT_375	[p14l549t2989r1051b3037],
6	12:6494	CD	NUMBER	12:6494	num	7	SENT_375	[p14l549t2989r1051b3037],
7	—	NN	O	—	dep	3	SENT_375	[p14l549t2989r1051b3037],
8	501	CD	NUMBER	501	dep	7	SENT_375	[p14l549t2989r1051b3037],
9	.	.	O	.	_	0	SENT_375	[p14l549t2989r1051b3037],

1	[	NN	O	[	_	0	SENT_376	[p14l7t3053r104b3108],
2	29	CD	NUMBER	29	num	1	SENT_376	[p14l7t3053r104b3108],
3	]	CD	NUMBER	]	num	5	SENT_376	[p14l7t3053r104b3108],
4	Kosaka	NNP	PERSON	Kosaka	nn	5	SENT_376	[p14l139t3053r317b3097],
5	T	NN	PERSON	t	dep	1	SENT_376	[p14l327t3056r366b3104],
6	,	,	O	,	_	0	SENT_376	[p14l327t3056r366b3104],
7	Yatabe	NNP	PERSON	Yatabe	nn	8	SENT_376	[p14l377t3053r548b3097],
8	Y	NN	PERSON	y	appos	5	SENT_376	[p14l559t3056r601b3103],
9	,	,	O	,	_	0	SENT_376	[p14l559t3056r601b3103],
10	Endoh	NN	PERSON	endoh	nn	11	SENT_376	[p14l614t3053r777b3097],
11	H	NN	PERSON	h	appos	5	SENT_376	[p14l789t3056r839b3103],
12	,	,	O	,	_	0	SENT_376	[p14l789t3056r839b3103],
13	Yoshida	NNP	PERSON	Yoshida	nn	14	SENT_376	[p14l850t3053r1051b3097],
14	K	NNP	PERSON	K	appos	5	SENT_376	[p14l1063t3056r1108b3104],
15	,	,	O	,	_	0	SENT_376	[p14l1063t3056r1108b3104],
16	Hida	NNP	PERSON	Hida	nn	17	SENT_376	[p14l1122t3053r1240b3097],
17	T	NN	O	t	appos	5	SENT_376	[p14l1250t3056r1289b3104],
18	,	,	O	,	_	0	SENT_376	[p14l1250t3056r1289b3104],
19	Tsuboi	NNP	PERSON	Tsuboi	nn	20	SENT_376	[p14l1299t3053r1468b3097],
20	M	NNP	O	M	appos	5	SENT_376	[p14l1481t3056r1542b3104],
21	,	,	O	,	_	0	SENT_376	[p14l1481t3056r1542b3104],
22	et	FW	O	et	nn	23	SENT_376	[p14l1555t3060r1603b3097],
23	al.	FW	O	al.	appos	5	SENT_376	[p14l1613t3053r1668b3097],
24	.	.	O	.	_	0	SENT_376	[p14l1613t3053r1668b3097],

1	Analysis	NN	O	analysis	nsubj	8	SENT_377	[p14l1679t3053r1891b3108],
2	of	IN	O	of	_	0	SENT_377	[p14l1905t3053r1958b3097],
3	epidermal	JJ	O	epidermal	amod	5	SENT_377	[p14l1964t3053r2147b3108, p14l139t3119r232b3162],
4	growth	NN	O	growth	nn	5	SENT_377	[p14l248t3119r434b3173],
5	factor	NN	O	factor	prep_of	1	SENT_377	[p14l451t3118r599b3162],
6	receptor	NN	O	receptor	nn	8	SENT_377	[p14l614t3125r829b3173],
7	gene	NN	O	gene	nn	8	SENT_377	[p14l842t3131r963b3173],
8	mutation	NN	O	mutation	_	0	SENT_377	[p14l980t3119r1217b3162],
9	in	IN	O	in	_	0	SENT_377	[p14l1234t3119r1281b3162],
10	patients	NNS	O	patient	prep_in	8	SENT_377	[p14l1297t3119r1504b3173],
11	with	IN	O	with	_	0	SENT_377	[p14l1520t3119r1639b3162],
12	non-small	JJ	O	non-small	amod	15	SENT_377	[p14l1655t3119r1915b3162],
13	cell	NN	O	cell	nn	15	SENT_377	[p14l1932t3119r2018b3162],
14	lung	NN	O	lung	nn	15	SENT_377	[p14l2036t3119r2148b3173],
15	cancer	NN	O	cancer	prep_with	8	SENT_377	[p14l139t3198r307b3229],
16	and	CC	O	and	_	0	SENT_377	[p14l323t3185r416b3229],
17	acquired	VBD	O	acquire	conj_and	8	SENT_377	[p14l434t3185r656b3240],
18	resistance	NN	O	resistance	dobj	17	SENT_377	[p14l674t3186r930b3229],
19	to	TO	O	to	_	0	SENT_377	[p14l948t3192r997b3229],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	17	SENT_377	[p14l1015t3185r1241b3240],
21	.	.	O	.	_	0	SENT_377	[p14l1015t3185r1241b3240],

1	Clin	NNP	O	Clin	nn	3	SENT_378	[p14l1260t3185r1358b3229],
2	Cancer	NNP	O	Cancer	nn	3	SENT_378	[p14l1376t3187r1551b3229],
3	Res	NNP	O	Res	_	0	SENT_378	[p14l1568t3188r1652b3229],
4	2006	CD	DATE	2006	num	3	SENT_378	[p14l1671t3187r2108b3235],
5	;	:	O	;	_	0	SENT_378	[p14l1671t3187r2108b3235],
6	12:5764	CD	NUMBER	12:5764	number	7	SENT_378	[p14l1671t3187r2108b3235],
7	—	CD	NUMBER	—	dep	3	SENT_378	[p14l1671t3187r2108b3235],
8	9	CD	NUMBER	9	dep	7	SENT_378	[p14l1671t3187r2108b3235],
9	.	.	O	.	_	0	SENT_378	[p14l1671t3187r2108b3235],

1	[	RB	O	[	advmod	2	SENT_379	[p14l7t3250r104b3305],
2	30	CD	NUMBER	30	_	0	SENT_379	[p14l7t3250r104b3305],
3	]	CD	NUMBER	]	num	5	SENT_379	[p14l7t3250r104b3305],
4	Uramoto	NN	O	uramoto	nn	5	SENT_379	[p14l138t3253r361b3294],
5	H	NN	O	h	dep	2	SENT_379	[p14l378t3253r429b3301],
6	,	,	O	,	_	0	SENT_379	[p14l378t3253r429b3301],
7	Uchiumi	NNP	ORGANIZATION	Uchiumi	nn	8	SENT_379	[p14l446t3251r663b3294],
8	T	NN	ORGANIZATION	t	appos	5	SENT_379	[p14l678t3253r717b3301],
9	,	,	O	,	_	0	SENT_379	[p14l678t3253r717b3301],
10	lzumi	NN	O	lzumus	nn	11	SENT_379	[p14l735t3251r879b3294],
11	H	NN	O	h	appos	5	SENT_379	[p14l897t3253r948b3301],
12	,	,	O	,	_	0	SENT_379	[p14l897t3253r948b3301],
13	Kohno	NNP	PERSON	Kohno	nn	14	SENT_379	[p14l965t3251r1128b3294],
14	K	NNP	PERSON	K	appos	5	SENT_379	[p14l1146t3253r1190b3301],
15	,	,	O	,	_	0	SENT_379	[p14l1146t3253r1190b3301],
16	Oyama	NNP	ORGANIZATION	Oyama	nn	17	SENT_379	[p14l1208t3253r1386b3305],
17	T	NN	ORGANIZATION	t	appos	5	SENT_379	[p14l1400t3253r1439b3301],
18	,	,	O	,	_	0	SENT_379	[p14l1400t3253r1439b3301],
19	Sugio	NNP	ORGANIZATION	Sugio	nn	20	SENT_379	[p14l1456t3251r1595b3305],
20	K	NNP	ORGANIZATION	K	appos	5	SENT_379	[p14l1613t3253r1658b3301],
21	,	,	O	,	_	0	SENT_379	[p14l1613t3253r1658b3301],
22	et	FW	O	et	nn	23	SENT_379	[p14l1675t3257r1722b3294],
23	al.	FW	O	al.	appos	5	SENT_379	[p14l1738t3251r1793b3295],
24	.	.	O	.	_	0	SENT_379	[p14l1738t3251r1793b3295],

1	A	DT	O	a	det	3	SENT_380	[p14l1808t3253r1846b3294],
2	new	JJ	O	new	amod	3	SENT_380	[p14l1860t3263r1970b3294],
3	mechanism	NN	O	mechanism	_	0	SENT_380	[p14l1985t3251r2147b3294, p14l138t3318r293b3361],
4	for	IN	O	for	_	0	SENT_380	[p14l310t3317r382b3361],
5	primary	JJ	O	primary	amod	6	SENT_380	[p14l397t3318r605b3371],
6	resistance	NN	O	resistance	prep_for	3	SENT_380	[p14l620t3318r876b3361],
7	to	TO	O	to	_	0	SENT_380	[p14l893t3323r942b3361],
8	geﬁtinib	NN	O	geﬁtinib	prep_to	6	SENT_380	[p14l958t3317r1172b3371],
9	in	IN	O	in	_	0	SENT_380	[p14l1190t3318r1237b3360],
10	lung	NN	O	lung	nn	11	SENT_380	[p14l1254t3317r1367b3371],
11	adenocarcinoma	NN	O	adenocarcinoma	prep_in	8	SENT_380	[p14l1382t3317r1824b3361],
12	:	:	O	:	_	0	SENT_380	[p14l1382t3317r1824b3361],
13	the	DT	O	the	det	14	SENT_380	[p14l1845t3317r1926b3361],
14	role	NN	O	role	dep	3	SENT_380	[p14l1944t3317r2041b3361],
15	of	IN	O	of	_	0	SENT_380	[p14l2058t3317r2111b3361],
16	a	DT	O	a	det	19	SENT_380	[p14l2121t3330r2147b3361],
17	novel	JJ	O	novel	amod	19	SENT_380	[p14l139t3382r276b3426],
18	G796A	NN	O	g796a	nn	19	SENT_380	[p14l294t3384r468b3426],
19	mutation	NN	O	mutation	prep_of	14	SENT_380	[p14l484t3383r721b3426],
20	in	IN	O	in	_	0	SENT_380	[p14l739t3383r786b3426],
21	exon	NN	O	exon	prep_in	19	SENT_380	[p14l804t3395r925b3426],
22	20	CD	NUMBER	20	num	21	SENT_380	[p14l942t3385r1004b3426],
23	of	IN	O	of	_	0	SENT_380	[p14l1022t3382r1075b3426],
24	EGFR	NN	ORGANIZATION	egfr	prep_of	21	SENT_380	[p14l1087t3385r1231b3426],
25	.	.	O	.	_	0	SENT_380	[p14l1087t3385r1231b3426],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_381	[p14l1247t3383r1527b3426],
2	Res	NNP	O	Res	_	0	SENT_381	[p14l1544t3385r1627b3426],
3	2007	CD	DATE	2007	dep	2	SENT_381	[p14l1646t3385r2146b3433],
4	;	:	O	;	_	0	SENT_381	[p14l1646t3385r2146b3433],
5	27:2297	CD	NUMBER	27:2297	num	6	SENT_381	[p14l1646t3385r2146b3433],
6	-303	CD	NUMBER	-303	dep	2	SENT_381	[p14l1646t3385r2146b3433],
7	.	.	O	.	_	0	SENT_381	[p14l1646t3385r2146b3433],

1	[	NN	O	[	nn	5	SENT_382	[p14l9t3449r104b3503],
2	31	CD	NUMBER	31	num	5	SENT_382	[p14l9t3449r104b3503],
3	]	CD	NUMBER	]	num	5	SENT_382	[p14l9t3449r104b3503],
4	Costa	NNP	O	Costa	nn	5	SENT_382	[p14l139t3451r276b3492],
5	DB	NNP	O	DB	nsubj	28	SENT_382	[p14l312t3452r395b3499],
6	,	,	O	,	_	0	SENT_382	[p14l312t3452r395b3499],
7	Schumer	NNP	PERSON	Schumer	appos	5	SENT_382	[p14l432t3449r659b3492],
8	ST	JJ	O	st	amod	11	SENT_382	[p14l694t3451r759b3499],
9	,	,	O	,	_	0	SENT_382	[p14l694t3451r759b3499],
10	Tenen	NNP	PERSON	Tenen	dep	11	SENT_382	[p14l794t3452r949b3492],
11	DG	NNS	O	dg	dep	7	SENT_382	[p14l985t3451r1073b3499],
12	,	,	O	,	_	0	SENT_382	[p14l985t3451r1073b3499],
13	Kobayashi	NNP	LOCATION	Kobayashi	nn	14	SENT_382	[p14l1110t3449r1369b3503],
14	S.	NNP	O	S.	nsubj	28	SENT_382	[p14l1406t3451r1444b3493],
15	Differential	JJ	O	differential	amod	16	SENT_382	[p14l1481t3449r1772b3492],
16	responses	NNS	O	response	nsubj	18	SENT_382	[p14l1809t3461r2062b3503],
17	to	TO	O	to	aux	18	SENT_382	[p14l2098t3455r2146b3492],
18	erlotinib	VB	O	erlotinib	infmod	14	SENT_382	[p14l139t3515r357b3559],
19	in	IN	O	in	_	0	SENT_382	[p14l384t3516r432b3558],
20	epidermal	JJ	O	epidermal	amod	25	SENT_382	[p14l458t3515r719b3570],
21	growth	NN	O	growth	nn	25	SENT_382	[p14l746t3515r931b3570],
22	factor	NN	O	factor	nn	25	SENT_382	[p14l958t3515r1106b3559],
23	receptor	NN	O	receptor	nn	25	SENT_382	[p14l1131t3522r1347b3570],
24	(	CD	NUMBER	(	num	25	SENT_382	[p14l1372t3515r1789b3569],
25	EGFR	NN	ORGANIZATION	egfr	prep_in	18	SENT_382	[p14l1372t3515r1789b3569],
26	)	SYM	O	)	dep	28	SENT_382	[p14l1372t3515r1789b3569],
27	-	:	O	-	_	0	SENT_382	[p14l1372t3515r1789b3569],
28	mutated	VBN	O	mutate	_	0	SENT_382	[p14l1372t3515r1789b3569],
29	lung	NN	O	lung	nn	30	SENT_382	[p14l1817t3515r1930b3570],
30	cancers	NNS	O	cancer	dobj	28	SENT_382	[p14l1955t3528r2146b3559],
31	with	IN	O	with	_	0	SENT_382	[p14l137t3581r256b3624],
32	acquired	VBN	O	acquire	amod	33	SENT_382	[p14l277t3581r499b3635],
33	resistance	NN	O	resistance	prep_with	28	SENT_382	[p14l522t3581r778b3624],
34	to	TO	O	to	_	0	SENT_382	[p14l799t3587r848b3624],
35	geﬁtinib	NN	O	geﬁtinib	prep_to	33	SENT_382	[p14l870t3580r1084b3635],
36	carrying	VBG	O	carry	partmod	35	SENT_382	[p14l1106t3581r1319b3635],
37	the	DT	O	the	det	38	SENT_382	[p14l1339t3581r1421b3624],
38	L747S	NN	O	l747	dobj	36	SENT_382	[p14l1444t3583r1588b3624],
39	or	CC	O	or	_	0	SENT_382	[p14l1611t3593r1664b3624],
40	T79OM	NN	O	t79om	nn	42	SENT_382	[p14l1682t3583r1862b3624],
41	secondary	JJ	O	secondary	amod	42	SENT_382	[p14l1886t3581r2149b3635],
42	mutations	NNS	O	mutation	dobj	36	SENT_382	[p14l139t3648r446b3701],
43	.	.	O	.	_	0	SENT_382	[p14l139t3648r446b3701],

1	J	NNP	O	J	nn	3	SENT_383	[p14l139t3648r446b3701],
2	Clin	NNP	O	Clin	nn	3	SENT_383	[p14l464t3647r563b3691],
3	Oncol	NNP	O	Oncol	_	0	SENT_383	[p14l580t3647r727b3691],
4	2008	CD	DATE	2008	num	3	SENT_383	[p14l745t3649r1178b3697],
5	;	:	O	;	_	0	SENT_383	[p14l745t3649r1178b3697],
6	26:1182	CD	NUMBER	26:1182	number	7	SENT_383	[p14l745t3649r1178b3697],
7	—	CD	NUMBER	—	dep	3	SENT_383	[p14l745t3649r1178b3697],
8	4	CD	NUMBER	4	dep	7	SENT_383	[p14l745t3649r1178b3697],
9	.	.	O	.	_	0	SENT_383	[p14l745t3649r1178b3697],

1	[	NN	O	[	nn	5	SENT_384	[p14l7t3712r103b3767],
2	32	CD	NUMBER	32	num	5	SENT_384	[p14l7t3712r103b3767],
3	]	CD	NUMBER	]	num	5	SENT_384	[p14l7t3712r103b3767],
4	Choong	NNP	ORGANIZATION	Choong	nn	5	SENT_384	[p14l139t3712r333b3767],
5	NW	NNP	ORGANIZATION	NW	_	0	SENT_384	[p14l348t3715r453b3763],
6	,	,	O	,	_	0	SENT_384	[p14l348t3715r453b3763],
7	Dietrich	NNP	PERSON	Dietrich	nn	8	SENT_384	[p14l469t3712r674b3756],
8	S	NNP	O	S	appos	5	SENT_384	[p14l690t3715r728b3763],
9	,	,	O	,	_	0	SENT_384	[p14l690t3715r728b3763],
10	Seiwert	NNP	PERSON	Seiwert	nn	11	SENT_384	[p14l744t3713r939b3756],
11	TY	NNP	O	TY	appos	8	SENT_384	[p14l951t3715r1026b3763],
12	,	,	O	,	_	0	SENT_384	[p14l951t3715r1026b3763],
13	Tretiakova	NNP	O	Tretiakova	nn	14	SENT_384	[p14l1040t3712r1309b3756],
14	MS	NN	O	m	appos	8	SENT_384	[p14l1325t3715r1415b3763],
15	,	,	O	,	_	0	SENT_384	[p14l1325t3715r1415b3763],
16	Nallasura	NNP	MISC	Nallasura	nn	17	SENT_384	[p14l1431t3712r1672b3756],
17	V	NNP	O	V	appos	8	SENT_384	[p14l1684t3715r1733b3763],
18	,	,	O	,	_	0	SENT_384	[p14l1684t3715r1733b3763],
19	Davies	NNP	PERSON	Davies	nn	20	SENT_384	[p14l1749t3713r1915b3756],
20	GC	NN	O	gc	appos	8	SENT_384	[p14l1932t3715r2014b3763],
21	,	,	O	,	_	0	SENT_384	[p14l1932t3715r2014b3763],
22	et	FW	O	et	nn	23	SENT_384	[p14l2030t3719r2077b3756],
23	al.	FW	O	al.	appos	8	SENT_384	[p14l2091t3712r2146b3756],
24	.	.	O	.	_	0	SENT_384	[p14l2091t3712r2146b3756],

1	Geﬁtinib	JJ	O	geﬁtinib	amod	2	SENT_385	[p14l139t3779r361b3822],
2	response	NN	O	response	_	0	SENT_385	[p14l376t3791r604b3833],
3	of	IN	O	of	_	0	SENT_385	[p14l619t3779r672b3822],
4	erlotinib	NN	O	erlotinib	nn	8	SENT_385	[p14l680t3779r1180b3833],
5	—	CD	NUMBER	—	num	8	SENT_385	[p14l680t3779r1180b3833],
6	refractory	JJ	O	refractory	amod	8	SENT_385	[p14l680t3779r1180b3833],
7	lung	NN	O	lung	nn	8	SENT_385	[p14l1193t3779r1306b3833],
8	cancer	NN	O	cancer	prep_of	2	SENT_385	[p14l1319t3791r1487b3822],
9	involving	VBG	O	involve	partmod	2	SENT_385	[p14l1500t3779r1738b3833],
10	meninges	NNS	O	meninx	nsubj	12	SENT_385	[p14l1751t3779r2147b3833],
11	—	CD	NUMBER	—	num	12	SENT_385	[p14l1751t3779r2147b3833],
12	role	NN	O	role	xcomp	9	SENT_385	[p14l1751t3779r2147b3833],
13	of	IN	O	of	_	0	SENT_385	[p15l139t18r191b62],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_385	[p15l203t20r338b62],
15	mutation	NN	O	mutation	prep_of	12	SENT_385	[p15l353t19r603b62],
16	.	.	O	.	_	0	SENT_385	[p15l353t19r603b62],

1	Nat	NNP	PERSON	Nat	nn	4	SENT_386	[p15l622t21r710b62],
2	Clin	NNP	O	Clin	nn	4	SENT_386	[p15l727t18r826b62],
3	Pract	NNP	O	Pract	nn	4	SENT_386	[p15l843t21r972b62],
4	Oncol	NNP	O	Oncol	_	0	SENT_386	[p15l989t18r1136b62],
5	2006	CD	DATE	2006	num	4	SENT_386	[p15l1154t20r1494b68],
6	;	:	O	;	_	0	SENT_386	[p15l1154t20r1494b68],
7	3:50	CD	TIME	3:50	num	8	SENT_386	[p15l1154t20r1494b68],
8	—	NN	O	—	dep	4	SENT_386	[p15l1154t20r1494b68],
9	7	CD	NUMBER	7	dep	8	SENT_386	[p15l1154t20r1494b68],
10	.	.	O	.	_	0	SENT_386	[p15l1154t20r1494b68],

1	[	NN	O	[	_	0	SENT_387	[p15l7t84r104b138],
2	33	CD	NUMBER	33	num	1	SENT_387	[p15l7t84r104b138],
3	]	CD	NUMBER	]	num	5	SENT_387	[p15l7t84r104b138],
4	Kosaka	NNP	PERSON	Kosaka	nn	5	SENT_387	[p15l139t84r317b127],
5	T	NN	PERSON	t	dep	1	SENT_387	[p15l334t87r373b134],
6	,	,	O	,	_	0	SENT_387	[p15l334t87r373b134],
7	Yatabe	NNP	PERSON	Yatabe	nn	8	SENT_387	[p15l392t84r563b127],
8	Y	NN	PERSON	y	conj_and	5	SENT_387	[p15l581t87r623b134],
9	,	,	O	,	_	0	SENT_387	[p15l581t87r623b134],
10	Endoh	NN	PERSON	endoh	nn	11	SENT_387	[p15l643t84r806b127],
11	H	NN	PERSON	h	conj_and	5	SENT_387	[p15l825t87r876b134],
12	,	,	O	,	_	0	SENT_387	[p15l825t87r876b134],
13	Kuwano	NNP	PERSON	Kuwano	nn	14	SENT_387	[p15l896t87r1104b127],
14	H	NNP	O	H	conj_and	5	SENT_387	[p15l1124t87r1175b134],
15	,	,	O	,	_	0	SENT_387	[p15l1124t87r1175b134],
16	Takahashi	NNP	PERSON	Takahashi	nn	17	SENT_387	[p15l1193t84r1449b127],
17	T	NN	O	t	dep	1	SENT_387	[p15l1467t87r1506b134],
18	,	,	O	,	_	0	SENT_387	[p15l1467t87r1506b134],
19	Mitsudomi	NNP	O	Mitsudomi	nn	21	SENT_387	[p15l1527t84r1807b127],
20	T.	NNP	O	T.	nn	21	SENT_387	[p15l1825t87r1864b128],
21	Mutations	NNS	O	mutation	dep	1	SENT_387	[p15l1885t85r2147b127],
22	of	IN	O	of	_	0	SENT_387	[p15l139t150r191b194],
23	the	DT	O	the	det	28	SENT_387	[p15l209t150r291b194],
24	epidermal	JJ	O	epidermal	amod	28	SENT_387	[p15l315t150r577b205],
25	growth	NN	O	growth	nn	28	SENT_387	[p15l601t150r786b205],
26	factor	NN	O	factor	nn	28	SENT_387	[p15l810t150r958b194],
27	receptor	NN	O	receptor	nn	28	SENT_387	[p15l981t157r1196b205],
28	gene	NN	O	gene	prep_of	21	SENT_387	[p15l1218t163r1338b205],
29	in	IN	O	in	_	0	SENT_387	[p15l1364t151r1411b193],
30	lung	NN	O	lung	nn	31	SENT_387	[p15l1435t150r1548b205],
31	cancer	NN	O	cancer	prep_in	28	SENT_387	[p15l1571t163r1753b194],
32	:	:	O	:	_	0	SENT_387	[p15l1571t163r1753b194],
33	biological	JJ	O	biological	dep	1	SENT_387	[p15l1781t150r2029b205],
34	and	CC	O	and	_	0	SENT_387	[p15l2054t150r2147b194],
35	clinical	JJ	O	clinical	amod	36	SENT_387	[p15l139t216r319b259],
36	implications	NNS	O	implication	dep	1	SENT_387	[p15l338t216r669b270],
37	.	.	O	.	_	0	SENT_387	[p15l338t216r669b270],

1	Cancer	NNP	O	Cancer	nn	2	SENT_388	[p15l688t218r864b259],
2	Res	NNP	O	Res	_	0	SENT_388	[p15l880t218r964b259],
3	2004	CD	DATE	2004	num	2	SENT_388	[p15l983t218r1454b266],
4	;	:	O	;	_	0	SENT_388	[p15l983t218r1454b266],
5	64:8919	CD	NUMBER	64:8919	number	6	SENT_388	[p15l983t218r1454b266],
6	—	CD	NUMBER	—	dep	2	SENT_388	[p15l983t218r1454b266],
7	23	CD	NUMBER	23	dep	6	SENT_388	[p15l983t218r1454b266],
8	.	.	O	.	_	0	SENT_388	[p15l983t218r1454b266],

1	[	NN	O	[	nn	5	SENT_389	[p15l7t282r104b336],
2	34	CD	NUMBER	34	num	5	SENT_389	[p15l7t282r104b336],
3	]	CD	NUMBER	]	num	5	SENT_389	[p15l7t282r104b336],
4	Pao	NNP	O	Pao	nn	5	SENT_389	[p15l139t285r227b326],
5	W	NNP	O	W	_	0	SENT_389	[p15l245t285r312b332],
6	,	,	O	,	_	0	SENT_389	[p15l245t285r312b332],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_389	[p15l331t285r481b336],
8	TY	NNP	PERSON	TY	appos	5	SENT_389	[p15l498t285r573b332],
9	,	,	O	,	_	0	SENT_389	[p15l498t285r573b332],
10	Riely	NNP	PERSON	Riely	nn	12	SENT_389	[p15l594t282r721b336],
11	G	NNP	O	G	nn	12	SENT_389	[p15l740t284r806b336],
12	]	NNS	O	]	appos	8	SENT_389	[p15l740t284r806b336],
13	,	,	O	,	_	0	SENT_389	[p15l740t284r806b336],
14	Miller	NNP	ORGANIZATION	Miller	nn	15	SENT_389	[p15l827t282r981b326],
15	VA	NNP	ORGANIZATION	VA	appos	8	SENT_389	[p15l997t284r1084b332],
16	,	,	O	,	_	0	SENT_389	[p15l997t284r1084b332],
17	Pan	NNP	O	Pan	nn	18	SENT_389	[p15l1106t285r1197b326],
18	Q	NNP	O	Q	appos	8	SENT_389	[p15l1217t284r1266b334],
19	,	,	O	,	_	0	SENT_389	[p15l1217t284r1266b334],
20	Ladanyi	NNP	PERSON	Ladanyi	nn	21	SENT_389	[p15l1287t282r1484b336],
21	M	NNP	PERSON	M	appos	8	SENT_389	[p15l1504t285r1566b332],
22	,	,	O	,	_	0	SENT_389	[p15l1504t285r1566b332],
23	et	FW	O	et	nn	24	SENT_389	[p15l1587t288r1634b326],
24	al.	FW	O	al.	appos	8	SENT_389	[p15l1653t282r1708b326],
25	.	.	O	.	_	0	SENT_389	[p15l1653t282r1708b326],

1	KRAS	NNP	ORGANIZATION	KRAS	_	0	SENT_390	[p15l1730t284r1864b326],
2	mutations	NNS	O	mutation	dep	1	SENT_390	[p15l1885t283r2146b326],
3	and	CC	O	and	_	0	SENT_390	[p15l138t347r231b391],
4	primary	JJ	O	primary	amod	5	SENT_390	[p15l250t348r457b402],
5	resistance	NN	O	resistance	dep	1	SENT_390	[p15l474t348r730b391],
6	of	IN	O	of	_	0	SENT_390	[p15l749t347r802b391],
7	lung	NN	O	lung	nn	8	SENT_390	[p15l814t347r927b402],
8	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	1	SENT_390	[p15l943t347r1394b391],
9	to	TO	O	to	_	0	SENT_390	[p15l1412t354r1460b391],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	8	SENT_390	[p15l1478t347r1692b402],
11	or	CC	O	or	_	0	SENT_390	[p15l1710t360r1763b391],
12	erlotinib	NN	O	erlotinib	conj_or	10	SENT_390	[p15l1779t347r2010b391],
13	.	.	O	.	_	0	SENT_390	[p15l1779t347r2010b391],

1	PLoS	NNP	O	PLoS	nn	2	SENT_391	[p15l2029t350r2147b391],
2	Med	NNP	O	Med	_	0	SENT_391	[p15l139t414r251b457],
3	2005	CD	DATE	2005	num	5	SENT_391	[p15l269t416r568b463],
4	;	:	O	;	_	0	SENT_391	[p15l269t416r568b463],
5	2	CD	NUMBER	2	dep	2	SENT_391	[p15l269t416r568b463],
6	:	:	O	:	_	0	SENT_391	[p15l269t416r568b463],
7	e17	NN	O	e17	dep	2	SENT_391	[p15l269t416r568b463],
8	.	.	O	.	_	0	SENT_391	[p15l269t416r568b463],

